date generated: 2020-12-06
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## -1266.6248017
## 5_8S_rRNA -15.7561510
## A1BG -1.6154621
## A1CF 0.2527981
## A2M -0.8454804
## A3GALT2 0.2338000
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 2408 |
num_genes_in_profile | 17707 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 9310 |
num_profile_genes_not_in_sets | 8397 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used: GMT file of genesets: ReactomePathways.gmt
Gene sets metrics | |
---|---|
num_genesets | 2408 |
num_genesets_excluded | 962 |
num_genesets_included | 1446 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Top N= 50 gene sets
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
Mitochondrial translation elongation | 85 | 6.41e-21 | 0.5880 | 7.06e-18 |
Mitochondrial translation | 91 | 9.76e-21 | 0.5660 | 7.06e-18 |
Mitochondrial translation termination | 85 | 3.68e-20 | 0.5770 | 1.77e-17 |
Translation | 263 | 2.86e-19 | 0.3220 | 1.03e-16 |
Mitochondrial translation initiation | 85 | 7.75e-19 | 0.5560 | 2.24e-16 |
The citric acid (TCA) cycle and respiratory electron transport | 165 | 3.56e-13 | 0.3280 | 8.58e-11 |
Macroautophagy | 108 | 3.98e-12 | 0.3860 | 8.22e-10 |
Autophagy | 122 | 1.98e-11 | 0.3520 | 3.57e-09 |
Protein localization | 156 | 4.45e-11 | 0.3060 | 7.14e-09 |
Metabolism of proteins | 1810 | 1.06e-10 | 0.0924 | 1.53e-08 |
Defective CFTR causes cystic fibrosis | 58 | 2.33e-09 | 0.4530 | 3.06e-07 |
ABC transporter disorders | 74 | 3.62e-09 | 0.3970 | 4.36e-07 |
Metabolism | 1943 | 4.82e-09 | 0.0812 | 5.36e-07 |
Respiratory electron transport | 96 | 5.36e-09 | 0.3450 | 5.53e-07 |
Selective autophagy | 56 | 1.25e-08 | 0.4400 | 1.20e-06 |
ABC-family proteins mediated transport | 97 | 1.32e-08 | 0.3340 | 1.20e-06 |
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD | 53 | 2.63e-08 | 0.4420 | 2.24e-06 |
Hh mutants abrogate ligand secretion | 56 | 3.10e-08 | 0.4280 | 2.49e-06 |
Interleukin-1 signaling | 94 | 4.17e-08 | 0.3270 | 3.18e-06 |
tRNA Aminoacylation | 42 | 5.94e-08 | 0.4830 | 4.24e-06 |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 117 | 6.16e-08 | 0.2900 | 4.24e-06 |
AUF1 (hnRNP D0) binds and destabilizes mRNA | 51 | 8.72e-08 | 0.4330 | 5.49e-06 |
Regulation of ornithine decarboxylase (ODC) | 49 | 8.74e-08 | 0.4420 | 5.49e-06 |
NIK-->noncanonical NF-kB signaling | 56 | 9.53e-08 | 0.4120 | 5.74e-06 |
Degradation of GLI2 by the proteasome | 55 | 1.10e-07 | 0.4140 | 6.39e-06 |
Regulation of Apoptosis | 50 | 1.34e-07 | 0.4310 | 7.20e-06 |
Pyruvate metabolism and Citric Acid (TCA) cycle | 52 | 1.34e-07 | 0.4230 | 7.20e-06 |
Metabolism of polyamines | 57 | 1.49e-07 | 0.4020 | 7.71e-06 |
Cross-presentation of soluble exogenous antigens (endosomes) | 48 | 1.56e-07 | 0.4380 | 7.80e-06 |
Mitochondrial Fatty Acid Beta-Oxidation | 36 | 1.69e-07 | 0.5040 | 8.09e-06 |
Vif-mediated degradation of APOBEC3G | 50 | 1.80e-07 | 0.4270 | 8.09e-06 |
Degradation of GLI1 by the proteasome | 56 | 1.80e-07 | 0.4030 | 8.09e-06 |
Vpu mediated degradation of CD4 | 49 | 1.85e-07 | 0.4310 | 8.09e-06 |
Mitochondrial protein import | 62 | 1.99e-07 | 0.3820 | 8.45e-06 |
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 52 | 2.46e-07 | 0.4140 | 1.02e-05 |
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 63 | 2.79e-07 | 0.3740 | 1.12e-05 |
Regulation of activated PAK-2p34 by proteasome mediated degradation | 47 | 2.88e-07 | 0.4330 | 1.13e-05 |
Deubiquitination | 231 | 2.98e-07 | 0.1960 | 1.13e-05 |
Interleukin-1 family signaling | 127 | 3.64e-07 | 0.2610 | 1.35e-05 |
GLI3 is processed to GLI3R by the proteasome | 56 | 3.98e-07 | 0.3920 | 1.44e-05 |
SCF-beta-TrCP mediated degradation of Emi1 | 52 | 4.35e-07 | 0.4050 | 1.53e-05 |
Cell surface interactions at the vascular wall | 155 | 4.47e-07 | -0.2350 | 1.54e-05 |
Hedgehog ligand biogenesis | 61 | 5.34e-07 | 0.3710 | 1.80e-05 |
Degradation of DVL | 54 | 5.86e-07 | 0.3930 | 1.90e-05 |
Regulation of RUNX2 expression and activity | 69 | 6.03e-07 | 0.3470 | 1.90e-05 |
Dectin-1 mediated noncanonical NF-kB signaling | 59 | 6.05e-07 | 0.3760 | 1.90e-05 |
Cellular response to hypoxia | 72 | 6.20e-07 | 0.3400 | 1.91e-05 |
Autodegradation of the E3 ubiquitin ligase COP1 | 47 | 6.40e-07 | 0.4200 | 1.93e-05 |
FCGR3A-mediated phagocytosis | 87 | 7.68e-07 | -0.3070 | 2.18e-05 |
Leishmania phagocytosis | 87 | 7.68e-07 | -0.3070 | 2.18e-05 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
Mitochondrial translation elongation | 85 | 6.41e-21 | 0.588000 | 7.06e-18 |
Mitochondrial translation | 91 | 9.76e-21 | 0.566000 | 7.06e-18 |
Mitochondrial translation termination | 85 | 3.68e-20 | 0.577000 | 1.77e-17 |
Translation | 263 | 2.86e-19 | 0.322000 | 1.03e-16 |
Mitochondrial translation initiation | 85 | 7.75e-19 | 0.556000 | 2.24e-16 |
The citric acid (TCA) cycle and respiratory electron transport | 165 | 3.56e-13 | 0.328000 | 8.58e-11 |
Macroautophagy | 108 | 3.98e-12 | 0.386000 | 8.22e-10 |
Autophagy | 122 | 1.98e-11 | 0.352000 | 3.57e-09 |
Protein localization | 156 | 4.45e-11 | 0.306000 | 7.14e-09 |
Metabolism of proteins | 1810 | 1.06e-10 | 0.092400 | 1.53e-08 |
Defective CFTR causes cystic fibrosis | 58 | 2.33e-09 | 0.453000 | 3.06e-07 |
ABC transporter disorders | 74 | 3.62e-09 | 0.397000 | 4.36e-07 |
Metabolism | 1943 | 4.82e-09 | 0.081200 | 5.36e-07 |
Respiratory electron transport | 96 | 5.36e-09 | 0.345000 | 5.53e-07 |
Selective autophagy | 56 | 1.25e-08 | 0.440000 | 1.20e-06 |
ABC-family proteins mediated transport | 97 | 1.32e-08 | 0.334000 | 1.20e-06 |
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD | 53 | 2.63e-08 | 0.442000 | 2.24e-06 |
Hh mutants abrogate ligand secretion | 56 | 3.10e-08 | 0.428000 | 2.49e-06 |
Interleukin-1 signaling | 94 | 4.17e-08 | 0.327000 | 3.18e-06 |
tRNA Aminoacylation | 42 | 5.94e-08 | 0.483000 | 4.24e-06 |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 117 | 6.16e-08 | 0.290000 | 4.24e-06 |
AUF1 (hnRNP D0) binds and destabilizes mRNA | 51 | 8.72e-08 | 0.433000 | 5.49e-06 |
Regulation of ornithine decarboxylase (ODC) | 49 | 8.74e-08 | 0.442000 | 5.49e-06 |
NIK-->noncanonical NF-kB signaling | 56 | 9.53e-08 | 0.412000 | 5.74e-06 |
Degradation of GLI2 by the proteasome | 55 | 1.10e-07 | 0.414000 | 6.39e-06 |
Regulation of Apoptosis | 50 | 1.34e-07 | 0.431000 | 7.20e-06 |
Pyruvate metabolism and Citric Acid (TCA) cycle | 52 | 1.34e-07 | 0.423000 | 7.20e-06 |
Metabolism of polyamines | 57 | 1.49e-07 | 0.402000 | 7.71e-06 |
Cross-presentation of soluble exogenous antigens (endosomes) | 48 | 1.56e-07 | 0.438000 | 7.80e-06 |
Mitochondrial Fatty Acid Beta-Oxidation | 36 | 1.69e-07 | 0.504000 | 8.09e-06 |
Vif-mediated degradation of APOBEC3G | 50 | 1.80e-07 | 0.427000 | 8.09e-06 |
Degradation of GLI1 by the proteasome | 56 | 1.80e-07 | 0.403000 | 8.09e-06 |
Vpu mediated degradation of CD4 | 49 | 1.85e-07 | 0.431000 | 8.09e-06 |
Mitochondrial protein import | 62 | 1.99e-07 | 0.382000 | 8.45e-06 |
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 52 | 2.46e-07 | 0.414000 | 1.02e-05 |
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 63 | 2.79e-07 | 0.374000 | 1.12e-05 |
Regulation of activated PAK-2p34 by proteasome mediated degradation | 47 | 2.88e-07 | 0.433000 | 1.13e-05 |
Deubiquitination | 231 | 2.98e-07 | 0.196000 | 1.13e-05 |
Interleukin-1 family signaling | 127 | 3.64e-07 | 0.261000 | 1.35e-05 |
GLI3 is processed to GLI3R by the proteasome | 56 | 3.98e-07 | 0.392000 | 1.44e-05 |
SCF-beta-TrCP mediated degradation of Emi1 | 52 | 4.35e-07 | 0.405000 | 1.53e-05 |
Cell surface interactions at the vascular wall | 155 | 4.47e-07 | -0.235000 | 1.54e-05 |
Hedgehog ligand biogenesis | 61 | 5.34e-07 | 0.371000 | 1.80e-05 |
Degradation of DVL | 54 | 5.86e-07 | 0.393000 | 1.90e-05 |
Regulation of RUNX2 expression and activity | 69 | 6.03e-07 | 0.347000 | 1.90e-05 |
Dectin-1 mediated noncanonical NF-kB signaling | 59 | 6.05e-07 | 0.376000 | 1.90e-05 |
Cellular response to hypoxia | 72 | 6.20e-07 | 0.340000 | 1.91e-05 |
Autodegradation of the E3 ubiquitin ligase COP1 | 47 | 6.40e-07 | 0.420000 | 1.93e-05 |
FCGR3A-mediated phagocytosis | 87 | 7.68e-07 | -0.307000 | 2.18e-05 |
Leishmania phagocytosis | 87 | 7.68e-07 | -0.307000 | 2.18e-05 |
Parasite infection | 87 | 7.68e-07 | -0.307000 | 2.18e-05 |
Degradation of AXIN | 51 | 8.36e-07 | 0.399000 | 2.33e-05 |
HSP90 chaperone cycle for steroid hormone receptors (SHR) | 35 | 8.53e-07 | 0.481000 | 2.33e-05 |
Neddylation | 225 | 1.07e-06 | 0.189000 | 2.86e-05 |
Extracellular matrix organization | 271 | 1.10e-06 | -0.172000 | 2.88e-05 |
Regulation of actin dynamics for phagocytic cup formation | 88 | 1.23e-06 | -0.299000 | 3.16e-05 |
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 48 | 1.75e-06 | 0.399000 | 4.28e-05 |
p53-Independent DNA Damage Response | 48 | 1.75e-06 | 0.399000 | 4.28e-05 |
p53-Independent G1/S DNA damage checkpoint | 48 | 1.75e-06 | 0.399000 | 4.28e-05 |
Ubiquitin-dependent degradation of Cyclin D | 49 | 1.84e-06 | 0.394000 | 4.43e-05 |
Negative regulation of NOTCH4 signaling | 52 | 2.08e-06 | 0.380000 | 4.94e-05 |
Degradation of beta-catenin by the destruction complex | 81 | 2.76e-06 | 0.301000 | 6.43e-05 |
Stabilization of p53 | 51 | 2.87e-06 | 0.379000 | 6.59e-05 |
Fcgamma receptor (FCGR) dependent phagocytosis | 113 | 3.31e-06 | -0.253000 | 7.48e-05 |
UCH proteinases | 84 | 3.43e-06 | 0.293000 | 7.64e-05 |
Downstream TCR signaling | 86 | 3.63e-06 | 0.289000 | 7.96e-05 |
Regulation of PTEN stability and activity | 66 | 3.87e-06 | 0.329000 | 8.35e-05 |
Complex I biogenesis | 53 | 6.84e-06 | 0.357000 | 1.45e-04 |
Ub-specific processing proteases | 159 | 6.98e-06 | 0.207000 | 1.46e-04 |
Activation of NF-kappaB in B cells | 62 | 9.21e-06 | 0.326000 | 1.88e-04 |
Asymmetric localization of PCP proteins | 61 | 9.23e-06 | 0.328000 | 1.88e-04 |
Regulation of RUNX3 expression and activity | 52 | 9.96e-06 | 0.354000 | 2.00e-04 |
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 131 | 1.26e-05 | -0.221000 | 2.49e-04 |
HSF1-dependent transactivation | 30 | 1.62e-05 | 0.455000 | 3.15e-04 |
MTOR signalling | 38 | 1.63e-05 | 0.404000 | 3.15e-04 |
Signaling by GPCR | 813 | 2.19e-05 | -0.088000 | 4.16e-04 |
Membrane Trafficking | 578 | 2.24e-05 | 0.104000 | 4.20e-04 |
PCP/CE pathway | 89 | 2.84e-05 | 0.257000 | 5.26e-04 |
DNA Damage/Telomere Stress Induced Senescence | 41 | 2.99e-05 | -0.377000 | 5.48e-04 |
GPCR downstream signalling | 746 | 3.32e-05 | -0.089600 | 5.94e-04 |
Citric acid cycle (TCA cycle) | 22 | 3.33e-05 | 0.511000 | 5.94e-04 |
Cellular responses to stress | 474 | 3.74e-05 | 0.111000 | 6.60e-04 |
Mitochondrial biogenesis | 87 | 4.08e-05 | 0.255000 | 7.11e-04 |
Signaling by Rho GTPases | 373 | 4.31e-05 | -0.124000 | 7.41e-04 |
Mitochondrial tRNA aminoacylation | 21 | 5.05e-05 | 0.511000 | 8.59e-04 |
Late endosomal microautophagy | 30 | 5.29e-05 | 0.426000 | 8.90e-04 |
Branched-chain amino acid catabolism | 21 | 7.19e-05 | 0.500000 | 1.20e-03 |
Chromosome Maintenance | 98 | 7.53e-05 | -0.231000 | 1.24e-03 |
Gluconeogenesis | 32 | 8.30e-05 | 0.402000 | 1.34e-03 |
Signaling by NOTCH4 | 78 | 8.42e-05 | 0.258000 | 1.34e-03 |
Autodegradation of Cdh1 by Cdh1:APC/C | 61 | 8.45e-05 | 0.291000 | 1.34e-03 |
FCERI mediated Ca+2 mobilization | 58 | 8.51e-05 | -0.298000 | 1.34e-03 |
Antigen processing-Cross presentation | 92 | 8.68e-05 | 0.237000 | 1.35e-03 |
MyD88-independent TLR4 cascade | 87 | 9.05e-05 | 0.243000 | 1.38e-03 |
TRIF(TICAM1)-mediated TLR4 signaling | 87 | 9.05e-05 | 0.243000 | 1.38e-03 |
TCR signaling | 107 | 9.13e-05 | 0.219000 | 1.38e-03 |
CLEC7A (Dectin-1) signaling | 94 | 9.72e-05 | 0.233000 | 1.44e-03 |
Cellular responses to external stimuli | 481 | 9.79e-05 | 0.104000 | 1.44e-03 |
HIV Infection | 219 | 1.09e-04 | 0.152000 | 1.58e-03 |
Cytosolic tRNA aminoacylation | 24 | 1.10e-04 | 0.456000 | 1.58e-03 |
Activation of ATR in response to replication stress | 36 | 1.13e-04 | -0.372000 | 1.62e-03 |
COPI-mediated anterograde transport | 78 | 1.29e-04 | 0.251000 | 1.83e-03 |
CDT1 association with the CDC6:ORC:origin complex | 56 | 1.30e-04 | 0.296000 | 1.83e-03 |
PINK1-PRKN Mediated Mitophagy | 19 | 1.35e-04 | 0.506000 | 1.88e-03 |
Antigen processing: Ubiquitination & Proteasome degradation | 290 | 1.69e-04 | 0.129000 | 2.33e-03 |
Deposition of new CENPA-containing nucleosomes at the centromere | 35 | 1.73e-04 | -0.367000 | 2.33e-03 |
Nucleosome assembly | 35 | 1.73e-04 | -0.367000 | 2.33e-03 |
Toll Like Receptor 9 (TLR9) Cascade | 84 | 1.74e-04 | 0.237000 | 2.33e-03 |
The role of GTSE1 in G2/M progression after G2 checkpoint | 54 | 1.82e-04 | 0.294000 | 2.41e-03 |
Toll Like Receptor 3 (TLR3) Cascade | 85 | 1.86e-04 | 0.235000 | 2.45e-03 |
Fatty acid metabolism | 165 | 1.92e-04 | 0.168000 | 2.50e-03 |
Cholesterol biosynthesis | 22 | 2.05e-04 | -0.457000 | 2.63e-03 |
APC/C:Cdc20 mediated degradation of Securin | 64 | 2.05e-04 | 0.268000 | 2.63e-03 |
Processing of DNA double-strand break ends | 66 | 2.16e-04 | -0.263000 | 2.74e-03 |
Xenobiotics | 22 | 2.22e-04 | -0.455000 | 2.79e-03 |
Glucose metabolism | 88 | 2.40e-04 | 0.227000 | 2.99e-03 |
DNA Damage Recognition in GG-NER | 37 | 2.93e-04 | 0.344000 | 3.59e-03 |
Class I MHC mediated antigen processing & presentation | 345 | 2.93e-04 | 0.114000 | 3.59e-03 |
mitochondrial fatty acid beta-oxidation of saturated fatty acids | 10 | 2.95e-04 | 0.661000 | 3.59e-03 |
Glycogen metabolism | 25 | 3.02e-04 | 0.417000 | 3.61e-03 |
Downstream signaling events of B Cell Receptor (BCR) | 75 | 3.02e-04 | 0.241000 | 3.61e-03 |
Hemostasis | 583 | 3.27e-04 | -0.087300 | 3.88e-03 |
Mitophagy | 26 | 3.37e-04 | 0.406000 | 3.96e-03 |
ER-Phagosome pathway | 79 | 3.45e-04 | 0.233000 | 4.02e-03 |
Transcriptional regulation by RUNX2 | 115 | 3.67e-04 | 0.192000 | 4.25e-03 |
ER to Golgi Anterograde Transport | 127 | 4.16e-04 | 0.181000 | 4.78e-03 |
Leishmania infection | 255 | 4.24e-04 | -0.128000 | 4.83e-03 |
Peroxisomal protein import | 60 | 4.31e-04 | 0.263000 | 4.87e-03 |
Metabolism of cofactors | 18 | 4.55e-04 | 0.477000 | 5.10e-03 |
MyD88 dependent cascade initiated on endosome | 80 | 4.61e-04 | 0.227000 | 5.13e-03 |
Disorders of transmembrane transporters | 169 | 5.04e-04 | 0.155000 | 5.56e-03 |
Metabolism of amino acids and derivatives | 335 | 5.21e-04 | 0.110000 | 5.71e-03 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 79 | 5.66e-04 | 0.224000 | 6.11e-03 |
RUNX1 regulates transcription of genes involved in differentiation of HSCs | 77 | 5.67e-04 | 0.227000 | 6.11e-03 |
FCGR activation | 42 | 5.76e-04 | -0.307000 | 6.17e-03 |
MyD88 cascade initiated on plasma membrane | 76 | 6.35e-04 | 0.227000 | 6.66e-03 |
Toll Like Receptor 10 (TLR10) Cascade | 76 | 6.35e-04 | 0.227000 | 6.66e-03 |
Toll Like Receptor 5 (TLR5) Cascade | 76 | 6.35e-04 | 0.227000 | 6.66e-03 |
Formation of TC-NER Pre-Incision Complex | 50 | 7.05e-04 | 0.277000 | 7.33e-03 |
Scavenging of heme from plasma | 41 | 7.10e-04 | -0.306000 | 7.34e-03 |
Toll Like Receptor 7/8 (TLR7/8) Cascade | 81 | 7.18e-04 | 0.217000 | 7.35e-03 |
Regulation of Complement cascade | 71 | 7.21e-04 | -0.232000 | 7.35e-03 |
Hedgehog 'off' state | 95 | 7.60e-04 | 0.200000 | 7.69e-03 |
Aggrephagy | 20 | 7.83e-04 | 0.434000 | 7.86e-03 |
Assembly of collagen fibrils and other multimeric structures | 50 | 7.95e-04 | -0.274000 | 7.93e-03 |
Mitochondrial calcium ion transport | 22 | 8.08e-04 | 0.413000 | 8.00e-03 |
COPI-independent Golgi-to-ER retrograde traffic | 33 | 8.54e-04 | 0.335000 | 8.39e-03 |
Asparagine N-linked glycosylation | 268 | 8.59e-04 | 0.118000 | 8.39e-03 |
Host Interactions of HIV factors | 123 | 8.80e-04 | 0.174000 | 8.54e-03 |
Energy dependent regulation of mTOR by LKB1-AMPK | 28 | 9.67e-04 | 0.360000 | 9.31e-03 |
Cellular response to heat stress | 92 | 9.72e-04 | 0.199000 | 9.31e-03 |
IRE1alpha activates chaperones | 50 | 1.01e-03 | 0.269000 | 9.62e-03 |
p53-Dependent G1 DNA Damage Response | 60 | 1.02e-03 | 0.245000 | 9.62e-03 |
p53-Dependent G1/S DNA damage checkpoint | 60 | 1.02e-03 | 0.245000 | 9.62e-03 |
Role of phospholipids in phagocytosis | 55 | 1.05e-03 | -0.255000 | 9.80e-03 |
SCF(Skp2)-mediated degradation of p27/p21 | 58 | 1.12e-03 | 0.247000 | 1.04e-02 |
PTEN Regulation | 145 | 1.13e-03 | 0.157000 | 1.04e-02 |
Presynaptic phase of homologous DNA pairing and strand exchange | 38 | 1.13e-03 | -0.305000 | 1.04e-02 |
Peroxisomal lipid metabolism | 27 | 1.15e-03 | 0.361000 | 1.04e-02 |
Keratinization | 92 | 1.15e-03 | -0.196000 | 1.04e-02 |
Meiosis | 67 | 1.20e-03 | -0.229000 | 1.08e-02 |
Vesicle-mediated transport | 642 | 1.21e-03 | 0.075100 | 1.08e-02 |
XBP1(S) activates chaperone genes | 48 | 1.22e-03 | 0.270000 | 1.08e-02 |
mTORC1-mediated signalling | 22 | 1.22e-03 | 0.398000 | 1.08e-02 |
FCGR3A-mediated IL10 synthesis | 67 | 1.24e-03 | -0.228000 | 1.09e-02 |
EPHB-mediated forward signaling | 33 | 1.31e-03 | -0.323000 | 1.13e-02 |
Common Pathway of Fibrin Clot Formation | 18 | 1.31e-03 | -0.437000 | 1.13e-02 |
MAPK6/MAPK4 signaling | 84 | 1.32e-03 | 0.203000 | 1.13e-02 |
G1/S DNA Damage Checkpoints | 61 | 1.32e-03 | 0.238000 | 1.13e-02 |
Pyruvate metabolism | 28 | 1.37e-03 | 0.349000 | 1.17e-02 |
CDK-mediated phosphorylation and removal of Cdc6 | 69 | 1.46e-03 | 0.222000 | 1.24e-02 |
Degradation of the extracellular matrix | 101 | 1.52e-03 | -0.183000 | 1.27e-02 |
Regulation of expression of SLITs and ROBOs | 144 | 1.52e-03 | 0.153000 | 1.27e-02 |
G2/M DNA damage checkpoint | 64 | 1.53e-03 | -0.229000 | 1.28e-02 |
Reproduction | 88 | 1.54e-03 | -0.195000 | 1.28e-02 |
Collagen chain trimerization | 35 | 1.61e-03 | -0.308000 | 1.32e-02 |
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 59 | 1.61e-03 | -0.237000 | 1.32e-02 |
Rho GTPase cycle | 134 | 1.66e-03 | -0.157000 | 1.35e-02 |
Formation of Fibrin Clot (Clotting Cascade) | 35 | 1.68e-03 | -0.307000 | 1.36e-02 |
Cell Cycle | 607 | 1.70e-03 | -0.074800 | 1.37e-02 |
Transcriptional regulation by RUNX3 | 88 | 1.73e-03 | 0.193000 | 1.38e-02 |
Activation of the pre-replicative complex | 32 | 1.77e-03 | -0.319000 | 1.41e-02 |
TNFR2 non-canonical NF-kB pathway | 94 | 1.78e-03 | 0.187000 | 1.41e-02 |
Attenuation phase | 21 | 1.84e-03 | 0.393000 | 1.44e-02 |
TP53 Regulates Metabolic Genes | 84 | 1.88e-03 | 0.196000 | 1.47e-02 |
N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 33 | 1.95e-03 | 0.312000 | 1.51e-02 |
MAP kinase activation | 60 | 1.96e-03 | 0.231000 | 1.51e-02 |
Role of LAT2/NTAL/LAB on calcium mobilization | 43 | 1.96e-03 | -0.273000 | 1.51e-02 |
Resolution of Sister Chromatid Cohesion | 103 | 2.00e-03 | -0.176000 | 1.53e-02 |
Cytosolic sensors of pathogen-associated DNA | 55 | 2.06e-03 | 0.240000 | 1.57e-02 |
Metabolism of steroids | 134 | 2.10e-03 | -0.154000 | 1.59e-02 |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 70 | 2.13e-03 | 0.212000 | 1.60e-02 |
Cytochrome P450 - arranged by substrate type | 60 | 2.14e-03 | -0.229000 | 1.60e-02 |
ATF6 (ATF6-alpha) activates chaperone genes | 10 | 2.20e-03 | 0.559000 | 1.64e-02 |
Cristae formation | 27 | 2.29e-03 | 0.339000 | 1.70e-02 |
Hedgehog 'on' state | 82 | 2.40e-03 | 0.194000 | 1.77e-02 |
Regulation of RAS by GAPs | 65 | 2.41e-03 | 0.218000 | 1.77e-02 |
RHO GTPase Effectors | 249 | 2.47e-03 | -0.112000 | 1.80e-02 |
Activation of the phototransduction cascade | 11 | 2.49e-03 | -0.527000 | 1.80e-02 |
rRNA processing in the mitochondrion | 21 | 2.49e-03 | 0.381000 | 1.80e-02 |
Collagen formation | 80 | 2.57e-03 | -0.195000 | 1.85e-02 |
Mitotic Prometaphase | 182 | 2.70e-03 | -0.129000 | 1.94e-02 |
Fatty acids | 14 | 2.73e-03 | -0.463000 | 1.95e-02 |
Josephin domain DUBs | 10 | 2.78e-03 | 0.546000 | 1.97e-02 |
Glycogen synthesis | 14 | 2.83e-03 | 0.461000 | 2.00e-02 |
MHC class II antigen presentation | 94 | 2.90e-03 | 0.178000 | 2.03e-02 |
Meiotic recombination | 37 | 2.91e-03 | -0.283000 | 2.03e-02 |
G alpha (i) signalling events | 347 | 2.96e-03 | -0.093000 | 2.06e-02 |
Cyclin A:Cdk2-associated events at S phase entry | 83 | 3.01e-03 | 0.188000 | 2.08e-02 |
HSF1 activation | 24 | 3.08e-03 | 0.349000 | 2.11e-02 |
Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 74 | 3.09e-03 | 0.199000 | 2.11e-02 |
Complement cascade | 79 | 3.21e-03 | -0.192000 | 2.19e-02 |
Carnitine metabolism | 11 | 3.31e-03 | 0.511000 | 2.25e-02 |
Cyclin E associated events during G1/S transition | 81 | 3.47e-03 | 0.188000 | 2.35e-02 |
Collagen biosynthesis and modifying enzymes | 58 | 3.60e-03 | -0.221000 | 2.42e-02 |
Crosslinking of collagen fibrils | 10 | 3.62e-03 | -0.531000 | 2.42e-02 |
N-Glycan antennae elongation | 14 | 3.64e-03 | -0.449000 | 2.43e-02 |
Visual phototransduction | 93 | 3.82e-03 | -0.174000 | 2.53e-02 |
Post-translational modification: synthesis of GPI-anchored proteins | 82 | 3.87e-03 | -0.185000 | 2.54e-02 |
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 98 | 3.87e-03 | -0.169000 | 2.54e-02 |
Beta-oxidation of very long chain fatty acids | 10 | 4.29e-03 | 0.522000 | 2.80e-02 |
Telomere C-strand (Lagging Strand) Synthesis | 33 | 4.29e-03 | -0.287000 | 2.80e-02 |
Signaling by ROBO receptors | 189 | 4.36e-03 | 0.120000 | 2.83e-02 |
Mitochondrial iron-sulfur cluster biogenesis | 11 | 4.48e-03 | 0.495000 | 2.89e-02 |
Ovarian tumor domain proteases | 35 | 4.75e-03 | 0.276000 | 3.05e-02 |
Apoptosis | 162 | 4.95e-03 | 0.128000 | 3.16e-02 |
FCERI mediated MAPK activation | 59 | 4.96e-03 | -0.212000 | 3.16e-02 |
Homology Directed Repair | 104 | 5.00e-03 | -0.159000 | 3.17e-02 |
Interleukin-17 signaling | 68 | 5.33e-03 | 0.195000 | 3.37e-02 |
Recycling of bile acids and salts | 16 | 5.37e-03 | -0.402000 | 3.37e-02 |
Programmed Cell Death | 172 | 5.62e-03 | 0.122000 | 3.52e-02 |
Homologous DNA Pairing and Strand Exchange | 41 | 5.70e-03 | -0.250000 | 3.55e-02 |
trans-Golgi Network Vesicle Budding | 70 | 5.80e-03 | 0.191000 | 3.60e-02 |
G alpha (q) signalling events | 198 | 5.91e-03 | -0.114000 | 3.64e-02 |
Transport of Mature mRNA derived from an Intron-Containing Transcript | 72 | 5.92e-03 | -0.188000 | 3.64e-02 |
Classical antibody-mediated complement activation | 35 | 6.00e-03 | -0.268000 | 3.68e-02 |
RHO GTPases Activate WASPs and WAVEs | 35 | 6.04e-03 | -0.268000 | 3.68e-02 |
Constitutive Signaling by Aberrant PI3K in Cancer | 71 | 6.07e-03 | -0.188000 | 3.69e-02 |
Glycolysis | 68 | 6.12e-03 | 0.192000 | 3.70e-02 |
RHO GTPases Activate Formins | 118 | 6.19e-03 | -0.146000 | 3.72e-02 |
Transcriptional activation of mitochondrial biogenesis | 53 | 6.21e-03 | 0.217000 | 3.72e-02 |
Glycogen storage diseases | 14 | 6.24e-03 | 0.422000 | 3.72e-02 |
CD28 dependent Vav1 pathway | 12 | 6.25e-03 | -0.456000 | 3.72e-02 |
Regulation of innate immune responses to cytosolic DNA | 13 | 6.58e-03 | 0.435000 | 3.90e-02 |
Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 69 | 6.61e-03 | 0.189000 | 3.90e-02 |
HDR through Single Strand Annealing (SSA) | 37 | 6.71e-03 | -0.258000 | 3.94e-02 |
GPCR ligand binding | 390 | 6.73e-03 | -0.080100 | 3.94e-02 |
KSRP (KHSRP) binds and destabilizes mRNA | 17 | 7.00e-03 | -0.378000 | 4.08e-02 |
Transcriptional regulation by RUNX1 | 185 | 7.25e-03 | 0.115000 | 4.21e-02 |
Miscellaneous substrates | 12 | 7.35e-03 | -0.447000 | 4.25e-02 |
Assembly of the pre-replicative complex | 65 | 7.65e-03 | 0.191000 | 4.41e-02 |
Processing of SMDT1 | 15 | 7.83e-03 | 0.397000 | 4.49e-02 |
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 26 | 7.89e-03 | -0.301000 | 4.51e-02 |
Inositol phosphate metabolism | 47 | 7.95e-03 | 0.224000 | 4.53e-02 |
CD22 mediated BCR regulation | 34 | 8.08e-03 | -0.263000 | 4.58e-02 |
Extension of Telomeres | 50 | 8.14e-03 | -0.216000 | 4.60e-02 |
Signaling by Hedgehog | 131 | 8.34e-03 | 0.134000 | 4.69e-02 |
Mitotic Spindle Checkpoint | 107 | 8.71e-03 | -0.147000 | 4.88e-02 |
G alpha (12/13) signalling events | 77 | 8.89e-03 | -0.173000 | 4.96e-02 |
Cyclin A/B1/B2 associated events during G2/M transition | 23 | 9.01e-03 | -0.315000 | 5.01e-02 |
MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 86 | 9.23e-03 | 0.162000 | 5.06e-02 |
Toll Like Receptor 2 (TLR2) Cascade | 86 | 9.23e-03 | 0.162000 | 5.06e-02 |
Toll Like Receptor TLR1:TLR2 Cascade | 86 | 9.23e-03 | 0.162000 | 5.06e-02 |
Toll Like Receptor TLR6:TLR2 Cascade | 86 | 9.23e-03 | 0.162000 | 5.06e-02 |
Cell Cycle Checkpoints | 251 | 9.47e-03 | -0.095200 | 5.17e-02 |
Elastic fibre formation | 38 | 9.66e-03 | -0.243000 | 5.25e-02 |
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 91 | 9.97e-03 | -0.156000 | 5.38e-02 |
Amplification of signal from the kinetochores | 91 | 9.97e-03 | -0.156000 | 5.38e-02 |
NRAGE signals death through JNK | 56 | 1.00e-02 | -0.199000 | 5.40e-02 |
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | 70 | 1.01e-02 | 0.178000 | 5.41e-02 |
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | 117 | 1.03e-02 | -0.137000 | 5.50e-02 |
Polymerase switching on the C-strand of the telomere | 25 | 1.04e-02 | -0.296000 | 5.51e-02 |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 23 | 1.06e-02 | 0.308000 | 5.62e-02 |
Condensation of Prophase Chromosomes | 24 | 1.08e-02 | -0.301000 | 5.68e-02 |
RNA Polymerase III Chain Elongation | 14 | 1.09e-02 | 0.393000 | 5.73e-02 |
Post-translational protein phosphorylation | 103 | 1.12e-02 | -0.145000 | 5.87e-02 |
Orc1 removal from chromatin | 68 | 1.15e-02 | 0.177000 | 6.00e-02 |
Role of second messengers in netrin-1 signaling | 10 | 1.16e-02 | -0.461000 | 6.05e-02 |
DNA strand elongation | 31 | 1.17e-02 | -0.262000 | 6.06e-02 |
Glycosphingolipid metabolism | 40 | 1.17e-02 | 0.230000 | 6.06e-02 |
Signaling by Retinoic Acid | 38 | 1.18e-02 | 0.236000 | 6.07e-02 |
VLDLR internalisation and degradation | 12 | 1.18e-02 | 0.420000 | 6.07e-02 |
Signal Transduction | 2291 | 1.21e-02 | -0.032500 | 6.16e-02 |
Netrin-1 signaling | 49 | 1.21e-02 | -0.207000 | 6.17e-02 |
Chaperone Mediated Autophagy | 18 | 1.22e-02 | 0.341000 | 6.20e-02 |
Endosomal Sorting Complex Required For Transport (ESCRT) | 29 | 1.23e-02 | 0.269000 | 6.23e-02 |
Iron uptake and transport | 54 | 1.28e-02 | 0.196000 | 6.45e-02 |
Toll-like Receptor Cascades | 138 | 1.28e-02 | 0.123000 | 6.45e-02 |
Post-translational protein modification | 1269 | 1.29e-02 | 0.041800 | 6.47e-02 |
EML4 and NUDC in mitotic spindle formation | 95 | 1.33e-02 | -0.147000 | 6.62e-02 |
HDR through Homologous Recombination (HRR) | 63 | 1.35e-02 | -0.180000 | 6.70e-02 |
Regulation of APC/C activators between G1/S and early anaphase | 77 | 1.35e-02 | 0.163000 | 6.70e-02 |
Eicosanoids | 12 | 1.38e-02 | -0.410000 | 6.81e-02 |
Toll Like Receptor 4 (TLR4) Cascade | 114 | 1.39e-02 | 0.133000 | 6.81e-02 |
Rab regulation of trafficking | 117 | 1.39e-02 | 0.132000 | 6.81e-02 |
Dectin-2 family | 19 | 1.39e-02 | -0.326000 | 6.81e-02 |
Binding and Uptake of Ligands by Scavenger Receptors | 66 | 1.40e-02 | -0.175000 | 6.82e-02 |
Cleavage of the damaged pyrimidine | 25 | 1.49e-02 | -0.281000 | 7.19e-02 |
Depyrimidination | 25 | 1.49e-02 | -0.281000 | 7.19e-02 |
Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 25 | 1.49e-02 | -0.281000 | 7.19e-02 |
Cell Cycle, Mitotic | 484 | 1.56e-02 | -0.064300 | 7.51e-02 |
Anti-inflammatory response favouring Leishmania parasite infection | 176 | 1.60e-02 | -0.105000 | 7.63e-02 |
Leishmania parasite growth and survival | 176 | 1.60e-02 | -0.105000 | 7.63e-02 |
Base-Excision Repair, AP Site Formation | 27 | 1.62e-02 | -0.267000 | 7.73e-02 |
Diseases associated with O-glycosylation of proteins | 60 | 1.65e-02 | -0.179000 | 7.82e-02 |
Regulation of HSF1-mediated heat shock response | 76 | 1.67e-02 | 0.159000 | 7.91e-02 |
N-glycan antennae elongation in the medial/trans-Golgi | 23 | 1.71e-02 | -0.287000 | 8.07e-02 |
Pexophagy | 10 | 1.72e-02 | 0.435000 | 8.07e-02 |
TRAF6 mediated NF-kB activation | 19 | 1.72e-02 | 0.316000 | 8.07e-02 |
Regulation of pyruvate dehydrogenase (PDH) complex | 15 | 1.74e-02 | 0.355000 | 8.10e-02 |
Nucleotide Excision Repair | 106 | 1.76e-02 | 0.134000 | 8.16e-02 |
Mitotic Telophase/Cytokinesis | 13 | 1.76e-02 | -0.380000 | 8.16e-02 |
FCERI mediated NF-kB activation | 102 | 1.82e-02 | 0.135000 | 8.41e-02 |
Acetylcholine Neurotransmitter Release Cycle | 15 | 1.89e-02 | 0.350000 | 8.68e-02 |
DARPP-32 events | 23 | 1.96e-02 | 0.281000 | 9.01e-02 |
DAP12 interactions | 38 | 1.99e-02 | -0.218000 | 9.09e-02 |
Amino acids regulate mTORC1 | 50 | 2.00e-02 | 0.190000 | 9.09e-02 |
Ca2+ pathway | 61 | 2.00e-02 | -0.172000 | 9.09e-02 |
RNA Polymerase I Transcription Termination | 28 | 2.01e-02 | 0.254000 | 9.10e-02 |
RNA Polymerase III Transcription Initiation From Type 3 Promoter | 24 | 2.02e-02 | 0.274000 | 9.10e-02 |
Creation of C4 and C2 activators | 41 | 2.02e-02 | -0.210000 | 9.10e-02 |
Metabolism of fat-soluble vitamins | 43 | 2.05e-02 | -0.204000 | 9.21e-02 |
PI Metabolism | 81 | 2.06e-02 | 0.149000 | 9.21e-02 |
Resolution of D-Loop Structures | 33 | 2.10e-02 | -0.232000 | 9.35e-02 |
G0 and Early G1 | 27 | 2.12e-02 | -0.256000 | 9.43e-02 |
C-type lectin receptors (CLRs) | 125 | 2.16e-02 | 0.119000 | 9.59e-02 |
RNA Polymerase I Transcription Initiation | 44 | 2.25e-02 | 0.199000 | 9.94e-02 |
Transport of organic anions | 12 | 2.30e-02 | -0.379000 | 1.01e-01 |
APC/C:Cdc20 mediated degradation of mitotic proteins | 72 | 2.32e-02 | 0.155000 | 1.02e-01 |
Calnexin/calreticulin cycle | 24 | 2.36e-02 | 0.267000 | 1.04e-01 |
Class I peroxisomal membrane protein import | 18 | 2.41e-02 | 0.307000 | 1.05e-01 |
Telomere Maintenance | 73 | 2.44e-02 | -0.152000 | 1.06e-01 |
Intrinsic Pathway of Fibrin Clot Formation | 22 | 2.46e-02 | -0.277000 | 1.07e-01 |
Regulation of cholesterol biosynthesis by SREBP (SREBF) | 53 | 2.47e-02 | -0.178000 | 1.07e-01 |
Striated Muscle Contraction | 34 | 2.48e-02 | 0.223000 | 1.07e-01 |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | 17 | 2.52e-02 | 0.314000 | 1.08e-01 |
Packaging Of Telomere Ends | 16 | 2.52e-02 | -0.323000 | 1.08e-01 |
Meiotic synapsis | 41 | 2.55e-02 | -0.202000 | 1.09e-01 |
Interleukin-6 signaling | 11 | 2.57e-02 | 0.389000 | 1.09e-01 |
Regulation of IFNA signaling | 24 | 2.59e-02 | -0.263000 | 1.10e-01 |
Interleukin-20 family signaling | 20 | 2.65e-02 | 0.287000 | 1.12e-01 |
Unfolded Protein Response (UPR) | 91 | 2.66e-02 | 0.135000 | 1.12e-01 |
Constitutive Signaling by AKT1 E17K in Cancer | 25 | 2.69e-02 | 0.256000 | 1.12e-01 |
Cleavage of the damaged purine | 20 | 2.69e-02 | -0.286000 | 1.12e-01 |
Depurination | 20 | 2.69e-02 | -0.286000 | 1.12e-01 |
Recognition and association of DNA glycosylase with site containing an affected purine | 20 | 2.69e-02 | -0.286000 | 1.12e-01 |
E2F mediated regulation of DNA replication | 21 | 2.69e-02 | -0.279000 | 1.12e-01 |
Glyoxylate metabolism and glycine degradation | 29 | 2.72e-02 | 0.237000 | 1.13e-01 |
Glycogen breakdown (glycogenolysis) | 14 | 2.78e-02 | 0.340000 | 1.15e-01 |
Prolactin receptor signaling | 12 | 2.80e-02 | 0.366000 | 1.16e-01 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 13 | 2.86e-02 | 0.351000 | 1.18e-01 |
NCAM1 interactions | 31 | 2.93e-02 | -0.226000 | 1.20e-01 |
Interleukin-27 signaling | 11 | 3.04e-02 | 0.377000 | 1.24e-01 |
Regulation of mRNA stability by proteins that bind AU-rich elements | 85 | 3.06e-02 | 0.136000 | 1.24e-01 |
Rap1 signalling | 14 | 3.06e-02 | 0.334000 | 1.24e-01 |
Translation of Replicase and Assembly of the Replication Transcription Complex | 12 | 3.06e-02 | 0.360000 | 1.24e-01 |
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | 13 | 3.11e-02 | 0.345000 | 1.26e-01 |
RNA Polymerase III Transcription Initiation From Type 2 Promoter | 23 | 3.20e-02 | 0.258000 | 1.29e-01 |
Glycosaminoglycan metabolism | 117 | 3.23e-02 | -0.115000 | 1.30e-01 |
SARS-CoV-1 Infection | 47 | 3.24e-02 | 0.180000 | 1.30e-01 |
CDC6 association with the ORC:origin complex | 11 | 3.30e-02 | -0.371000 | 1.32e-01 |
VEGFR2 mediated cell proliferation | 19 | 3.30e-02 | -0.283000 | 1.32e-01 |
Transcriptional regulation of granulopoiesis | 40 | 3.33e-02 | -0.195000 | 1.33e-01 |
TGF-beta receptor signaling activates SMADs | 30 | 3.40e-02 | 0.224000 | 1.35e-01 |
Class A/1 (Rhodopsin-like receptors) | 274 | 3.42e-02 | -0.074400 | 1.36e-01 |
MAP3K8 (TPL2)-dependent MAPK1/3 activation | 15 | 3.45e-02 | 0.315000 | 1.36e-01 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 14 | 3.45e-02 | -0.326000 | 1.36e-01 |
Syndecan interactions | 19 | 3.46e-02 | -0.280000 | 1.36e-01 |
DNA Double-Strand Break Repair | 131 | 3.47e-02 | -0.107000 | 1.36e-01 |
Diseases associated with glycosylation precursor biosynthesis | 18 | 3.48e-02 | 0.287000 | 1.36e-01 |
Diseases of signal transduction by growth factor receptors and second messengers | 364 | 3.51e-02 | 0.064400 | 1.37e-01 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 12 | 3.53e-02 | -0.351000 | 1.37e-01 |
Translocation of SLC2A4 (GLUT4) to the plasma membrane | 50 | 3.55e-02 | 0.172000 | 1.37e-01 |
Signaling by Interleukins | 404 | 3.55e-02 | 0.061100 | 1.37e-01 |
WNT ligand biogenesis and trafficking | 25 | 3.55e-02 | -0.243000 | 1.37e-01 |
Retrograde neurotrophin signalling | 14 | 3.59e-02 | 0.324000 | 1.38e-01 |
Interleukin-10 signaling | 38 | 3.60e-02 | -0.197000 | 1.38e-01 |
mRNA 3'-end processing | 55 | 3.61e-02 | -0.163000 | 1.38e-01 |
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 73 | 3.63e-02 | 0.142000 | 1.38e-01 |
Transport to the Golgi and subsequent modification | 155 | 3.65e-02 | 0.097400 | 1.39e-01 |
Golgi Associated Vesicle Biogenesis | 54 | 3.66e-02 | 0.164000 | 1.39e-01 |
Physiological factors | 12 | 3.67e-02 | 0.348000 | 1.39e-01 |
Surfactant metabolism | 24 | 3.68e-02 | 0.246000 | 1.39e-01 |
Base Excision Repair | 54 | 3.71e-02 | -0.164000 | 1.40e-01 |
TNF signaling | 43 | 3.77e-02 | 0.183000 | 1.42e-01 |
activated TAK1 mediates p38 MAPK activation | 18 | 3.78e-02 | 0.283000 | 1.42e-01 |
Dissolution of Fibrin Clot | 12 | 3.82e-02 | -0.346000 | 1.43e-01 |
Establishment of Sister Chromatid Cohesion | 11 | 3.87e-02 | -0.360000 | 1.44e-01 |
G beta:gamma signalling through CDC42 | 20 | 3.88e-02 | -0.267000 | 1.44e-01 |
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 27 | 3.91e-02 | 0.229000 | 1.45e-01 |
FLT3 Signaling | 278 | 3.91e-02 | 0.072000 | 1.45e-01 |
Regulation of TP53 Activity through Phosphorylation | 84 | 3.93e-02 | -0.130000 | 1.45e-01 |
Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 14 | 3.95e-02 | -0.318000 | 1.45e-01 |
Synthesis of PIPs at the plasma membrane | 51 | 3.99e-02 | 0.166000 | 1.46e-01 |
Phospholipid metabolism | 204 | 4.00e-02 | 0.083500 | 1.46e-01 |
Resolution of D-loop Structures through Holliday Junction Intermediates | 32 | 4.03e-02 | -0.209000 | 1.47e-01 |
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 17 | 4.20e-02 | -0.285000 | 1.53e-01 |
Condensation of Prometaphase Chromosomes | 10 | 4.31e-02 | -0.369000 | 1.56e-01 |
Activation of gene expression by SREBF (SREBP) | 41 | 4.32e-02 | -0.183000 | 1.56e-01 |
Transport of Mature Transcript to Cytoplasm | 80 | 4.32e-02 | -0.131000 | 1.56e-01 |
Post NMDA receptor activation events | 59 | 4.33e-02 | 0.152000 | 1.56e-01 |
Interferon gamma signaling | 78 | 4.45e-02 | 0.132000 | 1.60e-01 |
Negative regulation of NMDA receptor-mediated neuronal transmission | 20 | 4.49e-02 | 0.259000 | 1.61e-01 |
Initial triggering of complement | 48 | 4.51e-02 | -0.167000 | 1.62e-01 |
Senescence-Associated Secretory Phenotype (SASP) | 56 | 4.55e-02 | -0.155000 | 1.62e-01 |
G alpha (s) signalling events | 246 | 4.60e-02 | -0.074000 | 1.64e-01 |
YAP1- and WWTR1 (TAZ)-stimulated gene expression | 14 | 4.66e-02 | 0.307000 | 1.66e-01 |
Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS) | 11 | 4.75e-02 | -0.345000 | 1.68e-01 |
Golgi-to-ER retrograde transport | 112 | 4.76e-02 | 0.108000 | 1.68e-01 |
TICAM1-dependent activation of IRF3/IRF7 | 10 | 4.84e-02 | 0.360000 | 1.71e-01 |
Synthesis of Leukotrienes (LT) and Eoxins (EX) | 21 | 4.90e-02 | -0.248000 | 1.72e-01 |
Downregulation of TGF-beta receptor signaling | 25 | 4.91e-02 | 0.227000 | 1.72e-01 |
Erythrocytes take up carbon dioxide and release oxygen | 11 | 5.00e-02 | 0.341000 | 1.74e-01 |
O2/CO2 exchange in erythrocytes | 11 | 5.00e-02 | 0.341000 | 1.74e-01 |
Transport of small molecules | 680 | 5.03e-02 | 0.044200 | 1.75e-01 |
Metabolism of RNA | 630 | 5.07e-02 | 0.045800 | 1.76e-01 |
DAP12 signaling | 29 | 5.08e-02 | -0.210000 | 1.76e-01 |
Telomere C-strand synthesis initiation | 13 | 5.15e-02 | -0.312000 | 1.78e-01 |
Retinoid metabolism and transport | 39 | 5.16e-02 | -0.180000 | 1.78e-01 |
Beta-catenin independent WNT signaling | 142 | 5.18e-02 | 0.094600 | 1.78e-01 |
Biological oxidations | 178 | 5.21e-02 | -0.084500 | 1.79e-01 |
Switching of origins to a post-replicative state | 87 | 5.23e-02 | 0.120000 | 1.79e-01 |
Intra-Golgi and retrograde Golgi-to-ER traffic | 177 | 5.31e-02 | 0.084400 | 1.82e-01 |
TNFs bind their physiological receptors | 26 | 5.36e-02 | -0.219000 | 1.82e-01 |
Lysosome Vesicle Biogenesis | 34 | 5.37e-02 | 0.191000 | 1.82e-01 |
Unwinding of DNA | 12 | 5.37e-02 | -0.322000 | 1.82e-01 |
Cellular Senescence | 136 | 5.43e-02 | -0.095700 | 1.84e-01 |
Chylomicron remodeling | 10 | 5.62e-02 | -0.349000 | 1.90e-01 |
Interleukin-35 Signalling | 11 | 5.67e-02 | 0.332000 | 1.91e-01 |
ATF6 (ATF6-alpha) activates chaperones | 12 | 5.80e-02 | 0.316000 | 1.95e-01 |
The phototransduction cascade | 32 | 5.91e-02 | -0.193000 | 1.98e-01 |
Cell death signalling via NRAGE, NRIF and NADE | 72 | 5.93e-02 | -0.129000 | 1.98e-01 |
Metabolism of lipids | 693 | 5.95e-02 | 0.042200 | 1.99e-01 |
DNA Replication Pre-Initiation | 81 | 5.98e-02 | 0.121000 | 1.99e-01 |
G beta:gamma signalling through BTK | 18 | 6.01e-02 | -0.256000 | 2.00e-01 |
Global Genome Nucleotide Excision Repair (GG-NER) | 82 | 6.02e-02 | 0.120000 | 2.00e-01 |
tRNA processing | 118 | 6.11e-02 | 0.099900 | 2.02e-01 |
tRNA processing in the mitochondrion | 18 | 6.13e-02 | 0.255000 | 2.02e-01 |
Receptor Mediated Mitophagy | 11 | 6.16e-02 | 0.325000 | 2.03e-01 |
Metabolism of carbohydrates | 275 | 6.20e-02 | 0.065500 | 2.04e-01 |
RMTs methylate histone arginines | 36 | 6.22e-02 | 0.180000 | 2.04e-01 |
mRNA decay by 3' to 5' exoribonuclease | 16 | 6.25e-02 | -0.269000 | 2.05e-01 |
Non-integrin membrane-ECM interactions | 41 | 6.36e-02 | -0.167000 | 2.08e-01 |
Budding and maturation of HIV virion | 25 | 6.38e-02 | 0.214000 | 2.08e-01 |
Negative regulators of DDX58/IFIH1 signaling | 31 | 6.48e-02 | 0.192000 | 2.10e-01 |
Signaling by NOTCH | 183 | 6.49e-02 | 0.079200 | 2.10e-01 |
RAF/MAP kinase cascade | 264 | 6.50e-02 | 0.066100 | 2.10e-01 |
MAPK1/MAPK3 signaling | 270 | 6.55e-02 | 0.065200 | 2.11e-01 |
G-protein beta:gamma signalling | 32 | 6.65e-02 | -0.187000 | 2.14e-01 |
RNA Polymerase III Transcription Initiation From Type 1 Promoter | 24 | 6.75e-02 | 0.216000 | 2.17e-01 |
RNA Pol II CTD phosphorylation and interaction with CE | 25 | 7.01e-02 | 0.209000 | 2.24e-01 |
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 25 | 7.01e-02 | 0.209000 | 2.24e-01 |
ER Quality Control Compartment (ERQC) | 19 | 7.03e-02 | 0.240000 | 2.24e-01 |
TCF dependent signaling in response to WNT | 176 | 7.18e-02 | 0.078700 | 2.29e-01 |
Signaling by cytosolic FGFR1 fusion mutants | 17 | 7.26e-02 | 0.252000 | 2.30e-01 |
CLEC7A (Dectin-1) induces NFAT activation | 11 | 7.28e-02 | -0.312000 | 2.30e-01 |
Biotin transport and metabolism | 11 | 7.29e-02 | 0.312000 | 2.30e-01 |
PIP3 activates AKT signaling | 265 | 7.31e-02 | 0.064000 | 2.30e-01 |
Potassium Channels | 100 | 7.32e-02 | -0.104000 | 2.30e-01 |
Chondroitin sulfate biosynthesis | 20 | 7.33e-02 | -0.231000 | 2.30e-01 |
Inactivation, recovery and regulation of the phototransduction cascade | 31 | 7.41e-02 | -0.185000 | 2.32e-01 |
Metabolism of nucleotides | 94 | 7.51e-02 | 0.106000 | 2.35e-01 |
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 20 | 7.61e-02 | 0.229000 | 2.37e-01 |
FOXO-mediated transcription of cell death genes | 14 | 7.61e-02 | 0.274000 | 2.37e-01 |
Inactivation of APC/C via direct inhibition of the APC/C complex | 20 | 7.68e-02 | -0.229000 | 2.38e-01 |
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | 20 | 7.68e-02 | -0.229000 | 2.38e-01 |
Presynaptic depolarization and calcium channel opening | 12 | 7.70e-02 | -0.295000 | 2.38e-01 |
Processive synthesis on the C-strand of the telomere | 18 | 7.77e-02 | -0.240000 | 2.40e-01 |
DSCAM interactions | 11 | 7.83e-02 | -0.307000 | 2.41e-01 |
Defective GALNT12 causes colorectal cancer 1 (CRCS1) | 10 | 7.90e-02 | -0.321000 | 2.43e-01 |
Dual incision in TC-NER | 61 | 7.99e-02 | 0.130000 | 2.44e-01 |
APC/C-mediated degradation of cell cycle proteins | 84 | 7.99e-02 | 0.111000 | 2.44e-01 |
Regulation of mitotic cell cycle | 84 | 7.99e-02 | 0.111000 | 2.44e-01 |
Glutamate and glutamine metabolism | 13 | 8.02e-02 | 0.280000 | 2.45e-01 |
RHO GTPases activate CIT | 19 | 8.06e-02 | -0.232000 | 2.45e-01 |
Regulation of insulin secretion | 75 | 8.14e-02 | -0.116000 | 2.47e-01 |
Platelet sensitization by LDL | 16 | 8.16e-02 | 0.251000 | 2.47e-01 |
Phase I - Functionalization of compounds | 93 | 8.17e-02 | -0.104000 | 2.47e-01 |
Interleukin-6 family signaling | 24 | 8.20e-02 | 0.205000 | 2.47e-01 |
Extra-nuclear estrogen signaling | 72 | 8.24e-02 | -0.118000 | 2.48e-01 |
Cytosolic iron-sulfur cluster assembly | 13 | 8.26e-02 | 0.278000 | 2.48e-01 |
RAF activation | 33 | 8.27e-02 | 0.175000 | 2.48e-01 |
Transport of bile salts and organic acids, metal ions and amine compounds | 78 | 8.31e-02 | -0.114000 | 2.48e-01 |
Purine ribonucleoside monophosphate biosynthesis | 10 | 8.32e-02 | 0.316000 | 2.48e-01 |
Signaling by TGFB family members | 96 | 8.32e-02 | 0.102000 | 2.48e-01 |
Association of TriC/CCT with target proteins during biosynthesis | 38 | 8.40e-02 | 0.162000 | 2.49e-01 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 8.40e-02 | 0.288000 | 2.49e-01 |
alpha-linolenic acid (ALA) metabolism | 12 | 8.40e-02 | 0.288000 | 2.49e-01 |
PRC2 methylates histones and DNA | 23 | 8.43e-02 | -0.208000 | 2.49e-01 |
Synthesis of substrates in N-glycan biosythesis | 60 | 8.54e-02 | 0.128000 | 2.52e-01 |
Transferrin endocytosis and recycling | 29 | 8.60e-02 | 0.184000 | 2.53e-01 |
Defects in vitamin and cofactor metabolism | 22 | 8.61e-02 | 0.211000 | 2.53e-01 |
PIWI-interacting RNA (piRNA) biogenesis | 25 | 8.64e-02 | 0.198000 | 2.53e-01 |
Plasma lipoprotein remodeling | 31 | 8.70e-02 | -0.178000 | 2.55e-01 |
Aflatoxin activation and detoxification | 18 | 8.71e-02 | -0.233000 | 2.55e-01 |
Leading Strand Synthesis | 13 | 8.79e-02 | -0.273000 | 2.56e-01 |
Polymerase switching | 13 | 8.79e-02 | -0.273000 | 2.56e-01 |
RNA Polymerase II Transcription Termination | 63 | 8.83e-02 | -0.124000 | 2.56e-01 |
Ras activation upon Ca2+ influx through NMDA receptor | 19 | 8.85e-02 | 0.226000 | 2.57e-01 |
Nucleotide salvage | 22 | 8.99e-02 | 0.209000 | 2.60e-01 |
O-linked glycosylation | 100 | 9.01e-02 | -0.098100 | 2.60e-01 |
Class B/2 (Secretin family receptors) | 86 | 9.02e-02 | -0.106000 | 2.60e-01 |
Signaling by Leptin | 11 | 9.12e-02 | 0.294000 | 2.62e-01 |
HS-GAG degradation | 20 | 9.18e-02 | -0.218000 | 2.63e-01 |
Lagging Strand Synthesis | 19 | 9.20e-02 | -0.223000 | 2.63e-01 |
Adaptive Immune System | 691 | 9.26e-02 | 0.037700 | 2.64e-01 |
Activation of NMDA receptors and postsynaptic events | 71 | 9.26e-02 | 0.115000 | 2.64e-01 |
TBC/RABGAPs | 44 | 9.47e-02 | 0.146000 | 2.69e-01 |
Presynaptic function of Kainate receptors | 21 | 9.49e-02 | -0.211000 | 2.69e-01 |
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 13 | 9.49e-02 | -0.268000 | 2.69e-01 |
RET signaling | 39 | 9.68e-02 | -0.154000 | 2.74e-01 |
Developmental Biology | 866 | 9.74e-02 | -0.033300 | 2.75e-01 |
Phase 4 - resting membrane potential | 18 | 9.75e-02 | -0.226000 | 2.75e-01 |
Diseases of glycosylation | 132 | 9.97e-02 | -0.083000 | 2.80e-01 |
tRNA modification in the nucleus and cytosol | 42 | 1.01e-01 | 0.146000 | 2.83e-01 |
FGFR1 mutant receptor activation | 28 | 1.02e-01 | 0.179000 | 2.84e-01 |
HuR (ELAVL1) binds and stabilizes mRNA | 10 | 1.02e-01 | -0.299000 | 2.84e-01 |
Cap-dependent Translation Initiation | 93 | 1.02e-01 | 0.098100 | 2.85e-01 |
Eukaryotic Translation Initiation | 93 | 1.02e-01 | 0.098100 | 2.85e-01 |
NCAM signaling for neurite out-growth | 52 | 1.04e-01 | -0.130000 | 2.88e-01 |
HDMs demethylate histones | 21 | 1.04e-01 | -0.205000 | 2.89e-01 |
Protein methylation | 14 | 1.05e-01 | 0.250000 | 2.92e-01 |
Activation of Matrix Metalloproteinases | 28 | 1.06e-01 | -0.176000 | 2.94e-01 |
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 17 | 1.09e-01 | -0.224000 | 3.01e-01 |
Gap-filling DNA repair synthesis and ligation in TC-NER | 60 | 1.10e-01 | 0.119000 | 3.02e-01 |
RNA Polymerase III Transcription Termination | 19 | 1.10e-01 | 0.212000 | 3.02e-01 |
Uptake and actions of bacterial toxins | 26 | 1.11e-01 | 0.181000 | 3.05e-01 |
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 99 | 1.12e-01 | -0.092500 | 3.07e-01 |
Pre-NOTCH Transcription and Translation | 47 | 1.12e-01 | -0.134000 | 3.07e-01 |
Amino acid transport across the plasma membrane | 32 | 1.14e-01 | -0.161000 | 3.12e-01 |
Inwardly rectifying K+ channels | 35 | 1.14e-01 | -0.154000 | 3.12e-01 |
Signaling by Erythropoietin | 25 | 1.16e-01 | -0.182000 | 3.15e-01 |
RAB GEFs exchange GTP for GDP on RABs | 85 | 1.16e-01 | 0.098600 | 3.15e-01 |
Synthesis of IP3 and IP4 in the cytosol | 26 | 1.17e-01 | 0.178000 | 3.17e-01 |
VEGFA-VEGFR2 Pathway | 91 | 1.18e-01 | -0.094800 | 3.18e-01 |
Nuclear Envelope Breakdown | 50 | 1.18e-01 | -0.128000 | 3.18e-01 |
NOTCH2 Activation and Transmission of Signal to the Nucleus | 20 | 1.18e-01 | 0.202000 | 3.18e-01 |
GABA synthesis, release, reuptake and degradation | 18 | 1.19e-01 | 0.212000 | 3.18e-01 |
HIV elongation arrest and recovery | 34 | 1.19e-01 | 0.155000 | 3.18e-01 |
Pausing and recovery of HIV elongation | 34 | 1.19e-01 | 0.155000 | 3.18e-01 |
GABA receptor activation | 57 | 1.20e-01 | -0.119000 | 3.19e-01 |
Ion homeostasis | 47 | 1.20e-01 | 0.131000 | 3.19e-01 |
RNA Polymerase III Transcription Initiation | 32 | 1.20e-01 | 0.159000 | 3.19e-01 |
Glucagon-type ligand receptors | 31 | 1.20e-01 | -0.161000 | 3.20e-01 |
TRAF3-dependent IRF activation pathway | 12 | 1.22e-01 | 0.258000 | 3.24e-01 |
Dermatan sulfate biosynthesis | 11 | 1.22e-01 | -0.269000 | 3.24e-01 |
FOXO-mediated transcription of cell cycle genes | 16 | 1.23e-01 | -0.223000 | 3.26e-01 |
Constitutive Signaling by NOTCH1 HD Domain Mutants | 14 | 1.24e-01 | 0.238000 | 3.26e-01 |
Signaling by NOTCH1 HD Domain Mutants in Cancer | 14 | 1.24e-01 | 0.238000 | 3.26e-01 |
Signaling by NTRK2 (TRKB) | 25 | 1.26e-01 | -0.177000 | 3.30e-01 |
Olfactory Signaling Pathway | 123 | 1.26e-01 | -0.080000 | 3.30e-01 |
Heme biosynthesis | 13 | 1.26e-01 | 0.245000 | 3.30e-01 |
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | 17 | 1.26e-01 | -0.214000 | 3.30e-01 |
Phosphorylation of the APC/C | 19 | 1.27e-01 | -0.202000 | 3.31e-01 |
Chondroitin sulfate/dermatan sulfate metabolism | 49 | 1.27e-01 | -0.126000 | 3.31e-01 |
Activation of GABAB receptors | 43 | 1.29e-01 | -0.134000 | 3.34e-01 |
GABA B receptor activation | 43 | 1.29e-01 | -0.134000 | 3.34e-01 |
DNA methylation | 15 | 1.29e-01 | -0.227000 | 3.34e-01 |
Synthesis of PIPs at the late endosome membrane | 11 | 1.30e-01 | 0.264000 | 3.36e-01 |
Activation of the AP-1 family of transcription factors | 10 | 1.30e-01 | 0.276000 | 3.36e-01 |
Signaling by TGF-beta Receptor Complex | 69 | 1.30e-01 | 0.105000 | 3.36e-01 |
Adrenaline,noradrenaline inhibits insulin secretion | 28 | 1.31e-01 | -0.165000 | 3.36e-01 |
Nucleobase biosynthesis | 13 | 1.32e-01 | 0.241000 | 3.39e-01 |
ADP signalling through P2Y purinoceptor 12 | 22 | 1.32e-01 | -0.185000 | 3.39e-01 |
Peptide ligand-binding receptors | 158 | 1.33e-01 | -0.069300 | 3.40e-01 |
ZBP1(DAI) mediated induction of type I IFNs | 19 | 1.33e-01 | 0.199000 | 3.40e-01 |
Muscle contraction | 177 | 1.34e-01 | 0.065400 | 3.40e-01 |
MAPK family signaling cascades | 307 | 1.34e-01 | 0.049900 | 3.40e-01 |
Other semaphorin interactions | 19 | 1.34e-01 | -0.199000 | 3.40e-01 |
Nitric oxide stimulates guanylate cyclase | 19 | 1.34e-01 | -0.199000 | 3.40e-01 |
O-linked glycosylation of mucins | 53 | 1.35e-01 | -0.119000 | 3.43e-01 |
Amine ligand-binding receptors | 34 | 1.36e-01 | -0.148000 | 3.43e-01 |
GRB2:SOS provides linkage to MAPK signaling for Integrins | 15 | 1.36e-01 | -0.222000 | 3.43e-01 |
Activation of G protein gated Potassium channels | 29 | 1.37e-01 | -0.160000 | 3.44e-01 |
G protein gated Potassium channels | 29 | 1.37e-01 | -0.160000 | 3.44e-01 |
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | 29 | 1.37e-01 | -0.160000 | 3.44e-01 |
mRNA Capping | 27 | 1.38e-01 | 0.165000 | 3.45e-01 |
Defective B3GALTL causes Peters-plus syndrome (PpS) | 36 | 1.38e-01 | -0.143000 | 3.45e-01 |
Diseases of carbohydrate metabolism | 32 | 1.39e-01 | 0.151000 | 3.46e-01 |
Formation of the Early Elongation Complex | 31 | 1.39e-01 | 0.153000 | 3.47e-01 |
Formation of the HIV-1 Early Elongation Complex | 31 | 1.39e-01 | 0.153000 | 3.47e-01 |
Intracellular signaling by second messengers | 302 | 1.41e-01 | 0.049300 | 3.52e-01 |
Negative regulation of MAPK pathway | 42 | 1.42e-01 | 0.131000 | 3.52e-01 |
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | 37 | 1.42e-01 | 0.139000 | 3.53e-01 |
Chylomicron assembly | 10 | 1.44e-01 | -0.267000 | 3.56e-01 |
SARS-CoV Infections | 138 | 1.45e-01 | 0.072000 | 3.56e-01 |
APC-Cdc20 mediated degradation of Nek2A | 24 | 1.45e-01 | -0.172000 | 3.56e-01 |
Collagen degradation | 36 | 1.45e-01 | -0.140000 | 3.56e-01 |
Apoptosis induced DNA fragmentation | 12 | 1.46e-01 | -0.242000 | 3.56e-01 |
Signaling by Non-Receptor Tyrosine Kinases | 53 | 1.46e-01 | -0.115000 | 3.56e-01 |
Signaling by PTK6 | 53 | 1.46e-01 | -0.115000 | 3.56e-01 |
Cellular hexose transport | 19 | 1.46e-01 | 0.193000 | 3.56e-01 |
Apoptotic cleavage of cell adhesion proteins | 11 | 1.46e-01 | -0.253000 | 3.56e-01 |
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 11 | 1.47e-01 | 0.253000 | 3.56e-01 |
SUMOylation of DNA replication proteins | 44 | 1.47e-01 | -0.127000 | 3.56e-01 |
Pausing and recovery of Tat-mediated HIV elongation | 32 | 1.47e-01 | 0.148000 | 3.56e-01 |
Tat-mediated HIV elongation arrest and recovery | 32 | 1.47e-01 | 0.148000 | 3.56e-01 |
HIV Life Cycle | 142 | 1.48e-01 | 0.070400 | 3.57e-01 |
Tandem pore domain potassium channels | 11 | 1.48e-01 | -0.252000 | 3.57e-01 |
Acyl chain remodelling of PC | 26 | 1.48e-01 | 0.164000 | 3.57e-01 |
RNA Polymerase II Transcription | 1083 | 1.49e-01 | -0.026200 | 3.57e-01 |
Signaling by FGFR2 IIIa TM | 17 | 1.49e-01 | 0.202000 | 3.57e-01 |
p75 NTR receptor-mediated signalling | 92 | 1.49e-01 | -0.087100 | 3.57e-01 |
STING mediated induction of host immune responses | 16 | 1.49e-01 | 0.208000 | 3.58e-01 |
Response of Mtb to phagocytosis | 21 | 1.50e-01 | 0.182000 | 3.58e-01 |
Uptake and function of anthrax toxins | 10 | 1.50e-01 | 0.263000 | 3.58e-01 |
Negative regulation of the PI3K/AKT network | 106 | 1.50e-01 | -0.080900 | 3.58e-01 |
Abortive elongation of HIV-1 transcript in the absence of Tat | 21 | 1.51e-01 | 0.181000 | 3.60e-01 |
RA biosynthesis pathway | 18 | 1.53e-01 | 0.195000 | 3.62e-01 |
RNA Polymerase I Promoter Clearance | 56 | 1.53e-01 | 0.110000 | 3.62e-01 |
RNA Polymerase I Transcription | 56 | 1.53e-01 | 0.110000 | 3.62e-01 |
Signaling by NOTCH2 | 29 | 1.53e-01 | 0.153000 | 3.62e-01 |
Regulation of KIT signaling | 16 | 1.54e-01 | -0.206000 | 3.62e-01 |
Interferon alpha/beta signaling | 63 | 1.54e-01 | -0.104000 | 3.62e-01 |
Presynaptic nicotinic acetylcholine receptors | 10 | 1.54e-01 | -0.260000 | 3.62e-01 |
SHC1 events in EGFR signaling | 14 | 1.55e-01 | -0.219000 | 3.65e-01 |
Norepinephrine Neurotransmitter Release Cycle | 18 | 1.58e-01 | 0.192000 | 3.70e-01 |
GRB2 events in EGFR signaling | 13 | 1.58e-01 | -0.226000 | 3.70e-01 |
Molecules associated with elastic fibres | 28 | 1.59e-01 | -0.154000 | 3.70e-01 |
Signaling by FGFR4 in disease | 11 | 1.59e-01 | -0.245000 | 3.71e-01 |
Transcriptional Regulation by MECP2 | 56 | 1.60e-01 | 0.109000 | 3.72e-01 |
Glutathione conjugation | 30 | 1.62e-01 | -0.148000 | 3.76e-01 |
Serotonin Neurotransmitter Release Cycle | 18 | 1.62e-01 | 0.190000 | 3.76e-01 |
Cilium Assembly | 180 | 1.63e-01 | -0.060400 | 3.76e-01 |
G beta:gamma signalling through PLC beta | 20 | 1.63e-01 | -0.180000 | 3.76e-01 |
MicroRNA (miRNA) biogenesis | 24 | 1.63e-01 | 0.165000 | 3.76e-01 |
Late Phase of HIV Life Cycle | 130 | 1.63e-01 | 0.070900 | 3.76e-01 |
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | 16 | 1.63e-01 | -0.201000 | 3.76e-01 |
Diseases of hemostasis | 16 | 1.63e-01 | -0.201000 | 3.76e-01 |
G1/S-Specific Transcription | 29 | 1.64e-01 | -0.149000 | 3.76e-01 |
DCC mediated attractive signaling | 14 | 1.65e-01 | -0.215000 | 3.76e-01 |
Acetylcholine binding and downstream events | 11 | 1.65e-01 | -0.242000 | 3.76e-01 |
Postsynaptic nicotinic acetylcholine receptors | 11 | 1.65e-01 | -0.242000 | 3.76e-01 |
Formation of HIV elongation complex in the absence of HIV Tat | 46 | 1.65e-01 | 0.118000 | 3.77e-01 |
FGFR2 mutant receptor activation | 28 | 1.66e-01 | 0.151000 | 3.78e-01 |
Processing of Capped Intron-Containing Pre-mRNA | 227 | 1.66e-01 | -0.053400 | 3.78e-01 |
Aspartate and asparagine metabolism | 10 | 1.66e-01 | 0.253000 | 3.78e-01 |
Creatine metabolism | 10 | 1.67e-01 | 0.253000 | 3.78e-01 |
rRNA modification in the nucleus and cytosol | 57 | 1.67e-01 | 0.106000 | 3.79e-01 |
Regulation of localization of FOXO transcription factors | 11 | 1.70e-01 | 0.239000 | 3.84e-01 |
Interaction With Cumulus Cells And The Zona Pellucida | 10 | 1.70e-01 | -0.251000 | 3.84e-01 |
Caspase-mediated cleavage of cytoskeletal proteins | 12 | 1.70e-01 | 0.229000 | 3.84e-01 |
TRAF6 mediated IRF7 activation | 26 | 1.71e-01 | -0.155000 | 3.84e-01 |
Telomere Extension By Telomerase | 23 | 1.71e-01 | -0.165000 | 3.84e-01 |
Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC) | 10 | 1.72e-01 | -0.249000 | 3.86e-01 |
TNFR1-induced NFkappaB signaling pathway | 26 | 1.73e-01 | 0.155000 | 3.86e-01 |
SUMOylation of DNA methylation proteins | 16 | 1.73e-01 | 0.197000 | 3.87e-01 |
Unblocking of NMDA receptors, glutamate binding and activation | 20 | 1.76e-01 | 0.175000 | 3.90e-01 |
Folding of actin by CCT/TriC | 10 | 1.76e-01 | 0.247000 | 3.90e-01 |
Translation of structural proteins | 27 | 1.76e-01 | 0.151000 | 3.90e-01 |
Synthesis of IP2, IP, and Ins in the cytosol | 14 | 1.76e-01 | 0.209000 | 3.90e-01 |
SUMOylation | 163 | 1.76e-01 | -0.061500 | 3.90e-01 |
IRF3-mediated induction of type I IFN | 13 | 1.77e-01 | 0.216000 | 3.92e-01 |
RIP-mediated NFkB activation via ZBP1 | 15 | 1.78e-01 | 0.201000 | 3.92e-01 |
Membrane binding and targetting of GAG proteins | 13 | 1.78e-01 | 0.216000 | 3.92e-01 |
Synthesis And Processing Of GAG, GAGPOL Polyproteins | 13 | 1.78e-01 | 0.216000 | 3.92e-01 |
Integrin cell surface interactions | 60 | 1.78e-01 | -0.101000 | 3.92e-01 |
GPVI-mediated activation cascade | 32 | 1.78e-01 | -0.138000 | 3.92e-01 |
RHO GTPases activate PKNs | 44 | 1.79e-01 | -0.117000 | 3.93e-01 |
Defective B3GALT6 causes EDSP2 and SEMDJL1 | 19 | 1.81e-01 | -0.177000 | 3.96e-01 |
Sealing of the nuclear envelope (NE) by ESCRT-III | 24 | 1.81e-01 | 0.158000 | 3.96e-01 |
Interleukin-37 signaling | 19 | 1.81e-01 | 0.177000 | 3.96e-01 |
Sphingolipid de novo biosynthesis | 43 | 1.82e-01 | -0.118000 | 3.97e-01 |
cGMP effects | 15 | 1.84e-01 | -0.198000 | 4.01e-01 |
RNA Polymerase I Promoter Escape | 38 | 1.84e-01 | 0.125000 | 4.01e-01 |
p130Cas linkage to MAPK signaling for integrins | 15 | 1.85e-01 | -0.198000 | 4.01e-01 |
The canonical retinoid cycle in rods (twilight vision) | 23 | 1.85e-01 | -0.160000 | 4.02e-01 |
Interleukin-15 signaling | 14 | 1.85e-01 | 0.204000 | 4.02e-01 |
PD-1 signaling | 18 | 1.87e-01 | 0.180000 | 4.02e-01 |
IRAK4 deficiency (TLR2/4) | 10 | 1.87e-01 | -0.241000 | 4.02e-01 |
MAPK targets/ Nuclear events mediated by MAP kinases | 30 | 1.87e-01 | 0.139000 | 4.02e-01 |
Nuclear Pore Complex (NPC) Disassembly | 34 | 1.88e-01 | -0.131000 | 4.02e-01 |
Glutamate binding, activation of AMPA receptors and synaptic plasticity | 29 | 1.88e-01 | 0.141000 | 4.02e-01 |
Trafficking of AMPA receptors | 29 | 1.88e-01 | 0.141000 | 4.02e-01 |
Defective EXT1 causes exostoses 1, TRPS2 and CHDS | 13 | 1.89e-01 | -0.211000 | 4.04e-01 |
Defective EXT2 causes exostoses 2 | 13 | 1.89e-01 | -0.211000 | 4.04e-01 |
Activation of HOX genes during differentiation | 65 | 1.89e-01 | -0.094100 | 4.04e-01 |
Activation of anterior HOX genes in hindbrain development during early embryogenesis | 65 | 1.89e-01 | -0.094100 | 4.04e-01 |
Plasma lipoprotein assembly | 18 | 1.90e-01 | -0.178000 | 4.05e-01 |
CREB1 phosphorylation through the activation of Adenylate Cyclase | 11 | 1.91e-01 | 0.228000 | 4.05e-01 |
Long-term potentiation | 22 | 1.91e-01 | 0.161000 | 4.05e-01 |
Growth hormone receptor signaling | 21 | 1.91e-01 | 0.165000 | 4.05e-01 |
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 74 | 1.91e-01 | 0.087900 | 4.05e-01 |
Organic anion transporters | 10 | 1.92e-01 | 0.239000 | 4.05e-01 |
Platelet activation, signaling and aggregation | 252 | 1.92e-01 | -0.047800 | 4.05e-01 |
Removal of the Flap Intermediate from the C-strand | 16 | 1.93e-01 | -0.188000 | 4.07e-01 |
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | 12 | 1.93e-01 | -0.217000 | 4.07e-01 |
MET activates RAP1 and RAC1 | 11 | 1.94e-01 | -0.226000 | 4.07e-01 |
NOTCH3 Activation and Transmission of Signal to the Nucleus | 23 | 1.94e-01 | 0.156000 | 4.07e-01 |
Regulation of TNFR1 signaling | 34 | 1.94e-01 | 0.129000 | 4.07e-01 |
Pre-NOTCH Expression and Processing | 63 | 1.98e-01 | -0.093900 | 4.14e-01 |
Cohesin Loading onto Chromatin | 10 | 1.98e-01 | -0.235000 | 4.14e-01 |
Formation of HIV-1 elongation complex containing HIV-1 Tat | 44 | 1.99e-01 | 0.112000 | 4.14e-01 |
HIV Transcription Elongation | 44 | 1.99e-01 | 0.112000 | 4.14e-01 |
Tat-mediated elongation of the HIV-1 transcript | 44 | 1.99e-01 | 0.112000 | 4.14e-01 |
Signaling by FGFR3 fusions in cancer | 10 | 2.00e-01 | -0.234000 | 4.15e-01 |
Na+/Cl- dependent neurotransmitter transporters | 17 | 2.00e-01 | -0.179000 | 4.15e-01 |
G beta:gamma signalling through PI3Kgamma | 25 | 2.01e-01 | -0.148000 | 4.16e-01 |
L1CAM interactions | 98 | 2.02e-01 | 0.074700 | 4.17e-01 |
Aberrant regulation of mitotic cell cycle due to RB1 defects | 35 | 2.04e-01 | -0.124000 | 4.21e-01 |
Diseases of mitotic cell cycle | 35 | 2.04e-01 | -0.124000 | 4.21e-01 |
Zinc influx into cells by the SLC39 gene family | 10 | 2.04e-01 | -0.232000 | 4.21e-01 |
Endosomal/Vacuolar pathway | 10 | 2.06e-01 | -0.231000 | 4.23e-01 |
Potential therapeutics for SARS | 76 | 2.08e-01 | 0.083600 | 4.26e-01 |
Transcriptional Regulation by TP53 | 342 | 2.08e-01 | 0.039700 | 4.26e-01 |
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 22 | 2.09e-01 | 0.155000 | 4.26e-01 |
NR1H2 and NR1H3-mediated signaling | 48 | 2.09e-01 | -0.105000 | 4.26e-01 |
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 24 | 2.09e-01 | -0.148000 | 4.26e-01 |
Purine salvage | 13 | 2.10e-01 | 0.201000 | 4.26e-01 |
HIV Transcription Initiation | 42 | 2.10e-01 | 0.112000 | 4.26e-01 |
RNA Polymerase II HIV Promoter Escape | 42 | 2.10e-01 | 0.112000 | 4.26e-01 |
RNA Polymerase II Promoter Escape | 42 | 2.10e-01 | 0.112000 | 4.26e-01 |
RNA Polymerase II Transcription Initiation | 42 | 2.10e-01 | 0.112000 | 4.26e-01 |
RNA Polymerase II Transcription Initiation And Promoter Clearance | 42 | 2.10e-01 | 0.112000 | 4.26e-01 |
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 42 | 2.10e-01 | 0.112000 | 4.26e-01 |
Digestion and absorption | 21 | 2.12e-01 | -0.157000 | 4.28e-01 |
O-glycosylation of TSR domain-containing proteins | 37 | 2.12e-01 | -0.118000 | 4.28e-01 |
Thrombin signalling through proteinase activated receptors (PARs) | 31 | 2.13e-01 | -0.129000 | 4.30e-01 |
EPHA-mediated growth cone collapse | 15 | 2.15e-01 | -0.185000 | 4.33e-01 |
Chemokine receptors bind chemokines | 42 | 2.17e-01 | -0.110000 | 4.35e-01 |
SUMO E3 ligases SUMOylate target proteins | 157 | 2.17e-01 | -0.057200 | 4.35e-01 |
Activated NOTCH1 Transmits Signal to the Nucleus | 30 | 2.19e-01 | 0.130000 | 4.38e-01 |
EPH-Ephrin signaling | 90 | 2.21e-01 | -0.074600 | 4.43e-01 |
CD209 (DC-SIGN) signaling | 19 | 2.24e-01 | -0.161000 | 4.46e-01 |
Transcriptional Regulation by E2F6 | 32 | 2.25e-01 | -0.124000 | 4.49e-01 |
Passive transport by Aquaporins | 11 | 2.27e-01 | 0.210000 | 4.52e-01 |
ABC transporters in lipid homeostasis | 17 | 2.29e-01 | 0.169000 | 4.54e-01 |
Organelle biogenesis and maintenance | 267 | 2.29e-01 | 0.042900 | 4.54e-01 |
GTP hydrolysis and joining of the 60S ribosomal subunit | 87 | 2.30e-01 | 0.074500 | 4.55e-01 |
Deadenylation-dependent mRNA decay | 51 | 2.30e-01 | -0.097200 | 4.55e-01 |
RAF-independent MAPK1/3 activation | 23 | 2.31e-01 | 0.144000 | 4.56e-01 |
Phenylalanine and tyrosine metabolism | 11 | 2.32e-01 | -0.208000 | 4.58e-01 |
Arachidonic acid metabolism | 54 | 2.33e-01 | -0.093900 | 4.59e-01 |
Signaling by PDGF | 50 | 2.33e-01 | -0.097600 | 4.59e-01 |
Dual Incision in GG-NER | 39 | 2.34e-01 | 0.110000 | 4.60e-01 |
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 29 | 2.34e-01 | -0.128000 | 4.60e-01 |
Regulation of PTEN gene transcription | 58 | 2.34e-01 | 0.090300 | 4.60e-01 |
L13a-mediated translational silencing of Ceruloplasmin expression | 85 | 2.37e-01 | 0.074200 | 4.65e-01 |
Semaphorin interactions | 63 | 2.39e-01 | -0.085700 | 4.69e-01 |
Interferon Signaling | 178 | 2.40e-01 | 0.051100 | 4.69e-01 |
Nicotinamide salvaging | 19 | 2.41e-01 | 0.155000 | 4.70e-01 |
InlB-mediated entry of Listeria monocytogenes into host cell | 14 | 2.41e-01 | 0.181000 | 4.70e-01 |
p75NTR recruits signalling complexes | 12 | 2.45e-01 | 0.194000 | 4.77e-01 |
HDR through MMEJ (alt-NHEJ) | 10 | 2.46e-01 | -0.212000 | 4.79e-01 |
TP53 Regulates Transcription of Cell Cycle Genes | 47 | 2.47e-01 | -0.097700 | 4.79e-01 |
Glutamate Neurotransmitter Release Cycle | 24 | 2.50e-01 | 0.136000 | 4.83e-01 |
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | 31 | 2.50e-01 | -0.119000 | 4.83e-01 |
Regulation of Glucokinase by Glucokinase Regulatory Protein | 31 | 2.50e-01 | -0.119000 | 4.83e-01 |
Infection with Mycobacterium tuberculosis | 25 | 2.53e-01 | 0.132000 | 4.87e-01 |
Cytokine Signaling in Immune system | 787 | 2.53e-01 | 0.024100 | 4.87e-01 |
Nucleotide-like (purinergic) receptors | 15 | 2.53e-01 | 0.170000 | 4.88e-01 |
ADP signalling through P2Y purinoceptor 1 | 24 | 2.54e-01 | -0.134000 | 4.89e-01 |
Regulation of TLR by endogenous ligand | 15 | 2.59e-01 | -0.168000 | 4.97e-01 |
Acyl chain remodelling of PI | 16 | 2.59e-01 | 0.163000 | 4.97e-01 |
Metabolism of Angiotensinogen to Angiotensins | 17 | 2.61e-01 | -0.158000 | 4.99e-01 |
Urea cycle | 10 | 2.61e-01 | -0.205000 | 4.99e-01 |
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 46 | 2.61e-01 | -0.095800 | 4.99e-01 |
Nucleobase catabolism | 35 | 2.62e-01 | 0.110000 | 4.99e-01 |
Amyloid fiber formation | 56 | 2.62e-01 | -0.086700 | 4.99e-01 |
TP53 Regulates Transcription of Cell Death Genes | 34 | 2.63e-01 | -0.111000 | 5.01e-01 |
GAB1 signalosome | 17 | 2.64e-01 | -0.157000 | 5.01e-01 |
Diseases associated with glycosaminoglycan metabolism | 39 | 2.64e-01 | -0.103000 | 5.02e-01 |
Methylation | 14 | 2.66e-01 | 0.172000 | 5.03e-01 |
Basigin interactions | 24 | 2.68e-01 | -0.131000 | 5.07e-01 |
Suppression of phagosomal maturation | 12 | 2.69e-01 | 0.184000 | 5.07e-01 |
Transport of the SLBP Dependant Mature mRNA | 35 | 2.69e-01 | -0.108000 | 5.07e-01 |
ISG15 antiviral mechanism | 69 | 2.69e-01 | 0.077000 | 5.07e-01 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 50 | 2.72e-01 | 0.089900 | 5.10e-01 |
Defective B3GAT3 causes JDSSDHD | 19 | 2.72e-01 | -0.146000 | 5.10e-01 |
Tryptophan catabolism | 14 | 2.72e-01 | -0.170000 | 5.10e-01 |
Bicarbonate transporters | 10 | 2.72e-01 | 0.201000 | 5.10e-01 |
APC/C:Cdc20 mediated degradation of Cyclin B | 22 | 2.73e-01 | -0.135000 | 5.12e-01 |
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | 16 | 2.74e-01 | -0.158000 | 5.12e-01 |
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 11 | 2.74e-01 | 0.190000 | 5.12e-01 |
Phase II - Conjugation of compounds | 79 | 2.75e-01 | -0.071100 | 5.13e-01 |
Cell-cell junction organization | 60 | 2.76e-01 | -0.081400 | 5.13e-01 |
RHO GTPases activate KTN1 | 10 | 2.77e-01 | 0.198000 | 5.13e-01 |
G alpha (z) signalling events | 48 | 2.77e-01 | -0.090700 | 5.13e-01 |
Signaling by VEGF | 100 | 2.78e-01 | -0.062900 | 5.13e-01 |
PI3K/AKT Signaling in Cancer | 97 | 2.78e-01 | -0.063800 | 5.13e-01 |
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 17 | 2.79e-01 | -0.152000 | 5.13e-01 |
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 17 | 2.79e-01 | -0.152000 | 5.13e-01 |
WNT5A-dependent internalization of FZD4 | 15 | 2.79e-01 | 0.161000 | 5.13e-01 |
RHO GTPases activate PAKs | 21 | 2.79e-01 | -0.136000 | 5.13e-01 |
Neurexins and neuroligins | 54 | 2.79e-01 | -0.085100 | 5.13e-01 |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 54 | 2.81e-01 | 0.084900 | 5.13e-01 |
Constitutive Signaling by NOTCH1 PEST Domain Mutants | 54 | 2.81e-01 | 0.084900 | 5.13e-01 |
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 54 | 2.81e-01 | 0.084900 | 5.13e-01 |
Signaling by NOTCH1 PEST Domain Mutants in Cancer | 54 | 2.81e-01 | 0.084900 | 5.13e-01 |
Signaling by NOTCH1 in Cancer | 54 | 2.81e-01 | 0.084900 | 5.13e-01 |
Influenza Infection | 128 | 2.81e-01 | 0.055200 | 5.13e-01 |
Processive synthesis on the lagging strand | 14 | 2.81e-01 | -0.166000 | 5.13e-01 |
Thromboxane signalling through TP receptor | 23 | 2.81e-01 | -0.130000 | 5.13e-01 |
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | 11 | 2.83e-01 | 0.187000 | 5.16e-01 |
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 16 | 2.84e-01 | -0.155000 | 5.16e-01 |
COPII-mediated vesicle transport | 61 | 2.85e-01 | 0.079200 | 5.17e-01 |
Vpr-mediated nuclear import of PICs | 32 | 2.85e-01 | -0.109000 | 5.17e-01 |
SLC-mediated transmembrane transport | 235 | 2.86e-01 | -0.040500 | 5.18e-01 |
Downstream signaling of activated FGFR1 | 28 | 2.87e-01 | -0.116000 | 5.19e-01 |
Regulation of TP53 Activity through Methylation | 16 | 2.87e-01 | 0.154000 | 5.19e-01 |
Keratan sulfate biosynthesis | 26 | 2.88e-01 | -0.120000 | 5.19e-01 |
SUMOylation of SUMOylation proteins | 34 | 2.88e-01 | -0.105000 | 5.19e-01 |
Integration of energy metabolism | 103 | 2.89e-01 | -0.060500 | 5.19e-01 |
Miscellaneous transport and binding events | 23 | 2.89e-01 | -0.128000 | 5.19e-01 |
Lysosphingolipid and LPA receptors | 14 | 2.90e-01 | -0.163000 | 5.19e-01 |
SUMOylation of ubiquitinylation proteins | 38 | 2.90e-01 | -0.099300 | 5.19e-01 |
SUMOylation of intracellular receptors | 30 | 2.90e-01 | -0.112000 | 5.19e-01 |
Gene expression (Transcription) | 1215 | 2.90e-01 | -0.018100 | 5.20e-01 |
Transport of the SLBP independent Mature mRNA | 34 | 2.92e-01 | -0.105000 | 5.21e-01 |
Caspase activation via Death Receptors in the presence of ligand | 11 | 2.93e-01 | -0.183000 | 5.23e-01 |
Negative epigenetic regulation of rRNA expression | 57 | 2.93e-01 | 0.080500 | 5.23e-01 |
Transcription of the HIV genome | 68 | 2.93e-01 | 0.073700 | 5.23e-01 |
Anchoring of the basal body to the plasma membrane | 94 | 2.94e-01 | -0.062700 | 5.23e-01 |
NEP/NS2 Interacts with the Cellular Export Machinery | 31 | 2.95e-01 | -0.109000 | 5.24e-01 |
Neurotransmitter clearance | 10 | 2.98e-01 | -0.190000 | 5.29e-01 |
Acyl chain remodelling of PE | 26 | 3.01e-01 | 0.117000 | 5.34e-01 |
AURKA Activation by TPX2 | 70 | 3.02e-01 | -0.071400 | 5.34e-01 |
MAPK3 (ERK1) activation | 10 | 3.03e-01 | 0.188000 | 5.36e-01 |
Metabolism of porphyrins | 24 | 3.04e-01 | 0.121000 | 5.36e-01 |
NOD1/2 Signaling Pathway | 30 | 3.05e-01 | 0.108000 | 5.37e-01 |
RNA Polymerase III Abortive And Retractive Initiation | 37 | 3.05e-01 | 0.097400 | 5.37e-01 |
RNA Polymerase III Transcription | 37 | 3.05e-01 | 0.097400 | 5.37e-01 |
Translation initiation complex formation | 49 | 3.07e-01 | 0.084400 | 5.40e-01 |
SUMOylation of chromatin organization proteins | 56 | 3.08e-01 | -0.078700 | 5.41e-01 |
Metabolism of steroid hormones | 27 | 3.13e-01 | -0.112000 | 5.49e-01 |
MET receptor recycling | 10 | 3.15e-01 | 0.184000 | 5.51e-01 |
Endogenous sterols | 24 | 3.16e-01 | -0.118000 | 5.52e-01 |
Signaling by high-kinase activity BRAF mutants | 34 | 3.16e-01 | -0.099400 | 5.52e-01 |
Regulation of signaling by CBL | 18 | 3.17e-01 | -0.136000 | 5.52e-01 |
Bile acid and bile salt metabolism | 38 | 3.17e-01 | -0.093800 | 5.52e-01 |
Heparan sulfate/heparin (HS-GAG) metabolism | 51 | 3.18e-01 | -0.080900 | 5.52e-01 |
Effects of PIP2 hydrolysis | 26 | 3.18e-01 | -0.113000 | 5.52e-01 |
TP53 Regulates Transcription of Caspase Activators and Caspases | 10 | 3.18e-01 | 0.182000 | 5.53e-01 |
LDL clearance | 18 | 3.20e-01 | 0.136000 | 5.54e-01 |
HDACs deacetylate histones | 39 | 3.20e-01 | -0.092100 | 5.54e-01 |
Processing and activation of SUMO | 10 | 3.21e-01 | -0.181000 | 5.56e-01 |
Assembly and cell surface presentation of NMDA receptors | 23 | 3.24e-01 | 0.119000 | 5.59e-01 |
NRIF signals cell death from the nucleus | 15 | 3.24e-01 | 0.147000 | 5.59e-01 |
Defective B4GALT7 causes EDS, progeroid type | 19 | 3.25e-01 | -0.130000 | 5.61e-01 |
Signaling by EGFR in Cancer | 23 | 3.28e-01 | -0.118000 | 5.62e-01 |
Signaling by FGFR1 | 44 | 3.28e-01 | -0.085200 | 5.62e-01 |
Signaling by FGFR in disease | 57 | 3.28e-01 | 0.074900 | 5.62e-01 |
Formation of RNA Pol II elongation complex | 59 | 3.28e-01 | 0.073600 | 5.62e-01 |
RNA Polymerase II Transcription Elongation | 59 | 3.28e-01 | 0.073600 | 5.62e-01 |
Metalloprotease DUBs | 18 | 3.28e-01 | 0.133000 | 5.62e-01 |
Notch-HLH transcription pathway | 26 | 3.30e-01 | -0.110000 | 5.64e-01 |
Signal regulatory protein family interactions | 12 | 3.30e-01 | 0.162000 | 5.64e-01 |
Synthesis of glycosylphosphatidylinositol (GPI) | 17 | 3.32e-01 | -0.136000 | 5.65e-01 |
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 19 | 3.32e-01 | -0.129000 | 5.65e-01 |
Metabolism of water-soluble vitamins and cofactors | 119 | 3.33e-01 | 0.051500 | 5.66e-01 |
mRNA Splicing | 176 | 3.34e-01 | -0.042300 | 5.67e-01 |
Heme degradation | 13 | 3.34e-01 | -0.155000 | 5.67e-01 |
Resolution of Abasic Sites (AP sites) | 37 | 3.35e-01 | -0.091600 | 5.68e-01 |
Regulation of TP53 Activity through Acetylation | 28 | 3.36e-01 | 0.105000 | 5.69e-01 |
Signaling by FGFR | 74 | 3.37e-01 | -0.064600 | 5.70e-01 |
Regulation of TP53 Expression and Degradation | 34 | 3.39e-01 | 0.094900 | 5.72e-01 |
Cargo concentration in the ER | 29 | 3.39e-01 | 0.103000 | 5.72e-01 |
FGFRL1 modulation of FGFR1 signaling | 11 | 3.42e-01 | -0.165000 | 5.76e-01 |
Signaling by BMP | 26 | 3.42e-01 | 0.108000 | 5.76e-01 |
Polo-like kinase mediated events | 15 | 3.45e-01 | -0.141000 | 5.79e-01 |
Synthesis of DNA | 115 | 3.45e-01 | 0.051000 | 5.79e-01 |
Elevation of cytosolic Ca2+ levels | 16 | 3.46e-01 | -0.136000 | 5.80e-01 |
Regulation of TP53 Degradation | 33 | 3.46e-01 | 0.094800 | 5.80e-01 |
Interleukin-7 signaling | 23 | 3.46e-01 | 0.113000 | 5.80e-01 |
Mitotic Prophase | 89 | 3.47e-01 | -0.057700 | 5.80e-01 |
Listeria monocytogenes entry into host cells | 19 | 3.47e-01 | 0.125000 | 5.80e-01 |
Lysine catabolism | 12 | 3.49e-01 | 0.156000 | 5.82e-01 |
Erythropoietin activates RAS | 14 | 3.49e-01 | -0.144000 | 5.82e-01 |
Signaling by NTRKs | 129 | 3.49e-01 | 0.047700 | 5.82e-01 |
NOTCH3 Intracellular Domain Regulates Transcription | 22 | 3.52e-01 | -0.115000 | 5.84e-01 |
Vitamin B5 (pantothenate) metabolism | 15 | 3.54e-01 | -0.138000 | 5.88e-01 |
Insulin receptor recycling | 25 | 3.56e-01 | 0.107000 | 5.90e-01 |
Signaling by ERBB2 in Cancer | 24 | 3.57e-01 | -0.109000 | 5.91e-01 |
Removal of the Flap Intermediate | 13 | 3.58e-01 | -0.147000 | 5.91e-01 |
Signaling by NTRK1 (TRKA) | 110 | 3.58e-01 | 0.050800 | 5.91e-01 |
Pregnenolone biosynthesis | 11 | 3.63e-01 | -0.158000 | 5.99e-01 |
Biosynthesis of DHA-derived SPMs | 16 | 3.63e-01 | -0.131000 | 5.99e-01 |
TP53 Regulates Transcription of DNA Repair Genes | 61 | 3.65e-01 | 0.067100 | 5.99e-01 |
HATs acetylate histones | 84 | 3.65e-01 | 0.057200 | 5.99e-01 |
RHO GTPases Activate NADPH Oxidases | 23 | 3.65e-01 | 0.109000 | 5.99e-01 |
Synthesis of bile acids and bile salts via 27-hydroxycholesterol | 11 | 3.65e-01 | -0.158000 | 5.99e-01 |
G2/M Transition | 175 | 3.66e-01 | 0.039700 | 5.99e-01 |
Neuronal System | 368 | 3.67e-01 | -0.027500 | 6.00e-01 |
Intraflagellar transport | 39 | 3.67e-01 | -0.083400 | 6.00e-01 |
Prostacyclin signalling through prostacyclin receptor | 19 | 3.67e-01 | -0.119000 | 6.00e-01 |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 12 | 3.68e-01 | -0.150000 | 6.00e-01 |
Signal amplification | 32 | 3.68e-01 | -0.091900 | 6.00e-01 |
TRAF6-mediated induction of TAK1 complex within TLR4 complex | 12 | 3.70e-01 | 0.149000 | 6.02e-01 |
Formation of ATP by chemiosmotic coupling | 15 | 3.71e-01 | 0.133000 | 6.02e-01 |
Nuclear import of Rev protein | 33 | 3.71e-01 | -0.090000 | 6.02e-01 |
Formation of the beta-catenin:TCF transactivating complex | 41 | 3.71e-01 | -0.080700 | 6.02e-01 |
mRNA Splicing - Major Pathway | 168 | 3.71e-01 | -0.040000 | 6.02e-01 |
Interleukin-12 family signaling | 50 | 3.72e-01 | 0.073000 | 6.02e-01 |
SIRT1 negatively regulates rRNA expression | 18 | 3.73e-01 | -0.121000 | 6.03e-01 |
NF-kB is activated and signals survival | 11 | 3.73e-01 | 0.155000 | 6.03e-01 |
Cyclin D associated events in G1 | 43 | 3.74e-01 | -0.078300 | 6.03e-01 |
G1 Phase | 43 | 3.74e-01 | -0.078300 | 6.03e-01 |
Ribosomal scanning and start codon recognition | 50 | 3.75e-01 | 0.072500 | 6.03e-01 |
Inhibition of DNA recombination at telomere | 29 | 3.75e-01 | -0.095200 | 6.03e-01 |
Glycerophospholipid biosynthesis | 124 | 3.75e-01 | 0.046100 | 6.03e-01 |
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 28 | 3.76e-01 | 0.096700 | 6.03e-01 |
Detoxification of Reactive Oxygen Species | 33 | 3.77e-01 | 0.089000 | 6.04e-01 |
Generic Transcription Pathway | 967 | 3.78e-01 | -0.016900 | 6.05e-01 |
Transport of vitamins, nucleosides, and related molecules | 41 | 3.79e-01 | -0.079400 | 6.06e-01 |
Formation of a pool of free 40S subunits | 77 | 3.80e-01 | 0.057900 | 6.07e-01 |
Ephrin signaling | 19 | 3.81e-01 | -0.116000 | 6.07e-01 |
FGFR2 ligand binding and activation | 15 | 3.81e-01 | 0.131000 | 6.08e-01 |
Plasma lipoprotein clearance | 32 | 3.84e-01 | 0.088900 | 6.12e-01 |
Immune System | 1904 | 3.85e-01 | 0.012200 | 6.13e-01 |
Organic cation/anion/zwitterion transport | 12 | 3.87e-01 | -0.144000 | 6.14e-01 |
Metal ion SLC transporters | 26 | 3.89e-01 | -0.097600 | 6.17e-01 |
Regulation of signaling by NODAL | 10 | 3.89e-01 | -0.157000 | 6.17e-01 |
p75NTR signals via NF-kB | 14 | 3.90e-01 | 0.133000 | 6.17e-01 |
Signaling by SCF-KIT | 42 | 3.90e-01 | -0.076700 | 6.17e-01 |
NoRC negatively regulates rRNA expression | 54 | 3.91e-01 | 0.067600 | 6.17e-01 |
Transport of Ribonucleoproteins into the Host Nucleus | 31 | 3.93e-01 | -0.088700 | 6.20e-01 |
Ion transport by P-type ATPases | 51 | 3.93e-01 | -0.069100 | 6.20e-01 |
Intrinsic Pathway for Apoptosis | 47 | 3.96e-01 | 0.071600 | 6.23e-01 |
Negative regulation of TCF-dependent signaling by WNT ligand antagonists | 15 | 3.96e-01 | -0.127000 | 6.23e-01 |
RNA Polymerase II Pre-transcription Events | 79 | 3.97e-01 | 0.055100 | 6.24e-01 |
Antiviral mechanism by IFN-stimulated genes | 77 | 3.98e-01 | 0.055700 | 6.25e-01 |
DNA Repair | 281 | 3.99e-01 | -0.029300 | 6.25e-01 |
Stimuli-sensing channels | 96 | 4.00e-01 | -0.049800 | 6.25e-01 |
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 41 | 4.00e-01 | -0.076000 | 6.25e-01 |
CD28 co-stimulation | 33 | 4.00e-01 | -0.084700 | 6.25e-01 |
Transcriptional Regulation by VENTX | 36 | 4.01e-01 | -0.080900 | 6.26e-01 |
Downstream signal transduction | 29 | 4.04e-01 | 0.089500 | 6.30e-01 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 49 | 4.05e-01 | 0.068800 | 6.31e-01 |
Apoptotic factor-mediated response | 15 | 4.06e-01 | 0.124000 | 6.31e-01 |
Neutrophil degranulation | 441 | 4.06e-01 | 0.023100 | 6.31e-01 |
Retrograde transport at the Trans-Golgi-Network | 46 | 4.07e-01 | 0.070700 | 6.31e-01 |
Beta defensins | 12 | 4.07e-01 | -0.138000 | 6.31e-01 |
SUMOylation of DNA damage response and repair proteins | 73 | 4.07e-01 | -0.056100 | 6.31e-01 |
Mitotic G2-G2/M phases | 177 | 4.09e-01 | 0.036000 | 6.34e-01 |
Formation of apoptosome | 10 | 4.12e-01 | 0.150000 | 6.37e-01 |
Regulation of the apoptosome activity | 10 | 4.12e-01 | 0.150000 | 6.37e-01 |
Gastrin-CREB signalling pathway via PKC and MAPK | 17 | 4.15e-01 | -0.114000 | 6.40e-01 |
Diseases associated with N-glycosylation of proteins | 16 | 4.16e-01 | -0.117000 | 6.40e-01 |
RHO GTPases Activate ROCKs | 19 | 4.17e-01 | -0.108000 | 6.40e-01 |
IL-6-type cytokine receptor ligand interactions | 17 | 4.17e-01 | 0.114000 | 6.40e-01 |
MECP2 regulates neuronal receptors and channels | 16 | 4.17e-01 | -0.117000 | 6.40e-01 |
Cargo recognition for clathrin-mediated endocytosis | 101 | 4.18e-01 | 0.046700 | 6.40e-01 |
Adenylate cyclase activating pathway | 10 | 4.18e-01 | -0.148000 | 6.40e-01 |
Diseases associated with visual transduction | 13 | 4.19e-01 | -0.130000 | 6.40e-01 |
Diseases of the neuronal system | 13 | 4.19e-01 | -0.130000 | 6.40e-01 |
Retinoid cycle disease events | 13 | 4.19e-01 | -0.130000 | 6.40e-01 |
Hyaluronan uptake and degradation | 12 | 4.21e-01 | 0.134000 | 6.41e-01 |
Cell recruitment (pro-inflammatory response) | 22 | 4.21e-01 | -0.099100 | 6.41e-01 |
Purinergic signaling in leishmaniasis infection | 22 | 4.21e-01 | -0.099100 | 6.41e-01 |
Activation of SMO | 18 | 4.21e-01 | -0.110000 | 6.41e-01 |
Metabolism of vitamins and cofactors | 179 | 4.22e-01 | 0.034800 | 6.41e-01 |
Repression of WNT target genes | 14 | 4.23e-01 | 0.124000 | 6.41e-01 |
Aberrant regulation of mitotic exit in cancer due to RB1 defects | 19 | 4.23e-01 | -0.106000 | 6.41e-01 |
TNFR1-induced proapoptotic signaling | 13 | 4.25e-01 | 0.128000 | 6.41e-01 |
Fc epsilon receptor (FCERI) signaling | 155 | 4.25e-01 | 0.037100 | 6.41e-01 |
Signaling by ERBB2 ECD mutants | 14 | 4.26e-01 | -0.123000 | 6.41e-01 |
DNA Double Strand Break Response | 46 | 4.26e-01 | -0.067900 | 6.41e-01 |
RORA activates gene expression | 18 | 4.26e-01 | -0.108000 | 6.41e-01 |
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | 10 | 4.26e-01 | -0.145000 | 6.41e-01 |
Transcription of E2F targets under negative control by DREAM complex | 19 | 4.26e-01 | -0.105000 | 6.41e-01 |
Sema3A PAK dependent Axon repulsion | 15 | 4.26e-01 | -0.119000 | 6.41e-01 |
Regulation of PTEN mRNA translation | 21 | 4.29e-01 | -0.099600 | 6.43e-01 |
Hyaluronan metabolism | 17 | 4.29e-01 | -0.111000 | 6.43e-01 |
Pyrimidine salvage | 10 | 4.30e-01 | 0.144000 | 6.43e-01 |
Sphingolipid metabolism | 83 | 4.30e-01 | 0.050100 | 6.43e-01 |
Assembly Of The HIV Virion | 15 | 4.30e-01 | 0.118000 | 6.43e-01 |
HCMV Early Events | 67 | 4.30e-01 | -0.055700 | 6.43e-01 |
Response of EIF2AK1 (HRI) to heme deficiency | 15 | 4.31e-01 | 0.118000 | 6.44e-01 |
Mucopolysaccharidoses | 11 | 4.32e-01 | -0.137000 | 6.44e-01 |
Interleukin receptor SHC signaling | 26 | 4.32e-01 | 0.089000 | 6.44e-01 |
ECM proteoglycans | 53 | 4.32e-01 | -0.062400 | 6.44e-01 |
Activation of kainate receptors upon glutamate binding | 30 | 4.33e-01 | -0.082800 | 6.44e-01 |
G-protein activation | 28 | 4.33e-01 | -0.085600 | 6.44e-01 |
Intra-Golgi traffic | 42 | 4.39e-01 | 0.069000 | 6.52e-01 |
RNA Polymerase I Promoter Opening | 13 | 4.40e-01 | -0.124000 | 6.53e-01 |
Apoptotic execution phase | 51 | 4.44e-01 | -0.062000 | 6.57e-01 |
Export of Viral Ribonucleoproteins from Nucleus | 32 | 4.44e-01 | -0.078200 | 6.57e-01 |
Formation of tubulin folding intermediates by CCT/TriC | 21 | 4.46e-01 | 0.096100 | 6.59e-01 |
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 39 | 4.47e-01 | -0.070300 | 6.61e-01 |
Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 23 | 4.50e-01 | -0.091000 | 6.63e-01 |
Signaling by FGFR3 in disease | 20 | 4.50e-01 | -0.097500 | 6.63e-01 |
Signaling by FGFR3 point mutants in cancer | 20 | 4.50e-01 | -0.097500 | 6.63e-01 |
Transcriptional regulation by small RNAs | 54 | 4.52e-01 | -0.059200 | 6.65e-01 |
MAP2K and MAPK activation | 38 | 4.55e-01 | -0.070000 | 6.69e-01 |
Spry regulation of FGF signaling | 14 | 4.55e-01 | 0.115000 | 6.69e-01 |
Nonhomologous End-Joining (NHEJ) | 40 | 4.56e-01 | -0.068100 | 6.69e-01 |
HCMV Infection | 89 | 4.61e-01 | 0.045300 | 6.74e-01 |
Keratan sulfate/keratin metabolism | 31 | 4.61e-01 | -0.076500 | 6.74e-01 |
HCMV Late Events | 61 | 4.61e-01 | 0.054600 | 6.74e-01 |
ESR-mediated signaling | 165 | 4.64e-01 | -0.033100 | 6.77e-01 |
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | 19 | 4.64e-01 | -0.097000 | 6.77e-01 |
Other interleukin signaling | 21 | 4.66e-01 | -0.091900 | 6.79e-01 |
Activation of RAC1 | 13 | 4.68e-01 | -0.116000 | 6.81e-01 |
Signaling by Activin | 13 | 4.69e-01 | -0.116000 | 6.81e-01 |
DDX58/IFIH1-mediated induction of interferon-alpha/beta | 68 | 4.69e-01 | 0.050800 | 6.81e-01 |
Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 15 | 4.70e-01 | -0.108000 | 6.81e-01 |
Synthesis of PIPs at the Golgi membrane | 18 | 4.70e-01 | 0.098400 | 6.81e-01 |
Phospholipase C-mediated cascade: FGFR1 | 13 | 4.70e-01 | -0.116000 | 6.81e-01 |
Gamma carboxylation, hypusine formation and arylsulfatase activation | 37 | 4.70e-01 | 0.068600 | 6.81e-01 |
Synthesis of PE | 13 | 4.71e-01 | 0.115000 | 6.81e-01 |
PKA activation in glucagon signalling | 16 | 4.72e-01 | 0.104000 | 6.82e-01 |
Adherens junctions interactions | 31 | 4.73e-01 | -0.074500 | 6.82e-01 |
B-WICH complex positively regulates rRNA expression | 39 | 4.74e-01 | 0.066300 | 6.82e-01 |
VEGFR2 mediated vascular permeability | 26 | 4.74e-01 | 0.081200 | 6.82e-01 |
Tight junction interactions | 28 | 4.76e-01 | -0.077900 | 6.84e-01 |
Digestion | 16 | 4.76e-01 | -0.103000 | 6.84e-01 |
G2/M Checkpoints | 133 | 4.76e-01 | -0.035800 | 6.84e-01 |
Interactions of Rev with host cellular proteins | 36 | 4.77e-01 | -0.068500 | 6.84e-01 |
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | 15 | 4.79e-01 | 0.106000 | 6.87e-01 |
Infectious disease | 757 | 4.80e-01 | 0.015200 | 6.87e-01 |
Termination of O-glycan biosynthesis | 17 | 4.81e-01 | -0.098800 | 6.88e-01 |
Cobalamin (Cbl, vitamin B12) transport and metabolism | 20 | 4.81e-01 | -0.090900 | 6.88e-01 |
Ion channel transport | 168 | 4.82e-01 | -0.031400 | 6.89e-01 |
Signalling to ERKs | 33 | 4.84e-01 | 0.070400 | 6.91e-01 |
SUMOylation of transcription factors | 16 | 4.85e-01 | 0.101000 | 6.91e-01 |
Loss of Nlp from mitotic centrosomes | 67 | 4.86e-01 | -0.049200 | 6.91e-01 |
Loss of proteins required for interphase microtubule organization from the centrosome | 67 | 4.86e-01 | -0.049200 | 6.91e-01 |
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 45 | 4.87e-01 | -0.060000 | 6.91e-01 |
Fertilization | 21 | 4.89e-01 | -0.087200 | 6.93e-01 |
Interaction between L1 and Ankyrins | 29 | 4.90e-01 | 0.074100 | 6.93e-01 |
AKT phosphorylates targets in the cytosol | 14 | 4.90e-01 | 0.107000 | 6.93e-01 |
Formation of the ternary complex, and subsequently, the 43S complex | 44 | 4.91e-01 | 0.060000 | 6.93e-01 |
TRP channels | 25 | 4.92e-01 | -0.079500 | 6.93e-01 |
Centrosome maturation | 79 | 4.92e-01 | -0.044800 | 6.93e-01 |
Recruitment of mitotic centrosome proteins and complexes | 79 | 4.92e-01 | -0.044800 | 6.93e-01 |
rRNA processing | 187 | 4.92e-01 | 0.029200 | 6.93e-01 |
RNA polymerase II transcribes snRNA genes | 68 | 4.92e-01 | 0.048200 | 6.93e-01 |
Metabolism of amine-derived hormones | 17 | 4.93e-01 | -0.096100 | 6.93e-01 |
Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 12 | 4.93e-01 | -0.114000 | 6.93e-01 |
Protein-protein interactions at synapses | 83 | 4.94e-01 | -0.043500 | 6.93e-01 |
Signaling by FGFR1 in disease | 35 | 4.94e-01 | 0.066800 | 6.93e-01 |
Nuclear signaling by ERBB4 | 29 | 4.96e-01 | 0.073100 | 6.94e-01 |
Formation of Incision Complex in GG-NER | 42 | 4.97e-01 | 0.060600 | 6.95e-01 |
SARS-CoV-2 Infection | 64 | 4.98e-01 | 0.049000 | 6.97e-01 |
Regulation of PLK1 Activity at G2/M Transition | 83 | 4.99e-01 | -0.042900 | 6.97e-01 |
HS-GAG biosynthesis | 28 | 4.99e-01 | -0.073800 | 6.97e-01 |
Biosynthesis of specialized proresolving mediators (SPMs) | 18 | 5.01e-01 | -0.091700 | 6.98e-01 |
Negative regulation of FGFR2 signaling | 29 | 5.03e-01 | 0.071900 | 7.00e-01 |
DNA Replication | 122 | 5.03e-01 | 0.035100 | 7.00e-01 |
Depolymerisation of the Nuclear Lamina | 15 | 5.05e-01 | -0.099500 | 7.02e-01 |
Insulin receptor signalling cascade | 50 | 5.07e-01 | -0.054200 | 7.02e-01 |
PKMTs methylate histone lysines | 43 | 5.08e-01 | -0.058300 | 7.02e-01 |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 5.08e-01 | -0.078000 | 7.02e-01 |
A tetrasaccharide linker sequence is required for GAG synthesis | 25 | 5.09e-01 | -0.076300 | 7.02e-01 |
Recruitment of NuMA to mitotic centrosomes | 78 | 5.10e-01 | -0.043200 | 7.02e-01 |
Misspliced GSK3beta mutants stabilize beta-catenin | 14 | 5.10e-01 | 0.102000 | 7.02e-01 |
S33 mutants of beta-catenin aren't phosphorylated | 14 | 5.10e-01 | 0.102000 | 7.02e-01 |
S37 mutants of beta-catenin aren't phosphorylated | 14 | 5.10e-01 | 0.102000 | 7.02e-01 |
S45 mutants of beta-catenin aren't phosphorylated | 14 | 5.10e-01 | 0.102000 | 7.02e-01 |
T41 mutants of beta-catenin aren't phosphorylated | 14 | 5.10e-01 | 0.102000 | 7.02e-01 |
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | 14 | 5.10e-01 | 0.102000 | 7.02e-01 |
ROS and RNS production in phagocytes | 34 | 5.11e-01 | 0.065200 | 7.02e-01 |
Interactions of Vpr with host cellular proteins | 34 | 5.12e-01 | -0.065100 | 7.02e-01 |
SUMOylation of RNA binding proteins | 45 | 5.12e-01 | -0.056500 | 7.02e-01 |
Signaling by Hippo | 20 | 5.14e-01 | -0.084300 | 7.04e-01 |
Interleukin-2 family signaling | 41 | 5.15e-01 | 0.058800 | 7.05e-01 |
Downstream signaling of activated FGFR3 | 23 | 5.16e-01 | -0.078300 | 7.05e-01 |
Synthesis of PIPs at the early endosome membrane | 16 | 5.16e-01 | 0.093900 | 7.05e-01 |
Voltage gated Potassium channels | 41 | 5.18e-01 | -0.058400 | 7.06e-01 |
Signal attenuation | 10 | 5.18e-01 | -0.118000 | 7.06e-01 |
Diseases of DNA repair | 10 | 5.18e-01 | -0.118000 | 7.06e-01 |
Signaling by FGFR2 in disease | 38 | 5.21e-01 | 0.060100 | 7.10e-01 |
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 42 | 5.24e-01 | 0.056900 | 7.12e-01 |
Zinc transporters | 17 | 5.25e-01 | -0.089100 | 7.13e-01 |
FRS-mediated FGFR1 signaling | 20 | 5.25e-01 | -0.082100 | 7.13e-01 |
Diseases associated with the TLR signaling cascade | 20 | 5.27e-01 | -0.081800 | 7.13e-01 |
Diseases of Immune System | 20 | 5.27e-01 | -0.081800 | 7.13e-01 |
Postmitotic nuclear pore complex (NPC) reformation | 26 | 5.27e-01 | -0.071700 | 7.13e-01 |
Cytochrome c-mediated apoptotic response | 12 | 5.30e-01 | 0.105000 | 7.17e-01 |
Interleukin-4 and Interleukin-13 signaling | 101 | 5.34e-01 | -0.035800 | 7.22e-01 |
Signaling by ERBB2 KD Mutants | 23 | 5.35e-01 | -0.074700 | 7.23e-01 |
Glucagon signaling in metabolic regulation | 31 | 5.37e-01 | -0.064100 | 7.24e-01 |
Signaling by WNT | 271 | 5.39e-01 | 0.021700 | 7.25e-01 |
Activation of Ca-permeable Kainate Receptor | 10 | 5.39e-01 | 0.112000 | 7.25e-01 |
Ionotropic activity of kainate receptors | 10 | 5.39e-01 | 0.112000 | 7.25e-01 |
Cardiac conduction | 117 | 5.40e-01 | 0.032800 | 7.26e-01 |
MET promotes cell motility | 29 | 5.45e-01 | -0.064900 | 7.32e-01 |
VxPx cargo-targeting to cilium | 21 | 5.46e-01 | -0.076000 | 7.33e-01 |
Frs2-mediated activation | 12 | 5.47e-01 | 0.100000 | 7.34e-01 |
Nuclear Events (kinase and transcription factor activation) | 57 | 5.51e-01 | 0.045700 | 7.38e-01 |
Regulation of lipid metabolism by PPARalpha | 116 | 5.53e-01 | 0.031900 | 7.39e-01 |
Activated point mutants of FGFR2 | 14 | 5.53e-01 | 0.091600 | 7.39e-01 |
Signaling by MET | 66 | 5.53e-01 | 0.042200 | 7.39e-01 |
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 14 | 5.55e-01 | 0.091000 | 7.40e-01 |
Innate Immune System | 947 | 5.56e-01 | 0.011400 | 7.40e-01 |
Eukaryotic Translation Elongation | 70 | 5.57e-01 | 0.040600 | 7.41e-01 |
Influenza Viral RNA Transcription and Replication | 109 | 5.57e-01 | 0.032600 | 7.41e-01 |
PPARA activates gene expression | 114 | 5.58e-01 | 0.031700 | 7.42e-01 |
Trafficking and processing of endosomal TLR | 12 | 5.60e-01 | 0.097300 | 7.43e-01 |
Signalling to RAS | 19 | 5.62e-01 | 0.076900 | 7.45e-01 |
SLC transporter disorders | 95 | 5.62e-01 | -0.034400 | 7.45e-01 |
Caspase activation via extrinsic apoptotic signalling pathway | 21 | 5.63e-01 | -0.072900 | 7.45e-01 |
FOXO-mediated transcription | 64 | 5.64e-01 | 0.041700 | 7.47e-01 |
Reduction of cytosolic Ca++ levels | 12 | 5.69e-01 | 0.094900 | 7.52e-01 |
FGFR1 ligand binding and activation | 12 | 5.70e-01 | -0.094700 | 7.52e-01 |
PKA activation | 16 | 5.70e-01 | 0.082000 | 7.52e-01 |
Epigenetic regulation of gene expression | 94 | 5.70e-01 | 0.033900 | 7.52e-01 |
The NLRP3 inflammasome | 15 | 5.72e-01 | 0.084300 | 7.53e-01 |
Downregulation of ERBB2 signaling | 26 | 5.72e-01 | 0.064000 | 7.53e-01 |
Sodium/Calcium exchangers | 11 | 5.73e-01 | 0.098200 | 7.53e-01 |
Prefoldin mediated transfer of substrate to CCT/TriC | 25 | 5.73e-01 | 0.065100 | 7.53e-01 |
The role of Nef in HIV-1 replication and disease pathogenesis | 27 | 5.74e-01 | 0.062500 | 7.53e-01 |
SUMOylation of immune response proteins | 10 | 5.77e-01 | 0.102000 | 7.55e-01 |
Signaling by the B Cell Receptor (BCR) | 133 | 5.77e-01 | 0.028000 | 7.55e-01 |
Nuclear Receptor transcription pathway | 53 | 5.78e-01 | -0.044200 | 7.55e-01 |
Rev-mediated nuclear export of HIV RNA | 34 | 5.78e-01 | -0.055200 | 7.55e-01 |
PI3K events in ERBB4 signaling | 10 | 5.80e-01 | 0.101000 | 7.57e-01 |
Activation of BAD and translocation to mitochondria | 15 | 5.80e-01 | 0.082400 | 7.57e-01 |
Signal transduction by L1 | 21 | 5.81e-01 | 0.069600 | 7.57e-01 |
Deactivation of the beta-catenin transactivating complex | 39 | 5.81e-01 | -0.051000 | 7.57e-01 |
Sialic acid metabolism | 31 | 5.82e-01 | 0.057200 | 7.57e-01 |
CD28 dependent PI3K/Akt signaling | 22 | 5.84e-01 | 0.067500 | 7.59e-01 |
G-protein mediated events | 51 | 5.84e-01 | -0.044300 | 7.59e-01 |
Oncogene Induced Senescence | 30 | 5.86e-01 | -0.057400 | 7.61e-01 |
Prolonged ERK activation events | 14 | 5.87e-01 | 0.083900 | 7.61e-01 |
ERBB2 Activates PTK6 Signaling | 13 | 5.88e-01 | -0.086900 | 7.61e-01 |
Incretin synthesis, secretion, and inactivation | 20 | 5.88e-01 | 0.070000 | 7.61e-01 |
Pentose phosphate pathway | 14 | 5.88e-01 | 0.083600 | 7.61e-01 |
NS1 Mediated Effects on Host Pathways | 40 | 5.90e-01 | -0.049300 | 7.62e-01 |
Transport of inorganic cations/anions and amino acids/oligopeptides | 103 | 5.93e-01 | -0.030500 | 7.65e-01 |
Circadian Clock | 68 | 5.93e-01 | 0.037500 | 7.65e-01 |
ERKs are inactivated | 12 | 5.94e-01 | 0.088900 | 7.66e-01 |
Processing of Capped Intronless Pre-mRNA | 26 | 5.96e-01 | 0.060000 | 7.68e-01 |
Signaling by NOTCH1 | 69 | 6.02e-01 | 0.036300 | 7.75e-01 |
Adenylate cyclase inhibitory pathway | 14 | 6.03e-01 | -0.080400 | 7.75e-01 |
Costimulation by the CD28 family | 64 | 6.03e-01 | 0.037600 | 7.75e-01 |
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 13 | 6.05e-01 | 0.082900 | 7.75e-01 |
ADORA2B mediated anti-inflammatory cytokines production | 113 | 6.05e-01 | -0.028200 | 7.75e-01 |
Response of EIF2AK4 (GCN2) to amino acid deficiency | 78 | 6.06e-01 | 0.033800 | 7.75e-01 |
Killing mechanisms | 12 | 6.06e-01 | 0.085900 | 7.75e-01 |
WNT5:FZD7-mediated leishmania damping | 12 | 6.06e-01 | 0.085900 | 7.75e-01 |
Positive epigenetic regulation of rRNA expression | 52 | 6.07e-01 | 0.041300 | 7.75e-01 |
Cell junction organization | 85 | 6.07e-01 | -0.032300 | 7.75e-01 |
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | 10 | 6.07e-01 | 0.093800 | 7.75e-01 |
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | 10 | 6.08e-01 | -0.093600 | 7.75e-01 |
PI-3K cascade:FGFR1 | 18 | 6.09e-01 | -0.069700 | 7.75e-01 |
SHC-mediated cascade:FGFR1 | 18 | 6.11e-01 | -0.069200 | 7.78e-01 |
Disease | 1431 | 6.12e-01 | 0.008070 | 7.78e-01 |
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | 31 | 6.15e-01 | -0.052100 | 7.81e-01 |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 30 | 6.17e-01 | -0.052800 | 7.83e-01 |
Negative regulation of MET activity | 20 | 6.18e-01 | 0.064500 | 7.83e-01 |
Negative regulation of FGFR4 signaling | 26 | 6.19e-01 | 0.056400 | 7.83e-01 |
PKA-mediated phosphorylation of CREB | 18 | 6.23e-01 | 0.066900 | 7.89e-01 |
Selenoamino acid metabolism | 92 | 6.25e-01 | 0.029500 | 7.90e-01 |
Signaling by ERBB4 | 53 | 6.26e-01 | 0.038700 | 7.91e-01 |
Disassembly of the destruction complex and recruitment of AXIN to the membrane | 30 | 6.28e-01 | 0.051100 | 7.93e-01 |
mRNA decay by 5' to 3' exoribonuclease | 15 | 6.30e-01 | -0.071800 | 7.95e-01 |
Signaling by NODAL | 18 | 6.32e-01 | -0.065200 | 7.96e-01 |
SHC1 events in ERBB2 signaling | 22 | 6.33e-01 | -0.058700 | 7.96e-01 |
Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | 11 | 6.34e-01 | 0.083000 | 7.96e-01 |
Death Receptor Signalling | 132 | 6.34e-01 | -0.024000 | 7.96e-01 |
DAG and IP3 signaling | 38 | 6.34e-01 | -0.044600 | 7.96e-01 |
Kinesins | 40 | 6.36e-01 | -0.043300 | 7.96e-01 |
Blood group systems biosynthesis | 18 | 6.38e-01 | 0.064100 | 7.96e-01 |
Eicosanoid ligand-binding receptors | 13 | 6.39e-01 | 0.075000 | 7.96e-01 |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 49 | 6.39e-01 | -0.038700 | 7.96e-01 |
PI3K events in ERBB2 signaling | 16 | 6.40e-01 | -0.067500 | 7.96e-01 |
Triglyceride metabolism | 35 | 6.40e-01 | 0.045600 | 7.96e-01 |
ERK/MAPK targets | 21 | 6.41e-01 | 0.058700 | 7.96e-01 |
AMER1 mutants destabilize the destruction complex | 13 | 6.41e-01 | 0.074600 | 7.96e-01 |
APC truncation mutants have impaired AXIN binding | 13 | 6.41e-01 | 0.074600 | 7.96e-01 |
AXIN missense mutants destabilize the destruction complex | 13 | 6.41e-01 | 0.074600 | 7.96e-01 |
AXIN mutants destabilize the destruction complex, activating WNT signaling | 13 | 6.41e-01 | 0.074600 | 7.96e-01 |
Truncations of AMER1 destabilize the destruction complex | 13 | 6.41e-01 | 0.074600 | 7.96e-01 |
truncated APC mutants destabilize the destruction complex | 13 | 6.41e-01 | 0.074600 | 7.96e-01 |
Signaling by NOTCH3 | 44 | 6.45e-01 | 0.040100 | 8.00e-01 |
NGF-stimulated transcription | 36 | 6.47e-01 | 0.044100 | 8.02e-01 |
Response to elevated platelet cytosolic Ca2+ | 128 | 6.48e-01 | -0.023400 | 8.02e-01 |
SHC-mediated cascade:FGFR2 | 20 | 6.49e-01 | 0.058800 | 8.03e-01 |
Synthesis of PA | 38 | 6.50e-01 | -0.042600 | 8.03e-01 |
Signaling by KIT in disease | 20 | 6.52e-01 | 0.058300 | 8.03e-01 |
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | 20 | 6.52e-01 | 0.058300 | 8.03e-01 |
G1/S Transition | 127 | 6.52e-01 | 0.023200 | 8.03e-01 |
PI-3K cascade:FGFR2 | 20 | 6.52e-01 | 0.058300 | 8.03e-01 |
Class C/3 (Metabotropic glutamate/pheromone receptors) | 30 | 6.52e-01 | -0.047600 | 8.03e-01 |
Alpha-protein kinase 1 signaling pathway | 10 | 6.55e-01 | 0.081600 | 8.05e-01 |
Peptide hormone biosynthesis | 10 | 6.55e-01 | 0.081600 | 8.05e-01 |
Glutathione synthesis and recycling | 12 | 6.57e-01 | 0.074100 | 8.06e-01 |
Golgi Cisternae Pericentriolar Stack Reorganization | 12 | 6.58e-01 | 0.073800 | 8.07e-01 |
FGFR2c ligand binding and activation | 11 | 6.58e-01 | 0.077000 | 8.07e-01 |
EGR2 and SOX10-mediated initiation of Schwann cell myelination | 26 | 6.60e-01 | -0.049800 | 8.07e-01 |
Assembly of active LPL and LIPC lipase complexes | 19 | 6.60e-01 | -0.058200 | 8.07e-01 |
Major pathway of rRNA processing in the nucleolus and cytosol | 157 | 6.61e-01 | -0.020300 | 8.07e-01 |
NOTCH4 Intracellular Domain Regulates Transcription | 18 | 6.61e-01 | -0.059600 | 8.07e-01 |
LGI-ADAM interactions | 13 | 6.62e-01 | 0.070100 | 8.07e-01 |
Interleukin-3, Interleukin-5 and GM-CSF signaling | 43 | 6.62e-01 | 0.038500 | 8.07e-01 |
Dopamine Neurotransmitter Release Cycle | 23 | 6.67e-01 | 0.051800 | 8.13e-01 |
Regulation of TP53 Activity | 149 | 6.68e-01 | -0.020400 | 8.13e-01 |
Mitotic Metaphase and Anaphase | 218 | 6.69e-01 | 0.016800 | 8.14e-01 |
CTLA4 inhibitory signaling | 21 | 6.70e-01 | 0.053700 | 8.14e-01 |
Gap junction assembly | 16 | 6.70e-01 | -0.061500 | 8.14e-01 |
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 13 | 6.73e-01 | 0.067700 | 8.16e-01 |
Regulation of beta-cell development | 36 | 6.79e-01 | -0.039800 | 8.22e-01 |
RIPK1-mediated regulated necrosis | 24 | 6.80e-01 | -0.048700 | 8.22e-01 |
Regulated Necrosis | 24 | 6.80e-01 | -0.048700 | 8.22e-01 |
Regulation of necroptotic cell death | 24 | 6.80e-01 | -0.048700 | 8.22e-01 |
Removal of aminoterminal propeptides from gamma-carboxylated proteins | 10 | 6.82e-01 | 0.074700 | 8.24e-01 |
Phospholipase C-mediated cascade; FGFR2 | 15 | 6.83e-01 | 0.061000 | 8.24e-01 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 71 | 6.83e-01 | 0.028000 | 8.24e-01 |
Signaling by FGFR3 | 36 | 6.84e-01 | -0.039200 | 8.24e-01 |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 13 | 6.84e-01 | -0.065100 | 8.24e-01 |
Downstream signaling of activated FGFR4 | 24 | 6.87e-01 | -0.047500 | 8.26e-01 |
Metabolic disorders of biological oxidation enzymes | 32 | 6.88e-01 | -0.041000 | 8.26e-01 |
ERBB2 Regulates Cell Motility | 15 | 6.88e-01 | -0.059800 | 8.26e-01 |
Reversible hydration of carbon dioxide | 12 | 6.89e-01 | -0.066800 | 8.26e-01 |
Scavenging by Class A Receptors | 17 | 6.90e-01 | -0.056000 | 8.27e-01 |
Lewis blood group biosynthesis | 14 | 6.93e-01 | 0.060900 | 8.29e-01 |
Mitotic Anaphase | 217 | 6.93e-01 | 0.015600 | 8.29e-01 |
Synthesis of bile acids and bile salts via 24-hydroxycholesterol | 10 | 6.93e-01 | 0.072000 | 8.29e-01 |
Neurotransmitter release cycle | 48 | 6.94e-01 | 0.032900 | 8.29e-01 |
Signaling by Receptor Tyrosine Kinases | 458 | 6.96e-01 | -0.010700 | 8.31e-01 |
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | 19 | 6.99e-01 | 0.051300 | 8.33e-01 |
Neurodegenerative Diseases | 19 | 6.99e-01 | 0.051300 | 8.33e-01 |
Protein folding | 95 | 7.02e-01 | 0.022700 | 8.34e-01 |
Signaling by PDGFRA extracellular domain mutants | 12 | 7.02e-01 | 0.063800 | 8.34e-01 |
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 12 | 7.02e-01 | 0.063800 | 8.34e-01 |
M Phase | 346 | 7.02e-01 | -0.012000 | 8.34e-01 |
CRMPs in Sema3A signaling | 16 | 7.03e-01 | -0.055000 | 8.35e-01 |
PLC beta mediated events | 50 | 7.05e-01 | -0.030900 | 8.36e-01 |
Triglyceride catabolism | 22 | 7.06e-01 | 0.046500 | 8.36e-01 |
Defects in cobalamin (B12) metabolism | 14 | 7.09e-01 | 0.057700 | 8.39e-01 |
SHC1 events in ERBB4 signaling | 14 | 7.11e-01 | 0.057200 | 8.41e-01 |
Receptor-type tyrosine-protein phosphatases | 18 | 7.11e-01 | 0.050400 | 8.41e-01 |
Transport of Mature mRNAs Derived from Intronless Transcripts | 41 | 7.14e-01 | -0.033100 | 8.44e-01 |
Downregulation of SMAD2/3:SMAD4 transcriptional activity | 22 | 7.16e-01 | 0.044900 | 8.45e-01 |
FGFR2 alternative splicing | 22 | 7.19e-01 | -0.044400 | 8.47e-01 |
Diseases of programmed cell death | 25 | 7.19e-01 | 0.041600 | 8.47e-01 |
Signaling by ERBB2 TMD/JMD mutants | 20 | 7.21e-01 | -0.046100 | 8.49e-01 |
TICAM1, RIP1-mediated IKK complex recruitment | 16 | 7.22e-01 | 0.051400 | 8.49e-01 |
Regulation of FZD by ubiquitination | 19 | 7.24e-01 | 0.046900 | 8.51e-01 |
IGF1R signaling cascade | 48 | 7.24e-01 | -0.029400 | 8.51e-01 |
Maturation of nucleoprotein | 10 | 7.25e-01 | 0.064300 | 8.51e-01 |
rRNA processing in the nucleus and cytosol | 166 | 7.25e-01 | -0.015800 | 8.51e-01 |
Signaling by PDGFR in disease | 19 | 7.27e-01 | 0.046300 | 8.52e-01 |
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 17 | 7.27e-01 | -0.048800 | 8.52e-01 |
Vitamin D (calciferol) metabolism | 11 | 7.29e-01 | -0.060400 | 8.52e-01 |
FGFR4 ligand binding and activation | 11 | 7.29e-01 | 0.060400 | 8.52e-01 |
DNA Damage Bypass | 44 | 7.32e-01 | 0.029900 | 8.55e-01 |
MASTL Facilitates Mitotic Progression | 10 | 7.32e-01 | 0.062500 | 8.55e-01 |
IRS-mediated signalling | 44 | 7.33e-01 | -0.029700 | 8.55e-01 |
Platelet calcium homeostasis | 28 | 7.34e-01 | -0.037100 | 8.55e-01 |
IKK complex recruitment mediated by RIP1 | 18 | 7.35e-01 | 0.046200 | 8.55e-01 |
Platelet homeostasis | 82 | 7.36e-01 | -0.021600 | 8.56e-01 |
Carboxyterminal post-translational modifications of tubulin | 33 | 7.37e-01 | 0.033700 | 8.57e-01 |
RUNX2 regulates osteoblast differentiation | 24 | 7.39e-01 | 0.039300 | 8.57e-01 |
Viral mRNA Translation | 66 | 7.39e-01 | 0.023700 | 8.57e-01 |
Smooth Muscle Contraction | 32 | 7.40e-01 | 0.033900 | 8.57e-01 |
Constitutive Signaling by EGFRvIII | 14 | 7.40e-01 | -0.051200 | 8.57e-01 |
Signaling by EGFRvIII in Cancer | 14 | 7.40e-01 | -0.051200 | 8.57e-01 |
Plasma lipoprotein assembly, remodeling, and clearance | 68 | 7.42e-01 | -0.023100 | 8.59e-01 |
Clathrin-mediated endocytosis | 138 | 7.46e-01 | 0.016000 | 8.62e-01 |
IRS-related events triggered by IGF1R | 47 | 7.47e-01 | -0.027200 | 8.62e-01 |
BMAL1:CLOCK,NPAS2 activates circadian gene expression | 27 | 7.47e-01 | -0.035900 | 8.62e-01 |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | 13 | 7.48e-01 | 0.051400 | 8.63e-01 |
Pre-NOTCH Processing in Golgi | 18 | 7.49e-01 | -0.043500 | 8.63e-01 |
Estrogen-dependent gene expression | 96 | 7.51e-01 | 0.018800 | 8.64e-01 |
Oncogenic MAPK signaling | 78 | 7.51e-01 | -0.020800 | 8.64e-01 |
Signaling by NTRK3 (TRKC) | 17 | 7.53e-01 | 0.044000 | 8.66e-01 |
Cell-extracellular matrix interactions | 16 | 7.55e-01 | 0.045100 | 8.67e-01 |
Synthesis of bile acids and bile salts | 29 | 7.56e-01 | 0.033400 | 8.67e-01 |
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 10 | 7.57e-01 | 0.056600 | 8.68e-01 |
Transport of Mature mRNA Derived from an Intronless Transcript | 40 | 7.57e-01 | -0.028200 | 8.68e-01 |
Transcriptional regulation of white adipocyte differentiation | 81 | 7.60e-01 | -0.019700 | 8.70e-01 |
Termination of translesion DNA synthesis | 30 | 7.61e-01 | -0.032200 | 8.70e-01 |
EGFR downregulation | 30 | 7.61e-01 | -0.032100 | 8.70e-01 |
Post-chaperonin tubulin folding pathway | 18 | 7.63e-01 | -0.041100 | 8.71e-01 |
Regulation of MECP2 expression and activity | 29 | 7.67e-01 | 0.031900 | 8.75e-01 |
MET activates RAS signaling | 11 | 7.69e-01 | -0.051200 | 8.75e-01 |
Signaling by FGFR4 | 36 | 7.69e-01 | -0.028200 | 8.75e-01 |
Translocation of ZAP-70 to Immunological synapse | 14 | 7.70e-01 | 0.045200 | 8.75e-01 |
CS/DS degradation | 14 | 7.71e-01 | -0.044900 | 8.75e-01 |
GP1b-IX-V activation signalling | 10 | 7.71e-01 | -0.053100 | 8.75e-01 |
Signaling by WNT in cancer | 33 | 7.72e-01 | -0.029100 | 8.75e-01 |
Metabolism of nitric oxide: NOS3 activation and regulation | 14 | 7.72e-01 | 0.044700 | 8.75e-01 |
Phase 2 - plateau phase | 15 | 7.73e-01 | -0.043000 | 8.75e-01 |
Mismatch Repair | 14 | 7.73e-01 | 0.044500 | 8.75e-01 |
Defensins | 21 | 7.74e-01 | 0.036300 | 8.75e-01 |
FRS-mediated FGFR2 signaling | 22 | 7.74e-01 | 0.035400 | 8.75e-01 |
Activated NTRK2 signals through FRS2 and FRS3 | 11 | 7.74e-01 | 0.049900 | 8.75e-01 |
Signaling by ERBB2 | 47 | 7.76e-01 | -0.024000 | 8.76e-01 |
Insulin processing | 27 | 7.78e-01 | -0.031300 | 8.78e-01 |
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 19 | 7.79e-01 | 0.037100 | 8.79e-01 |
Negative regulation of FGFR3 signaling | 25 | 7.81e-01 | 0.032200 | 8.80e-01 |
Chaperonin-mediated protein folding | 89 | 7.82e-01 | 0.017000 | 8.81e-01 |
Triglyceride biosynthesis | 13 | 7.84e-01 | 0.044000 | 8.82e-01 |
Gap junction trafficking and regulation | 26 | 7.84e-01 | -0.031000 | 8.82e-01 |
Eukaryotic Translation Termination | 70 | 7.85e-01 | 0.018900 | 8.82e-01 |
Synthesis of PC | 27 | 7.87e-01 | -0.030100 | 8.83e-01 |
Acyl chain remodelling of PG | 17 | 7.87e-01 | 0.037800 | 8.83e-01 |
EPH-ephrin mediated repulsion of cells | 48 | 7.88e-01 | 0.022400 | 8.83e-01 |
Caspase activation via Dependence Receptors in the absence of ligand | 10 | 7.91e-01 | 0.048500 | 8.85e-01 |
P2Y receptors | 11 | 7.91e-01 | -0.046000 | 8.86e-01 |
Transcriptional regulation of pluripotent stem cells | 28 | 7.93e-01 | 0.028700 | 8.86e-01 |
Formation of the cornified envelope | 35 | 7.94e-01 | 0.025600 | 8.87e-01 |
Sema4D in semaphorin signaling | 24 | 7.98e-01 | -0.030200 | 8.91e-01 |
Downregulation of ERBB2:ERBB3 signaling | 12 | 7.99e-01 | 0.042400 | 8.92e-01 |
Interleukin-2 signaling | 12 | 8.00e-01 | -0.042300 | 8.92e-01 |
BBSome-mediated cargo-targeting to cilium | 22 | 8.01e-01 | 0.031100 | 8.92e-01 |
Chromatin modifying enzymes | 208 | 8.02e-01 | 0.010100 | 8.92e-01 |
Chromatin organization | 208 | 8.02e-01 | 0.010100 | 8.92e-01 |
Regulation of gene expression by Hypoxia-inducible Factor | 11 | 8.04e-01 | 0.043200 | 8.93e-01 |
Integrin signaling | 27 | 8.06e-01 | -0.027300 | 8.95e-01 |
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | 12 | 8.09e-01 | 0.040400 | 8.97e-01 |
RUNX3 regulates NOTCH signaling | 12 | 8.10e-01 | -0.040100 | 8.98e-01 |
Inflammasomes | 20 | 8.12e-01 | 0.030700 | 8.99e-01 |
Regulated proteolysis of p75NTR | 11 | 8.13e-01 | 0.041300 | 8.99e-01 |
Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 22 | 8.13e-01 | 0.029200 | 8.99e-01 |
Signaling by EGFR | 49 | 8.14e-01 | -0.019400 | 9.00e-01 |
SHC-mediated cascade:FGFR4 | 17 | 8.15e-01 | 0.032700 | 9.01e-01 |
Peptide hormone metabolism | 81 | 8.17e-01 | -0.014900 | 9.02e-01 |
PI-3K cascade:FGFR4 | 17 | 8.19e-01 | 0.032100 | 9.02e-01 |
Translesion synthesis by POLI | 16 | 8.19e-01 | 0.033100 | 9.02e-01 |
Nuclear Envelope (NE) Reassembly | 64 | 8.20e-01 | 0.016500 | 9.03e-01 |
PECAM1 interactions | 11 | 8.22e-01 | -0.039300 | 9.04e-01 |
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 29 | 8.26e-01 | 0.023600 | 9.08e-01 |
Synaptic adhesion-like molecules | 21 | 8.28e-01 | -0.027300 | 9.10e-01 |
Antimicrobial peptides | 47 | 8.30e-01 | 0.018100 | 9.11e-01 |
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 10 | 8.31e-01 | 0.039100 | 9.11e-01 |
RHO GTPases activate IQGAPs | 11 | 8.32e-01 | 0.037000 | 9.12e-01 |
Fatty acyl-CoA biosynthesis | 35 | 8.33e-01 | 0.020600 | 9.13e-01 |
FRS-mediated FGFR3 signaling | 18 | 8.37e-01 | -0.028000 | 9.15e-01 |
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | 35 | 8.38e-01 | 0.020000 | 9.15e-01 |
Gap-filling DNA repair synthesis and ligation in GG-NER | 23 | 8.39e-01 | 0.024500 | 9.15e-01 |
NOTCH2 intracellular domain regulates transcription | 10 | 8.39e-01 | -0.037100 | 9.15e-01 |
Translesion Synthesis by POLH | 16 | 8.39e-01 | 0.029300 | 9.15e-01 |
ATF4 activates genes in response to endoplasmic reticulum stress | 26 | 8.41e-01 | -0.022800 | 9.15e-01 |
Degradation of cysteine and homocysteine | 11 | 8.41e-01 | 0.035000 | 9.15e-01 |
Fanconi Anemia Pathway | 35 | 8.42e-01 | -0.019500 | 9.15e-01 |
COPI-dependent Golgi-to-ER retrograde traffic | 79 | 8.42e-01 | 0.012900 | 9.15e-01 |
Platelet degranulation | 123 | 8.42e-01 | -0.010400 | 9.15e-01 |
Purine catabolism | 17 | 8.44e-01 | 0.027600 | 9.15e-01 |
Regulation of TP53 Activity through Association with Co-factors | 13 | 8.44e-01 | -0.031600 | 9.15e-01 |
PCNA-Dependent Long Patch Base Excision Repair | 20 | 8.44e-01 | -0.025500 | 9.15e-01 |
PI3K Cascade | 40 | 8.44e-01 | -0.018000 | 9.15e-01 |
Selenocysteine synthesis | 69 | 8.45e-01 | -0.013600 | 9.15e-01 |
Oxidative Stress Induced Senescence | 69 | 8.46e-01 | 0.013500 | 9.16e-01 |
Generation of second messenger molecules | 28 | 8.48e-01 | 0.020900 | 9.16e-01 |
Phospholipase C-mediated cascade; FGFR3 | 11 | 8.48e-01 | -0.033300 | 9.16e-01 |
Factors involved in megakaryocyte development and platelet production | 124 | 8.49e-01 | -0.009940 | 9.16e-01 |
Myogenesis | 28 | 8.49e-01 | -0.020800 | 9.16e-01 |
MET activates PTK2 signaling | 18 | 8.52e-01 | -0.025500 | 9.18e-01 |
Laminin interactions | 23 | 8.57e-01 | -0.021800 | 9.21e-01 |
Metabolism of non-coding RNA | 51 | 8.57e-01 | 0.014600 | 9.21e-01 |
snRNP Assembly | 51 | 8.57e-01 | 0.014600 | 9.21e-01 |
Recognition of DNA damage by PCNA-containing replication complex | 28 | 8.58e-01 | 0.019600 | 9.21e-01 |
E3 ubiquitin ligases ubiquitinate target proteins | 46 | 8.58e-01 | -0.015300 | 9.21e-01 |
Beta-catenin phosphorylation cascade | 16 | 8.61e-01 | 0.025200 | 9.23e-01 |
Phosphorylation of CD3 and TCR zeta chains | 17 | 8.62e-01 | 0.024400 | 9.23e-01 |
Downstream signaling of activated FGFR2 | 27 | 8.62e-01 | -0.019300 | 9.23e-01 |
Disorders of Developmental Biology | 13 | 8.64e-01 | -0.027400 | 9.23e-01 |
Disorders of Nervous System Development | 13 | 8.64e-01 | -0.027400 | 9.23e-01 |
Loss of function of MECP2 in Rett syndrome | 13 | 8.64e-01 | -0.027400 | 9.23e-01 |
Pervasive developmental disorders | 13 | 8.64e-01 | -0.027400 | 9.23e-01 |
Regulation of commissural axon pathfinding by SLIT and ROBO | 10 | 8.66e-01 | 0.030700 | 9.25e-01 |
Deadenylation of mRNA | 20 | 8.67e-01 | 0.021600 | 9.25e-01 |
Processing of Intronless Pre-mRNAs | 18 | 8.72e-01 | 0.022000 | 9.30e-01 |
Recycling pathway of L1 | 27 | 8.73e-01 | 0.017800 | 9.30e-01 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 90 | 8.75e-01 | 0.009570 | 9.31e-01 |
Nonsense-Mediated Decay (NMD) | 90 | 8.75e-01 | 0.009570 | 9.31e-01 |
Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 27 | 8.76e-01 | 0.017400 | 9.31e-01 |
Signaling by FGFR2 | 62 | 8.78e-01 | -0.011300 | 9.33e-01 |
SRP-dependent cotranslational protein targeting to membrane | 89 | 8.80e-01 | -0.009230 | 9.35e-01 |
Synthesis of very long-chain fatty acyl-CoAs | 24 | 8.82e-01 | -0.017500 | 9.35e-01 |
Phospholipase C-mediated cascade; FGFR4 | 12 | 8.82e-01 | 0.024700 | 9.35e-01 |
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 41 | 8.83e-01 | -0.013200 | 9.36e-01 |
Platelet Adhesion to exposed collagen | 13 | 8.84e-01 | -0.023400 | 9.36e-01 |
Signaling by Insulin receptor | 73 | 8.87e-01 | 0.009580 | 9.38e-01 |
FGFR3 ligand binding and activation | 11 | 8.88e-01 | 0.024500 | 9.38e-01 |
FGFR3c ligand binding and activation | 11 | 8.88e-01 | 0.024500 | 9.38e-01 |
Platelet Aggregation (Plug Formation) | 37 | 8.89e-01 | -0.013300 | 9.38e-01 |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 17 | 8.91e-01 | 0.019200 | 9.38e-01 |
Signaling by Ligand-Responsive EGFR Variants in Cancer | 17 | 8.91e-01 | 0.019200 | 9.38e-01 |
Cargo trafficking to the periciliary membrane | 49 | 8.91e-01 | -0.011300 | 9.38e-01 |
Nephrin family interactions | 21 | 8.92e-01 | -0.017200 | 9.38e-01 |
Peptide chain elongation | 66 | 8.94e-01 | 0.009510 | 9.40e-01 |
Keratan sulfate degradation | 12 | 8.96e-01 | -0.021800 | 9.41e-01 |
eNOS activation | 10 | 8.97e-01 | -0.023700 | 9.42e-01 |
Viral Messenger RNA Synthesis | 41 | 8.98e-01 | 0.011600 | 9.42e-01 |
Interleukin-12 signaling | 40 | 8.98e-01 | 0.011700 | 9.42e-01 |
Signaling by Nuclear Receptors | 235 | 9.01e-01 | -0.004720 | 9.44e-01 |
Initiation of Nuclear Envelope (NE) Reformation | 16 | 9.04e-01 | 0.017400 | 9.47e-01 |
NOTCH1 Intracellular Domain Regulates Transcription | 43 | 9.05e-01 | -0.010600 | 9.47e-01 |
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | 11 | 9.08e-01 | -0.020100 | 9.47e-01 |
Mitotic G1 phase and G1/S transition | 143 | 9.09e-01 | 0.005550 | 9.47e-01 |
Signaling by BRAF and RAF fusions | 61 | 9.11e-01 | 0.008320 | 9.47e-01 |
Paradoxical activation of RAF signaling by kinase inactive BRAF | 42 | 9.11e-01 | 0.010000 | 9.47e-01 |
Signaling by RAS mutants | 42 | 9.11e-01 | 0.010000 | 9.47e-01 |
Signaling by moderate kinase activity BRAF mutants | 42 | 9.11e-01 | 0.010000 | 9.47e-01 |
Signaling downstream of RAS mutants | 42 | 9.11e-01 | 0.010000 | 9.47e-01 |
Vasopressin regulates renal water homeostasis via Aquaporins | 41 | 9.11e-01 | -0.010100 | 9.47e-01 |
Negative regulation of FGFR1 signaling | 27 | 9.11e-01 | -0.012400 | 9.47e-01 |
Regulation of IFNG signaling | 14 | 9.12e-01 | 0.017000 | 9.47e-01 |
Axon guidance | 490 | 9.13e-01 | 0.002910 | 9.47e-01 |
Metabolism of folate and pterines | 17 | 9.16e-01 | 0.014900 | 9.49e-01 |
Neurotransmitter receptors and postsynaptic signal transmission | 172 | 9.16e-01 | -0.004690 | 9.49e-01 |
Synthesis, secretion, and deacylation of Ghrelin | 18 | 9.17e-01 | -0.014100 | 9.50e-01 |
Separation of Sister Chromatids | 165 | 9.19e-01 | 0.004570 | 9.52e-01 |
Nervous system development | 513 | 9.20e-01 | 0.002590 | 9.52e-01 |
Early Phase of HIV Life Cycle | 13 | 9.25e-01 | -0.015000 | 9.56e-01 |
Acyl chain remodelling of PS | 21 | 9.29e-01 | -0.011300 | 9.59e-01 |
Activation of BH3-only proteins | 27 | 9.29e-01 | 0.009910 | 9.59e-01 |
RUNX2 regulates bone development | 30 | 9.32e-01 | 0.009040 | 9.61e-01 |
Regulation of RUNX1 Expression and Activity | 23 | 9.37e-01 | -0.009580 | 9.63e-01 |
Trafficking of GluR2-containing AMPA receptors | 17 | 9.37e-01 | -0.011100 | 9.63e-01 |
Gamma-carboxylation of protein precursors | 10 | 9.38e-01 | -0.014300 | 9.63e-01 |
PERK regulates gene expression | 31 | 9.38e-01 | -0.008090 | 9.63e-01 |
CaM pathway | 32 | 9.38e-01 | 0.007950 | 9.63e-01 |
Calmodulin induced events | 32 | 9.38e-01 | 0.007950 | 9.63e-01 |
Aquaporin-mediated transport | 49 | 9.39e-01 | 0.006330 | 9.64e-01 |
mRNA Splicing - Minor Pathway | 48 | 9.40e-01 | -0.006240 | 9.64e-01 |
Translesion synthesis by POLK | 16 | 9.40e-01 | 0.010800 | 9.64e-01 |
Interconversion of nucleotide di- and triphosphates | 28 | 9.44e-01 | -0.007740 | 9.66e-01 |
Pyrimidine catabolism | 12 | 9.48e-01 | -0.010900 | 9.70e-01 |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | 18 | 9.49e-01 | 0.008780 | 9.70e-01 |
FRS-mediated FGFR4 signaling | 19 | 9.50e-01 | 0.008370 | 9.70e-01 |
NOTCH4 Activation and Transmission of Signal to the Nucleus | 11 | 9.50e-01 | 0.010900 | 9.70e-01 |
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | 13 | 9.51e-01 | -0.009840 | 9.70e-01 |
PI-3K cascade:FGFR3 | 16 | 9.60e-01 | -0.007270 | 9.79e-01 |
Gap junction trafficking | 24 | 9.62e-01 | 0.005650 | 9.80e-01 |
Cell-Cell communication | 117 | 9.63e-01 | -0.002500 | 9.80e-01 |
SHC-mediated cascade:FGFR3 | 16 | 9.63e-01 | -0.006650 | 9.80e-01 |
tRNA processing in the nucleus | 57 | 9.64e-01 | 0.003490 | 9.80e-01 |
Ca-dependent events | 34 | 9.65e-01 | -0.004380 | 9.80e-01 |
RAB geranylgeranylation | 60 | 9.66e-01 | -0.003190 | 9.81e-01 |
Gene Silencing by RNA | 84 | 9.69e-01 | -0.002440 | 9.83e-01 |
Protein ubiquitination | 65 | 9.69e-01 | 0.002760 | 9.83e-01 |
Translesion synthesis by REV1 | 15 | 9.76e-01 | 0.004540 | 9.89e-01 |
Signaling by RAF1 mutants | 38 | 9.80e-01 | -0.002370 | 9.92e-01 |
Transmission across Chemical Synapses | 234 | 9.81e-01 | 0.000910 | 9.93e-01 |
Opioid Signalling | 87 | 9.82e-01 | 0.001400 | 9.93e-01 |
Diseases of metabolism | 228 | 9.84e-01 | 0.000781 | 9.94e-01 |
Tie2 Signaling | 18 | 9.86e-01 | 0.002310 | 9.95e-01 |
Cytosolic sulfonation of small molecules | 23 | 9.87e-01 | -0.001990 | 9.95e-01 |
p38MAPK events | 13 | 9.87e-01 | 0.002550 | 9.95e-01 |
RAS processing | 19 | 9.88e-01 | 0.002020 | 9.95e-01 |
GRB2 events in ERBB2 signaling | 16 | 9.89e-01 | 0.001980 | 9.95e-01 |
SUMOylation of transcription cofactors | 43 | 9.91e-01 | 0.001030 | 9.95e-01 |
Regulation of gene expression in beta cells | 19 | 9.91e-01 | 0.001490 | 9.95e-01 |
S Phase | 157 | 9.91e-01 | 0.000515 | 9.95e-01 |
Sema4D induced cell migration and growth-cone collapse | 20 | 9.91e-01 | 0.001400 | 9.95e-01 |
Nicotinate metabolism | 31 | 9.92e-01 | -0.001010 | 9.96e-01 |
Phase 0 - rapid depolarisation | 30 | 9.95e-01 | 0.000603 | 9.98e-01 |
Sulfur amino acid metabolism | 25 | 9.96e-01 | 0.000575 | 9.98e-01 |
Apoptotic cleavage of cellular proteins | 38 | 9.98e-01 | -0.000284 | 9.99e-01 |
FGFR3 mutant receptor activation | 10 | 9.99e-01 | 0.000147 | 9.99e-01 |
Signaling by activated point mutants of FGFR3 | 10 | 9.99e-01 | 0.000147 | 9.99e-01 |
Mitochondrial translation elongation
710 | |
---|---|
set | Mitochondrial translation elongation |
setSize | 85 |
pANOVA | 6.41e-21 |
s.dist | 0.588 |
p.adjustANOVA | 7.06e-18 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MRPS18B | 9007.5 |
PTCD3 | 8917.5 |
MRPL30 | 8739.0 |
MRPL38 | 8381.5 |
MRPL37 | 8373.5 |
GFM1 | 8370.5 |
MRPS34 | 8288.5 |
MRPL10 | 8203.5 |
MRPL36 | 8147.5 |
MRPS5 | 8097.5 |
MRPS17 | 7940.0 |
MRPL4 | 7909.5 |
MRPL12 | 7898.5 |
MRPL28 | 7858.5 |
MRPL45 | 7805.5 |
TSFM | 7754.5 |
MRPS15 | 7718.5 |
MRPL1 | 7666.5 |
MRPS30 | 7513.5 |
MRPL9 | 7452.5 |
GeneID | Gene Rank |
---|---|
MRPS18B | 9007.5 |
PTCD3 | 8917.5 |
MRPL30 | 8739.0 |
MRPL38 | 8381.5 |
MRPL37 | 8373.5 |
GFM1 | 8370.5 |
MRPS34 | 8288.5 |
MRPL10 | 8203.5 |
MRPL36 | 8147.5 |
MRPS5 | 8097.5 |
MRPS17 | 7940.0 |
MRPL4 | 7909.5 |
MRPL12 | 7898.5 |
MRPL28 | 7858.5 |
MRPL45 | 7805.5 |
TSFM | 7754.5 |
MRPS15 | 7718.5 |
MRPL1 | 7666.5 |
MRPS30 | 7513.5 |
MRPL9 | 7452.5 |
MRPL19 | 7446.5 |
MRPL44 | 7423.5 |
TUFM | 7412.5 |
OXA1L | 7295.5 |
MRPL14 | 7233.5 |
MRPL42 | 7151.5 |
MRPL58 | 7145.5 |
MRPS9 | 7125.5 |
MRPS21 | 7123.5 |
MRPL33 | 7108.5 |
MRPL46 | 7097.5 |
MRPS2 | 7088.5 |
MRPL15 | 7081.5 |
MRPS14 | 7080.5 |
MRPS23 | 7023.5 |
MRPL34 | 7010.5 |
DAP3 | 6808.5 |
MRPL53 | 6767.5 |
MRPL39 | 6593.5 |
MRPL17 | 6570.5 |
MRPL11 | 6448.5 |
MRPL54 | 6383.5 |
MRPS6 | 6299.5 |
MRPL47 | 6290.5 |
MRPS18A | 6180.5 |
MRPL50 | 6063.5 |
MRPS24 | 6060.5 |
MRPL24 | 6022.5 |
MRPL13 | 5793.5 |
MRPL3 | 5792.5 |
MRPS7 | 5442.5 |
MRPL22 | 5316.5 |
GADD45GIP1 | 5315.5 |
MRPL49 | 5221.5 |
MRPL55 | 5154.5 |
MRPS26 | 5107.5 |
MRPS11 | 5060.5 |
MRPL2 | 4996.5 |
MRPS12 | 4860.5 |
MRPL35 | 4577.5 |
MRPL20 | 4398.5 |
MRPL52 | 4008.5 |
MRPL32 | 3649.5 |
MRPS27 | 3638.5 |
MRPS31 | 3476.5 |
MRPL40 | 3261.5 |
MRPS18C | 3041.5 |
ERAL1 | 2960.5 |
MRPS10 | 2736.5 |
MRPS22 | 2728.5 |
MRPS33 | 2646.5 |
CHCHD1 | 2605.5 |
MRPL18 | 2121.5 |
MRPS25 | 1771.5 |
MRPL21 | 1681.5 |
MRPL41 | 1669.5 |
MRPL16 | 1300.5 |
MRPL51 | 1260.5 |
MRPL48 | 1028.5 |
MRPL43 | -1166.5 |
MRPS16 | -1420.5 |
MRPL27 | -1728.5 |
MRPS28 | -1815.5 |
MRPS35 | -2568.5 |
MRPS36 | -2886.5 |
Mitochondrial translation
709 | |
---|---|
set | Mitochondrial translation |
setSize | 91 |
pANOVA | 9.76e-21 |
s.dist | 0.566 |
p.adjustANOVA | 7.06e-18 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MRPS18B | 9007.5 |
PTCD3 | 8917.5 |
MRPL30 | 8739.0 |
MRPL38 | 8381.5 |
MRPL37 | 8373.5 |
GFM1 | 8370.5 |
GFM2 | 8363.5 |
MRPS34 | 8288.5 |
MRPL10 | 8203.5 |
MRPL36 | 8147.5 |
MRPS5 | 8097.5 |
MRPS17 | 7940.0 |
MRPL4 | 7909.5 |
MRPL12 | 7898.5 |
MRPL28 | 7858.5 |
MRPL45 | 7805.5 |
TSFM | 7754.5 |
MRPS15 | 7718.5 |
MRPL1 | 7666.5 |
MRPS30 | 7513.5 |
GeneID | Gene Rank |
---|---|
MRPS18B | 9007.5 |
PTCD3 | 8917.5 |
MRPL30 | 8739.0 |
MRPL38 | 8381.5 |
MRPL37 | 8373.5 |
GFM1 | 8370.5 |
GFM2 | 8363.5 |
MRPS34 | 8288.5 |
MRPL10 | 8203.5 |
MRPL36 | 8147.5 |
MRPS5 | 8097.5 |
MRPS17 | 7940.0 |
MRPL4 | 7909.5 |
MRPL12 | 7898.5 |
MRPL28 | 7858.5 |
MRPL45 | 7805.5 |
TSFM | 7754.5 |
MRPS15 | 7718.5 |
MRPL1 | 7666.5 |
MRPS30 | 7513.5 |
MRPL9 | 7452.5 |
MRPL19 | 7446.5 |
MRPL44 | 7423.5 |
TUFM | 7412.5 |
OXA1L | 7295.5 |
MRPL14 | 7233.5 |
MRPL42 | 7151.5 |
MRPL58 | 7145.5 |
MRPS9 | 7125.5 |
MRPS21 | 7123.5 |
MRPL33 | 7108.5 |
MRPL46 | 7097.5 |
MRPS2 | 7088.5 |
MRPL15 | 7081.5 |
MRPS14 | 7080.5 |
MRPS23 | 7023.5 |
MRPL34 | 7010.5 |
DAP3 | 6808.5 |
MRPL53 | 6767.5 |
MRPL39 | 6593.5 |
MRPL17 | 6570.5 |
MRPL11 | 6448.5 |
MRPL54 | 6383.5 |
MRPS6 | 6299.5 |
MRPL47 | 6290.5 |
MRPS18A | 6180.5 |
MRPL50 | 6063.5 |
MRPS24 | 6060.5 |
MRPL24 | 6022.5 |
MRPL13 | 5793.5 |
MRPL3 | 5792.5 |
MRPS7 | 5442.5 |
MRPL22 | 5316.5 |
GADD45GIP1 | 5315.5 |
MRPL49 | 5221.5 |
MRPL55 | 5154.5 |
MRPS26 | 5107.5 |
MRPS11 | 5060.5 |
MRPL2 | 4996.5 |
MRPS12 | 4860.5 |
MRPL35 | 4577.5 |
MRPL20 | 4398.5 |
MRPL52 | 4008.5 |
MRPL32 | 3649.5 |
MRPS27 | 3638.5 |
MRPS31 | 3476.5 |
MRRF | 3438.5 |
MRPL40 | 3261.5 |
MRPS18C | 3041.5 |
MTRF1L | 3028.5 |
ERAL1 | 2960.5 |
MTIF2 | 2857.5 |
MRPS10 | 2736.5 |
MRPS22 | 2728.5 |
MRPS33 | 2646.5 |
CHCHD1 | 2605.5 |
MRPL18 | 2121.5 |
MTIF3 | 2088.5 |
MRPS25 | 1771.5 |
MRPL21 | 1681.5 |
MRPL41 | 1669.5 |
MRPL16 | 1300.5 |
MRPL51 | 1260.5 |
MRPL48 | 1028.5 |
MRPL43 | -1166.5 |
MRPS16 | -1420.5 |
MRPL27 | -1728.5 |
MRPS28 | -1815.5 |
MRPS35 | -2568.5 |
MRPS36 | -2886.5 |
MTFMT | -5744.5 |
Mitochondrial translation termination
712 | |
---|---|
set | Mitochondrial translation termination |
setSize | 85 |
pANOVA | 3.68e-20 |
s.dist | 0.577 |
p.adjustANOVA | 1.77e-17 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MRPS18B | 9007.5 |
PTCD3 | 8917.5 |
MRPL30 | 8739.0 |
MRPL38 | 8381.5 |
MRPL37 | 8373.5 |
GFM2 | 8363.5 |
MRPS34 | 8288.5 |
MRPL10 | 8203.5 |
MRPL36 | 8147.5 |
MRPS5 | 8097.5 |
MRPS17 | 7940.0 |
MRPL4 | 7909.5 |
MRPL12 | 7898.5 |
MRPL28 | 7858.5 |
MRPL45 | 7805.5 |
MRPS15 | 7718.5 |
MRPL1 | 7666.5 |
MRPS30 | 7513.5 |
MRPL9 | 7452.5 |
MRPL19 | 7446.5 |
GeneID | Gene Rank |
---|---|
MRPS18B | 9007.5 |
PTCD3 | 8917.5 |
MRPL30 | 8739.0 |
MRPL38 | 8381.5 |
MRPL37 | 8373.5 |
GFM2 | 8363.5 |
MRPS34 | 8288.5 |
MRPL10 | 8203.5 |
MRPL36 | 8147.5 |
MRPS5 | 8097.5 |
MRPS17 | 7940.0 |
MRPL4 | 7909.5 |
MRPL12 | 7898.5 |
MRPL28 | 7858.5 |
MRPL45 | 7805.5 |
MRPS15 | 7718.5 |
MRPL1 | 7666.5 |
MRPS30 | 7513.5 |
MRPL9 | 7452.5 |
MRPL19 | 7446.5 |
MRPL44 | 7423.5 |
OXA1L | 7295.5 |
MRPL14 | 7233.5 |
MRPL42 | 7151.5 |
MRPL58 | 7145.5 |
MRPS9 | 7125.5 |
MRPS21 | 7123.5 |
MRPL33 | 7108.5 |
MRPL46 | 7097.5 |
MRPS2 | 7088.5 |
MRPL15 | 7081.5 |
MRPS14 | 7080.5 |
MRPS23 | 7023.5 |
MRPL34 | 7010.5 |
DAP3 | 6808.5 |
MRPL53 | 6767.5 |
MRPL39 | 6593.5 |
MRPL17 | 6570.5 |
MRPL11 | 6448.5 |
MRPL54 | 6383.5 |
MRPS6 | 6299.5 |
MRPL47 | 6290.5 |
MRPS18A | 6180.5 |
MRPL50 | 6063.5 |
MRPS24 | 6060.5 |
MRPL24 | 6022.5 |
MRPL13 | 5793.5 |
MRPL3 | 5792.5 |
MRPS7 | 5442.5 |
MRPL22 | 5316.5 |
GADD45GIP1 | 5315.5 |
MRPL49 | 5221.5 |
MRPL55 | 5154.5 |
MRPS26 | 5107.5 |
MRPS11 | 5060.5 |
MRPL2 | 4996.5 |
MRPS12 | 4860.5 |
MRPL35 | 4577.5 |
MRPL20 | 4398.5 |
MRPL52 | 4008.5 |
MRPL32 | 3649.5 |
MRPS27 | 3638.5 |
MRPS31 | 3476.5 |
MRRF | 3438.5 |
MRPL40 | 3261.5 |
MRPS18C | 3041.5 |
MTRF1L | 3028.5 |
ERAL1 | 2960.5 |
MRPS10 | 2736.5 |
MRPS22 | 2728.5 |
MRPS33 | 2646.5 |
CHCHD1 | 2605.5 |
MRPL18 | 2121.5 |
MRPS25 | 1771.5 |
MRPL21 | 1681.5 |
MRPL41 | 1669.5 |
MRPL16 | 1300.5 |
MRPL51 | 1260.5 |
MRPL48 | 1028.5 |
MRPL43 | -1166.5 |
MRPS16 | -1420.5 |
MRPL27 | -1728.5 |
MRPS28 | -1815.5 |
MRPS35 | -2568.5 |
MRPS36 | -2886.5 |
Translation
1343 | |
---|---|
set | Translation |
setSize | 263 |
pANOVA | 2.86e-19 |
s.dist | 0.322 |
p.adjustANOVA | 1.03e-16 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MRPS18B | 9007.5 |
PTCD3 | 8917.5 |
VARS1 | 8908.5 |
RPL13A | 8886.5 |
VARS2 | 8870.5 |
IARS2 | 8848.5 |
NARS1 | 8747.5 |
MRPL30 | 8739.0 |
IARS1 | 8710.5 |
FARS2 | 8703.5 |
NARS2 | 8624.5 |
RPLP2 | 8590.5 |
EIF4G1 | 8580.5 |
GSPT1 | 8520.5 |
LARS2 | 8505.5 |
MRPL38 | 8381.5 |
MRPL37 | 8373.5 |
GFM1 | 8370.5 |
GFM2 | 8363.5 |
MRPS34 | 8288.5 |
GeneID | Gene Rank |
---|---|
MRPS18B | 9007.5 |
PTCD3 | 8917.5 |
VARS1 | 8908.5 |
RPL13A | 8886.5 |
VARS2 | 8870.5 |
IARS2 | 8848.5 |
NARS1 | 8747.5 |
MRPL30 | 8739.0 |
IARS1 | 8710.5 |
FARS2 | 8703.5 |
NARS2 | 8624.5 |
RPLP2 | 8590.5 |
EIF4G1 | 8580.5 |
GSPT1 | 8520.5 |
LARS2 | 8505.5 |
MRPL38 | 8381.5 |
MRPL37 | 8373.5 |
GFM1 | 8370.5 |
GFM2 | 8363.5 |
MRPS34 | 8288.5 |
MRPL10 | 8203.5 |
SEC61G | 8169.5 |
MRPL36 | 8147.5 |
MRPS5 | 8097.5 |
RPS9 | 7978.5 |
MARS2 | 7972.5 |
EIF2B5 | 7944.5 |
MRPS17 | 7940.0 |
AARS1 | 7920.5 |
MRPL4 | 7909.5 |
MRPL12 | 7898.5 |
MRPL28 | 7858.5 |
WARS1 | 7854.5 |
MRPL45 | 7805.5 |
EEF2 | 7789.5 |
EPRS1 | 7782.5 |
TSFM | 7754.5 |
MRPS15 | 7718.5 |
MRPL1 | 7666.5 |
EIF4E | 7655.5 |
EIF3K | 7589.5 |
MRPS30 | 7513.5 |
HARS2 | 7498.5 |
EEF1G | 7481.5 |
MRPL9 | 7452.5 |
MRPL19 | 7446.5 |
MRPL44 | 7423.5 |
TUFM | 7412.5 |
UBA52 | 7357.5 |
OXA1L | 7295.5 |
AIMP2 | 7246.5 |
MRPL14 | 7233.5 |
MRPL42 | 7151.5 |
MRPL58 | 7145.5 |
MRPS9 | 7125.5 |
MRPS21 | 7123.5 |
MRPL33 | 7108.5 |
DARS2 | 7106.5 |
MRPL46 | 7097.5 |
MRPS2 | 7088.5 |
MRPL15 | 7081.5 |
MRPS14 | 7080.5 |
EEF1A2 | 7029.5 |
MRPS23 | 7023.5 |
MRPL34 | 7010.5 |
EEF1D | 6906.5 |
DAP3 | 6808.5 |
RPL28 | 6806.5 |
EIF3C | 6805.0 |
EARS2 | 6792.5 |
MRPL53 | 6767.5 |
RPL19 | 6608.5 |
MRPL39 | 6593.5 |
MRPL17 | 6570.5 |
EIF4A2 | 6546.5 |
RPL29 | 6487.5 |
RPS10 | 6457.0 |
KARS1 | 6454.5 |
MRPL11 | 6448.5 |
MRPL54 | 6383.5 |
RPN2 | 6347.5 |
N6AMT1 | 6322.5 |
RPS11 | 6306.5 |
MRPS6 | 6299.5 |
MRPL47 | 6290.5 |
EIF2B1 | 6227.5 |
EIF5B | 6216.5 |
MRPS18A | 6180.5 |
SRP68 | 6138.5 |
MRPL50 | 6063.5 |
MRPS24 | 6060.5 |
MRPL24 | 6022.5 |
RPL35 | 5961.5 |
RPL13 | 5882.5 |
MARS1 | 5857.5 |
MRPL13 | 5793.5 |
MRPL3 | 5792.5 |
EIF3G | 5745.5 |
PPA1 | 5736.5 |
AARS2 | 5661.5 |
RPSA | 5610.5 |
EIF2B2 | 5602.5 |
EIF3L | 5597.5 |
SEC11C | 5517.5 |
RPS14 | 5480.5 |
MRPS7 | 5442.5 |
TARS2 | 5405.5 |
EIF3J | 5336.5 |
MRPL22 | 5316.5 |
GADD45GIP1 | 5315.5 |
RPS7 | 5274.5 |
MRPL49 | 5221.5 |
RPL3L | 5191.5 |
MRPL55 | 5154.5 |
MRPS26 | 5107.5 |
MRPS11 | 5060.5 |
MRPL2 | 4996.5 |
RPL18 | 4957.5 |
RPL10A | 4938.5 |
MRPS12 | 4860.5 |
EIF2S2 | 4761.5 |
RPL18A | 4656.5 |
MRPL35 | 4577.5 |
RPL9 | 4522.5 |
GARS1 | 4498.5 |
DDOST | 4494.5 |
RPS4X | 4442.5 |
RARS2 | 4410.5 |
MRPL20 | 4398.5 |
YARS1 | 4257.5 |
RPL15 | 4191.5 |
CARS1 | 4157.5 |
ETF1 | 4118.5 |
HARS1 | 4044.5 |
MRPL52 | 4008.5 |
SRPRA | 3989.5 |
SARS2 | 3976.0 |
EIF3B | 3961.5 |
TARS1 | 3797.5 |
EIF3H | 3755.5 |
MRPL32 | 3649.5 |
MRPS27 | 3638.5 |
SSR4 | 3584.5 |
MRPS31 | 3476.5 |
APEH | 3470.5 |
MRRF | 3438.5 |
EIF2B4 | 3425.5 |
RPS26 | 3411.5 |
EIF4EBP1 | 3336.5 |
MRPL40 | 3261.5 |
RPS6 | 3167.5 |
FARSA | 3117.5 |
RPL23 | 3101.5 |
EIF3A | 3054.5 |
MRPS18C | 3041.5 |
MTRF1L | 3028.5 |
EIF2S3 | 3002.0 |
ERAL1 | 2960.5 |
EIF3D | 2883.5 |
MTIF2 | 2857.5 |
SPCS1 | 2770.5 |
MRPS10 | 2736.5 |
MRPS22 | 2728.5 |
AIMP1 | 2707.5 |
MRPS33 | 2646.5 |
CHCHD1 | 2605.5 |
RPL8 | 2340.5 |
RPS27A | 2261.5 |
PARS2 | 2174.5 |
MRPL18 | 2121.5 |
MTIF3 | 2088.5 |
RPL24 | 2057.5 |
RPS5 | 2028.5 |
SRP14 | 1989.5 |
QARS1 | 1901.5 |
EIF1AX | 1826.5 |
RPL22 | 1825.5 |
SSR3 | 1807.5 |
MRPS25 | 1771.5 |
SARS1 | 1720.5 |
MRPL21 | 1681.5 |
MRPL41 | 1669.5 |
SRP9 | 1648.5 |
RPN1 | 1646.5 |
FARSB | 1504.5 |
RARS1 | 1477.5 |
MRPL16 | 1300.5 |
MRPL51 | 1260.5 |
SPCS2 | 1231.5 |
CARS2 | 1179.5 |
RPS8 | 1133.5 |
RPS27L | 1090.5 |
MRPL48 | 1028.5 |
EIF3E | 897.5 |
SRP19 | 616.5 |
LARS1 | 552.5 |
RPS15 | 545.5 |
RPL37 | 367.5 |
RPL37A | 302.5 |
RPS3A | 133.5 |
RPL21 | 45.0 |
RPL32 | 0.5 |
RPS28 | -86.5 |
MRPL43 | -1166.5 |
EEF1B2 | -1217.5 |
YARS2 | -1276.5 |
MRPS16 | -1420.5 |
RPL36 | -1676.5 |
RPL31 | -1702.5 |
MRPL27 | -1728.5 |
MRPS28 | -1815.5 |
SRP54 | -1887.5 |
DARS1 | -1997.5 |
EIF4A1 | -2162.5 |
EIF2B3 | -2357.5 |
RPL7A | -2363.5 |
SEC61A1 | -2411.5 |
MRPS35 | -2568.5 |
RPS23 | -2786.5 |
MRPS36 | -2886.5 |
EIF3F | -2965.5 |
SEC11A | -3017.5 |
WARS2 | -3221.5 |
RPL7 | -3262.5 |
SPCS3 | -3307.5 |
RPS3 | -3309.5 |
RPS2 | -3580.5 |
EEF1A1 | -3659.5 |
EIF2S1 | -4178.5 |
RPL5 | -4208.5 |
RPS15A | -4306.5 |
EIF5 | -4315.5 |
RPS25 | -4440.5 |
RPL10L | -4738.5 |
TRMT112 | -4815.5 |
EIF3M | -4836.5 |
RPL38 | -4919.5 |
RPL35A | -4964.5 |
SSR2 | -5139.5 |
SEC61B | -5336.5 |
SRPRB | -5708.5 |
SEC61A2 | -5711.5 |
MTFMT | -5744.5 |
RPL27 | -5778.5 |
PPA2 | -5799.5 |
EEF1E1 | -6270.0 |
RPS18 | -6410.5 |
RPS19 | -6473.5 |
TRAM1 | -6569.5 |
EIF4H | -6631.5 |
RPL30 | -6652.5 |
RPS21 | -6677.5 |
RPLP1 | -6712.5 |
GSPT2 | -6727.5 |
FAU | -6841.5 |
RPS17 | -7220.5 |
RPL3 | -7355.5 |
RPS16 | -7482.5 |
SRP72 | -7684.5 |
RPL6 | -7781.5 |
RPL23A | -8061.5 |
SSR1 | -8085.5 |
RPS13 | -8475.5 |
Mitochondrial translation initiation
711 | |
---|---|
set | Mitochondrial translation initiation |
setSize | 85 |
pANOVA | 7.75e-19 |
s.dist | 0.556 |
p.adjustANOVA | 2.24e-16 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MRPS18B | 9007.5 |
PTCD3 | 8917.5 |
MRPL30 | 8739.0 |
MRPL38 | 8381.5 |
MRPL37 | 8373.5 |
MRPS34 | 8288.5 |
MRPL10 | 8203.5 |
MRPL36 | 8147.5 |
MRPS5 | 8097.5 |
MRPS17 | 7940.0 |
MRPL4 | 7909.5 |
MRPL12 | 7898.5 |
MRPL28 | 7858.5 |
MRPL45 | 7805.5 |
MRPS15 | 7718.5 |
MRPL1 | 7666.5 |
MRPS30 | 7513.5 |
MRPL9 | 7452.5 |
MRPL19 | 7446.5 |
MRPL44 | 7423.5 |
GeneID | Gene Rank |
---|---|
MRPS18B | 9007.5 |
PTCD3 | 8917.5 |
MRPL30 | 8739.0 |
MRPL38 | 8381.5 |
MRPL37 | 8373.5 |
MRPS34 | 8288.5 |
MRPL10 | 8203.5 |
MRPL36 | 8147.5 |
MRPS5 | 8097.5 |
MRPS17 | 7940.0 |
MRPL4 | 7909.5 |
MRPL12 | 7898.5 |
MRPL28 | 7858.5 |
MRPL45 | 7805.5 |
MRPS15 | 7718.5 |
MRPL1 | 7666.5 |
MRPS30 | 7513.5 |
MRPL9 | 7452.5 |
MRPL19 | 7446.5 |
MRPL44 | 7423.5 |
OXA1L | 7295.5 |
MRPL14 | 7233.5 |
MRPL42 | 7151.5 |
MRPL58 | 7145.5 |
MRPS9 | 7125.5 |
MRPS21 | 7123.5 |
MRPL33 | 7108.5 |
MRPL46 | 7097.5 |
MRPS2 | 7088.5 |
MRPL15 | 7081.5 |
MRPS14 | 7080.5 |
MRPS23 | 7023.5 |
MRPL34 | 7010.5 |
DAP3 | 6808.5 |
MRPL53 | 6767.5 |
MRPL39 | 6593.5 |
MRPL17 | 6570.5 |
MRPL11 | 6448.5 |
MRPL54 | 6383.5 |
MRPS6 | 6299.5 |
MRPL47 | 6290.5 |
MRPS18A | 6180.5 |
MRPL50 | 6063.5 |
MRPS24 | 6060.5 |
MRPL24 | 6022.5 |
MRPL13 | 5793.5 |
MRPL3 | 5792.5 |
MRPS7 | 5442.5 |
MRPL22 | 5316.5 |
GADD45GIP1 | 5315.5 |
MRPL49 | 5221.5 |
MRPL55 | 5154.5 |
MRPS26 | 5107.5 |
MRPS11 | 5060.5 |
MRPL2 | 4996.5 |
MRPS12 | 4860.5 |
MRPL35 | 4577.5 |
MRPL20 | 4398.5 |
MRPL52 | 4008.5 |
MRPL32 | 3649.5 |
MRPS27 | 3638.5 |
MRPS31 | 3476.5 |
MRPL40 | 3261.5 |
MRPS18C | 3041.5 |
ERAL1 | 2960.5 |
MTIF2 | 2857.5 |
MRPS10 | 2736.5 |
MRPS22 | 2728.5 |
MRPS33 | 2646.5 |
CHCHD1 | 2605.5 |
MRPL18 | 2121.5 |
MTIF3 | 2088.5 |
MRPS25 | 1771.5 |
MRPL21 | 1681.5 |
MRPL41 | 1669.5 |
MRPL16 | 1300.5 |
MRPL51 | 1260.5 |
MRPL48 | 1028.5 |
MRPL43 | -1166.5 |
MRPS16 | -1420.5 |
MRPL27 | -1728.5 |
MRPS28 | -1815.5 |
MRPS35 | -2568.5 |
MRPS36 | -2886.5 |
MTFMT | -5744.5 |
The citric acid (TCA) cycle and respiratory electron transport
1303 | |
---|---|
set | The citric acid (TCA) cycle and respiratory electron transport |
setSize | 165 |
pANOVA | 3.56e-13 |
s.dist | 0.328 |
p.adjustANOVA | 8.58e-11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ACO2 | 8817.5 |
NDUFA12 | 8677.5 |
ATP5F1D | 8640.5 |
PDP1 | 8638.5 |
NDUFA8 | 8607.5 |
PDHX | 8564.5 |
ATP5PB | 8530.5 |
NDUFS5 | 8426.5 |
PDHB | 8238.5 |
BSG | 8186.5 |
ECSIT | 8154.5 |
DLST | 8106.5 |
COX11 | 8096.5 |
ACAD9 | 8063.5 |
ME3 | 8005.5 |
FAHD1 | 7997.5 |
NDUFS7 | 7874.5 |
MT-CO1 | 7459.5 |
LDHB | 7435.0 |
IDH2 | 7427.5 |
GeneID | Gene Rank |
---|---|
ACO2 | 8817.5 |
NDUFA12 | 8677.5 |
ATP5F1D | 8640.5 |
PDP1 | 8638.5 |
NDUFA8 | 8607.5 |
PDHX | 8564.5 |
ATP5PB | 8530.5 |
NDUFS5 | 8426.5 |
PDHB | 8238.5 |
BSG | 8186.5 |
ECSIT | 8154.5 |
DLST | 8106.5 |
COX11 | 8096.5 |
ACAD9 | 8063.5 |
ME3 | 8005.5 |
FAHD1 | 7997.5 |
NDUFS7 | 7874.5 |
MT-CO1 | 7459.5 |
LDHB | 7435.0 |
IDH2 | 7427.5 |
LDHC | 7413.5 |
TACO1 | 7403.5 |
NDUFA13 | 7316.5 |
TRAP1 | 7311.5 |
ETFDH | 7282.5 |
PDK2 | 7219.5 |
TIMMDC1 | 7186.5 |
IDH3A | 7182.5 |
NDUFAF3 | 7105.5 |
SCO1 | 6994.5 |
NDUFS2 | 6971.5 |
MT-CO2 | 6945.5 |
NDUFV1 | 6920.5 |
SDHB | 6907.5 |
DLAT | 6848.5 |
HAGH | 6790.5 |
NDUFAF4 | 6785.5 |
IDH3B | 6732.5 |
PDHA1 | 6639.5 |
FH | 6469.5 |
ADHFE1 | 6444.5 |
NDUFB10 | 6419.5 |
COX7A2L | 6410.5 |
UQCRC1 | 6324.5 |
NDUFS3 | 6318.5 |
UQCRFS1 | 6235.5 |
ETFB | 6145.5 |
NDUFV2 | 6127.5 |
PDPR | 6116.5 |
NDUFA10 | 6103.5 |
DMAC2L | 5929.5 |
COX5B | 5910.5 |
CS | 5894.5 |
NDUFA6 | 5887.5 |
MPC1 | 5835.5 |
NDUFA2 | 5728.5 |
ETFA | 5655.5 |
NDUFB9 | 5536.5 |
NDUFS8 | 5518.5 |
CYC1 | 5440.5 |
SURF1 | 5398.5 |
NDUFA11 | 5077.0 |
ATP5F1B | 5063.5 |
UQCRH | 4971.0 |
MPC2 | 4845.5 |
COX18 | 4765.5 |
UQCRQ | 4627.5 |
NDUFB8 | 4615.0 |
SDHC | 4606.5 |
NDUFB2 | 4587.5 |
OGDH | 4470.5 |
L2HGDH | 4434.5 |
NDUFAB1 | 4350.5 |
VDAC1 | 4260.5 |
SDHA | 4232.0 |
PDK1 | 4175.5 |
UCP2 | 4090.5 |
NDUFA7 | 3973.0 |
COX4I1 | 3926.5 |
UQCR10 | 3843.5 |
SLC25A27 | 3731.5 |
NDUFA9 | 3708.5 |
COX14 | 3517.5 |
NDUFA5 | 3514.5 |
UQCRC2 | 3503.5 |
ATP5PD | 3402.5 |
NDUFB6 | 3329.5 |
SUCLG1 | 3325.5 |
SUCLA2 | 3268.5 |
NDUFC1 | 3113.5 |
NDUFS1 | 3068.5 |
DLD | 2984.5 |
NDUFAF1 | 2966.5 |
ATP5PO | 2930.0 |
COQ10B | 2915.5 |
NDUFAF7 | 2842.5 |
COX7B | 2750.5 |
UQCR11 | 2718.0 |
NDUFC2 | 2669.0 |
ATP5MF | 2647.5 |
IDH3G | 2586.5 |
MT-ND1 | 2529.5 |
PPARD | 2501.5 |
NDUFB7 | 2448.5 |
NDUFS4 | 2412.5 |
PDP2 | 2306.5 |
NDUFA3 | 2298.5 |
SDHD | 2278.0 |
NDUFAF5 | 2012.5 |
MT-ND3 | 1861.5 |
CYCS | 1802.5 |
MT-CO3 | 1568.5 |
LDHA | 1562.5 |
MT-CYB | 1377.5 |
MT-ND5 | 1325.5 |
GLO1 | 1280.5 |
NDUFA4 | 1265.5 |
MT-ATP6 | 1243.5 |
MDH2 | 1129.5 |
COX6A1 | 1068.5 |
NDUFB5 | 1061.5 |
NNT | 785.5 |
COX20 | 681.5 |
D2HGDH | 530.5 |
COX5A | 481.5 |
RXRA | 395.5 |
MT-ND4 | 390.5 |
ATP5MC3 | 319.5 |
MT-ND2 | 306.5 |
ME2 | 9.5 |
ME1 | -80.5 |
SUCLG2 | -231.5 |
UCP1 | -358.5 |
NDUFB11 | -363.5 |
SLC16A1 | -369.5 |
SLC16A3 | -371.5 |
ATP5PF | -401.5 |
PDK4 | -495.5 |
MT-ND6 | -790.5 |
NUBPL | -1174.5 |
COX19 | -1192.5 |
ATP5F1E | -1407.5 |
COQ10A | -2127.5 |
COX7C | -2174.5 |
TMEM126B | -2544.5 |
ATP5MG | -2690.0 |
NDUFAF6 | -2759.5 |
NDUFS6 | -2838.5 |
ATP5ME | -3145.5 |
NDUFB3 | -3539.5 |
NDUFA1 | -3668.5 |
NDUFB4 | -3950.5 |
SLC25A14 | -4573.5 |
MT-ATP8 | -4868.5 |
UCP3 | -5025.5 |
COX8A | -5052.5 |
SLC16A8 | -5262.5 |
COX6B1 | -5355.5 |
ATP5F1A | -6042.5 |
PDK3 | -6753.5 |
NDUFV3 | -6831.5 |
PM20D1 | -7706.5 |
UQCRB | -7789.5 |
GSTZ1 | -7866.5 |
COX16 | -7904.5 |
Macroautophagy
664 | |
---|---|
set | Macroautophagy |
setSize | 108 |
pANOVA | 3.98e-12 |
s.dist | 0.386 |
p.adjustANOVA | 8.22e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CSNK2B | 8941.5 |
PARK7 | 8928.5 |
PRKAB2 | 8910.5 |
TSC2 | 8824.5 |
IFT88 | 8744.5 |
SQSTM1 | 8697.5 |
ARL13B | 8606.5 |
MFN2 | 8568.5 |
ATG16L1 | 8537.5 |
PINK1 | 8514.5 |
MTMR3 | 8415.5 |
MTOR | 8379.5 |
TOMM40 | 8333.5 |
MAP1LC3B | 8304.0 |
LAMTOR2 | 8098.5 |
CHMP7 | 7921.5 |
HSPA8 | 7910.5 |
ATG4D | 7848.5 |
MFN1 | 7800.5 |
ATG10 | 7735.5 |
GeneID | Gene Rank |
---|---|
CSNK2B | 8941.5 |
PARK7 | 8928.5 |
PRKAB2 | 8910.5 |
TSC2 | 8824.5 |
IFT88 | 8744.5 |
SQSTM1 | 8697.5 |
ARL13B | 8606.5 |
MFN2 | 8568.5 |
ATG16L1 | 8537.5 |
PINK1 | 8514.5 |
MTMR3 | 8415.5 |
MTOR | 8379.5 |
TOMM40 | 8333.5 |
MAP1LC3B | 8304.0 |
LAMTOR2 | 8098.5 |
CHMP7 | 7921.5 |
HSPA8 | 7910.5 |
ATG4D | 7848.5 |
MFN1 | 7800.5 |
ATG10 | 7735.5 |
PLIN3 | 7535.5 |
NBR1 | 7530.5 |
ATG4B | 7497.5 |
UBA52 | 7357.5 |
USP30 | 7330.5 |
PIK3C3 | 7250.5 |
DYNC1LI1 | 7142.5 |
DYNC1H1 | 6922.5 |
WIPI1 | 6633.5 |
WIPI2 | 6622.5 |
WDR45 | 6616.5 |
ATG101 | 6600.5 |
VCP | 6599.5 |
PLIN2 | 6558.5 |
MTMR14 | 6538.5 |
TOMM6 | 6247.5 |
PRKAA2 | 6239.5 |
DYNLL2 | 6153.5 |
CHMP3 | 6105.0 |
CHMP4C | 6023.5 |
LAMTOR4 | 5855.5 |
LAMTOR1 | 5813.5 |
PRKAB1 | 5775.5 |
GABARAPL1 | 5606.5 |
CHMP2B | 5497.5 |
RPTOR | 5295.5 |
ATG5 | 5242.5 |
MAP1LC3A | 5210.5 |
DYNC1I2 | 5195.5 |
ATG12 | 5189.5 |
CHMP4B | 5087.5 |
CSNK2A1 | 5083.0 |
CHMP6 | 4654.5 |
RHEB | 4650.5 |
ATG9A | 4630.5 |
ATG4C | 4511.5 |
HDAC6 | 4383.5 |
RRAGC | 4344.5 |
VDAC1 | 4260.5 |
UBE2N | 3887.0 |
EPAS1 | 3670.5 |
LAMTOR3 | 3663.5 |
ATG4A | 3180.5 |
TOMM20 | 3158.5 |
GABARAP | 3124.5 |
PRKAG3 | 3034.5 |
RRAGD | 2970.5 |
TOMM22 | 2933.5 |
TOMM70 | 2806.5 |
WDR45B | 2742.5 |
DYNC1I1 | 2733.5 |
PCNT | 2681.5 |
RPS27A | 2261.5 |
ATG13 | 2194.5 |
HSF1 | 1964.5 |
PIK3R4 | 1910.5 |
FUNDC1 | 1863.5 |
TSC1 | 1679.5 |
RRAGA | 1100.5 |
DYNLL1 | 767.5 |
MLST8 | 534.5 |
GABARAPL2 | 501.5 |
ULK1 | 458.5 |
CFTR | 341.5 |
CHMP2A | 160.5 |
PGAM5 | 146.5 |
UBC | 100.5 |
ATG7 | -152.5 |
PEX5 | -258.5 |
PRKAG2 | -768.5 |
RB1CC1 | -785.5 |
ATG14 | -1324.5 |
LAMTOR5 | -1790.5 |
MTERF3 | -1961.5 |
SRC | -2361.5 |
DYNC1LI2 | -2368.5 |
RRAGB | -2380.5 |
CETN1 | -2424.5 |
AMBRA1 | -2944.5 |
ATG9B | -3412.5 |
CSNK2A2 | -4612.5 |
ATM | -4881.5 |
TOMM7 | -4954.5 |
UVRAG | -5167.5 |
SLC38A9 | -6332.5 |
PRKAA1 | -7243.5 |
BECN1 | -7524.5 |
ATG3 | -7988.5 |
Autophagy
103 | |
---|---|
set | Autophagy |
setSize | 122 |
pANOVA | 1.98e-11 |
s.dist | 0.352 |
p.adjustANOVA | 3.57e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CSNK2B | 8941.5 |
PARK7 | 8928.5 |
PRKAB2 | 8910.5 |
TSC2 | 8824.5 |
IFT88 | 8744.5 |
SQSTM1 | 8697.5 |
ARL13B | 8606.5 |
MFN2 | 8568.5 |
ATG16L1 | 8537.5 |
PINK1 | 8514.5 |
HSP90AB1 | 8445.5 |
VPS37C | 8441.5 |
MTMR3 | 8415.5 |
MTOR | 8379.5 |
TOMM40 | 8333.5 |
MAP1LC3B | 8304.0 |
LAMTOR2 | 8098.5 |
CHMP7 | 7921.5 |
HSPA8 | 7910.5 |
ATG4D | 7848.5 |
GeneID | Gene Rank |
---|---|
CSNK2B | 8941.5 |
PARK7 | 8928.5 |
PRKAB2 | 8910.5 |
TSC2 | 8824.5 |
IFT88 | 8744.5 |
SQSTM1 | 8697.5 |
ARL13B | 8606.5 |
MFN2 | 8568.5 |
ATG16L1 | 8537.5 |
PINK1 | 8514.5 |
HSP90AB1 | 8445.5 |
VPS37C | 8441.5 |
MTMR3 | 8415.5 |
MTOR | 8379.5 |
TOMM40 | 8333.5 |
MAP1LC3B | 8304.0 |
LAMTOR2 | 8098.5 |
CHMP7 | 7921.5 |
HSPA8 | 7910.5 |
ATG4D | 7848.5 |
MFN1 | 7800.5 |
ATG10 | 7735.5 |
PLIN3 | 7535.5 |
NBR1 | 7530.5 |
ATG4B | 7497.5 |
UBA52 | 7357.5 |
USP30 | 7330.5 |
PIK3C3 | 7250.5 |
DYNC1LI1 | 7142.5 |
DYNC1H1 | 6922.5 |
WIPI1 | 6633.5 |
WIPI2 | 6622.5 |
WDR45 | 6616.5 |
ATG101 | 6600.5 |
VCP | 6599.5 |
PLIN2 | 6558.5 |
MTMR14 | 6538.5 |
MVB12A | 6344.5 |
TOMM6 | 6247.5 |
PRKAA2 | 6239.5 |
DYNLL2 | 6153.5 |
CHMP3 | 6105.0 |
VPS28 | 6061.5 |
CHMP4C | 6023.5 |
LAMTOR4 | 5855.5 |
LAMTOR1 | 5813.5 |
PRKAB1 | 5775.5 |
GABARAPL1 | 5606.5 |
CHMP2B | 5497.5 |
RPTOR | 5295.5 |
ATG5 | 5242.5 |
MAP1LC3A | 5210.5 |
DYNC1I2 | 5195.5 |
ATG12 | 5189.5 |
CHMP4B | 5087.5 |
CSNK2A1 | 5083.0 |
UBAP1 | 4743.5 |
CHMP6 | 4654.5 |
RHEB | 4650.5 |
ATG9A | 4630.5 |
ATG4C | 4511.5 |
HDAC6 | 4383.5 |
RRAGC | 4344.5 |
VDAC1 | 4260.5 |
UBE2N | 3887.0 |
EPAS1 | 3670.5 |
LAMTOR3 | 3663.5 |
ATG4A | 3180.5 |
TOMM20 | 3158.5 |
GABARAP | 3124.5 |
PRKAG3 | 3034.5 |
RRAGD | 2970.5 |
TOMM22 | 2933.5 |
TOMM70 | 2806.5 |
WDR45B | 2742.5 |
DYNC1I1 | 2733.5 |
PCNT | 2681.5 |
RPS27A | 2261.5 |
ATG13 | 2194.5 |
HSF1 | 1964.5 |
PIK3R4 | 1910.5 |
FUNDC1 | 1863.5 |
MVB12B | 1759.5 |
TSC1 | 1679.5 |
RNASE1 | 1484.5 |
RRAGA | 1100.5 |
DYNLL1 | 767.5 |
MLST8 | 534.5 |
GABARAPL2 | 501.5 |
ULK1 | 458.5 |
TSG101 | 385.5 |
CFTR | 341.5 |
CHMP2A | 160.5 |
PGAM5 | 146.5 |
UBC | 100.5 |
VPS37A | -109.5 |
ATG7 | -152.5 |
PEX5 | -258.5 |
PRKAG2 | -768.5 |
RB1CC1 | -785.5 |
ATG14 | -1324.5 |
LAMTOR5 | -1790.5 |
MTERF3 | -1961.5 |
SRC | -2361.5 |
DYNC1LI2 | -2368.5 |
RRAGB | -2380.5 |
CETN1 | -2424.5 |
AMBRA1 | -2944.5 |
ATG9B | -3412.5 |
EEF1A1 | -3659.5 |
VPS37D | -4235.5 |
LAMP2 | -4242.5 |
CSNK2A2 | -4612.5 |
ATM | -4881.5 |
TOMM7 | -4954.5 |
UVRAG | -5167.5 |
VPS37B | -5376.5 |
SLC38A9 | -6332.5 |
PRKAA1 | -7243.5 |
BECN1 | -7524.5 |
GFAP | -7775.5 |
ATG3 | -7988.5 |
Protein localization
925 | |
---|---|
set | Protein localization |
setSize | 156 |
pANOVA | 4.45e-11 |
s.dist | 0.306 |
p.adjustANOVA | 7.14e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PEX16 | 8967.5 |
TIMM50 | 8913.5 |
ACO2 | 8817.5 |
LDHD | 8757.5 |
ECI2 | 8721.5 |
LONP2 | 8717.5 |
ACOX1 | 8680.5 |
AMACR | 8598.5 |
CRAT | 8595.5 |
CMC2 | 8574.5 |
HSD17B4 | 8517.5 |
PITRM1 | 8463.5 |
PEX19 | 8449.5 |
PECR | 8397.5 |
BAG6 | 8345.5 |
TOMM40 | 8333.5 |
FXN | 8330.5 |
GET3 | 8251.5 |
PEX10 | 8221.5 |
PMPCA | 8171.5 |
GeneID | Gene Rank |
---|---|
PEX16 | 8967.5 |
TIMM50 | 8913.5 |
ACO2 | 8817.5 |
LDHD | 8757.5 |
ECI2 | 8721.5 |
LONP2 | 8717.5 |
ACOX1 | 8680.5 |
AMACR | 8598.5 |
CRAT | 8595.5 |
CMC2 | 8574.5 |
HSD17B4 | 8517.5 |
PITRM1 | 8463.5 |
PEX19 | 8449.5 |
PECR | 8397.5 |
BAG6 | 8345.5 |
TOMM40 | 8333.5 |
FXN | 8330.5 |
GET3 | 8251.5 |
PEX10 | 8221.5 |
PMPCA | 8171.5 |
SEC61G | 8169.5 |
ACOT8 | 8091.5 |
MLYCD | 8087.5 |
SGTA | 7938.5 |
APP | 7804.5 |
PAOX | 7705.0 |
SLC25A13 | 7672.5 |
SLC25A12 | 7665.5 |
GRPEL1 | 7654.5 |
CHCHD5 | 7532.5 |
UBA52 | 7357.5 |
PHYH | 7272.5 |
UBE2D3 | 7189.5 |
TIMM44 | 7140.5 |
HAO2 | 7043.5 |
ABCD1 | 7028.5 |
PXMP2 | 6909.5 |
PEX26 | 6833.5 |
GET1 | 6611.5 |
MTX1 | 6581.5 |
NUDT19 | 6554.5 |
IDH1 | 6455.5 |
HAO1 | 6395.5 |
DHRS4 | 6392.0 |
PEX14 | 6265.5 |
GDAP1 | 6263.5 |
ABCD3 | 6258.5 |
TOMM6 | 6247.5 |
TIMM23 | 6237.5 |
PMPCB | 6193.5 |
TIMM8A | 6184.5 |
HMOX1 | 6170.5 |
SAMM50 | 6128.5 |
UBE2J2 | 6118.5 |
PEX1 | 6091.5 |
TIMM21 | 6056.5 |
CHCHD4 | 6017.5 |
CS | 5894.5 |
TIMM8B | 5797.5 |
HSPD1 | 5605.5 |
TAZ | 5561.5 |
UBL4A | 5498.5 |
CYC1 | 5440.5 |
ACOT2 | 5390.0 |
ECH1 | 5378.5 |
COQ2 | 5364.5 |
TIMM10 | 5314.5 |
SLC25A4 | 5264.5 |
ACOX2 | 5204.5 |
HSPA9 | 5108.5 |
TIMM10B | 5095.0 |
ABCD2 | 5081.5 |
ATP5F1B | 5063.5 |
CHCHD3 | 5047.5 |
TYSND1 | 4821.5 |
NDUFB8 | 4615.0 |
PEX7 | 4597.5 |
PXMP4 | 4371.5 |
VDAC1 | 4260.5 |
EMD | 4197.5 |
TIMM17A | 3995.5 |
EHHADH | 3987.5 |
HMGCL | 3899.5 |
TIMM22 | 3837.5 |
OTC | 3799.5 |
CAT | 3746.5 |
BCS1L | 3714.5 |
PEX2 | 3648.5 |
SLC25A17 | 3212.5 |
UBE2D1 | 3169.5 |
TOMM20 | 3158.5 |
COA4 | 3056.5 |
TOMM22 | 2933.5 |
TOMM70 | 2806.5 |
ACAA1 | 2649.5 |
IDH3G | 2586.5 |
ACOX3 | 2390.5 |
PEX6 | 2355.5 |
RPS27A | 2261.5 |
PAM16 | 1923.5 |
CHCHD7 | 1405.5 |
TIMM9 | 1333.5 |
GNPAT | 1278.5 |
COA6 | 1213.5 |
CMC4 | 1002.5 |
MTX2 | 965.5 |
PRNP | 772.5 |
CYB5A | 701.5 |
COX17 | 646.5 |
UBE2D2 | 126.5 |
UBC | 100.5 |
TIMM13 | 27.5 |
VAMP2 | -124.0 |
PEX12 | -239.5 |
PEX5 | -258.5 |
IDE | -266.5 |
DNAJC19 | -270.5 |
MPV17 | -541.5 |
CAMLG | -1154.5 |
DAO | -1182.5 |
COX19 | -1192.5 |
ZFAND6 | -1338.5 |
OTOF | -1453.5 |
AGXT | -1460.5 |
SLC27A2 | -1841.5 |
STX5 | -1984.5 |
PEX13 | -2723.5 |
USP9X | -2762.5 |
HACL1 | -2803.5 |
PIPOX | -3049.5 |
SERP1 | -3120.5 |
PEX11B | -3698.5 |
GRPEL2 | -4259.5 |
ALDH3A2 | -4314.5 |
AGPS | -4511.5 |
GFER | -4610.5 |
PEX3 | -4652.5 |
HSCB | -4732.5 |
TOMM7 | -4954.5 |
EPHX2 | -5201.5 |
GSTK1 | -5244.5 |
SEC61B | -5336.5 |
GET4 | -5543.5 |
ACBD5 | -5836.5 |
DDO | -6010.5 |
ATP5F1A | -6042.5 |
CROT | -6097.5 |
ACOT4 | -6347.5 |
VAPA | -6554.5 |
BAAT | -6684.5 |
TIMM17B | -6725.5 |
NUDT7 | -6823.5 |
NOS2 | -6925.5 |
STX1A | -7287.5 |
CHCHD10 | -7851.5 |
CHCHD2 | -7918.5 |
Metabolism of proteins
688 | |
---|---|
set | Metabolism of proteins |
setSize | 1810 |
pANOVA | 1.06e-10 |
s.dist | 0.0924 |
p.adjustANOVA | 1.53e-08 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ANK2 | 9013.5 |
MRPS18B | 9007.5 |
GAS6 | 9006.5 |
ADAMTSL1 | 9001.5 |
MIA2 | 8992.5 |
COPE | 8984.5 |
COPG1 | 8946.5 |
TTLL9 | 8942.5 |
CSNK2B | 8941.5 |
DDIT3 | 8934.5 |
PARK7 | 8928.5 |
PTCD3 | 8917.5 |
DAXX | 8914.5 |
VARS1 | 8908.5 |
MFGE8 | 8899.5 |
ALG3 | 8889.5 |
RPL13A | 8886.5 |
FBXO31 | 8879.5 |
VARS2 | 8870.5 |
RPA1 | 8853.5 |
GeneID | Gene Rank |
---|---|
ANK2 | 9013.5 |
MRPS18B | 9007.5 |
GAS6 | 9006.5 |
ADAMTSL1 | 9001.5 |
MIA2 | 8992.5 |
COPE | 8984.5 |
COPG1 | 8946.5 |
TTLL9 | 8942.5 |
CSNK2B | 8941.5 |
DDIT3 | 8934.5 |
PARK7 | 8928.5 |
PTCD3 | 8917.5 |
DAXX | 8914.5 |
VARS1 | 8908.5 |
MFGE8 | 8899.5 |
ALG3 | 8889.5 |
RPL13A | 8886.5 |
FBXO31 | 8879.5 |
VARS2 | 8870.5 |
RPA1 | 8853.5 |
IARS2 | 8848.5 |
RAD52 | 8823.5 |
GALNT2 | 8816.5 |
FBXL19 | 8799.5 |
USP2 | 8778.5 |
DNAJB9 | 8768.5 |
USP20 | 8761.5 |
PSMB8 | 8750.5 |
CUL4A | 8748.5 |
NARS1 | 8747.5 |
MRPL30 | 8739.0 |
DCAF11 | 8735.0 |
NSMCE1 | 8727.5 |
SPTAN1 | 8726.5 |
NEU1 | 8725.5 |
DCTN1 | 8719.0 |
LONP2 | 8717.5 |
RANGAP1 | 8716.5 |
SPTBN1 | 8714.5 |
IARS1 | 8710.5 |
PSMD1 | 8707.5 |
FARS2 | 8703.5 |
CALU | 8681.5 |
EXOC3 | 8672.5 |
FOXO4 | 8664.5 |
NICN1 | 8655.5 |
NARS2 | 8624.5 |
GPS1 | 8619.5 |
RAD23A | 8618.5 |
GORASP1 | 8615.5 |
RPLP2 | 8590.5 |
EIF4G1 | 8580.5 |
PPP6R1 | 8570.5 |
TOP1 | 8567.5 |
PFDN6 | 8550.5 |
COMMD9 | 8546.5 |
SELENOS | 8543.5 |
PRMT3 | 8532.5 |
DCAF8 | 8526.5 |
GSPT1 | 8520.5 |
YIF1A | 8509.5 |
LARS2 | 8505.5 |
ZBTB17 | 8498.5 |
ATP6V0D1 | 8493.5 |
TNIP1 | 8492.5 |
RNF5 | 8489.5 |
RING1 | 8483.5 |
CCT3 | 8472.5 |
USP25 | 8470.5 |
TBCD | 8459.5 |
RHOT1 | 8433.5 |
COMMD4 | 8430.5 |
KLHL22 | 8420.0 |
DCTN2 | 8402.5 |
TTLL7 | 8389.5 |
USP4 | 8388.5 |
MRPL38 | 8381.5 |
MRPL37 | 8373.5 |
GFM1 | 8370.5 |
GFM2 | 8363.5 |
CTBP1 | 8359.5 |
ARL2 | 8351.5 |
GBF1 | 8347.5 |
CDC34 | 8326.5 |
SULT1A3 | 8318.0 |
FBXW10 | 8307.0 |
HDGF | 8302.5 |
WRAP53 | 8290.5 |
MRPS34 | 8288.5 |
COG4 | 8282.5 |
LMNA | 8271.5 |
RUVBL1 | 8255.5 |
MAVS | 8242.5 |
RAB30 | 8230.5 |
USP15 | 8228.5 |
PEX10 | 8221.5 |
B4GALT5 | 8216.5 |
MRPL10 | 8203.5 |
QSOX1 | 8202.5 |
FN3K | 8187.5 |
ANK3 | 8175.5 |
MAN2A2 | 8172.5 |
SEC61G | 8169.5 |
HERPUD1 | 8157.5 |
MRPL36 | 8147.5 |
NFRKB | 8144.5 |
SPSB3 | 8137.5 |
ST3GAL1 | 8113.5 |
NOD1 | 8105.5 |
NUP50 | 8100.5 |
MRPS5 | 8097.5 |
TECTA | 8092.5 |
KIF5A | 8088.5 |
EXTL1 | 8084.5 |
OTULIN | 8083.5 |
MAT2B | 8081.5 |
HIC1 | 8078.5 |
HERC2 | 8073.5 |
DCAF5 | 8013.5 |
ACTR8 | 8001.5 |
TUBA4A | 7992.5 |
IGF2 | 7988.5 |
COPS2 | 7987.5 |
WFS1 | 7981.5 |
RPS9 | 7978.5 |
UBE2R2 | 7975.5 |
MARS2 | 7972.5 |
CNIH3 | 7953.5 |
CHM | 7950.5 |
EIF2B5 | 7944.5 |
MRPS17 | 7940.0 |
COPS7A | 7934.5 |
AARS1 | 7920.5 |
PIAS4 | 7919.5 |
HSPA8 | 7910.5 |
MRPL4 | 7909.5 |
MRPL12 | 7898.5 |
RNF40 | 7887.5 |
FEM1A | 7869.5 |
HGS | 7865.5 |
MRPL28 | 7858.5 |
WARS1 | 7854.5 |
MLEC | 7849.5 |
NAPA | 7830.5 |
SPSB4 | 7829.5 |
STS | 7827.5 |
ART3 | 7824.5 |
FKBP8 | 7818.5 |
MEPE | 7815.5 |
NFYC | 7813.5 |
LARGE1 | 7807.5 |
MRPL45 | 7805.5 |
APP | 7804.5 |
GNB3 | 7796.5 |
EEF2 | 7789.5 |
EPRS1 | 7782.5 |
ATF4 | 7774.5 |
DDA1 | 7763.5 |
TSFM | 7754.5 |
MIA3 | 7748.5 |
KIFC3 | 7743.5 |
NEDD8 | 7736.5 |
ASB9 | 7731.5 |
MRPS15 | 7718.5 |
SYVN1 | 7703.5 |
FBXW8 | 7695.5 |
COG1 | 7689.5 |
USP48 | 7686.5 |
GNAT3 | 7676.5 |
MRPL1 | 7666.5 |
DCUN1D2 | 7661.5 |
EIF4E | 7655.5 |
ANKRD9 | 7645.5 |
ATF3 | 7639.5 |
TUBA8 | 7628.5 |
PSMC1 | 7622.5 |
PMM2 | 7602.5 |
WAC | 7598.5 |
C4A | 7594.0 |
EIF3K | 7589.5 |
USP19 | 7579.5 |
FBXW5 | 7571.5 |
DOHH | 7552.5 |
TATDN2 | 7538.0 |
MRPS30 | 7513.5 |
USP5 | 7503.5 |
HARS2 | 7498.5 |
ASB10 | 7484.5 |
EEF1G | 7481.5 |
RAB4A | 7480.5 |
DPH5 | 7476.5 |
PAX6 | 7474.5 |
MRPL9 | 7452.5 |
MRPL19 | 7446.5 |
MRPL44 | 7423.5 |
RAB1B | 7416.5 |
TUFM | 7412.5 |
LAMB2 | 7390.5 |
PCSK9 | 7387.5 |
SKP1 | 7381.5 |
UBE2M | 7376.5 |
CAPZB | 7374.5 |
UBA52 | 7357.5 |
SPTA1 | 7356.5 |
UIMC1 | 7349.5 |
TTL | 7348.5 |
PSMA6 | 7345.5 |
ASB12 | 7338.5 |
INO80E | 7337.5 |
ADAMTS20 | 7332.5 |
USP30 | 7330.5 |
COPS4 | 7310.5 |
MCFD2 | 7307.5 |
NPPA | 7300.5 |
OXA1L | 7295.5 |
HSPA5 | 7276.5 |
EXTL2 | 7266.5 |
NUP58 | 7254.5 |
TNIP2 | 7247.5 |
AIMP2 | 7246.5 |
MRPL14 | 7233.5 |
AGBL1 | 7227.5 |
REN | 7205.5 |
AAAS | 7196.5 |
CUL2 | 7195.5 |
UBE2D3 | 7189.5 |
KLHDC3 | 7188.5 |
PROZ | 7183.5 |
HYOU1 | 7179.5 |
RAB5B | 7162.5 |
RAB22A | 7156.5 |
MRPL42 | 7151.5 |
MRPL58 | 7145.5 |
DYNC1LI1 | 7142.5 |
NFYA | 7132.5 |
MRPS9 | 7125.5 |
MRPS21 | 7123.5 |
CRHR2 | 7121.5 |
ST6GALNAC4 | 7119.5 |
ASB1 | 7112.5 |
MRPL33 | 7108.5 |
DARS2 | 7106.5 |
SEC24D | 7100.5 |
MRPL46 | 7097.5 |
ANK1 | 7089.5 |
MRPS2 | 7088.5 |
MRPL15 | 7081.5 |
MRPS14 | 7080.5 |
NCSTN | 7078.5 |
PTEN | 7076.5 |
CCT6A | 7075.5 |
RAB36 | 7069.5 |
SKIV2L | 7051.5 |
LMCD1 | 7050.5 |
DHPS | 7035.0 |
EEF1A2 | 7029.5 |
PSMD4 | 7024.5 |
MRPS23 | 7023.5 |
UBE2G2 | 7017.5 |
MRPL34 | 7010.5 |
USP13 | 7000.5 |
VDR | 6987.5 |
TAF10 | 6985.5 |
LMAN1 | 6981.5 |
TMEM115 | 6978.5 |
ST3GAL5 | 6969.5 |
GGA3 | 6955.5 |
ST6GALNAC6 | 6936.0 |
DYNC1H1 | 6922.5 |
FPGT | 6916.5 |
PSMB5 | 6910.5 |
EEF1D | 6906.5 |
ASNS | 6904.5 |
GAPDHS | 6874.5 |
POFUT2 | 6868.5 |
SOCS2 | 6842.5 |
ASB6 | 6841.5 |
CBX8 | 6838.5 |
NEURL2 | 6829.5 |
PSMB9 | 6825.5 |
UBA1 | 6820.5 |
ESR1 | 6813.5 |
DAP3 | 6808.5 |
RPL28 | 6806.5 |
EIF3C | 6805.0 |
ACADVL | 6798.5 |
EARS2 | 6792.5 |
TPGS1 | 6786.5 |
BMI1 | 6780.0 |
THSD7B | 6773.5 |
GPAA1 | 6770.5 |
MRPL53 | 6767.5 |
CANX | 6765.5 |
TRAPPC5 | 6759.5 |
FBXO40 | 6751.5 |
ACTR1A | 6743.5 |
NAPB | 6739.5 |
INO80B | 6726.0 |
PPARA | 6721.5 |
MEN1 | 6707.5 |
MDM2 | 6693.5 |
RNF185 | 6684.5 |
METTL21A | 6669.5 |
OTUD3 | 6668.5 |
GNG8 | 6665.5 |
FUCA1 | 6664.5 |
SPP1 | 6663.5 |
CBX4 | 6653.5 |
WIPI1 | 6633.5 |
TRAF2 | 6628.5 |
TNFAIP3 | 6624.5 |
ST6GALNAC2 | 6618.5 |
RPL19 | 6608.5 |
MSRB2 | 6607.5 |
DNMT3B | 6605.5 |
VCP | 6599.5 |
MRPL39 | 6593.5 |
GATA4 | 6591.5 |
TRAPPC6A | 6582.5 |
BAP1 | 6571.5 |
MRPL17 | 6570.5 |
PIGB | 6565.5 |
CSF2RA | 6556.5 |
SLC30A5 | 6555.5 |
EIF4A2 | 6546.5 |
DHDDS | 6534.5 |
PIGC | 6530.5 |
PSMA8 | 6529.5 |
GNG5 | 6527.5 |
KEAP1 | 6518.5 |
DDB1 | 6499.5 |
SFTPB | 6488.5 |
RPL29 | 6487.5 |
GCNT7 | 6473.5 |
CCT7 | 6470.5 |
USP21 | 6463.5 |
UBXN1 | 6458.5 |
RPS10 | 6457.0 |
KARS1 | 6454.5 |
MRPL11 | 6448.5 |
PSME1 | 6431.5 |
FUOM | 6424.5 |
FBXL22 | 6398.5 |
MRPL54 | 6383.5 |
RPN2 | 6347.5 |
POMT1 | 6342.5 |
ALG12 | 6339.5 |
SAR1B | 6335.5 |
MVD | 6331.5 |
N6AMT1 | 6322.5 |
PARP1 | 6319.5 |
AMFR | 6316.5 |
RPS11 | 6306.5 |
MRPS6 | 6299.5 |
MRPL47 | 6290.5 |
PENK | 6289.5 |
DCTN5 | 6287.5 |
P4HB | 6271.5 |
PEX14 | 6265.5 |
EIF2B1 | 6227.5 |
BTBD1 | 6223.5 |
SFTPD | 6222.5 |
MPI | 6217.5 |
EIF5B | 6216.5 |
RAB4B | 6215.0 |
VDAC2 | 6210.5 |
SEC16B | 6207.5 |
RAB3A | 6182.5 |
MRPS18A | 6180.5 |
BGLAP | 6176.5 |
ADORA2A | 6160.5 |
PSMD14 | 6156.5 |
DYNLL2 | 6153.5 |
ADAMTS7 | 6147.5 |
ETFB | 6145.5 |
SRP68 | 6138.5 |
INO80C | 6134.5 |
RTN4RL1 | 6122.5 |
SMC3 | 6121.5 |
UBE2J2 | 6118.5 |
TRAPPC4 | 6114.5 |
MBD5 | 6111.5 |
TRAPPC10 | 6107.0 |
NUS1 | 6096.5 |
PSMB6 | 6079.5 |
STAT3 | 6074.5 |
MRPL50 | 6063.5 |
MRPS24 | 6060.5 |
HSP90B1 | 6043.5 |
KAT2B | 6027.5 |
MRPL24 | 6022.5 |
USP47 | 6014.5 |
FBXO30 | 6011.5 |
MBOAT4 | 5997.5 |
DMP1 | 5991.5 |
PSMB7 | 5988.5 |
RAB25 | 5987.5 |
DPAGT1 | 5977.5 |
OTUB1 | 5970.5 |
RPL35 | 5961.5 |
ATXN3 | 5958.0 |
ATXN3L | 5958.0 |
PSMD7 | 5955.5 |
DPH3 | 5953.5 |
CTSD | 5945.0 |
ADAMTSL5 | 5934.5 |
NFKB2 | 5930.5 |
METTL22 | 5926.5 |
ELOC | 5925.5 |
FBXO11 | 5918.5 |
TGFBR2 | 5914.5 |
SRD5A3 | 5897.5 |
COPS3 | 5891.5 |
SNCA | 5890.5 |
RPL13 | 5882.5 |
ARFGEF2 | 5877.5 |
RAB21 | 5868.5 |
MUL1 | 5864.5 |
COPS8 | 5863.5 |
MARS1 | 5857.5 |
FBXO17 | 5852.5 |
RBBP5 | 5832.5 |
MYC | 5828.5 |
UBE2S | 5823.5 |
RTF1 | 5815.5 |
CUL1 | 5811.5 |
LMAN2L | 5803.5 |
MRPL13 | 5793.5 |
MRPL3 | 5792.5 |
PSMD11 | 5787.5 |
IKBKG | 5786.5 |
CREBRF | 5771.5 |
TMEM132A | 5761.5 |
SLC34A2 | 5755.5 |
EIF3G | 5745.5 |
PPA1 | 5736.5 |
PLA2G7 | 5717.5 |
CREB3L2 | 5716.5 |
MDGA1 | 5705.5 |
MSRB1 | 5687.5 |
PSMD8 | 5682.5 |
TRAPPC2L | 5676.5 |
APOL1 | 5666.0 |
AARS2 | 5661.5 |
RAD23B | 5659.5 |
GOLM1 | 5651.5 |
ST3GAL3 | 5647.5 |
ASB2 | 5646.5 |
TTLL8 | 5644.5 |
EXTL3 | 5629.5 |
LMAN2 | 5626.5 |
SOCS3 | 5624.5 |
RPSA | 5610.5 |
EIF2B2 | 5602.5 |
EIF3L | 5597.5 |
APLP2 | 5581.5 |
NUB1 | 5569.5 |
MYRIP | 5566.5 |
PSMA4 | 5533.5 |
ASB5 | 5531.5 |
SEC11C | 5517.5 |
PSMD3 | 5512.5 |
RBBP7 | 5506.5 |
PCMT1 | 5488.5 |
RPS14 | 5480.5 |
KLHL21 | 5463.5 |
MRPS7 | 5442.5 |
TADA3 | 5438.5 |
SENP2 | 5433.5 |
USP12 | 5428.5 |
NR1H3 | 5426.5 |
APH1A | 5425.5 |
PSMC2 | 5421.5 |
TARS2 | 5405.5 |
FBXL15 | 5402.5 |
NANS | 5353.5 |
ARF5 | 5340.5 |
EIF3J | 5336.5 |
NR3C1 | 5325.5 |
MRPL22 | 5316.5 |
GADD45GIP1 | 5315.5 |
CD59 | 5311.0 |
H2AZ1 | 5299.5 |
KAT2A | 5284.5 |
RPS7 | 5274.5 |
SAFB | 5272.5 |
MITF | 5268.5 |
RAB11B | 5266.5 |
SMAD7 | 5247.5 |
COMMD5 | 5237.5 |
ARF1 | 5233.5 |
USO1 | 5229.5 |
PSME4 | 5222.5 |
MRPL49 | 5221.5 |
PSMB1 | 5207.5 |
ADGRF5 | 5202.5 |
FBXO21 | 5197.5 |
DYNC1I2 | 5195.5 |
RPL3L | 5191.5 |
TRAF3 | 5171.5 |
B2M | 5167.5 |
COPG2 | 5161.5 |
TRAPPC9 | 5159.5 |
UBE2G1 | 5157.5 |
MRPL55 | 5154.5 |
GNAI1 | 5149.5 |
COPS5 | 5147.5 |
RNF123 | 5138.5 |
GLB1 | 5131.5 |
ASB8 | 5124.5 |
USP14 | 5122.5 |
SCMH1 | 5110.5 |
MRPS26 | 5107.5 |
PSMD10 | 5093.5 |
RAB35 | 5091.5 |
CSNK2A1 | 5083.0 |
B3GNT4 | 5073.5 |
MRPS11 | 5060.5 |
RAB6A | 5054.5 |
SATB1 | 5049.5 |
CREB3L3 | 5035.5 |
MDGA2 | 5030.5 |
PFDN1 | 5016.5 |
DCTN6 | 5013.5 |
TBCB | 5009.5 |
SFTPC | 5007.5 |
NAPSA | 5002.5 |
SPTB | 5001.5 |
MRPL2 | 4996.5 |
PSMC3 | 4982.5 |
PLAUR | 4965.5 |
DPH2 | 4963.5 |
RPL18 | 4957.5 |
EIF5A | 4949.0 |
RPL10A | 4938.5 |
KTN1 | 4932.5 |
PIGK | 4930.5 |
NEU2 | 4929.5 |
CD55 | 4922.5 |
EXOSC6 | 4913.5 |
ADRM1 | 4905.5 |
FBXO9 | 4904.5 |
COMMD3 | 4874.5 |
GALNT18 | 4871.5 |
PMM1 | 4867.5 |
MRPS12 | 4860.5 |
COG7 | 4858.5 |
FCGR3B | 4854.0 |
B3GALNT2 | 4852.5 |
COG5 | 4835.5 |
NR4A2 | 4829.5 |
PSMA2 | 4823.0 |
TTLL13P | 4818.0 |
OS9 | 4799.5 |
GALNTL5 | 4794.5 |
TFAP2B | 4790.5 |
PPP2R5B | 4784.5 |
RAB5C | 4783.5 |
WSB2 | 4768.5 |
EIF2S2 | 4761.5 |
PSMC4 | 4751.5 |
ISL1 | 4716.5 |
TLN1 | 4705.5 |
CUL5 | 4698.5 |
EXOC7 | 4692.5 |
BET1L | 4690.5 |
PSMD2 | 4685.5 |
THRB | 4674.5 |
RPL18A | 4656.5 |
PSMD5 | 4655.5 |
OTUD5 | 4643.5 |
EXOC4 | 4639.5 |
THSD1 | 4628.5 |
TBC1D20 | 4621.5 |
USP24 | 4607.5 |
H2AC1 | 4603.5 |
GNGT2 | 4590.5 |
MRPL35 | 4577.5 |
DOLK | 4576.5 |
ADRA2C | 4558.5 |
MYDGF | 4557.5 |
SEL1L | 4548.5 |
GATA6 | 4534.5 |
CCDC59 | 4523.5 |
RPL9 | 4522.5 |
ADORA2B | 4518.5 |
PHC2 | 4513.5 |
B3GNT6 | 4510.5 |
GARS1 | 4498.5 |
DDOST | 4494.5 |
KIN | 4487.5 |
AOPEP | 4478.5 |
SHISA5 | 4475.5 |
NUP62 | 4455.5 |
XPC | 4452.5 |
RPS4X | 4442.5 |
SENP5 | 4439.5 |
CCT5 | 4438.5 |
GATA3 | 4430.5 |
PSMD6 | 4428.5 |
COG2 | 4421.5 |
CALR | 4416.5 |
RARS2 | 4410.5 |
SLC35C1 | 4406.5 |
MRPL20 | 4398.5 |
DNAJC3 | 4351.5 |
PSMC5 | 4349.5 |
RAB11A | 4327.5 |
APC | 4290.5 |
H2AC21 | 4285.5 |
PREB | 4275.5 |
HIPK2 | 4273.5 |
CPE | 4263.5 |
PFDN5 | 4262.5 |
VDAC1 | 4260.5 |
YARS1 | 4257.5 |
NEU4 | 4217.5 |
TUBB4B | 4215.5 |
USP11 | 4212.5 |
TP53BP1 | 4208.5 |
RPL15 | 4191.5 |
POMC | 4179.5 |
ADAMTS15 | 4172.5 |
CTNNB1 | 4165.5 |
RBX1 | 4159.5 |
CARS1 | 4157.5 |
CCT8 | 4121.5 |
ETF1 | 4118.5 |
GALNT15 | 4101.5 |
ENGASE | 4091.5 |
AXIN2 | 4074.5 |
FOLR2 | 4060.5 |
HARS1 | 4044.5 |
PRKCSH | 4043.5 |
PGAP1 | 4042.5 |
WDR48 | 4040.5 |
CNIH1 | 4023.5 |
DDX58 | 4015.5 |
MRPL52 | 4008.5 |
KLHL3 | 4002.5 |
IGFBP6 | 3999.5 |
SRPRA | 3989.5 |
SARS2 | 3976.0 |
KLHL25 | 3970.5 |
PSMA7 | 3962.5 |
EIF3B | 3961.5 |
JOSD1 | 3957.5 |
ARFGAP2 | 3941.5 |
STAMBP | 3927.5 |
ADAMTS10 | 3907.5 |
DNMT3A | 3900.5 |
PNPLA2 | 3894.5 |
POMGNT2 | 3893.5 |
UBE2N | 3887.0 |
USP10 | 3877.5 |
ADRA2A | 3874.5 |
TMEM129 | 3873.5 |
NPL | 3871.5 |
ENPEP | 3862.5 |
RAB40C | 3852.5 |
SUDS3 | 3848.5 |
HRC | 3828.5 |
DNAJB11 | 3817.0 |
SLC30A6 | 3807.5 |
TARS1 | 3797.5 |
HIF3A | 3792.5 |
AGTPBP1 | 3790.5 |
GFPT1 | 3782.5 |
KBTBD8 | 3780.5 |
MARCHF6 | 3779.5 |
LRRC49 | 3760.5 |
EIF3H | 3755.5 |
DCP2 | 3743.5 |
OTUB2 | 3739.5 |
TNIP3 | 3734.5 |
GANAB | 3728.5 |
PGR | 3723.5 |
IZUMO1R | 3694.5 |
TADA2B | 3675.5 |
EPAS1 | 3670.5 |
PIGS | 3657.5 |
MRPL32 | 3649.5 |
PEX2 | 3648.5 |
USP49 | 3646.5 |
MRPS27 | 3638.5 |
GMPPB | 3635.5 |
APOA1 | 3608.5 |
MUC4 | 3605.5 |
WDR5 | 3598.5 |
CCNE1 | 3590.5 |
SSR4 | 3584.5 |
DCTN3 | 3564.5 |
DERL1 | 3559.5 |
BABAM1 | 3557.5 |
WDTC1 | 3554.5 |
RABGGTA | 3527.5 |
IKBKE | 3512.5 |
EXOSC5 | 3498.5 |
TUBA1B | 3495.5 |
JOSD2 | 3490.5 |
CBX2 | 3478.5 |
MRPS31 | 3476.5 |
INHBE | 3474.5 |
APEH | 3470.5 |
MPDU1 | 3465.5 |
GGA2 | 3462.5 |
USP16 | 3451.5 |
HDAC2 | 3446.5 |
FBXO27 | 3439.5 |
MRRF | 3438.5 |
CCT4 | 3429.5 |
EIF2B4 | 3425.5 |
GAN | 3422.5 |
GHRL | 3419.5 |
RPS26 | 3411.5 |
GNAO1 | 3374.5 |
CALM1 | 3372.5 |
OTUD7B | 3367.5 |
EIF4EBP1 | 3336.5 |
B3GNT5 | 3294.5 |
SPON1 | 3293.5 |
NUP153 | 3291.5 |
CST3 | 3278.5 |
ADAMTSL4 | 3269.5 |
DERL2 | 3262.5 |
MRPL40 | 3261.5 |
FBXL20 | 3258.5 |
CCT2 | 3257.5 |
TAB1 | 3233.5 |
NUP35 | 3225.5 |
PSMD12 | 3211.5 |
GSK3A | 3191.5 |
EIF5A2 | 3188.5 |
UBE2D1 | 3169.5 |
STC2 | 3168.5 |
RPS6 | 3167.5 |
TOMM20 | 3158.5 |
TMED10 | 3153.5 |
FBXW12 | 3144.5 |
RENBP | 3132.5 |
FARSA | 3117.5 |
RGS6 | 3103.5 |
RPL23 | 3101.5 |
NUP42 | 3099.5 |
IL33 | 3098.5 |
TPP1 | 3094.5 |
NSMCE3 | 3081.5 |
RNF146 | 3078.5 |
ASB17 | 3075.5 |
SLC30A8 | 3069.5 |
EIF3A | 3054.5 |
COMMD7 | 3053.0 |
CNTN3 | 3046.5 |
MGAT2 | 3043.5 |
MRPS18C | 3041.5 |
MTRF1L | 3028.5 |
EIF2S3 | 3002.0 |
NUDT14 | 2990.5 |
MBD1 | 2985.5 |
ERAL1 | 2960.5 |
EP300 | 2949.5 |
PSMB2 | 2944.5 |
VDAC3 | 2927.5 |
TTLL6 | 2918.5 |
ARSA | 2907.5 |
EDEM2 | 2905.5 |
CMAS | 2889.5 |
EIF3D | 2883.5 |
FBXO6 | 2870.5 |
MTIF2 | 2857.5 |
DAG1 | 2817.5 |
TOMM70 | 2806.5 |
COMMD1 | 2777.5 |
LYPD3 | 2772.5 |
SPCS1 | 2770.5 |
LRRC41 | 2769.5 |
RAB40B | 2765.5 |
B3GNTL1 | 2755.5 |
ST3GAL6 | 2752.5 |
RCE1 | 2747.5 |
MRPS10 | 2736.5 |
DYNC1I1 | 2733.5 |
MRPS22 | 2728.5 |
AIMP1 | 2707.5 |
DNAJC24 | 2699.5 |
GBA | 2686.5 |
B4GALT3 | 2679.5 |
SUMF1 | 2678.5 |
MRPS33 | 2646.5 |
TPR | 2614.5 |
CHCHD1 | 2605.5 |
KLHL41 | 2601.5 |
SMURF2 | 2597.5 |
TSPAN15 | 2576.5 |
POLB | 2550.5 |
PSME2 | 2547.5 |
TRIM28 | 2545.5 |
AP3M1 | 2544.5 |
RAB33A | 2537.5 |
GALNT3 | 2536.5 |
TTLL12 | 2488.5 |
H2BC1 | 2483.5 |
RAB9B | 2475.5 |
FOXK1 | 2423.5 |
PHC1 | 2419.5 |
TRAPPC6B | 2394.5 |
YY1 | 2391.5 |
XBP1 | 2388.5 |
LGALS1 | 2386.5 |
MGAT1 | 2351.5 |
TRAPPC1 | 2349.5 |
CHRDL1 | 2342.5 |
RPL8 | 2340.5 |
ARF3 | 2323.5 |
ZRANB1 | 2308.5 |
CBX5 | 2304.5 |
PIGT | 2300.5 |
RPS27A | 2261.5 |
YOD1 | 2244.5 |
ABCA3 | 2242.5 |
CCDC8 | 2233.5 |
TSHB | 2225.5 |
RAB20 | 2222.5 |
DCAF4 | 2206.0 |
NUCB1 | 2192.5 |
PARS2 | 2174.5 |
ADAM10 | 2171.5 |
BACE1 | 2157.5 |
VBP1 | 2152.5 |
RAB13 | 2137.0 |
MRPL18 | 2121.5 |
CXXC1 | 2096.5 |
MTIF3 | 2088.5 |
SPTBN5 | 2087.5 |
FBXO32 | 2080.5 |
RAB5A | 2068.5 |
GALNT9 | 2059.5 |
RPL24 | 2057.5 |
UBE2F | 2049.0 |
RAB10 | 2046.5 |
RPS5 | 2028.5 |
OBSL1 | 2025.5 |
TTLL3 | 2019.0 |
RHOA | 2014.5 |
UGGT1 | 2006.5 |
RABGGTB | 1993.5 |
NFYB | 1992.5 |
MELTF | 1990.5 |
SRP14 | 1989.5 |
CUL9 | 1983.5 |
TFPT | 1969.5 |
TTF1 | 1943.5 |
COMMD8 | 1941.5 |
CTSA | 1936.5 |
CTDSP2 | 1935.5 |
COPA | 1926.5 |
SAE1 | 1914.5 |
QARS1 | 1901.5 |
SMC1A | 1891.5 |
ADAMTS1 | 1877.5 |
PSMA1 | 1867.5 |
EIF1AX | 1826.5 |
RPL22 | 1825.5 |
SSR3 | 1807.5 |
SEMG1 | 1806.0 |
TECTB | 1795.5 |
SOCS5 | 1794.5 |
COPB2 | 1778.5 |
MRPS25 | 1771.5 |
MAN1A2 | 1767.5 |
UCHL5 | 1761.5 |
LY6D | 1755.5 |
DPH6 | 1751.5 |
GOSR2 | 1741.0 |
UBA3 | 1735.5 |
SARS1 | 1720.5 |
ASB14 | 1714.5 |
MRPL21 | 1681.5 |
TSPAN5 | 1675.5 |
MRPL41 | 1669.5 |
SRP9 | 1648.5 |
RPN1 | 1646.5 |
FBXL12 | 1644.5 |
PRSS21 | 1641.0 |
CDX2 | 1614.5 |
ACTR10 | 1585.5 |
SP3 | 1581.5 |
PSMB4 | 1567.5 |
ING2 | 1559.5 |
CEBPG | 1551.5 |
PPP6R3 | 1521.5 |
KLHL42 | 1513.5 |
RAB12 | 1511.5 |
FARSB | 1504.5 |
CREB3 | 1499.5 |
PSMC6 | 1488.5 |
RARS1 | 1477.5 |
SLC17A5 | 1470.5 |
TSPAN33 | 1466.5 |
ASB13 | 1465.5 |
INHBC | 1464.5 |
GCNT1 | 1450.5 |
IGFBP2 | 1448.5 |
ST3GAL4 | 1445.5 |
PSME3 | 1442.5 |
ASB18 | 1438.5 |
SEMA5A | 1419.5 |
PFDN2 | 1418.5 |
ITIH2 | 1402.5 |
XRCC4 | 1393.5 |
CTSZ | 1359.5 |
RANBP2 | 1353.5 |
VGF | 1314.5 |
AMDHD2 | 1304.0 |
MRPL16 | 1300.5 |
PTP4A2 | 1297.5 |
GMPPA | 1290.5 |
ERO1A | 1289.5 |
SATB2 | 1284.5 |
FSHB | 1274.5 |
RAB2A | 1266.5 |
MRPL51 | 1260.5 |
PCSK1 | 1258.5 |
H2BC11 | 1257.5 |
USP8 | 1256.5 |
MUC1 | 1254.5 |
MATN3 | 1246.5 |
SPCS2 | 1231.5 |
SOCS6 | 1180.5 |
CARS2 | 1179.5 |
PIGX | 1176.5 |
LEO1 | 1162.5 |
RAB14 | 1158.5 |
ZDHHC2 | 1157.5 |
DCAF13 | 1143.5 |
RPS8 | 1133.5 |
PPARGC1A | 1116.5 |
ADAMTSL2 | 1114.5 |
RRAGA | 1100.5 |
COG3 | 1093.5 |
RPS27L | 1090.5 |
TRIM27 | 1088.5 |
MCRS1 | 1074.5 |
NAPG | 1073.5 |
RNF7 | 1064.5 |
GALNT14 | 1059.5 |
MRPL48 | 1028.5 |
CAPZA2 | 1017.5 |
ITM2B | 983.5 |
CES1 | 953.5 |
EIF3E | 897.5 |
CGA | 845.5 |
GZMH | 845.5 |
IAPP | 845.5 |
KLK13 | 845.5 |
LYPD5 | 845.5 |
UMOD | 845.5 |
FBXO4 | 807.5 |
HDAC3 | 774.5 |
ARRB1 | 770.5 |
DYNLL1 | 767.5 |
TUBB3 | 760.0 |
MAN1C1 | 758.5 |
ARFGAP3 | 737.5 |
CFP | 733.5 |
FSTL3 | 715.5 |
COPS6 | 698.5 |
DCUN1D3 | 688.5 |
FBXO22 | 659.5 |
RAB18 | 658.5 |
IGFALS | 652.5 |
F2 | 644.5 |
SRP19 | 616.5 |
ARSL | 606.5 |
SMC6 | 600.5 |
CUL7 | 597.5 |
CUL4B | 587.5 |
TTLL4 | 576.5 |
CUL3 | 572.5 |
SUMO3 | 571.5 |
BTBD6 | 559.5 |
KIF13A | 558.5 |
LARS1 | 552.5 |
DCAF6 | 546.5 |
RPS15 | 545.5 |
F9 | 544.5 |
CALB1 | 528.5 |
EXOC1 | 518.5 |
APOA5 | 517.5 |
UAP1 | 507.5 |
WDR20 | 500.5 |
ART4 | 498.5 |
SENP8 | 470.5 |
COMMD2 | 469.5 |
ADAMTS16 | 468.5 |
CCL2 | 464.5 |
CNIH2 | 455.5 |
ALG5 | 453.5 |
FKBP14 | 439.5 |
PIGH | 434.5 |
ADD1 | 414.5 |
IGFBP5 | 409.5 |
HDAC7 | 402.5 |
RXRA | 395.5 |
PSMB3 | 391.5 |
BARD1 | 384.5 |
RPL37 | 367.5 |
KLK2 | 344.0 |
KLK3 | 344.0 |
CFTR | 341.5 |
GSN | 316.5 |
EXOC5 | 307.5 |
RPL37A | 302.5 |
FBXW2 | 264.5 |
BIRC2 | 238.5 |
CTSC | 225.5 |
ATP6AP2 | 220.5 |
MUC5B | 199.5 |
TMED2 | 181.5 |
LY6H | 172.5 |
NCOA2 | 159.5 |
RPS3A | 133.5 |
UBE2D2 | 126.5 |
CETN2 | 125.5 |
NRN1 | 109.5 |
ADAMTS9 | 102.5 |
COPS7B | 101.5 |
UBC | 100.5 |
FOXL2 | 88.5 |
GALNT11 | 81.5 |
LYPD6B | 53.0 |
ODAM | 53.0 |
RPL21 | 45.0 |
PDIA6 | 16.5 |
PSMA5 | 5.5 |
RPL32 | 0.5 |
CNTN5 | -13.5 |
SEC23A | -37.5 |
DCUN1D5 | -55.5 |
NUP54 | -72.5 |
RPS28 | -86.5 |
GNG3 | -91.5 |
SPSB2 | -102.5 |
CTR9 | -103.5 |
VAMP2 | -124.0 |
NUP205 | -128.5 |
ATXN7 | -150.5 |
PIGA | -165.5 |
DPM1 | -182.5 |
CCP110 | -194.5 |
ADAMTSL3 | -195.5 |
PML | -220.5 |
PEX12 | -239.5 |
NCOR2 | -240.5 |
PEX5 | -258.5 |
IDE | -266.5 |
PIGQ | -284.5 |
SEC16A | -288.5 |
NEU3 | -291.5 |
PAPPA2 | -293.5 |
RAB44 | -325.5 |
ASB15 | -327.5 |
TRAF6 | -331.5 |
SPP2 | -345.5 |
SUMO1 | -348.5 |
CEBPB | -366.5 |
APCS | -372.5 |
ST8SIA4 | -377.5 |
COPZ1 | -411.5 |
RNF103 | -425.5 |
PIGM | -432.5 |
TFAP2A | -436.5 |
ADAMTS8 | -440.5 |
NDC1 | -444.5 |
B3GNT3 | -475.5 |
C1GALT1C1 | -482.5 |
SBSPON | -483.5 |
KLHL9 | -513.5 |
FURIN | -528.5 |
GMDS | -539.5 |
AGBL2 | -547.5 |
INHBA | -562.5 |
FEM1C | -578.5 |
GNG4 | -595.5 |
MUC6 | -599.5 |
VNN1 | -605.5 |
PIGG | -608.5 |
RNF139 | -616.5 |
PSMA3 | -754.5 |
FAM20A | -774.5 |
NUP88 | -800.5 |
DCTN4 | -814.5 |
B3GNT8 | -834.5 |
CCDC22 | -868.5 |
LMAN1L | -882.5 |
AGBL5 | -897.5 |
CPM | -899.5 |
KCTD7 | -902.5 |
UBE2I | -909.5 |
TGFBI | -935.5 |
INHBB | -949.5 |
POM121 | -968.0 |
POM121C | -968.0 |
AURKA | -982.5 |
ASXL2 | -989.5 |
NR3C2 | -1003.5 |
SHC1 | -1008.5 |
ALG6 | -1014.5 |
TRIM25 | -1015.5 |
TRIM13 | -1027.5 |
TXN | -1082.5 |
UCN | -1083.5 |
EXOC8 | -1084.5 |
FCSK | -1086.5 |
TUBA3E | -1087.5 |
MMP2 | -1091.5 |
ANO8 | -1094.5 |
FFAR4 | -1114.5 |
GCNT4 | -1123.5 |
ALG10 | -1129.0 |
ALG10B | -1129.0 |
ST8SIA5 | -1153.5 |
DPH7 | -1164.5 |
MRPL43 | -1166.5 |
PROC | -1175.5 |
PSMB10 | -1181.5 |
ACTL6A | -1190.5 |
IGFBP7 | -1193.5 |
USP28 | -1197.5 |
FBXW11 | -1203.5 |
EEF1B2 | -1217.5 |
PIGF | -1220.5 |
ARSG | -1228.5 |
RAB24 | -1272.5 |
YARS2 | -1276.5 |
LTBP1 | -1317.5 |
NAT8 | -1347.0 |
NAT8B | -1347.0 |
ARRB2 | -1362.5 |
FBXL18 | -1363.5 |
SCG2 | -1375.5 |
CISH | -1377.5 |
GNAT1 | -1378.5 |
NUP160 | -1394.5 |
GOLGB1 | -1400.5 |
PIGY | -1411.5 |
SEC13 | -1413.5 |
MRPS16 | -1420.5 |
PSMF1 | -1438.5 |
MBD6 | -1439.5 |
KLF4 | -1440.5 |
BCL10 | -1468.5 |
RCN1 | -1485.0 |
ERO1B | -1490.5 |
TGFB1 | -1494.5 |
PIGU | -1506.5 |
B4GALT2 | -1507.5 |
CAPZA3 | -1550.5 |
GNAZ | -1587.5 |
STAM | -1589.5 |
TBCC | -1597.5 |
DCAF10 | -1610.5 |
CDC25A | -1611.5 |
OTOA | -1614.5 |
NR1H2 | -1637.5 |
RAB3D | -1641.5 |
HDAC4 | -1650.5 |
POMT2 | -1668.5 |
RPL36 | -1676.5 |
AMTN | -1679.5 |
RAD18 | -1683.5 |
ASB7 | -1685.5 |
GNG12 | -1688.5 |
NOP56 | -1690.5 |
RPL31 | -1702.5 |
ZBTB16 | -1703.5 |
NUP210 | -1705.5 |
RIPK2 | -1709.5 |
MRPL27 | -1728.5 |
SCFD1 | -1743.5 |
ALG14 | -1762.5 |
DCAF7 | -1767.5 |
ARSK | -1772.5 |
RAB7A | -1781.5 |
UHRF2 | -1794.5 |
KLHL5 | -1802.5 |
USP44 | -1803.5 |
PDIA3 | -1811.5 |
MRPS28 | -1815.5 |
MSRB3 | -1828.5 |
STAM2 | -1842.5 |
BTRC | -1843.5 |
GNAI2 | -1866.5 |
NUP188 | -1868.5 |
TMED9 | -1874.5 |
SRP54 | -1887.5 |
RNF152 | -1891.5 |
CCT6B | -1900.5 |
CD52 | -1904.5 |
USP33 | -1939.5 |
ACTR5 | -1944.5 |
AR | -1955.5 |
STX5 | -1984.5 |
DARS1 | -1997.5 |
EXOC6 | -2014.5 |
GALNT6 | -2027.5 |
USP22 | -2034.5 |
PLET1 | -2044.5 |
GNGT1 | -2049.5 |
FUT8 | -2055.5 |
RAB3B | -2066.5 |
DPM3 | -2068.5 |
DAD1 | -2086.5 |
GFPT2 | -2096.5 |
ANKRD28 | -2102.5 |
LEP | -2110.5 |
PCGF2 | -2133.5 |
UBE2Q2 | -2148.5 |
GNG11 | -2149.5 |
EIF4A1 | -2162.5 |
MOGS | -2164.5 |
PIGO | -2167.5 |
LMO7 | -2173.5 |
CHGB | -2180.5 |
USP18 | -2198.0 |
EXOSC4 | -2203.5 |
TPST2 | -2228.5 |
SLC34A1 | -2251.0 |
TTR | -2281.5 |
EVA1A | -2285.5 |
ARF4 | -2289.5 |
RAB29 | -2295.5 |
UBE2K | -2298.5 |
TUBB1 | -2306.5 |
GALNT1 | -2316.5 |
TULP4 | -2320.5 |
RAB23 | -2336.5 |
DDX5 | -2353.5 |
EIF2B3 | -2357.5 |
RPL7A | -2363.5 |
DYNC1LI2 | -2368.5 |
BRCC3 | -2379.5 |
PRKDC | -2381.5 |
RGS9 | -2392.5 |
PIAS3 | -2404.5 |
FBXO2 | -2409.5 |
UBE2H | -2410.5 |
SEC61A1 | -2411.5 |
DOLPP1 | -2413.5 |
USP3 | -2439.5 |
THBS1 | -2452.5 |
MDM4 | -2459.5 |
CSF2RB | -2462.5 |
SEC22A | -2470.5 |
AGBL4 | -2525.5 |
SFTPA1 | -2527.0 |
SFTPA2 | -2527.0 |
ASGR1 | -2535.5 |
TNKS2 | -2539.5 |
USP34 | -2548.5 |
NTM | -2549.5 |
FBXL5 | -2550.5 |
F7 | -2554.5 |
MRPS35 | -2568.5 |
ST6GALNAC5 | -2592.5 |
PGM3 | -2617.5 |
MSLN | -2626.5 |
CLTRN | -2630.0 |
GNG10 | -2665.5 |
ATF6 | -2670.5 |
PSENEN | -2678.5 |
TIMP1 | -2680.5 |
HSPG2 | -2698.5 |
ERN1 | -2704.5 |
ACE2 | -2706.5 |
PIGW | -2715.5 |
FEM1B | -2716.5 |
PEX13 | -2723.5 |
EXOSC9 | -2726.5 |
DCUN1D1 | -2732.5 |
DPM2 | -2752.5 |
PSMD9 | -2755.0 |
B4GAT1 | -2761.5 |
USP9X | -2762.5 |
PSMD13 | -2775.5 |
ST3GAL2 | -2776.5 |
TRAPPC3 | -2779.5 |
ACHE | -2783.5 |
RPS23 | -2786.5 |
TPGS2 | -2790.5 |
RAB31 | -2791.5 |
LYPD8 | -2797.0 |
INS | -2798.5 |
STAMBPL1 | -2799.5 |
INO80D | -2837.5 |
TCF7L2 | -2848.5 |
KDELR1 | -2857.5 |
CPB2 | -2868.5 |
BST1 | -2872.5 |
AFP | -2884.5 |
IFIH1 | -2885.5 |
MRPS36 | -2886.5 |
CREBBP | -2899.5 |
RFT1 | -2901.0 |
RAB38 | -2906.5 |
NR5A1 | -2913.5 |
ST8SIA1 | -2915.5 |
UBE2W | -2941.0 |
EIF3F | -2965.5 |
TTLL11 | -2971.5 |
WDR61 | -2988.5 |
KIF5C | -2998.5 |
THY1 | -3012.5 |
SEC11A | -3017.5 |
KIF5B | -3021.5 |
MUC16 | -3039.5 |
INCENP | -3046.5 |
FN3KRP | -3059.5 |
B3GLCT | -3087.5 |
SERP1 | -3120.5 |
RAB27B | -3126.5 |
PPP6C | -3128.5 |
SUZ12 | -3134.5 |
RORA | -3141.5 |
LARGE2 | -3146.5 |
GALNT16 | -3148.5 |
NUP85 | -3156.5 |
UCHL1 | -3161.5 |
XPNPEP2 | -3162.5 |
PCNA | -3165.5 |
RGS7 | -3177.5 |
MUC20 | -3184.5 |
TOPORS | -3191.5 |
ADRB2 | -3195.5 |
WARS2 | -3221.5 |
NRIP1 | -3232.5 |
NUP43 | -3243.5 |
RPL7 | -3262.5 |
PPARG | -3265.5 |
HCFC1 | -3268.5 |
CHST8 | -3284.5 |
PSCA | -3285.5 |
NOD2 | -3286.5 |
GPLD1 | -3296.5 |
FAM20C | -3301.5 |
SPCS3 | -3307.5 |
RPS3 | -3309.5 |
ETFBKMT | -3317.5 |
NCOA1 | -3368.5 |
EDEM3 | -3377.5 |
FBXL7 | -3388.5 |
TTLL10 | -3395.5 |
ALG2 | -3421.5 |
CMA1 | -3445.5 |
TMED3 | -3454.5 |
TAF9B | -3457.5 |
CASP8AP2 | -3463.5 |
PCSK2 | -3470.5 |
FBXW4 | -3486.5 |
GCG | -3500.5 |
COPB1 | -3511.5 |
UBE2B | -3529.5 |
POMK | -3530.5 |
SMAD3 | -3534.5 |
OTUD7A | -3546.5 |
DCSTAMP | -3549.0 |
CHST10 | -3554.5 |
SP100 | -3563.5 |
RPS2 | -3580.5 |
RAB2B | -3586.5 |
TUBB6 | -3594.5 |
NAE1 | -3606.5 |
PLA2G4B | -3614.0 |
FBXW7 | -3647.5 |
EEF1A1 | -3659.5 |
CDH2 | -3669.5 |
AREG | -3687.5 |
MAP3K7 | -3694.5 |
GPC3 | -3706.5 |
STX17 | -3717.5 |
DCAF17 | -3740.5 |
BCHE | -3751.5 |
TGOLN2 | -3765.5 |
TCP1 | -3778.5 |
ADAMTS3 | -3789.5 |
GALNT12 | -3791.5 |
SEC24B | -3799.5 |
VCPIP1 | -3803.5 |
SIAH2 | -3808.5 |
MYSM1 | -3819.5 |
APOA4 | -3825.5 |
GALNT5 | -3833.5 |
RAB19 | -3864.5 |
IL6 | -3914.5 |
RNF128 | -3922.5 |
UBE2Z | -3933.5 |
CREB3L1 | -3946.5 |
NGLY1 | -3967.5 |
MAN1B1 | -4029.5 |
ARFGAP1 | -4032.5 |
PIGV | -4034.5 |
WRN | -4072.5 |
COMMD6 | -4074.5 |
PDCL | -4136.5 |
UCHL3 | -4145.5 |
LYZ | -4146.5 |
EXOSC7 | -4155.5 |
FBXO15 | -4156.5 |
NAGK | -4160.5 |
EIF2S1 | -4178.5 |
CDC73 | -4185.5 |
ASXL1 | -4189.5 |
KCTD6 | -4195.5 |
FBXO7 | -4204.5 |
RPL5 | -4208.5 |
FOXK2 | -4210.5 |
CKAP4 | -4212.5 |
MGAT3 | -4218.5 |
RNF168 | -4223.5 |
SEMA5B | -4239.5 |
ADAMTS13 | -4240.5 |
SKP2 | -4252.5 |
TUBB4A | -4256.5 |
IGFBP4 | -4257.5 |
RNF144A | -4282.5 |
BMP15 | -4299.5 |
LY6G6D | -4304.5 |
RPS15A | -4306.5 |
EIF5 | -4315.5 |
SMAD1 | -4336.5 |
RTN4RL2 | -4356.5 |
INHA | -4369.5 |
NANP | -4418.5 |
NSMCE4A | -4422.5 |
ST6GALNAC1 | -4426.5 |
RPS25 | -4440.5 |
YKT6 | -4449.5 |
NSF | -4467.5 |
ALG8 | -4469.5 |
NUP98 | -4473.5 |
CAND1 | -4498.5 |
PIGL | -4510.5 |
RAB33B | -4533.5 |
SPTBN4 | -4538.5 |
RAB8A | -4539.5 |
GGA1 | -4549.5 |
UBD | -4558.5 |
L3MBTL2 | -4584.5 |
ALG1 | -4606.5 |
CSNK2A2 | -4612.5 |
CDCA8 | -4631.5 |
VHL | -4639.5 |
SEC31A | -4647.5 |
ARCN1 | -4656.5 |
ARSB | -4665.5 |
CHST4 | -4701.5 |
PIAS2 | -4718.5 |
PIGP | -4723.5 |
RPL10L | -4738.5 |
B4GALT1 | -4742.5 |
HDAC1 | -4797.5 |
TRMT112 | -4815.5 |
SPARCL1 | -4833.5 |
EIF3M | -4836.5 |
KLHL20 | -4856.5 |
COPZ2 | -4860.5 |
RPL38 | -4919.5 |
FBXO41 | -4920.5 |
ACE | -4922.5 |
UBA6 | -4924.5 |
NR2C1 | -4930.5 |
RPL35A | -4964.5 |
NUP93 | -4965.5 |
COG6 | -4981.5 |
GPR119 | -5023.5 |
KLHL11 | -5032.5 |
GALNT10 | -5046.5 |
GNG2 | -5056.5 |
CREB3L4 | -5057.5 |
ELOB | -5059.5 |
F8 | -5061.5 |
PTRH2 | -5069.5 |
CPB1 | -5071.5 |
FGF23 | -5072.5 |
PHC3 | -5074.5 |
RNF20 | -5077.5 |
B3GNT9 | -5091.5 |
NUP107 | -5093.5 |
FBXL8 | -5096.0 |
RAB39A | -5101.5 |
ICMT | -5125.5 |
CPA3 | -5129.5 |
USP7 | -5134.5 |
SMAD4 | -5135.5 |
SSR2 | -5139.5 |
SPRN | -5143.5 |
POMGNT1 | -5150.5 |
RAB1A | -5165.5 |
APOA2 | -5197.5 |
P2RY2 | -5215.5 |
ALPL | -5259.5 |
ALG11 | -5260.5 |
AGBL3 | -5288.5 |
TFG | -5293.5 |
B3GNT7 | -5294.5 |
RAB37 | -5302.5 |
UBA2 | -5311.5 |
GALNTL6 | -5323.5 |
NUP133 | -5325.5 |
NOTUM | -5332.5 |
SEC61B | -5336.5 |
RAB7B | -5352.5 |
MUC19 | -5359.5 |
TSPAN14 | -5364.5 |
ARSI | -5379.5 |
CSF1 | -5418.5 |
RAB26 | -5424.5 |
XRN2 | -5434.5 |
UBE2L6 | -5445.5 |
CTSH | -5458.5 |
PROS1 | -5462.5 |
UBE2V2 | -5483.5 |
UBE2E1 | -5485.5 |
CHD3 | -5496.5 |
LAMB1 | -5500.5 |
HLA-A | -5511.0 |
HLA-B | -5511.0 |
FBN1 | -5514.5 |
RAB15 | -5537.5 |
SUMO2 | -5548.5 |
ADAMTS18 | -5549.5 |
LRR1 | -5573.5 |
USP42 | -5582.5 |
F10 | -5595.5 |
RAB27A | -5601.5 |
ADAMTS6 | -5605.5 |
MGAT4B | -5613.5 |
EEF2KMT | -5623.5 |
LYPD2 | -5649.5 |
GPIHBP1 | -5652.5 |
RAB17 | -5670.5 |
RAB43 | -5678.5 |
SRPRB | -5708.5 |
SEC61A2 | -5711.5 |
FUCA2 | -5728.5 |
MTFMT | -5744.5 |
GOSR1 | -5774.5 |
SERPINA10 | -5777.5 |
RPL27 | -5778.5 |
GALNT13 | -5791.5 |
PPA2 | -5799.5 |
CSNK1D | -5844.5 |
EXOSC8 | -5869.5 |
RAE1 | -5897.5 |
TNC | -5911.5 |
GNG13 | -5917.5 |
H2BC3 | -5930.5 |
AGT | -5931.5 |
RIPK1 | -5961.5 |
AMBN | -5988.5 |
TBCA | -5992.5 |
BMP4 | -6003.5 |
LYPD1 | -6021.5 |
RAB9A | -6033.5 |
SIN3A | -6055.5 |
NUP155 | -6056.5 |
SEC23IP | -6087.5 |
PFDN4 | -6092.5 |
TNKS | -6095.5 |
USP37 | -6101.5 |
DTL | -6103.5 |
RECK | -6124.5 |
MGAT5 | -6125.5 |
CCNE2 | -6133.5 |
ADAMTS19 | -6164.5 |
FN1 | -6177.5 |
H2BU1 | -6178.5 |
TMED7 | -6180.5 |
FKBP9 | -6182.5 |
BRCA1 | -6186.5 |
HNRNPK | -6187.5 |
FBXL13 | -6212.5 |
RAB34 | -6217.5 |
ST8SIA6 | -6219.5 |
RELA | -6220.5 |
KLHL2 | -6254.5 |
IGFBP3 | -6259.5 |
EEF1E1 | -6270.0 |
ZNF131 | -6276.5 |
ADAMTS5 | -6278.5 |
SHPRH | -6283.5 |
FGG | -6286.5 |
ADAMTS12 | -6289.5 |
APOE | -6290.5 |
KDM1B | -6307.5 |
GNAT2 | -6310.5 |
TGFBR1 | -6311.5 |
ST8SIA3 | -6329.5 |
CNTN4 | -6335.5 |
UBE2A | -6339.5 |
THSD7A | -6351.5 |
RAB6B | -6359.5 |
STT3A | -6362.5 |
PRND | -6374.5 |
FGA | -6382.5 |
RPS18 | -6410.5 |
MGAT4C | -6415.5 |
B4GALT4 | -6422.5 |
THBS2 | -6443.5 |
SPACA4 | -6448.5 |
DDX11 | -6454.5 |
F5 | -6460.5 |
RAD21 | -6461.5 |
RPS19 | -6473.5 |
TTLL1 | -6483.5 |
NTNG2 | -6485.5 |
KLHL13 | -6491.5 |
MXRA8 | -6502.5 |
GCNT3 | -6517.5 |
PLG | -6522.5 |
FSTL1 | -6540.5 |
ALB | -6541.5 |
NPM1 | -6547.5 |
VWA1 | -6552.5 |
NR1I2 | -6566.5 |
TRAM1 | -6569.5 |
ENAM | -6615.5 |
RAB3C | -6620.5 |
RAB8B | -6622.5 |
EIF4H | -6631.5 |
GNB5 | -6634.5 |
RPL30 | -6652.5 |
SNCAIP | -6658.5 |
LTF | -6660.5 |
RPS21 | -6677.5 |
RWDD3 | -6691.5 |
RPLP1 | -6712.5 |
B3GNT2 | -6719.5 |
GSPT2 | -6727.5 |
COMMD10 | -6733.5 |
THRA | -6740.5 |
IGFBP1 | -6742.5 |
SDC2 | -6795.5 |
GNB1 | -6797.5 |
FAU | -6841.5 |
HIF1A | -6851.5 |
MGAT4A | -6859.5 |
UBXN7 | -6860.5 |
ADAMTS4 | -6871.5 |
EXOSC3 | -6877.5 |
DDB2 | -6883.5 |
CCNF | -6884.5 |
PUM2 | -6908.5 |
KDELR2 | -6922.5 |
GNG7 | -6928.5 |
RARA | -6942.5 |
RAB42 | -6944.5 |
MAN2A1 | -6966.5 |
H2BC12 | -7021.5 |
BIRC5 | -7024.5 |
EIF2AK3 | -7029.5 |
TUBA1A | -7062.5 |
SEC22C | -7089.5 |
SCG3 | -7093.5 |
NEGR1 | -7118.5 |
CCNA1 | -7120.5 |
CP | -7124.5 |
SPSB1 | -7140.5 |
HLTF | -7165.5 |
GNAI3 | -7185.5 |
AURKB | -7193.5 |
RPS17 | -7220.5 |
ADAMTS17 | -7223.5 |
SLC30A7 | -7224.5 |
NR1H4 | -7229.5 |
INO80 | -7269.5 |
MANEA | -7273.5 |
KHSRP | -7285.5 |
STX1A | -7287.5 |
MSRA | -7292.5 |
NOP58 | -7294.5 |
TTLL5 | -7327.5 |
EDEM1 | -7348.5 |
RPL3 | -7355.5 |
ALG9 | -7371.0 |
PIGN | -7372.5 |
MRTFA | -7387.5 |
STAG2 | -7408.5 |
PRSS23 | -7410.5 |
ASB4 | -7412.5 |
SPTBN2 | -7414.5 |
LAMC1 | -7420.5 |
CALCA | -7427.5 |
SIAH1 | -7434.5 |
GNB2 | -7445.5 |
FBXL16 | -7460.5 |
ADAMTS2 | -7475.5 |
RPS16 | -7482.5 |
TGFA | -7488.5 |
WSB1 | -7494.5 |
CCNA2 | -7508.5 |
TBCE | -7521.0 |
BECN1 | -7524.5 |
UBE2C | -7543.5 |
LSAMP | -7559.5 |
UBE2T | -7584.5 |
EXOC2 | -7589.5 |
MBTPS2 | -7595.5 |
DIS3 | -7602.5 |
MME | -7616.5 |
LY6G6C | -7624.5 |
ASB3 | -7631.5 |
ST6GAL1 | -7635.5 |
VNN3 | -7642.5 |
ST6GALNAC3 | -7651.5 |
MAGT1 | -7656.5 |
SRP72 | -7684.5 |
PDIA5 | -7694.5 |
KDELR3 | -7698.5 |
BIRC3 | -7702.5 |
MUC13 | -7711.5 |
SEC22B | -7731.5 |
CD109 | -7756.5 |
B4GALT6 | -7779.5 |
RPL6 | -7781.5 |
TUBB2A | -7796.5 |
BLM | -7824.5 |
GALNT7 | -7835.5 |
RNF2 | -7887.5 |
H3-3A | -7895.5 |
KBTBD6 | -7935.0 |
KBTBD7 | -7935.0 |
OGT | -7946.5 |
SENP1 | -7954.5 |
GNB4 | -7962.5 |
PIAS1 | -7967.5 |
TDG | -7977.5 |
DNMT1 | -7997.5 |
MBTPS1 | -8002.5 |
NTNG1 | -8006.5 |
GNPNAT1 | -8010.5 |
SPON2 | -8013.5 |
OPCML | -8017.5 |
CAMKMT | -8018.5 |
VCAN | -8054.5 |
RPL23A | -8061.5 |
NLRP3 | -8069.5 |
ACTB | -8079.5 |
SSR1 | -8085.5 |
CYLD | -8088.5 |
FBXO10 | -8091.5 |
DCUN1D4 | -8092.5 |
EXOSC1 | -8113.5 |
ANPEP | -8118.5 |
MUC15 | -8136.5 |
ASB16 | -8155.5 |
CEACAM5 | -8171.0 |
CEACAM7 | -8171.0 |
SEC24A | -8183.5 |
FBXW9 | -8190.5 |
TUSC3 | -8204.5 |
SERPIND1 | -8205.5 |
NUP37 | -8222.5 |
ALPG | -8227.5 |
ALPI | -8227.5 |
ASGR2 | -8230.5 |
GRIA1 | -8233.5 |
EXOSC2 | -8248.5 |
NR5A2 | -8252.5 |
PAF1 | -8255.5 |
NSMCE2 | -8258.5 |
FBXL4 | -8265.5 |
MDC1 | -8298.5 |
GNE | -8301.5 |
TUBB2B | -8309.5 |
C3 | -8310.5 |
STAG1 | -8335.5 |
SLC35A1 | -8338.5 |
DPP4 | -8343.5 |
SPHK1 | -8349.5 |
C1GALT1 | -8351.5 |
CDC20 | -8352.5 |
APOB | -8370.5 |
CLSPN | -8372.5 |
GALNT17 | -8392.5 |
FBXL3 | -8399.5 |
AHSG | -8405.5 |
GGCX | -8408.5 |
MAN1A1 | -8412.5 |
SMAD2 | -8431.5 |
PRL | -8438.5 |
NUP214 | -8440.5 |
H4C1 | -8450.0 |
RPS13 | -8475.5 |
TOP2A | -8480.5 |
TSPYL2 | -8481.5 |
MYO5A | -8482.5 |
PAPPA | -8549.5 |
IGF1 | -8567.5 |
ADAMTS14 | -8568.5 |
ERCC8 | -8584.5 |
CDK1 | -8596.5 |
APH1B | -8609.5 |
SERPINC1 | -8610.5 |
DPH1 | -8637.5 |
TPST1 | -8639.5 |
DDX17 | -8649.5 |
KNG1 | -8666.5 |
PARN | -8669.5 |
AMELX | -8682.5 |
Defective CFTR causes cystic fibrosis
272 | |
---|---|
set | Defective CFTR causes cystic fibrosis |
setSize | 58 |
pANOVA | 2.33e-09 |
s.dist | 0.453 |
p.adjustANOVA | 3.06e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
RNF5 | 8489.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
DERL3 | 7165.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
RNF185 | 6684.5 |
VCP | 6599.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
RNF5 | 8489.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
DERL3 | 7165.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
RNF185 | 6684.5 |
VCP | 6599.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
OS9 | 4799.5 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
SEL1L | 4548.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
PSMA7 | 3962.5 |
ERLIN1 | 3915.5 |
DERL1 | 3559.5 |
DERL2 | 3262.5 |
PSMD12 | 3211.5 |
ERLIN2 | 3026.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
ERLEC1 | 2361.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
CFTR | 341.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
ABC transporter disorders
2 | |
---|---|
set | ABC transporter disorders |
setSize | 74 |
pANOVA | 3.62e-09 |
s.dist | 0.397 |
p.adjustANOVA | 4.36e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ABCB4 | 8969.5 |
ABCB6 | 8912.5 |
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
RNF5 | 8489.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
DERL3 | 7165.5 |
ABCD1 | 7028.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
RNF185 | 6684.5 |
VCP | 6599.5 |
PSMA8 | 6529.5 |
ABCC8 | 6498.5 |
PSME1 | 6431.5 |
KCNJ11 | 6359.5 |
PSMD14 | 6156.5 |
GeneID | Gene Rank |
---|---|
ABCB4 | 8969.5 |
ABCB6 | 8912.5 |
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
RNF5 | 8489.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
DERL3 | 7165.5 |
ABCD1 | 7028.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
RNF185 | 6684.5 |
VCP | 6599.5 |
PSMA8 | 6529.5 |
ABCC8 | 6498.5 |
PSME1 | 6431.5 |
KCNJ11 | 6359.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
OS9 | 4799.5 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
SEL1L | 4548.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
ABCC2 | 4308.5 |
PSMA7 | 3962.5 |
ERLIN1 | 3915.5 |
APOA1 | 3608.5 |
DERL1 | 3559.5 |
DERL2 | 3262.5 |
PSMD12 | 3211.5 |
ERLIN2 | 3026.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
ERLEC1 | 2361.5 |
RPS27A | 2261.5 |
ABCA3 | 2242.5 |
ABCA12 | 2188.5 |
PSMA1 | 1867.5 |
ABCG5 | 1736.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
ABCD4 | 1103.5 |
PSMB3 | 391.5 |
CFTR | 341.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
ABCB11 | -1502.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
ABCC9 | -3974.5 |
ABCA1 | -5132.5 |
ABCG8 | -5691.5 |
ABCC6 | -7281.5 |
Metabolism
673 | |
---|---|
set | Metabolism |
setSize | 1943 |
pANOVA | 4.82e-09 |
s.dist | 0.0812 |
p.adjustANOVA | 5.36e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RXRB | 9009.5 |
SLC37A2 | 8998.5 |
PPIP5K1 | 8970.5 |
ABCB4 | 8969.5 |
SGMS1 | 8963.5 |
PPT2 | 8959.0 |
ELOVL1 | 8947.5 |
GPX4 | 8944.5 |
CSNK2B | 8941.5 |
PFKFB3 | 8932.5 |
PRKAB2 | 8910.5 |
RPL13A | 8886.5 |
MED16 | 8883.5 |
TPMT | 8880.5 |
COQ7 | 8860.5 |
DGUOK | 8859.5 |
SLC25A44 | 8858.5 |
PLCB4 | 8855.5 |
ALAS1 | 8847.5 |
PPIP5K2 | 8843.5 |
GeneID | Gene Rank |
---|---|
RXRB | 9009.5 |
SLC37A2 | 8998.5 |
PPIP5K1 | 8970.5 |
ABCB4 | 8969.5 |
SGMS1 | 8963.5 |
PPT2 | 8959.0 |
ELOVL1 | 8947.5 |
GPX4 | 8944.5 |
CSNK2B | 8941.5 |
PFKFB3 | 8932.5 |
PRKAB2 | 8910.5 |
RPL13A | 8886.5 |
MED16 | 8883.5 |
TPMT | 8880.5 |
COQ7 | 8860.5 |
DGUOK | 8859.5 |
SLC25A44 | 8858.5 |
PLCB4 | 8855.5 |
ALAS1 | 8847.5 |
PPIP5K2 | 8843.5 |
HMOX2 | 8835.5 |
ASS1 | 8829.5 |
ACO2 | 8817.5 |
MED9 | 8812.5 |
AKR1B10 | 8808.5 |
INPP5K | 8806.5 |
PKM | 8792.5 |
ACSL6 | 8787.0 |
HSD17B8 | 8783.5 |
SERINC4 | 8782.5 |
AK1 | 8781.5 |
BBOX1 | 8764.5 |
PISD | 8759.5 |
ASAH2 | 8756.5 |
PSMB8 | 8750.5 |
OPLAH | 8736.5 |
INPP4B | 8729.5 |
NEU1 | 8725.5 |
ECI2 | 8721.5 |
ESRRA | 8712.5 |
IARS1 | 8710.5 |
PSMD1 | 8707.5 |
GBA3 | 8704.5 |
GSTO1 | 8682.5 |
ACOX1 | 8680.5 |
NDUFA12 | 8677.5 |
UGT2A3 | 8675.5 |
MAN2C1 | 8662.5 |
CPNE7 | 8650.5 |
CKMT1A | 8644.0 |
CES2 | 8642.5 |
ATP5F1D | 8640.5 |
PDP1 | 8638.5 |
SPR | 8636.5 |
SYNJ2 | 8630.5 |
PHKG2 | 8609.5 |
NDUFA8 | 8607.5 |
HK1 | 8603.5 |
HYAL2 | 8601.5 |
SLC19A1 | 8600.5 |
AMACR | 8598.5 |
CRAT | 8595.5 |
PARP4 | 8593.5 |
RPLP2 | 8590.5 |
GLDC | 8582.5 |
PDHX | 8564.5 |
PLAAT3 | 8555.5 |
B4GALT7 | 8547.5 |
INPPL1 | 8545.5 |
HIBCH | 8541.5 |
MOCS2 | 8539.5 |
ATP5PB | 8530.5 |
HSD17B4 | 8517.5 |
SCAP | 8507.5 |
MED20 | 8506.5 |
ALDOA | 8495.5 |
DCXR | 8491.5 |
PLA2G6 | 8484.5 |
MED29 | 8477.5 |
ADK | 8474.5 |
PHKA1 | 8469.5 |
DGAT2 | 8466.5 |
GMPR | 8456.5 |
GAMT | 8452.5 |
CHST15 | 8448.5 |
HSP90AB1 | 8445.5 |
SAMHD1 | 8440.5 |
PFKFB2 | 8437.5 |
SELENOI | 8432.5 |
NDUFS5 | 8426.5 |
BCKDK | 8425.5 |
MTMR3 | 8415.5 |
ACP5 | 8411.5 |
CIAO1 | 8408.5 |
BPGM | 8406.5 |
PECR | 8397.5 |
ACAA2 | 8392.5 |
ACSL1 | 8383.5 |
GMPS | 8360.5 |
ALAD | 8349.5 |
FXN | 8330.5 |
HS6ST1 | 8328.5 |
SULT1A3 | 8318.0 |
SULT1A4 | 8318.0 |
STARD10 | 8309.5 |
NHLRC1 | 8293.5 |
ORMDL3 | 8292.5 |
SLC25A20 | 8291.5 |
PRKAR2A | 8262.5 |
POR | 8261.5 |
BPNT1 | 8259.5 |
MAT2A | 8239.5 |
PDHB | 8238.5 |
NT5C3A | 8235.5 |
PCCA | 8219.5 |
B4GALT5 | 8216.5 |
MCCC2 | 8214.5 |
HMBS | 8204.5 |
ACOXL | 8189.5 |
BSG | 8186.5 |
NFS1 | 8160.5 |
ECSIT | 8154.5 |
KYAT1 | 8136.0 |
FLAD1 | 8131.5 |
CSNK1G2 | 8129.5 |
SLC5A5 | 8126.5 |
PPP1CA | 8118.5 |
ST3GAL1 | 8113.5 |
GPAM | 8112.5 |
DLST | 8106.5 |
PTGR2 | 8102.0 |
NUP50 | 8100.5 |
COX11 | 8096.5 |
ACOT8 | 8091.5 |
MLYCD | 8087.5 |
MAT2B | 8081.5 |
LIPH | 8080.5 |
NMRK2 | 8079.5 |
ABO | 8068.5 |
ACAD9 | 8063.5 |
MTMR7 | 8052.5 |
PIP5K1B | 8043.5 |
DGAT1 | 8042.5 |
AKR7L | 8041.5 |
PTGES2 | 8034.5 |
NRF1 | 8006.5 |
ME3 | 8005.5 |
GYG1 | 8004.5 |
FAHD1 | 7997.5 |
ACADS | 7996.5 |
ENPP6 | 7991.5 |
RPS9 | 7978.5 |
GPD1 | 7968.5 |
ENTPD5 | 7967.5 |
PDSS2 | 7955.5 |
CYP4F8 | 7954.5 |
PGK1 | 7945.5 |
PIAS4 | 7919.5 |
PAPSS2 | 7904.5 |
PLCD1 | 7891.5 |
DBI | 7888.5 |
HYAL1 | 7885.5 |
COQ5 | 7884.5 |
UCKL1 | 7880.5 |
NDUFS7 | 7874.5 |
LPIN1 | 7864.5 |
PCYT2 | 7859.5 |
NUDT9 | 7844.5 |
STS | 7827.5 |
NFYC | 7813.5 |
MED31 | 7809.5 |
GSS | 7797.5 |
GNB3 | 7796.5 |
COQ9 | 7787.5 |
EPRS1 | 7782.5 |
OSBPL1A | 7776.5 |
HS3ST6 | 7772.5 |
PGLS | 7765.5 |
PLB1 | 7757.5 |
RUFY1 | 7756.5 |
COX10 | 7751.5 |
HK3 | 7740.5 |
IMPA2 | 7734.5 |
HS3ST1 | 7726.5 |
B4GALNT1 | 7717.5 |
PPCDC | 7714.5 |
PAOX | 7705.0 |
MPST | 7683.5 |
GCSH | 7674.5 |
SLC25A13 | 7672.5 |
ABHD10 | 7670.5 |
SLC25A12 | 7665.5 |
PPARGC1B | 7660.5 |
ECI1 | 7640.5 |
PITPNB | 7638.5 |
CYP7A1 | 7634.5 |
PSMC1 | 7622.5 |
RIMKLA | 7610.5 |
CIAPIN1 | 7608.5 |
CYP27A1 | 7595.5 |
NAMPT | 7590.5 |
SMARCD3 | 7588.5 |
PIP4K2C | 7587.5 |
TXNRD1 | 7572.5 |
CDA | 7570.5 |
GAPDH | 7566.5 |
GBE1 | 7557.5 |
SLC27A1 | 7555.5 |
PGP | 7540.5 |
PLIN3 | 7535.5 |
STK11 | 7504.5 |
CPT1B | 7496.5 |
RAB4A | 7480.5 |
MOCS1 | 7475.5 |
GYS1 | 7463.5 |
MT-CO1 | 7459.5 |
PFKM | 7448.5 |
OAT | 7447.5 |
ACP6 | 7444.5 |
ACBD6 | 7437.5 |
MMAB | 7436.5 |
LDHB | 7435.0 |
CARNS1 | 7433.5 |
IDH2 | 7427.5 |
LDHC | 7413.5 |
MECR | 7404.5 |
TACO1 | 7403.5 |
NOSIP | 7380.5 |
AIP | 7363.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PLA2G4F | 7341.5 |
ASPA | 7336.5 |
NUDT3 | 7335.5 |
NT5M | 7333.5 |
MID1IP1 | 7325.5 |
NDUFA13 | 7316.5 |
GUK1 | 7313.5 |
TRAP1 | 7311.5 |
MED26 | 7297.0 |
PLCD3 | 7285.5 |
ETFDH | 7282.5 |
PHYH | 7272.5 |
PRKACA | 7262.5 |
GDE1 | 7261.5 |
FECH | 7256.5 |
NUP58 | 7254.5 |
PGM1 | 7253.5 |
PIK3C3 | 7250.5 |
AIMP2 | 7246.5 |
PHKB | 7245.5 |
DCTD | 7241.5 |
SRM | 7229.5 |
CA14 | 7226.5 |
PDK2 | 7219.5 |
UROS | 7201.5 |
AAAS | 7196.5 |
TIMMDC1 | 7186.5 |
IDH3A | 7182.5 |
INPP5J | 7166.5 |
ECHS1 | 7149.5 |
TNFAIP8 | 7137.5 |
NFYA | 7132.5 |
PLA2G12A | 7130.5 |
VAPB | 7129.5 |
SIN3B | 7124.5 |
MTRR | 7118.5 |
NDUFAF3 | 7105.5 |
SEC24D | 7100.5 |
GPI | 7099.5 |
PTEN | 7076.5 |
SLC37A4 | 7073.5 |
MED11 | 7072.5 |
SLC25A11 | 7070.5 |
STXBP1 | 7068.5 |
GPD1L | 7049.5 |
ISCU | 7048.5 |
HAO2 | 7043.5 |
INMT | 7038.0 |
ABCD1 | 7028.5 |
PSMD4 | 7024.5 |
CIAO3 | 7015.5 |
MDH1 | 7013.5 |
CKMT2 | 7012.5 |
SCO1 | 6994.5 |
NAPRT | 6991.5 |
VDR | 6987.5 |
MED4 | 6976.5 |
NDUFS2 | 6971.5 |
AK7 | 6958.5 |
NDST2 | 6950.0 |
GNA14 | 6948.5 |
MT-CO2 | 6945.5 |
ST6GALNAC6 | 6936.0 |
FMO1 | 6932.5 |
GLA | 6921.5 |
NDUFV1 | 6920.5 |
RDH11 | 6913.0 |
PSMB5 | 6910.5 |
PXMP2 | 6909.5 |
SDHB | 6907.5 |
ASNS | 6904.5 |
NCAN | 6888.5 |
RRM2B | 6885.5 |
GAPDHS | 6874.5 |
ENO3 | 6866.5 |
ODC1 | 6863.5 |
DLAT | 6848.5 |
PPP2R1A | 6847.5 |
CYP8B1 | 6843.5 |
SMPD1 | 6835.5 |
PGAM2 | 6832.5 |
PSMB9 | 6825.5 |
RPL28 | 6806.5 |
CPT2 | 6802.5 |
ACADVL | 6798.5 |
GPT | 6797.5 |
HAGH | 6790.5 |
NDUFAF4 | 6785.5 |
FMO2 | 6782.5 |
GLRX5 | 6778.5 |
GNPDA1 | 6777.5 |
PYGM | 6750.5 |
MTMR2 | 6745.5 |
PARP6 | 6741.5 |
AUH | 6735.5 |
IDH3B | 6732.5 |
PPARA | 6721.5 |
ACADM | 6715.5 |
PLCE1 | 6711.5 |
KYAT3 | 6687.5 |
SLC25A19 | 6672.5 |
GNG8 | 6665.5 |
DPEP1 | 6660.5 |
GLRX | 6659.5 |
SLC35B2 | 6657.5 |
GSTM2 | 6652.5 |
PNPLA6 | 6645.5 |
PDHA1 | 6639.5 |
CYP2F1 | 6637.5 |
MTMR4 | 6626.5 |
GLUL | 6620.5 |
RPL19 | 6608.5 |
NAXD | 6580.5 |
FAM120B | 6573.5 |
PLIN2 | 6558.5 |
ENTPD6 | 6557.5 |
NUDT19 | 6554.5 |
SLC19A2 | 6550.5 |
MTMR14 | 6538.5 |
PSMA8 | 6529.5 |
GNG5 | 6527.5 |
TSPO | 6509.5 |
ABCC8 | 6498.5 |
CIAO2B | 6496.5 |
RPL29 | 6487.5 |
OXCT1 | 6479.5 |
FH | 6469.5 |
CYB5R3 | 6464.5 |
GNAS | 6461.5 |
APIP | 6459.5 |
RPS10 | 6457.0 |
IDH1 | 6455.5 |
KARS1 | 6454.5 |
ADHFE1 | 6444.5 |
PSME1 | 6431.5 |
RETSAT | 6428.5 |
PYGB | 6421.5 |
NDUFB10 | 6419.5 |
COX7A2L | 6410.5 |
LRP12 | 6409.5 |
PHOSPHO1 | 6396.5 |
HAO1 | 6395.5 |
BCKDHA | 6385.0 |
KCNJ11 | 6359.5 |
APRT | 6350.5 |
HADHB | 6348.5 |
CYP11A1 | 6346.5 |
GCDH | 6343.5 |
SAR1B | 6335.5 |
MIGA2 | 6333.5 |
MVD | 6331.5 |
ACSM4 | 6327.5 |
UQCRC1 | 6324.5 |
N6AMT1 | 6322.5 |
NDUFS3 | 6318.5 |
SLC44A4 | 6314.5 |
GPC1 | 6312.5 |
RPS11 | 6306.5 |
ITPKA | 6298.5 |
MORC2 | 6277.5 |
ADSL | 6261.5 |
MTM1 | 6242.5 |
PRKAA2 | 6239.5 |
UQCRFS1 | 6235.5 |
NUDT13 | 6228.5 |
AACS | 6219.5 |
ADIPOR2 | 6204.5 |
GAA | 6197.5 |
CPTP | 6189.5 |
DERA | 6188.5 |
HMOX1 | 6170.5 |
MCAT | 6165.5 |
PSMD14 | 6156.5 |
ETFB | 6145.5 |
FABP3 | 6143.5 |
NDUFV2 | 6127.5 |
NUDT12 | 6124.5 |
PDPR | 6116.5 |
NDUFA10 | 6103.5 |
PIP4K2B | 6099.5 |
AKT1 | 6092.5 |
GLUD1 | 6087.0 |
GLUD2 | 6087.0 |
PSMB6 | 6079.5 |
FDFT1 | 6031.5 |
SLC25A10 | 6026.0 |
PPP2R5D | 6015.5 |
TALDO1 | 6010.5 |
AMPD2 | 6008.5 |
PARP10 | 6005.5 |
LIAS | 5989.5 |
PSMB7 | 5988.5 |
B3GAT3 | 5984.5 |
FIG4 | 5967.5 |
ISCA2 | 5966.5 |
RPL35 | 5961.5 |
HADH | 5956.5 |
PSMD7 | 5955.5 |
HSD17B10 | 5948.5 |
PTGR1 | 5937.5 |
PRKAR1A | 5935.5 |
DMAC2L | 5929.5 |
NUBP1 | 5920.5 |
MTMR6 | 5917.5 |
CYP2U1 | 5915.5 |
COX5B | 5910.5 |
TYMP | 5908.5 |
STAB2 | 5904.5 |
SRD5A3 | 5897.5 |
CS | 5894.5 |
GBA2 | 5889.5 |
NDUFA6 | 5887.5 |
MTMR1 | 5883.5 |
RPL13 | 5882.5 |
SHMT2 | 5866.5 |
MARS1 | 5857.5 |
AGK | 5849.5 |
PPOX | 5848.5 |
TPTE | 5843.0 |
TPTE2 | 5843.0 |
MPC1 | 5835.5 |
RAPGEF3 | 5818.5 |
PLEKHA2 | 5809.5 |
NME2 | 5802.5 |
ACOT11 | 5798.5 |
PSMD11 | 5787.5 |
GOT1 | 5784.5 |
ATIC | 5763.5 |
GPHN | 5762.5 |
NQO2 | 5753.5 |
BLVRB | 5751.5 |
PPA1 | 5736.5 |
PLBD1 | 5731.5 |
NDUFA2 | 5728.5 |
PFKL | 5725.5 |
PDSS1 | 5718.5 |
MED28 | 5709.5 |
DNM2 | 5708.5 |
CPT1A | 5701.5 |
RPIA | 5686.5 |
PSMD8 | 5682.5 |
AMD1 | 5673.5 |
ACOT7 | 5658.5 |
ITPKC | 5656.5 |
ETFA | 5655.5 |
ST3GAL3 | 5647.5 |
DBT | 5632.5 |
ADIPOR1 | 5618.5 |
CKM | 5616.5 |
PNPLA3 | 5611.5 |
RPSA | 5610.5 |
CARNMT1 | 5601.5 |
KDSR | 5592.5 |
UGP2 | 5586.5 |
HIBADH | 5578.5 |
GALT | 5567.5 |
TAZ | 5561.5 |
MAPKAPK2 | 5540.5 |
NDUFB9 | 5536.5 |
PSMA4 | 5533.5 |
PLA2G10 | 5530.5 |
IL4I1 | 5522.5 |
NDUFS8 | 5518.5 |
GPC2 | 5513.5 |
PSMD3 | 5512.5 |
GPS2 | 5505.5 |
BDH1 | 5493.5 |
AKR1B1 | 5489.5 |
SHMT1 | 5482.5 |
RPS14 | 5480.5 |
NMNAT1 | 5464.5 |
SLC25A28 | 5456.5 |
ARV1 | 5453.5 |
PLA2G5 | 5452.5 |
CYC1 | 5440.5 |
GSTO2 | 5439.5 |
CHAC2 | 5437.5 |
NR1H3 | 5426.5 |
AK2 | 5424.5 |
GCLM | 5423.5 |
PSMC2 | 5421.5 |
SURF1 | 5398.5 |
ABHD4 | 5393.5 |
ACOT1 | 5390.0 |
ACOT2 | 5390.0 |
MED27 | 5382.5 |
ACACB | 5379.5 |
NOS3 | 5373.5 |
COQ2 | 5364.5 |
BCAT2 | 5358.5 |
ACAT1 | 5356.5 |
OSBPL2 | 5333.5 |
PLA2G15 | 5305.5 |
UPP1 | 5300.5 |
PSAP | 5285.5 |
CYP46A1 | 5277.5 |
HADHA | 5276.5 |
RPS7 | 5274.5 |
PFAS | 5269.5 |
HS3ST5 | 5240.5 |
ARF1 | 5233.5 |
MCEE | 5227.5 |
PRPS1 | 5226.5 |
PSME4 | 5222.5 |
BCKDHB | 5209.5 |
PSMB1 | 5207.5 |
ACOX2 | 5204.5 |
ANKRD1 | 5199.5 |
IPPK | 5193.5 |
RPL3L | 5191.5 |
OAZ2 | 5164.5 |
AMPD3 | 5160.5 |
FABP6 | 5150.5 |
GNAI1 | 5149.5 |
B3GAT2 | 5146.5 |
ACBD4 | 5145.5 |
GLB1 | 5131.5 |
AGPAT2 | 5121.5 |
OSBP | 5117.5 |
CTPS1 | 5112.5 |
PSMD10 | 5093.5 |
CSNK2A1 | 5083.0 |
ALOXE3 | 5079.5 |
NDUFA11 | 5077.0 |
B3GNT4 | 5073.5 |
ATP5F1B | 5063.5 |
NQO1 | 5061.5 |
HACD1 | 5037.5 |
PPM1K | 5032.5 |
PIK3R1 | 5011.5 |
PANK4 | 4995.5 |
PSMC3 | 4982.5 |
MCCC1 | 4978.5 |
INPP5A | 4977.5 |
GPCPD1 | 4975.5 |
UQCRH | 4971.0 |
RPL18 | 4957.5 |
ACBD7 | 4955.5 |
RPL10A | 4938.5 |
NEU2 | 4929.5 |
LGMN | 4928.5 |
HDC | 4926.5 |
ACSS3 | 4914.5 |
SLC25A37 | 4882.5 |
ADCY8 | 4866.5 |
PLCB1 | 4864.5 |
NUDT11 | 4863.5 |
MED24 | 4861.5 |
PGM2L1 | 4850.5 |
PKLR | 4848.5 |
MGST3 | 4847.5 |
MPC2 | 4845.5 |
CDS1 | 4824.5 |
PSMA2 | 4823.0 |
SMPD2 | 4820.5 |
BMX | 4810.5 |
MRI1 | 4801.5 |
ACAN | 4789.5 |
CARM1 | 4781.5 |
ALDOC | 4780.5 |
ALDH7A1 | 4769.5 |
COX18 | 4765.5 |
PLA2G4C | 4756.5 |
PSMC4 | 4751.5 |
LPCAT4 | 4744.5 |
SPTLC3 | 4741.5 |
CYP26B1 | 4735.5 |
PTGDS | 4723.0 |
NMRK1 | 4712.5 |
NUBP2 | 4703.5 |
RNLS | 4686.5 |
PSMD2 | 4685.5 |
PC | 4683.5 |
SMPD4 | 4682.5 |
PODXL2 | 4678.5 |
PLD3 | 4675.5 |
RPL18A | 4656.5 |
PSMD5 | 4655.5 |
UQCRQ | 4627.5 |
NDUFB8 | 4615.0 |
CDIPT | 4612.5 |
CIDEA | 4610.5 |
SDHC | 4606.5 |
GNGT2 | 4590.5 |
NDUFB2 | 4587.5 |
AKAP5 | 4574.5 |
MED19 | 4573.5 |
ADPRM | 4568.5 |
ADRA2C | 4558.5 |
ACAD10 | 4554.5 |
LHPP | 4549.5 |
RPL9 | 4522.5 |
DCTPP1 | 4516.5 |
SLC45A2 | 4514.5 |
ENTPD3 | 4490.5 |
AZIN2 | 4480.5 |
HEXB | 4476.5 |
OGDH | 4470.5 |
DSE | 4463.0 |
DDHD1 | 4461.5 |
NUP62 | 4455.5 |
PYCR1 | 4446.5 |
RPS4X | 4442.5 |
MLX | 4435.5 |
L2HGDH | 4434.5 |
PSMD6 | 4428.5 |
SCLY | 4420.5 |
SPHK2 | 4418.5 |
HK2 | 4414.5 |
ACADL | 4411.5 |
MVK | 4402.5 |
NUDT18 | 4401.5 |
FABP12 | 4365.5 |
UCK1 | 4364.5 |
MTHFD1L | 4362.5 |
NDUFAB1 | 4350.5 |
PSMC5 | 4349.5 |
FDX2 | 4347.0 |
AKR1A1 | 4321.5 |
BCAN | 4318.5 |
ABCC2 | 4308.5 |
GART | 4297.5 |
ACAD11 | 4281.5 |
MOGAT2 | 4276.5 |
CRYM | 4267.5 |
SULT1A1 | 4265.5 |
SULT1A2 | 4265.5 |
VDAC1 | 4260.5 |
SUOX | 4249.5 |
AK5 | 4242.5 |
SDHA | 4232.0 |
SERINC1 | 4220.5 |
NEU4 | 4217.5 |
PCYT1A | 4196.5 |
RPL15 | 4191.5 |
ELOVL3 | 4185.5 |
POMC | 4179.5 |
PDK1 | 4175.5 |
ACER1 | 4169.5 |
LIPT2 | 4163.5 |
ASAH1 | 4150.5 |
IVD | 4144.5 |
SLC25A15 | 4142.5 |
IP6K3 | 4126.5 |
SRD5A2 | 4122.5 |
B3GALT1 | 4114.5 |
CYP1A2 | 4097.5 |
PIP5K1C | 4096.5 |
ACOT13 | 4095.5 |
UCP2 | 4090.5 |
STARD5 | 4071.5 |
FOLR2 | 4060.5 |
EPM2A | 4052.5 |
NUDT15 | 4035.5 |
PNPLA4 | 4031.5 |
HSD17B12 | 4028.5 |
GDPD5 | 4021.5 |
EHHADH | 3987.5 |
PNPO | 3977.5 |
NDUFA7 | 3973.0 |
PSMA7 | 3962.5 |
HLCS | 3952.5 |
UMPS | 3946.5 |
SLC2A1 | 3939.5 |
ENO2 | 3938.5 |
GNMT | 3935.5 |
COX4I1 | 3926.5 |
ACSF2 | 3919.5 |
ACSS1 | 3902.5 |
HMGCL | 3899.5 |
PNPLA2 | 3894.5 |
CYP4V2 | 3891.5 |
UGT8 | 3888.5 |
PLCD4 | 3885.5 |
ALAS2 | 3881.5 |
ADRA2A | 3874.5 |
CMBL | 3867.5 |
CHP1 | 3866.5 |
COQ3 | 3858.5 |
UQCR10 | 3843.5 |
B3GALT4 | 3841.5 |
SGPL1 | 3836.5 |
GALC | 3835.5 |
MTARC2 | 3831.5 |
BPHL | 3824.5 |
MED6 | 3823.5 |
GGT6 | 3811.5 |
OTC | 3799.5 |
ABCB7 | 3781.5 |
SLC25A27 | 3731.5 |
SHPK | 3721.0 |
ADCY5 | 3713.5 |
NDUFA9 | 3708.5 |
SLC2A2 | 3700.5 |
KCNG2 | 3698.5 |
TECR | 3697.5 |
ALOX15B | 3679.5 |
MMUT | 3678.5 |
CYP26C1 | 3674.5 |
HMGCLL1 | 3627.5 |
COQ6 | 3617.5 |
NR1D1 | 3615.5 |
APOA1 | 3608.5 |
ITPK1 | 3577.5 |
LPL | 3569.5 |
SERPINA6 | 3567.5 |
COX14 | 3517.5 |
NDUFA5 | 3514.5 |
UQCRC2 | 3503.5 |
XDH | 3492.5 |
NDST3 | 3487.5 |
RAPGEF4 | 3416.5 |
RPS26 | 3411.5 |
ATP5PD | 3402.5 |
HYAL3 | 3392.5 |
DIO2 | 3389.5 |
ERCC2 | 3386.5 |
TPH1 | 3380.5 |
CALM1 | 3372.5 |
AMT | 3370.0 |
ISCA1 | 3368.5 |
B3GALT5 | 3354.5 |
CA1 | 3352.5 |
LPCAT1 | 3334.5 |
NDUFB6 | 3329.5 |
SUCLG1 | 3325.5 |
CDS2 | 3311.5 |
ALDH3A1 | 3308.5 |
THEM5 | 3298.5 |
NUP153 | 3291.5 |
PLCB3 | 3290.5 |
SAMD8 | 3287.5 |
CYP1A1 | 3279.5 |
SUCLA2 | 3268.5 |
ALOX12 | 3264.5 |
ENTPD8 | 3260.5 |
CYP2D6 | 3254.0 |
PPP2R1B | 3230.5 |
NUP35 | 3225.5 |
SLC25A17 | 3212.5 |
PSMD12 | 3211.5 |
CSGALNACT1 | 3209.5 |
AGPAT4 | 3198.5 |
ABHD5 | 3179.5 |
NT5C | 3172.5 |
RPS6 | 3167.5 |
FMO3 | 3133.5 |
CBR3 | 3116.0 |
GK2 | 3116.0 |
NDUFC1 | 3113.5 |
ESD | 3111.5 |
RPL23 | 3101.5 |
NUP42 | 3099.5 |
SEPSECS | 3071.5 |
MMAA | 3070.5 |
NDUFS1 | 3068.5 |
PCCB | 3066.5 |
GPT2 | 3055.5 |
GRHL1 | 3027.5 |
MMACHC | 3025.5 |
SMPD3 | 3010.5 |
DLD | 2984.5 |
NDUFAF1 | 2966.5 |
CD320 | 2951.5 |
EP300 | 2949.5 |
PSMB2 | 2944.5 |
PANK1 | 2939.5 |
ATP5PO | 2930.0 |
COQ10B | 2915.5 |
ARSA | 2907.5 |
PTGES | 2895.5 |
NDOR1 | 2887.5 |
FABP7 | 2873.5 |
DEGS2 | 2849.5 |
IMPDH2 | 2846.5 |
NDUFAF7 | 2842.5 |
KCNB1 | 2840.5 |
DHRS7B | 2814.5 |
TMEM86B | 2808.5 |
HMGCS2 | 2803.5 |
ADAL | 2796.5 |
PLA2G3 | 2764.5 |
NUDT1 | 2759.5 |
ST3GAL6 | 2752.5 |
SULT2B1 | 2751.5 |
COX7B | 2750.5 |
CA6 | 2723.5 |
UQCR11 | 2718.0 |
OCRL | 2708.5 |
AIMP1 | 2707.5 |
MED21 | 2698.5 |
MED25 | 2697.5 |
GBA | 2686.5 |
B4GALT3 | 2679.5 |
SUMF1 | 2678.5 |
NDUFC2 | 2669.0 |
ACAA1 | 2649.5 |
ATP5MF | 2647.5 |
TPR | 2614.5 |
IDH3G | 2586.5 |
SLC25A32 | 2585.0 |
DEGS1 | 2549.5 |
PSME2 | 2547.5 |
MT-ND1 | 2529.5 |
PLA2G4E | 2517.5 |
SLC27A5 | 2502.5 |
PPARD | 2501.5 |
AZIN1 | 2497.5 |
CNDP2 | 2481.5 |
HS3ST2 | 2452.5 |
ACMSD | 2451.5 |
NDUFB7 | 2448.5 |
FTCD | 2441.5 |
PLAAT1 | 2413.5 |
NDUFS4 | 2412.5 |
SLC37A1 | 2401.5 |
ACOX3 | 2390.5 |
ACSF3 | 2370.5 |
CHKA | 2366.5 |
G6PC3 | 2353.5 |
RPL8 | 2340.5 |
ARF3 | 2323.5 |
PDP2 | 2306.5 |
NDUFA3 | 2298.5 |
SDHD | 2278.0 |
ELOVL6 | 2275.5 |
RPS27A | 2261.5 |
GOT2 | 2260.5 |
AGL | 2254.5 |
GNS | 2237.5 |
SARDH | 2232.5 |
TSHB | 2225.5 |
ALDOB | 2220.5 |
PPP1CC | 2218.5 |
PLA1A | 2198.5 |
FBP1 | 2195.5 |
MED30 | 2191.5 |
FHL2 | 2190.5 |
OAZ1 | 2182.5 |
FMOD | 2173.5 |
STARD7 | 2167.5 |
PI4K2B | 2154.5 |
MTHFD1 | 2143.5 |
ETHE1 | 2138.5 |
MED7 | 2133.5 |
PI4K2A | 2128.5 |
PPP1R3C | 2101.5 |
MIOX | 2098.5 |
CHKB | 2095.5 |
LRP8 | 2094.5 |
ACY3 | 2085.5 |
SGPP1 | 2083.5 |
CHST9 | 2079.5 |
RAB5A | 2068.5 |
RPL24 | 2057.5 |
ADCY4 | 2051.5 |
ACSM3 | 2050.5 |
PRKG2 | 2039.5 |
RPS5 | 2028.5 |
MED13 | 2016.5 |
NDUFAF5 | 2012.5 |
TECRL | 2005.5 |
BHMT2 | 2001.5 |
TKFC | 1998.5 |
ACSS2 | 1997.5 |
PRODH | 1996.0 |
NFYB | 1992.5 |
FBP2 | 1984.5 |
ALDH6A1 | 1978.5 |
FITM2 | 1951.5 |
CTSA | 1936.5 |
SLC22A13 | 1913.5 |
PIK3R4 | 1910.5 |
QARS1 | 1901.5 |
SLC19A3 | 1894.5 |
PTGS1 | 1892.5 |
CBR4 | 1888.5 |
THEM4 | 1879.5 |
PON1 | 1875.5 |
G6PD | 1872.5 |
PSMA1 | 1867.5 |
MT-ND3 | 1861.5 |
GATM | 1845.5 |
ENTPD2 | 1838.5 |
GPC4 | 1831.5 |
RPL22 | 1825.5 |
PLPP3 | 1824.0 |
PGS1 | 1811.5 |
ENTPD4 | 1809.5 |
CYCS | 1802.5 |
FABP5 | 1801.5 |
CYP4F2 | 1790.5 |
ISYNA1 | 1779.5 |
HSD17B3 | 1748.5 |
SLC35B3 | 1734.5 |
SARS1 | 1720.5 |
DNPH1 | 1707.5 |
DGAT2L6 | 1698.0 |
ACOT9 | 1689.5 |
G0S2 | 1684.5 |
KPNB1 | 1665.5 |
GCK | 1664.5 |
MTHFD2 | 1649.5 |
MT-CO3 | 1568.5 |
PSMB4 | 1567.5 |
UPP2 | 1563.5 |
LDHA | 1562.5 |
CACNB2 | 1544.5 |
CDK19 | 1539.5 |
PIK3R2 | 1532.0 |
SULT4A1 | 1525.5 |
PRKACB | 1490.5 |
PSMC6 | 1488.5 |
CKB | 1483.5 |
RARS1 | 1477.5 |
BTD | 1449.5 |
NT5C2 | 1446.5 |
ST3GAL4 | 1445.5 |
PSME3 | 1442.5 |
HEXA | 1424.0 |
ABHD14B | 1422.5 |
SDC3 | 1408.5 |
FITM1 | 1404.5 |
MMS19 | 1397.5 |
MT-CYB | 1377.5 |
PCK1 | 1371.5 |
CA13 | 1369.5 |
RBKS | 1368.5 |
PCK2 | 1364.5 |
RANBP2 | 1353.5 |
HSD17B1 | 1339.5 |
MED1 | 1332.5 |
MT-ND5 | 1325.5 |
PRKAR1B | 1313.5 |
IDO1 | 1311.5 |
ENO1 | 1307.5 |
GLO1 | 1280.5 |
GNPAT | 1278.5 |
PEMT | 1267.5 |
NDUFA4 | 1265.5 |
MT-ATP6 | 1243.5 |
ENPP1 | 1224.5 |
PFKP | 1186.5 |
PHYKPL | 1177.5 |
PI4KB | 1165.5 |
RAB14 | 1158.5 |
ASMT | 1147.5 |
LRP10 | 1135.5 |
RPS8 | 1133.5 |
PAH | 1132.5 |
MDH2 | 1129.5 |
CYP26A1 | 1119.5 |
PPARGC1A | 1116.5 |
ASRGL1 | 1107.5 |
ABCD4 | 1103.5 |
RPS27L | 1090.5 |
GCHFR | 1089.5 |
PTPN13 | 1079.5 |
HYKK | 1069.5 |
COX6A1 | 1068.5 |
NDUFB5 | 1061.5 |
BDH2 | 1057.5 |
LPGAT1 | 1010.5 |
SC5D | 1005.5 |
GLS | 992.5 |
SBF1 | 979.5 |
PPM1L | 964.5 |
CES1 | 953.5 |
PLD4 | 942.5 |
CHPT1 | 936.5 |
GGCT | 924.0 |
GCH1 | 922.5 |
FUT11 | 900.5 |
CGA | 845.5 |
HSD17B2 | 845.5 |
PNLIP | 845.5 |
DCN | 798.5 |
LPCAT3 | 794.5 |
SLC44A3 | 789.5 |
NNT | 785.5 |
HDAC3 | 774.5 |
FUT2 | 749.5 |
SPNS2 | 736.5 |
IP6K2 | 735.5 |
XYLT1 | 732.5 |
CA7 | 728.5 |
PLEKHA4 | 719.5 |
ACACA | 711.5 |
CA4 | 706.5 |
CYB5A | 701.5 |
CTH | 694.5 |
SLC35D1 | 685.5 |
COX20 | 681.5 |
ARG2 | 673.5 |
CAD | 672.5 |
ITPA | 668.5 |
B3GALT6 | 632.5 |
MBOAT7 | 613.5 |
GNA11 | 611.5 |
HACD4 | 609.5 |
ARSL | 606.5 |
HACD2 | 581.5 |
MOCS3 | 577.5 |
FASN | 566.5 |
ALDH1A1 | 561.5 |
LARS1 | 552.5 |
RPS15 | 545.5 |
HAL | 542.5 |
D2HGDH | 530.5 |
HILPDA | 526.5 |
OLAH | 522.5 |
APOA5 | 517.5 |
COX5A | 481.5 |
PRPS2 | 477.5 |
NADK2 | 422.5 |
RXRA | 395.5 |
PSMB3 | 391.5 |
MT-ND4 | 390.5 |
PNPLA7 | 377.5 |
FOLH1 | 374.5 |
RPL37 | 367.5 |
PIK3R3 | 358.0 |
FDX1 | 347.5 |
OAZ3 | 346.5 |
NMNAT3 | 327.5 |
RBP2 | 325.5 |
ATP5MC3 | 319.5 |
PRELP | 313.5 |
MT-ND2 | 306.5 |
RPL37A | 302.5 |
PNP | 301.5 |
EPHX1 | 290.5 |
ADCY6 | 282.5 |
FA2H | 277.5 |
ASPG | 274.5 |
TSTD1 | 249.5 |
NCOA3 | 231.5 |
ADCY1 | 230.5 |
LIPE | 223.5 |
APOC2 | 211.0 |
GALE | 207.5 |
SLC5A6 | 204.5 |
CYB5B | 197.5 |
CERK | 183.5 |
ADCY9 | 180.5 |
SGSH | 178.5 |
NCOA2 | 159.5 |
MTR | 153.5 |
FPGS | 142.5 |
RPS3A | 133.5 |
CYP2R1 | 132.5 |
CBS | 128.0 |
CBSL | 128.0 |
LTC4S | 115.5 |
GPAT3 | 105.5 |
ABCC1 | 103.5 |
UBC | 100.5 |
AADAC | 70.5 |
CYP2C19 | 62.0 |
CYP2C9 | 62.0 |
GLYATL3 | 53.0 |
RPL21 | 45.0 |
GPAT2 | 29.5 |
ME2 | 9.5 |
PSMA5 | 5.5 |
RPL32 | 0.5 |
SLC6A7 | -1.5 |
OSBPL5 | -2.5 |
SLC44A2 | -5.5 |
SLC6A11 | -14.5 |
UROC1 | -21.5 |
FUT1 | -27.5 |
SLC22A1 | -29.5 |
SEC23A | -37.5 |
GYS2 | -40.5 |
INPP4A | -49.5 |
NUP54 | -72.5 |
SGPP2 | -76.5 |
SERINC2 | -78.5 |
ME1 | -80.5 |
UBIAD1 | -83.5 |
LPIN2 | -85.5 |
RPS28 | -86.5 |
GNG3 | -91.5 |
MOCOS | -97.5 |
PARP9 | -110.5 |
PRXL2B | -119.5 |
VAMP2 | -124.0 |
NUP205 | -128.5 |
IDUA | -148.5 |
FUT10 | -159.5 |
XYLT2 | -164.5 |
HAAO | -207.5 |
AASDHPPT | -218.5 |
BCO1 | -227.5 |
SUCLG2 | -231.5 |
NCOR2 | -240.5 |
SERINC3 | -247.5 |
PLEKHA3 | -248.5 |
AADAT | -279.5 |
NEU3 | -291.5 |
IPMK | -334.5 |
UCP1 | -358.5 |
SGMS2 | -360.5 |
MED22 | -361.5 |
NDUFB11 | -363.5 |
SLC16A1 | -369.5 |
SLC16A3 | -371.5 |
PNMT | -380.5 |
ALDH2 | -391.0 |
ACAD8 | -392.5 |
ATP5PF | -401.5 |
GLIPR1 | -417.5 |
COASY | -424.5 |
PRKD2 | -442.5 |
NDC1 | -444.5 |
PITPNM1 | -459.5 |
B3GNT3 | -475.5 |
PAICS | -480.5 |
PDK4 | -495.5 |
SLCO2B1 | -527.5 |
ACY1 | -532.0 |
MAOA | -533.5 |
SRD5A1 | -565.5 |
PSTK | -576.5 |
INPP5D | -584.5 |
TH | -588.5 |
GNG4 | -595.5 |
FABP9 | -598.5 |
VNN1 | -605.5 |
CUBN | -609.5 |
SACM1L | -613.5 |
PTGS2 | -620.5 |
LIPI | -695.0 |
RAN | -695.0 |
PSMA3 | -754.5 |
GUSB | -761.5 |
PIK3C2B | -762.5 |
NT5C1A | -764.5 |
OSBPL3 | -766.5 |
PRKAG2 | -768.5 |
KCNS3 | -779.5 |
ESYT2 | -783.5 |
DPEP3 | -788.5 |
MT-ND6 | -790.5 |
ORMDL1 | -793.5 |
NUP88 | -800.5 |
SULT1E1 | -803.0 |
INPP5E | -821.5 |
SLC52A1 | -854.0 |
SLC52A2 | -854.0 |
CHPF | -874.5 |
UBE2I | -909.5 |
AK4 | -910.5 |
CPOX | -940.5 |
AANAT | -943.5 |
HS3ST3A1 | -955.5 |
POM121 | -968.0 |
POM121C | -968.0 |
SLC6A8 | -974.0 |
GPX1 | -1059.5 |
PPP2CA | -1075.5 |
TXN | -1082.5 |
CYP2W1 | -1089.5 |
DPYS | -1098.5 |
TGS1 | -1108.5 |
SMS | -1156.5 |
PLA2G2D | -1167.5 |
NUBPL | -1174.5 |
PSMB10 | -1181.5 |
DAO | -1182.5 |
PPP2CB | -1185.5 |
COX19 | -1192.5 |
BHMT | -1201.5 |
CA2 | -1202.5 |
PLA2R1 | -1219.5 |
GDPD3 | -1227.5 |
ARSG | -1228.5 |
ADPGK | -1273.5 |
AHRR | -1304.5 |
DMGDH | -1312.5 |
SORD | -1329.5 |
PPCS | -1330.5 |
THRSP | -1334.5 |
INPP1 | -1341.5 |
TDO2 | -1342.5 |
CHST12 | -1345.5 |
SPTLC2 | -1355.5 |
PPAT | -1367.5 |
TPK1 | -1370.5 |
EXT1 | -1387.5 |
SLC3A2 | -1390.5 |
NUP160 | -1394.5 |
ATP5F1E | -1407.5 |
SEC13 | -1413.5 |
PARP8 | -1424.5 |
PSMF1 | -1438.5 |
AGXT | -1460.5 |
AWAT1 | -1460.5 |
G6PC2 | -1460.5 |
SMOX | -1471.5 |
TCN2 | -1473.5 |
CACNA2D2 | -1500.5 |
ABCB11 | -1502.5 |
B4GALT2 | -1507.5 |
CYP24A1 | -1550.5 |
DDAH2 | -1601.5 |
GDA | -1609.5 |
ALOX5AP | -1617.5 |
IP6K1 | -1631.5 |
ACOT6 | -1635.5 |
NR1H2 | -1637.5 |
UCK2 | -1642.5 |
LYVE1 | -1649.5 |
RPL36 | -1676.5 |
GNG12 | -1688.5 |
SNAP25 | -1689.5 |
THRAP3 | -1692.5 |
RPL31 | -1702.5 |
DECR1 | -1704.5 |
NUP210 | -1705.5 |
LTA4H | -1739.5 |
ARSK | -1772.5 |
PPP1CB | -1775.5 |
RGL1 | -1778.5 |
NCOR1 | -1780.5 |
CRYL1 | -1787.5 |
PI4KA | -1819.5 |
TKT | -1820.5 |
PLA2G2A | -1826.5 |
SLC27A2 | -1841.5 |
TYR | -1854.5 |
CHST1 | -1862.5 |
GNAI2 | -1866.5 |
NUP188 | -1868.5 |
ACER2 | -1873.5 |
B3GALNT1 | -1890.5 |
ACADSB | -1894.5 |
PDXK | -1897.5 |
CD36 | -1918.5 |
MTHFR | -1922.5 |
ALOX15 | -1942.5 |
RBP4 | -1959.5 |
DBH | -1964.5 |
FABP2 | -1965.5 |
ALDH1B1 | -1967.5 |
DARS1 | -1997.5 |
MED23 | -2037.5 |
GNGT1 | -2049.5 |
HPSE2 | -2064.5 |
COMT | -2069.5 |
MTMR9 | -2080.5 |
PITPNM3 | -2081.5 |
NOSTRIN | -2083.5 |
OSBPL7 | -2104.5 |
ACSL5 | -2111.5 |
PHKG1 | -2112.5 |
COQ10A | -2127.5 |
TTPA | -2139.5 |
GNG11 | -2149.5 |
DHFR | -2160.0 |
DHFR2 | -2160.0 |
RIMKLB | -2163.5 |
ENTPD1 | -2171.5 |
COX7C | -2174.5 |
PSAT1 | -2184.5 |
MMADHC | -2185.5 |
CYP27B1 | -2187.5 |
IMPA1 | -2191.5 |
CIDEC | -2192.5 |
AHCY | -2211.5 |
GPX2 | -2223.5 |
TPST2 | -2228.5 |
TTR | -2281.5 |
CACNA1A | -2300.5 |
DIO1 | -2326.5 |
CH25H | -2328.5 |
GGT7 | -2343.5 |
TPH2 | -2348.5 |
PLA2G1B | -2349.5 |
CYGB | -2358.5 |
RPL7A | -2363.5 |
RHCE | -2367.0 |
RHD | -2367.0 |
CSAD | -2388.5 |
PNPLA8 | -2389.5 |
ESYT1 | -2394.5 |
CA12 | -2398.5 |
DPEP2 | -2406.5 |
GCLC | -2430.5 |
PLD2 | -2440.5 |
ELOVL4 | -2448.5 |
PIP4K2A | -2457.5 |
NUDT4 | -2477.0 |
INSIG2 | -2486.5 |
KERA | -2513.5 |
POLD1 | -2524.5 |
VAC14 | -2537.5 |
HPD | -2540.5 |
TMEM126B | -2544.5 |
PLCZ1 | -2556.5 |
CHST2 | -2558.5 |
CHST7 | -2569.5 |
TNFRSF21 | -2575.5 |
MBOAT2 | -2579.5 |
PTDSS1 | -2612.5 |
RFK | -2632.5 |
PARP14 | -2642.5 |
RAP1A | -2646.5 |
GNG10 | -2665.5 |
MAOB | -2668.5 |
CERT1 | -2672.5 |
SLC23A2 | -2686.5 |
CYP4B1 | -2687.5 |
ATP5MG | -2690.0 |
GNPDA2 | -2695.5 |
HSPG2 | -2698.5 |
SLC26A2 | -2702.5 |
PLA2G4A | -2714.5 |
PPT1 | -2725.5 |
WASL | -2730.5 |
BPNT2 | -2733.5 |
HPRT1 | -2737.5 |
PSMD9 | -2755.0 |
NDUFAF6 | -2759.5 |
B4GAT1 | -2761.5 |
PSMD13 | -2775.5 |
ST3GAL2 | -2776.5 |
ACHE | -2783.5 |
RPS23 | -2786.5 |
INS | -2798.5 |
HACL1 | -2803.5 |
HGD | -2821.5 |
GLTP | -2828.5 |
NDUFS6 | -2838.5 |
PLPP2 | -2849.5 |
UROD | -2854.5 |
BST1 | -2872.5 |
ORMDL2 | -2877.5 |
ENPP3 | -2880.5 |
ACSBG1 | -2898.5 |
CREBBP | -2899.5 |
HS2ST1 | -2912.0 |
PON3 | -2920.5 |
HPGD | -2939.5 |
SLC9A1 | -2945.5 |
NCOA6 | -2951.5 |
NDST4 | -2957.5 |
CYP39A1 | -2975.5 |
TPO | -2993.5 |
MED18 | -3007.5 |
PIK3R6 | -3023.5 |
BGN | -3040.5 |
NME3 | -3042.5 |
PIPOX | -3049.5 |
CA5B | -3071.5 |
AMPD1 | -3079.5 |
MED17 | -3091.0 |
PLCG1 | -3094.5 |
RORA | -3141.5 |
ATP5ME | -3145.5 |
NUP85 | -3156.5 |
SLC7A5 | -3157.5 |
CHSY1 | -3167.5 |
ALDH18A1 | -3171.5 |
PLD6 | -3181.5 |
AMDHD1 | -3197.5 |
DHCR24 | -3198.5 |
HELZ2 | -3208.5 |
LUM | -3215.5 |
NUP43 | -3243.5 |
RPL7 | -3262.5 |
CRLS1 | -3263.5 |
GPC6 | -3264.5 |
PPARG | -3265.5 |
PRSS1 | -3277.5 |
PRSS3 | -3277.5 |
DDC | -3288.5 |
RPS3 | -3309.5 |
HSD17B7 | -3326.5 |
DDAH1 | -3329.5 |
TIAM2 | -3332.5 |
HAS1 | -3350.5 |
QDPR | -3354.5 |
PIP5K1A | -3355.5 |
AHCYL1 | -3359.5 |
NCOA1 | -3368.5 |
ACOT12 | -3398.5 |
CA9 | -3419.5 |
TYMS | -3433.5 |
SLC46A1 | -3448.5 |
CHAC1 | -3483.5 |
GCG | -3500.5 |
SLC25A21 | -3501.5 |
CERS1 | -3507.5 |
LRP1 | -3516.5 |
DUOX1 | -3517.5 |
TST | -3528.5 |
MIGA1 | -3532.5 |
NDUFB3 | -3539.5 |
HAS2 | -3559.5 |
SDC4 | -3567.5 |
NAXE | -3573.5 |
RBP1 | -3579.5 |
RPS2 | -3580.5 |
ITPKB | -3591.5 |
FAAH | -3599.5 |
ETNK1 | -3611.5 |
PLA2G4B | -3614.0 |
TBXAS1 | -3636.5 |
CHPF2 | -3638.5 |
CBLIF | -3640.5 |
OMD | -3645.5 |
AGPAT3 | -3651.5 |
MAN2B2 | -3658.5 |
GCAT | -3664.5 |
ADCY7 | -3667.5 |
NDUFA1 | -3668.5 |
PHKA2 | -3683.5 |
GPC3 | -3706.5 |
AFMID | -3713.5 |
BCHE | -3751.5 |
ELOVL7 | -3762.5 |
MTHFD2L | -3771.5 |
SLC25A1 | -3780.5 |
PIK3CA | -3786.5 |
GSTM3 | -3787.5 |
GM2A | -3790.5 |
AK6 | -3796.5 |
SEC24B | -3799.5 |
RIDA | -3802.5 |
APOA4 | -3825.5 |
ASL | -3827.0 |
SLC5A8 | -3828.5 |
HSD17B11 | -3840.5 |
NAGLU | -3869.5 |
EXT2 | -3876.5 |
PANK2 | -3877.5 |
CPNE1 | -3891.5 |
ARNT2 | -3895.5 |
XYLB | -3905.5 |
CPNE6 | -3918.5 |
NDUFB4 | -3950.5 |
SLC25A2 | -3958.5 |
PTS | -3961.5 |
DHCR7 | -4004.5 |
UGCG | -4014.5 |
PYCR2 | -4028.0 |
CTRB1 | -4046.0 |
CTRB2 | -4046.0 |
CYP1B1 | -4084.5 |
OCA2 | -4102.5 |
ENOPH1 | -4106.5 |
PRPS1L1 | -4113.5 |
PTDSS2 | -4128.5 |
MTHFS | -4150.0 |
STAR | -4173.5 |
PIK3CD | -4177.5 |
PCBD1 | -4187.5 |
ACER3 | -4196.5 |
RPL5 | -4208.5 |
HS6ST2 | -4211.5 |
PLCH2 | -4255.5 |
TNFAIP8L1 | -4263.5 |
UST | -4264.5 |
SCD | -4268.5 |
PIK3CB | -4270.5 |
PMVK | -4277.5 |
PRKD1 | -4279.5 |
FUT7 | -4294.5 |
RPS15A | -4306.5 |
ALDH3A2 | -4314.5 |
PLEKHA8 | -4323.5 |
CHRM3 | -4341.5 |
NDST1 | -4351.5 |
AS3MT | -4357.5 |
DHODH | -4364.5 |
ALDH1L1 | -4367.5 |
B3GALT2 | -4377.5 |
DUOX2 | -4399.5 |
AOC3 | -4419.5 |
LYPLA1 | -4435.5 |
RPS25 | -4440.5 |
NUP98 | -4473.5 |
PIK3CG | -4490.5 |
AGPS | -4511.5 |
MED10 | -4534.5 |
SLC26A1 | -4536.5 |
CYP19A1 | -4541.5 |
HPGDS | -4553.5 |
CPNE3 | -4561.5 |
AGMAT | -4568.5 |
SLC25A14 | -4573.5 |
ARG1 | -4574.5 |
PIKFYVE | -4587.5 |
ITPR2 | -4590.5 |
DCK | -4603.5 |
CSNK2A2 | -4612.5 |
CSGALNACT2 | -4620.5 |
AGRN | -4633.5 |
LPIN3 | -4637.5 |
PLPP6 | -4658.5 |
ARSB | -4665.5 |
FAR1 | -4667.5 |
NADK | -4668.5 |
SYNJ1 | -4672.5 |
AKR7A3 | -4673.5 |
ACSBG2 | -4675.5 |
CEPT1 | -4693.5 |
ITPR3 | -4707.5 |
HSCB | -4732.5 |
RPL10L | -4738.5 |
ALOX5 | -4740.5 |
B4GALT1 | -4742.5 |
INPP5B | -4755.5 |
PLAAT5 | -4768.5 |
CYP2C18 | -4771.0 |
GPAT4 | -4776.5 |
ELOVL5 | -4787.5 |
TRMT112 | -4815.5 |
PTPMT1 | -4823.5 |
PLA2G4D | -4864.5 |
MT-ATP8 | -4868.5 |
GPD2 | -4892.5 |
CDO1 | -4894.5 |
ADA | -4899.5 |
OSBPL6 | -4900.5 |
NAT1 | -4902.0 |
NAT2 | -4902.0 |
HSD3B7 | -4908.5 |
GSTP1 | -4914.5 |
RPL38 | -4919.5 |
PRKCA | -4927.5 |
PLCG2 | -4936.5 |
RPL35A | -4964.5 |
NUP93 | -4965.5 |
NME1 | -4994.5 |
ARNT | -4995.5 |
PCTP | -5012.5 |
INPP5F | -5022.5 |
UCP3 | -5025.5 |
CA3 | -5043.5 |
COX8A | -5052.5 |
GNG2 | -5056.5 |
ACLY | -5064.5 |
SPTLC1 | -5066.5 |
NUP107 | -5093.5 |
TK1 | -5116.5 |
IDS | -5120.0 |
GLYCTK | -5123.5 |
ABCA1 | -5132.5 |
MBOAT1 | -5133.5 |
LIPT1 | -5144.5 |
TSPOAP1 | -5146.5 |
AK9 | -5151.5 |
FUT9 | -5159.5 |
PTGIS | -5179.5 |
HS3ST3B1 | -5185.5 |
CHSY3 | -5190.5 |
APOA2 | -5197.5 |
MANBA | -5199.5 |
EPHX2 | -5201.5 |
MED15 | -5227.5 |
KYNU | -5240.5 |
GSTK1 | -5244.5 |
SLC16A8 | -5262.5 |
GDPD1 | -5272.5 |
PITPNM2 | -5276.5 |
LPCAT2 | -5277.5 |
GCKR | -5290.5 |
B3GNT7 | -5294.5 |
NUP133 | -5325.5 |
ABHD3 | -5337.5 |
CSPG4 | -5340.5 |
COX6B1 | -5355.5 |
ELOVL2 | -5358.5 |
ARSI | -5379.5 |
SAT1 | -5390.5 |
TBL1XR1 | -5408.5 |
SLC10A2 | -5409.5 |
MGST1 | -5414.5 |
TNFAIP8L2 | -5465.5 |
AMN | -5484.5 |
PGM2 | -5494.5 |
SUMO2 | -5548.5 |
NAGS | -5551.5 |
ITPR1 | -5566.5 |
ACSL3 | -5585.5 |
CYP17A1 | -5593.5 |
SREBF2 | -5602.5 |
SULT1B1 | -5607.5 |
TNFAIP8L3 | -5612.5 |
PIK3R5 | -5631.5 |
IQGAP1 | -5645.5 |
GPIHBP1 | -5652.5 |
OSBPL8 | -5658.5 |
ENTPD7 | -5664.5 |
BLVRA | -5672.5 |
UPB1 | -5700.5 |
GLB1L | -5725.5 |
LMBRD1 | -5726.5 |
STARD3 | -5731.5 |
GNA15 | -5733.5 |
CAV1 | -5750.5 |
SLC22A3 | -5757.5 |
CHST13 | -5766.5 |
RPL27 | -5778.5 |
ESYT3 | -5782.5 |
PHGDH | -5798.5 |
PPA2 | -5799.5 |
OGN | -5813.5 |
CERS2 | -5833.5 |
ACBD5 | -5836.5 |
GMPR2 | -5870.5 |
IMPDH1 | -5881.5 |
EBP | -5884.0 |
HSD11B2 | -5896.5 |
RAE1 | -5897.5 |
GNG13 | -5917.5 |
ADCY2 | -5924.5 |
FUT4 | -5927.5 |
AGT | -5931.5 |
SULT6B1 | -5932.5 |
MTARC1 | -5946.0 |
GLS2 | -5976.5 |
NAT8L | -5982.5 |
SDSL | -5984.5 |
MAN2B1 | -6007.0 |
DDO | -6010.5 |
HMMR | -6015.5 |
ATP5F1A | -6042.5 |
SIN3A | -6055.5 |
NUP155 | -6056.5 |
HPSE | -6059.5 |
LRP2 | -6066.5 |
ANGPTL4 | -6076.5 |
CROT | -6097.5 |
CSPG5 | -6102.5 |
CA5A | -6114.5 |
CHST3 | -6115.5 |
DDHD2 | -6123.5 |
TAT | -6128.5 |
AK8 | -6136.5 |
PIK3C2A | -6139.5 |
PLIN1 | -6150.5 |
CACNB3 | -6160.5 |
PLPP1 | -6170.5 |
CHDH | -6185.5 |
SREBF1 | -6213.5 |
FABP1 | -6232.5 |
CYP4F22 | -6238.5 |
SPTSSA | -6249.5 |
EEF1E1 | -6270.0 |
STARD4 | -6281.5 |
CD38 | -6284.5 |
APOE | -6290.5 |
FADS2 | -6303.5 |
VKORC1L1 | -6308.5 |
MOGAT1 | -6309.5 |
SLC27A3 | -6314.5 |
SLCO1B1 | -6316.5 |
SLCO1B3 | -6316.5 |
VKORC1 | -6319.5 |
B3GAT1 | -6322.5 |
ACOT4 | -6347.5 |
CCNC | -6352.5 |
PON2 | -6353.5 |
SLC23A1 | -6369.5 |
ADI1 | -6383.5 |
PLCB2 | -6389.5 |
AGMO | -6395.5 |
PFKFB1 | -6409.5 |
RPS18 | -6410.5 |
GLCE | -6414.5 |
B4GALT4 | -6422.5 |
PSPH | -6432.5 |
GLP1R | -6437.5 |
HSD17B14 | -6440.5 |
ZDHHC21 | -6469.5 |
HOGA1 | -6470.5 |
RPS19 | -6473.5 |
PAPSS1 | -6478.5 |
OSBPL9 | -6482.5 |
AGPAT5 | -6488.5 |
SLC10A1 | -6507.5 |
PYGL | -6536.5 |
HACD3 | -6538.5 |
ALB | -6541.5 |
GSTM4 | -6543.5 |
VAPA | -6554.5 |
OSBPL10 | -6564.5 |
SLC35D2 | -6586.0 |
CHST14 | -6592.5 |
QPRT | -6597.5 |
GNB5 | -6634.5 |
MTMR12 | -6648.5 |
RPL30 | -6652.5 |
SECISBP2 | -6655.5 |
BRIP1 | -6657.5 |
MED13L | -6673.5 |
RPS21 | -6677.5 |
ADH7 | -6680.5 |
BAAT | -6684.5 |
ALDH3B1 | -6699.5 |
CERS4 | -6704.5 |
HMGCR | -6711.5 |
RPLP1 | -6712.5 |
B3GNT2 | -6719.5 |
SLC36A4 | -6726.5 |
CYP2S1 | -6743.5 |
SERINC5 | -6746.5 |
CMPK1 | -6747.5 |
PDK3 | -6753.5 |
SP1 | -6760.5 |
SYT5 | -6783.5 |
EEFSEC | -6785.5 |
SDC2 | -6795.5 |
GNB1 | -6797.5 |
MTAP | -6822.0 |
NUDT7 | -6823.5 |
NDUFV3 | -6831.5 |
TK2 | -6839.5 |
FAU | -6841.5 |
MAT1A | -6853.5 |
MTMR10 | -6886.5 |
KHK | -6910.5 |
AGXT2 | -6924.5 |
GNG7 | -6928.5 |
CYP4F3 | -6929.5 |
GSR | -6931.5 |
TM7SF2 | -6992.5 |
PEX11A | -6997.5 |
IDI1 | -7006.5 |
IDO2 | -7011.5 |
GLYAT | -7026.5 |
ADCY3 | -7027.5 |
NSDHL | -7119.5 |
CTPS2 | -7123.5 |
CYP51A1 | -7126.5 |
RPE | -7132.0 |
RPEL1 | -7132.0 |
FABP4 | -7138.5 |
MGST2 | -7153.5 |
PFKFB4 | -7154.5 |
NADSYN1 | -7182.5 |
SLC52A3 | -7186.5 |
GC | -7191.5 |
RPS17 | -7220.5 |
TRIB3 | -7228.5 |
NR1H4 | -7229.5 |
STARD3NL | -7230.5 |
SDC1 | -7234.5 |
MGLL | -7261.5 |
HAS3 | -7263.5 |
HMGCS1 | -7277.5 |
STX1A | -7287.5 |
PANK3 | -7289.5 |
MTF1 | -7295.5 |
TXN2 | -7297.5 |
FAR2 | -7313.5 |
ETNPPL | -7315.5 |
RRM2 | -7343.5 |
TBL1X | -7352.0 |
RPL3 | -7355.5 |
CACNA1D | -7378.5 |
AWAT2 | -7388.5 |
GSTA5 | -7402.5 |
PTGES3 | -7413.5 |
PIK3C2G | -7419.5 |
MARCKS | -7421.5 |
GSTM1 | -7436.5 |
LCLAT1 | -7440.5 |
CERS6 | -7443.5 |
GNB2 | -7445.5 |
FAH | -7467.5 |
SLC44A1 | -7471.5 |
DSEL | -7476.5 |
RPS16 | -7482.5 |
AHR | -7492.0 |
FADS1 | -7500.5 |
UGDH | -7503.5 |
ADIPOQ | -7514.5 |
DTYMK | -7519.5 |
SQLE | -7540.5 |
GALK1 | -7553.5 |
CEMIP | -7561.5 |
SRR | -7564.5 |
CHST11 | -7582.5 |
CYP7B1 | -7588.5 |
MBTPS2 | -7595.5 |
CYP3A4 | -7611.5 |
CYP3A43 | -7611.5 |
CYP3A5 | -7611.5 |
CYP3A7 | -7611.5 |
NPAS2 | -7617.5 |
DHTKD1 | -7643.5 |
GK | -7655.0 |
GK3P | -7655.0 |
CYP2E1 | -7664.5 |
TMLHE | -7675.5 |
PM20D1 | -7706.5 |
CTRC | -7707.5 |
NNMT | -7709.5 |
PLEKHA1 | -7740.5 |
NMRAL1 | -7748.5 |
DUT | -7757.5 |
THTPA | -7761.5 |
NT5E | -7766.5 |
BCO2 | -7771.5 |
B4GALT6 | -7779.5 |
RPL6 | -7781.5 |
NUDT5 | -7785.5 |
UQCRB | -7789.5 |
PRODH2 | -7791.5 |
MED12 | -7797.5 |
PARP16 | -7800.5 |
APOC3 | -7801.5 |
ARNTL | -7817.5 |
AGPAT1 | -7831.5 |
CERS3 | -7832.5 |
PLA2G2F | -7836.5 |
AASS | -7838.5 |
LDLR | -7842.5 |
GSTZ1 | -7866.5 |
MFSD2A | -7867.5 |
MINPP1 | -7877.5 |
LSS | -7884.5 |
BCAT1 | -7890.5 |
COX16 | -7904.5 |
AKR1D1 | -7916.5 |
ALDH1L2 | -7917.5 |
SBF2 | -7925.5 |
GNB4 | -7962.5 |
HSD17B13 | -7973.5 |
CD44 | -7979.5 |
CYP2J2 | -7983.5 |
ACSL4 | -7994.5 |
MBTPS1 | -8002.5 |
GGT1 | -8036.5 |
ETNK2 | -8040.5 |
AOC1 | -8042.5 |
IYD | -8049.5 |
VCAN | -8054.5 |
CERS5 | -8055.5 |
NMNAT2 | -8056.5 |
RPL23A | -8061.5 |
SLC6A12 | -8096.5 |
STARD6 | -8103.5 |
PRKD3 | -8116.5 |
LRAT | -8126.5 |
CACNA1C | -8127.5 |
RRM1 | -8133.5 |
PRKAR2B | -8138.5 |
PCYT1B | -8157.5 |
AOX1 | -8158.5 |
SEC24A | -8183.5 |
ACSM1 | -8188.5 |
PLEKHA5 | -8201.5 |
INSIG1 | -8208.5 |
G6PC | -8214.5 |
NUP37 | -8222.5 |
FLVCR1 | -8223.5 |
ALPI | -8227.5 |
PLCH1 | -8229.5 |
ENPP2 | -8236.5 |
SLCO1A2 | -8246.5 |
KMO | -8249.5 |
NAALAD2 | -8305.5 |
CHD9 | -8313.5 |
SDS | -8322.5 |
CPS1 | -8324.5 |
RTEL1 | -8330.0 |
ABCC5 | -8348.5 |
SPHK1 | -8349.5 |
APOB | -8370.5 |
MSMO1 | -8374.5 |
CYP4A11 | -8385.0 |
CYP4A22 | -8385.0 |
CYP4F11 | -8385.0 |
CYP4F12 | -8385.0 |
ADH5 | -8387.5 |
KCNC2 | -8389.5 |
GSTT2 | -8398.0 |
GSTT2B | -8398.0 |
SLC22A2 | -8417.5 |
CYP21A2 | -8437.5 |
NUP214 | -8440.5 |
ACSM5 | -8442.5 |
SLC44A5 | -8444.5 |
ABCC3 | -8455.5 |
DPYD | -8466.5 |
RPS13 | -8475.5 |
ABCG2 | -8477.5 |
SULT1C2 | -8488.5 |
NT5C1B | -8494.0 |
APOM | -8495.5 |
GGT5 | -8496.5 |
GGPS1 | -8600.5 |
PLD1 | -8613.5 |
SULT2A1 | -8618.5 |
ACAT2 | -8629.5 |
CLOCK | -8631.5 |
CYP2A13 | -8633.5 |
CYP2A6 | -8633.5 |
CYP2A7 | -8633.5 |
GRHPR | -8636.5 |
TPST1 | -8639.5 |
TPI1 | -8641.5 |
CACNA1E | -8644.5 |
MED14 | -8670.5 |
PDZD11 | -8676.5 |
UGT1A1 | -8678.5 |
Respiratory electron transport
1070 | |
---|---|
set | Respiratory electron transport |
setSize | 96 |
pANOVA | 5.36e-09 |
s.dist | 0.345 |
p.adjustANOVA | 5.53e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NDUFA12 | 8677.5 |
NDUFA8 | 8607.5 |
NDUFS5 | 8426.5 |
ECSIT | 8154.5 |
COX11 | 8096.5 |
ACAD9 | 8063.5 |
NDUFS7 | 7874.5 |
MT-CO1 | 7459.5 |
TACO1 | 7403.5 |
NDUFA13 | 7316.5 |
TRAP1 | 7311.5 |
ETFDH | 7282.5 |
TIMMDC1 | 7186.5 |
NDUFAF3 | 7105.5 |
SCO1 | 6994.5 |
NDUFS2 | 6971.5 |
MT-CO2 | 6945.5 |
NDUFV1 | 6920.5 |
SDHB | 6907.5 |
NDUFAF4 | 6785.5 |
GeneID | Gene Rank |
---|---|
NDUFA12 | 8677.5 |
NDUFA8 | 8607.5 |
NDUFS5 | 8426.5 |
ECSIT | 8154.5 |
COX11 | 8096.5 |
ACAD9 | 8063.5 |
NDUFS7 | 7874.5 |
MT-CO1 | 7459.5 |
TACO1 | 7403.5 |
NDUFA13 | 7316.5 |
TRAP1 | 7311.5 |
ETFDH | 7282.5 |
TIMMDC1 | 7186.5 |
NDUFAF3 | 7105.5 |
SCO1 | 6994.5 |
NDUFS2 | 6971.5 |
MT-CO2 | 6945.5 |
NDUFV1 | 6920.5 |
SDHB | 6907.5 |
NDUFAF4 | 6785.5 |
NDUFB10 | 6419.5 |
COX7A2L | 6410.5 |
UQCRC1 | 6324.5 |
NDUFS3 | 6318.5 |
UQCRFS1 | 6235.5 |
ETFB | 6145.5 |
NDUFV2 | 6127.5 |
NDUFA10 | 6103.5 |
COX5B | 5910.5 |
NDUFA6 | 5887.5 |
NDUFA2 | 5728.5 |
ETFA | 5655.5 |
NDUFB9 | 5536.5 |
NDUFS8 | 5518.5 |
CYC1 | 5440.5 |
SURF1 | 5398.5 |
NDUFA11 | 5077.0 |
UQCRH | 4971.0 |
COX18 | 4765.5 |
UQCRQ | 4627.5 |
NDUFB8 | 4615.0 |
SDHC | 4606.5 |
NDUFB2 | 4587.5 |
NDUFAB1 | 4350.5 |
SDHA | 4232.0 |
NDUFA7 | 3973.0 |
COX4I1 | 3926.5 |
UQCR10 | 3843.5 |
NDUFA9 | 3708.5 |
COX14 | 3517.5 |
NDUFA5 | 3514.5 |
UQCRC2 | 3503.5 |
NDUFB6 | 3329.5 |
NDUFC1 | 3113.5 |
NDUFS1 | 3068.5 |
NDUFAF1 | 2966.5 |
COQ10B | 2915.5 |
NDUFAF7 | 2842.5 |
COX7B | 2750.5 |
UQCR11 | 2718.0 |
NDUFC2 | 2669.0 |
MT-ND1 | 2529.5 |
NDUFB7 | 2448.5 |
NDUFS4 | 2412.5 |
NDUFA3 | 2298.5 |
SDHD | 2278.0 |
NDUFAF5 | 2012.5 |
MT-ND3 | 1861.5 |
CYCS | 1802.5 |
MT-CO3 | 1568.5 |
MT-CYB | 1377.5 |
MT-ND5 | 1325.5 |
NDUFA4 | 1265.5 |
COX6A1 | 1068.5 |
NDUFB5 | 1061.5 |
COX20 | 681.5 |
COX5A | 481.5 |
MT-ND4 | 390.5 |
MT-ND2 | 306.5 |
NDUFB11 | -363.5 |
MT-ND6 | -790.5 |
NUBPL | -1174.5 |
COX19 | -1192.5 |
COQ10A | -2127.5 |
COX7C | -2174.5 |
TMEM126B | -2544.5 |
NDUFAF6 | -2759.5 |
NDUFS6 | -2838.5 |
NDUFB3 | -3539.5 |
NDUFA1 | -3668.5 |
NDUFB4 | -3950.5 |
COX8A | -5052.5 |
COX6B1 | -5355.5 |
NDUFV3 | -6831.5 |
UQCRB | -7789.5 |
COX16 | -7904.5 |
Selective autophagy
1127 | |
---|---|
set | Selective autophagy |
setSize | 56 |
pANOVA | 1.25e-08 |
s.dist | 0.44 |
p.adjustANOVA | 1.2e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CSNK2B | 8941.5 |
PARK7 | 8928.5 |
PRKAB2 | 8910.5 |
IFT88 | 8744.5 |
SQSTM1 | 8697.5 |
ARL13B | 8606.5 |
MFN2 | 8568.5 |
PINK1 | 8514.5 |
TOMM40 | 8333.5 |
MAP1LC3B | 8304.0 |
HSPA8 | 7910.5 |
MFN1 | 7800.5 |
PLIN3 | 7535.5 |
NBR1 | 7530.5 |
UBA52 | 7357.5 |
USP30 | 7330.5 |
DYNC1LI1 | 7142.5 |
DYNC1H1 | 6922.5 |
VCP | 6599.5 |
PLIN2 | 6558.5 |
GeneID | Gene Rank |
---|---|
CSNK2B | 8941.5 |
PARK7 | 8928.5 |
PRKAB2 | 8910.5 |
IFT88 | 8744.5 |
SQSTM1 | 8697.5 |
ARL13B | 8606.5 |
MFN2 | 8568.5 |
PINK1 | 8514.5 |
TOMM40 | 8333.5 |
MAP1LC3B | 8304.0 |
HSPA8 | 7910.5 |
MFN1 | 7800.5 |
PLIN3 | 7535.5 |
NBR1 | 7530.5 |
UBA52 | 7357.5 |
USP30 | 7330.5 |
DYNC1LI1 | 7142.5 |
DYNC1H1 | 6922.5 |
VCP | 6599.5 |
PLIN2 | 6558.5 |
TOMM6 | 6247.5 |
PRKAA2 | 6239.5 |
DYNLL2 | 6153.5 |
PRKAB1 | 5775.5 |
ATG5 | 5242.5 |
MAP1LC3A | 5210.5 |
DYNC1I2 | 5195.5 |
ATG12 | 5189.5 |
CSNK2A1 | 5083.0 |
HDAC6 | 4383.5 |
VDAC1 | 4260.5 |
UBE2N | 3887.0 |
EPAS1 | 3670.5 |
TOMM20 | 3158.5 |
PRKAG3 | 3034.5 |
TOMM22 | 2933.5 |
TOMM70 | 2806.5 |
DYNC1I1 | 2733.5 |
PCNT | 2681.5 |
RPS27A | 2261.5 |
HSF1 | 1964.5 |
FUNDC1 | 1863.5 |
DYNLL1 | 767.5 |
ULK1 | 458.5 |
CFTR | 341.5 |
PGAM5 | 146.5 |
UBC | 100.5 |
PEX5 | -258.5 |
PRKAG2 | -768.5 |
MTERF3 | -1961.5 |
SRC | -2361.5 |
DYNC1LI2 | -2368.5 |
CETN1 | -2424.5 |
CSNK2A2 | -4612.5 |
ATM | -4881.5 |
TOMM7 | -4954.5 |
ABC-family proteins mediated transport
4 | |
---|---|
set | ABC-family proteins mediated transport |
setSize | 97 |
pANOVA | 1.32e-08 |
s.dist | 0.334 |
p.adjustANOVA | 1.2e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ABCF1 | 8999.5 |
ABCB4 | 8969.5 |
ABCB6 | 8912.5 |
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
ABCB8 | 8594.5 |
RNF5 | 8489.5 |
PEX19 | 8449.5 |
PSMC1 | 7622.5 |
ABCC4 | 7377.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
DERL3 | 7165.5 |
ABCD1 | 7028.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
RNF185 | 6684.5 |
VCP | 6599.5 |
PSMA8 | 6529.5 |
GeneID | Gene Rank |
---|---|
ABCF1 | 8999.5 |
ABCB4 | 8969.5 |
ABCB6 | 8912.5 |
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
ABCB8 | 8594.5 |
RNF5 | 8489.5 |
PEX19 | 8449.5 |
PSMC1 | 7622.5 |
ABCC4 | 7377.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
DERL3 | 7165.5 |
ABCD1 | 7028.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
RNF185 | 6684.5 |
VCP | 6599.5 |
PSMA8 | 6529.5 |
ABCG4 | 6520.5 |
PSME1 | 6431.5 |
KCNJ11 | 6359.5 |
ABCD3 | 6258.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
ABCD2 | 5081.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
OS9 | 4799.5 |
EIF2S2 | 4761.5 |
PSMC4 | 4751.5 |
ABCC10 | 4709.5 |
PSMD2 | 4685.5 |
ABCA7 | 4681.5 |
PSMD5 | 4655.5 |
SEL1L | 4548.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
ABCC2 | 4308.5 |
ABCA4 | 4066.5 |
PSMA7 | 3962.5 |
ERLIN1 | 3915.5 |
ABCB7 | 3781.5 |
APOA1 | 3608.5 |
DERL1 | 3559.5 |
DERL2 | 3262.5 |
PSMD12 | 3211.5 |
ERLIN2 | 3026.5 |
EIF2S3 | 3002.0 |
PSMB2 | 2944.5 |
ABCG1 | 2687.5 |
PSME2 | 2547.5 |
ERLEC1 | 2361.5 |
RPS27A | 2261.5 |
ABCA3 | 2242.5 |
ABCA12 | 2188.5 |
PSMA1 | 1867.5 |
ABCB10 | 1793.5 |
ABCG5 | 1736.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
ABCB9 | 935.5 |
PSMB3 | 391.5 |
CFTR | 341.5 |
ABCC1 | 103.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
ABCA2 | -465.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
ABCA9 | -2610.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
ABCC9 | -3974.5 |
EIF2S1 | -4178.5 |
ABCA6 | -4286.5 |
ABCA5 | -4648.5 |
PEX3 | -4652.5 |
ABCG8 | -5691.5 |
ABCB5 | -6245.5 |
ABCA8 | -6809.5 |
ABCC6 | -7281.5 |
ABCC5 | -8348.5 |
ABCC3 | -8455.5 |
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD
534 | |
---|---|
set | Hh mutants that don't undergo autocatalytic processing are degraded by ERAD |
setSize | 53 |
pANOVA | 2.63e-08 |
s.dist | 0.442 |
p.adjustANOVA | 2.24e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
SYVN1 | 7703.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
VCP | 6599.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
SYVN1 | 7703.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
VCP | 6599.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
OS9 | 4799.5 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
SEL1L | 4548.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
PSMA7 | 3962.5 |
DERL2 | 3262.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
ERLEC1 | 2361.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
SHH | -695.0 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
Hh mutants abrogate ligand secretion
533 | |
---|---|
set | Hh mutants abrogate ligand secretion |
setSize | 56 |
pANOVA | 3.1e-08 |
s.dist | 0.428 |
p.adjustANOVA | 2.49e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
SYVN1 | 7703.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
VCP | 6599.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
SYVN1 | 7703.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
VCP | 6599.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
OS9 | 4799.5 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
HHAT | 4670.5 |
PSMD5 | 4655.5 |
SEL1L | 4548.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
PSMA7 | 3962.5 |
DERL2 | 3262.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
ERLEC1 | 2361.5 |
IHH | 2289.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
SHH | -695.0 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
DHH | -1812.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
Interleukin-1 signaling
587 | |
---|---|
set | Interleukin-1 signaling |
setSize | 94 |
pANOVA | 4.17e-08 |
s.dist | 0.327 |
p.adjustANOVA | 3.18e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
AGER | 8956.5 |
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
SQSTM1 | 8697.5 |
NFKBIB | 8429.5 |
NOD1 | 8105.5 |
NKIRAS2 | 7943.5 |
APP | 7804.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
NKIRAS1 | 7353.5 |
PSMA6 | 7345.5 |
TNIP2 | 7247.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
TAB2 | 6793.5 |
PELI3 | 6700.5 |
IL1B | 6648.5 |
GeneID | Gene Rank |
---|---|
AGER | 8956.5 |
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
SQSTM1 | 8697.5 |
NFKBIB | 8429.5 |
NOD1 | 8105.5 |
NKIRAS2 | 7943.5 |
APP | 7804.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
NKIRAS1 | 7353.5 |
PSMA6 | 7345.5 |
TNIP2 | 7247.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
TAB2 | 6793.5 |
PELI3 | 6700.5 |
IL1B | 6648.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
MAP3K8 | 6329.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
NFKB2 | 5930.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
IKBKG | 5786.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
IL1RAP | 5449.5 |
TAB3 | 5441.5 |
PSMC2 | 5421.5 |
MAP2K1 | 5275.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
RBX1 | 4159.5 |
PSMA7 | 3962.5 |
UBE2N | 3887.0 |
MAP2K6 | 3880.5 |
TAB1 | 3233.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
IRAK2 | 2926.5 |
PSME2 | 2547.5 |
MAP3K3 | 2535.5 |
NFKB1 | 2395.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
MYD88 | 1336.5 |
TOLLIP | 1309.5 |
IKBKB | 1146.5 |
IL1R2 | 1075.5 |
IL1RN | 670.5 |
IRAK1 | 408.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
TRAF6 | -331.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
FBXW11 | -1203.5 |
MAP2K4 | -1376.5 |
PSMF1 | -1438.5 |
RIPK2 | -1709.5 |
BTRC | -1843.5 |
CHUK | -2390.5 |
HMGB1 | -2574.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
NOD2 | -3286.5 |
MAP3K7 | -3694.5 |
PELI2 | -4274.5 |
IRAK3 | -5654.5 |
PELI1 | -6202.5 |
RELA | -6220.5 |
IRAK4 | -6357.5 |
IL1R1 | -7048.5 |
IL1A | -7386.5 |
tRNA Aminoacylation
1440 | |
---|---|
set | tRNA Aminoacylation |
setSize | 42 |
pANOVA | 5.94e-08 |
s.dist | 0.483 |
p.adjustANOVA | 4.24e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
VARS1 | 8908.5 |
VARS2 | 8870.5 |
IARS2 | 8848.5 |
NARS1 | 8747.5 |
IARS1 | 8710.5 |
FARS2 | 8703.5 |
NARS2 | 8624.5 |
LARS2 | 8505.5 |
MARS2 | 7972.5 |
AARS1 | 7920.5 |
WARS1 | 7854.5 |
EPRS1 | 7782.5 |
HARS2 | 7498.5 |
AIMP2 | 7246.5 |
DARS2 | 7106.5 |
EARS2 | 6792.5 |
KARS1 | 6454.5 |
MARS1 | 5857.5 |
PPA1 | 5736.5 |
AARS2 | 5661.5 |
GeneID | Gene Rank |
---|---|
VARS1 | 8908.5 |
VARS2 | 8870.5 |
IARS2 | 8848.5 |
NARS1 | 8747.5 |
IARS1 | 8710.5 |
FARS2 | 8703.5 |
NARS2 | 8624.5 |
LARS2 | 8505.5 |
MARS2 | 7972.5 |
AARS1 | 7920.5 |
WARS1 | 7854.5 |
EPRS1 | 7782.5 |
HARS2 | 7498.5 |
AIMP2 | 7246.5 |
DARS2 | 7106.5 |
EARS2 | 6792.5 |
KARS1 | 6454.5 |
MARS1 | 5857.5 |
PPA1 | 5736.5 |
AARS2 | 5661.5 |
TARS2 | 5405.5 |
GARS1 | 4498.5 |
RARS2 | 4410.5 |
YARS1 | 4257.5 |
CARS1 | 4157.5 |
HARS1 | 4044.5 |
SARS2 | 3976.0 |
TARS1 | 3797.5 |
FARSA | 3117.5 |
AIMP1 | 2707.5 |
PARS2 | 2174.5 |
QARS1 | 1901.5 |
SARS1 | 1720.5 |
FARSB | 1504.5 |
RARS1 | 1477.5 |
CARS2 | 1179.5 |
LARS1 | 552.5 |
YARS2 | -1276.5 |
DARS1 | -1997.5 |
WARS2 | -3221.5 |
PPA2 | -5799.5 |
EEF1E1 | -6270.0 |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
1071 | |
---|---|
set | Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
setSize | 117 |
pANOVA | 6.16e-08 |
s.dist | 0.29 |
p.adjustANOVA | 4.24e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NDUFA12 | 8677.5 |
ATP5F1D | 8640.5 |
NDUFA8 | 8607.5 |
ATP5PB | 8530.5 |
NDUFS5 | 8426.5 |
ECSIT | 8154.5 |
COX11 | 8096.5 |
ACAD9 | 8063.5 |
NDUFS7 | 7874.5 |
MT-CO1 | 7459.5 |
TACO1 | 7403.5 |
NDUFA13 | 7316.5 |
TRAP1 | 7311.5 |
ETFDH | 7282.5 |
TIMMDC1 | 7186.5 |
NDUFAF3 | 7105.5 |
SCO1 | 6994.5 |
NDUFS2 | 6971.5 |
MT-CO2 | 6945.5 |
NDUFV1 | 6920.5 |
GeneID | Gene Rank |
---|---|
NDUFA12 | 8677.5 |
ATP5F1D | 8640.5 |
NDUFA8 | 8607.5 |
ATP5PB | 8530.5 |
NDUFS5 | 8426.5 |
ECSIT | 8154.5 |
COX11 | 8096.5 |
ACAD9 | 8063.5 |
NDUFS7 | 7874.5 |
MT-CO1 | 7459.5 |
TACO1 | 7403.5 |
NDUFA13 | 7316.5 |
TRAP1 | 7311.5 |
ETFDH | 7282.5 |
TIMMDC1 | 7186.5 |
NDUFAF3 | 7105.5 |
SCO1 | 6994.5 |
NDUFS2 | 6971.5 |
MT-CO2 | 6945.5 |
NDUFV1 | 6920.5 |
SDHB | 6907.5 |
NDUFAF4 | 6785.5 |
NDUFB10 | 6419.5 |
COX7A2L | 6410.5 |
UQCRC1 | 6324.5 |
NDUFS3 | 6318.5 |
UQCRFS1 | 6235.5 |
ETFB | 6145.5 |
NDUFV2 | 6127.5 |
NDUFA10 | 6103.5 |
DMAC2L | 5929.5 |
COX5B | 5910.5 |
NDUFA6 | 5887.5 |
NDUFA2 | 5728.5 |
ETFA | 5655.5 |
NDUFB9 | 5536.5 |
NDUFS8 | 5518.5 |
CYC1 | 5440.5 |
SURF1 | 5398.5 |
NDUFA11 | 5077.0 |
ATP5F1B | 5063.5 |
UQCRH | 4971.0 |
COX18 | 4765.5 |
UQCRQ | 4627.5 |
NDUFB8 | 4615.0 |
SDHC | 4606.5 |
NDUFB2 | 4587.5 |
NDUFAB1 | 4350.5 |
SDHA | 4232.0 |
UCP2 | 4090.5 |
NDUFA7 | 3973.0 |
COX4I1 | 3926.5 |
UQCR10 | 3843.5 |
SLC25A27 | 3731.5 |
NDUFA9 | 3708.5 |
COX14 | 3517.5 |
NDUFA5 | 3514.5 |
UQCRC2 | 3503.5 |
ATP5PD | 3402.5 |
NDUFB6 | 3329.5 |
NDUFC1 | 3113.5 |
NDUFS1 | 3068.5 |
NDUFAF1 | 2966.5 |
ATP5PO | 2930.0 |
COQ10B | 2915.5 |
NDUFAF7 | 2842.5 |
COX7B | 2750.5 |
UQCR11 | 2718.0 |
NDUFC2 | 2669.0 |
ATP5MF | 2647.5 |
MT-ND1 | 2529.5 |
NDUFB7 | 2448.5 |
NDUFS4 | 2412.5 |
NDUFA3 | 2298.5 |
SDHD | 2278.0 |
NDUFAF5 | 2012.5 |
MT-ND3 | 1861.5 |
CYCS | 1802.5 |
MT-CO3 | 1568.5 |
MT-CYB | 1377.5 |
MT-ND5 | 1325.5 |
NDUFA4 | 1265.5 |
MT-ATP6 | 1243.5 |
COX6A1 | 1068.5 |
NDUFB5 | 1061.5 |
COX20 | 681.5 |
COX5A | 481.5 |
MT-ND4 | 390.5 |
ATP5MC3 | 319.5 |
MT-ND2 | 306.5 |
UCP1 | -358.5 |
NDUFB11 | -363.5 |
ATP5PF | -401.5 |
MT-ND6 | -790.5 |
NUBPL | -1174.5 |
COX19 | -1192.5 |
ATP5F1E | -1407.5 |
COQ10A | -2127.5 |
COX7C | -2174.5 |
TMEM126B | -2544.5 |
ATP5MG | -2690.0 |
NDUFAF6 | -2759.5 |
NDUFS6 | -2838.5 |
ATP5ME | -3145.5 |
NDUFB3 | -3539.5 |
NDUFA1 | -3668.5 |
NDUFB4 | -3950.5 |
SLC25A14 | -4573.5 |
MT-ATP8 | -4868.5 |
UCP3 | -5025.5 |
COX8A | -5052.5 |
COX6B1 | -5355.5 |
ATP5F1A | -6042.5 |
NDUFV3 | -6831.5 |
PM20D1 | -7706.5 |
UQCRB | -7789.5 |
COX16 | -7904.5 |
AUF1 (hnRNP D0) binds and destabilizes mRNA
21 | |
---|---|
set | AUF1 (hnRNP D0) binds and destabilizes mRNA |
setSize | 51 |
pANOVA | 8.72e-08 |
s.dist | 0.433 |
p.adjustANOVA | 5.49e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
EIF4G1 | 8580.5 |
HSPA8 | 7910.5 |
HSPA1A | 7838.0 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
EIF4G1 | 8580.5 |
HSPA8 | 7910.5 |
HSPA1A | 7838.0 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
HSPB1 | 682.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
HNRNPD | -8425.5 |
Regulation of ornithine decarboxylase (ODC)
1054 | |
---|---|
set | Regulation of ornithine decarboxylase (ODC) |
setSize | 49 |
pANOVA | 8.74e-08 |
s.dist | 0.442 |
p.adjustANOVA | 5.49e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
ODC1 | 6863.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
ODC1 | 6863.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
OAZ2 | 5164.5 |
PSMD10 | 5093.5 |
NQO1 | 5061.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
AZIN1 | 2497.5 |
OAZ1 | 2182.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
OAZ3 | 346.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
NIK-->noncanonical NF-kB signaling
739 | |
---|---|
set | NIK-->noncanonical NF-kB signaling |
setSize | 56 |
pANOVA | 9.53e-08 |
s.dist | 0.412 |
p.adjustANOVA | 5.74e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBE2M | 7376.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
NFKB2 | 5930.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBE2M | 7376.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
NFKB2 | 5930.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
MAP3K14 | 2011.5 |
PSMA1 | 1867.5 |
UBA3 | 1735.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
RELB | 1279.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
FBXW11 | -1203.5 |
PSMF1 | -1438.5 |
BTRC | -1843.5 |
CHUK | -2390.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
Degradation of GLI2 by the proteasome
286 | |
---|---|
set | Degradation of GLI2 by the proteasome |
setSize | 55 |
pANOVA | 1.1e-07 |
s.dist | 0.414 |
p.adjustANOVA | 6.39e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PRKACA | 7262.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PRKACA | 7262.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
SUFU | 5369.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
RBX1 | 4159.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PRKACB | 1490.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
GSK3B | -787.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
BTRC | -1843.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
CSNK1A1 | -5751.5 |
Regulation of Apoptosis
1010 | |
---|---|
set | Regulation of Apoptosis |
setSize | 50 |
pANOVA | 1.34e-07 |
s.dist | 0.431 |
p.adjustANOVA | 7.2e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
OPA1 | 8625.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
OMA1 | 5608.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
OPA1 | 8625.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
OMA1 | 5608.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PAK2 | 449.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
ARHGAP10 | -2997.5 |
Pyruvate metabolism and Citric Acid (TCA) cycle
936 | |
---|---|
set | Pyruvate metabolism and Citric Acid (TCA) cycle |
setSize | 52 |
pANOVA | 1.34e-07 |
s.dist | 0.423 |
p.adjustANOVA | 7.2e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ACO2 | 8817.5 |
PDP1 | 8638.5 |
PDHX | 8564.5 |
PDHB | 8238.5 |
BSG | 8186.5 |
DLST | 8106.5 |
ME3 | 8005.5 |
FAHD1 | 7997.5 |
LDHB | 7435.0 |
IDH2 | 7427.5 |
LDHC | 7413.5 |
PDK2 | 7219.5 |
IDH3A | 7182.5 |
SDHB | 6907.5 |
DLAT | 6848.5 |
HAGH | 6790.5 |
IDH3B | 6732.5 |
PDHA1 | 6639.5 |
FH | 6469.5 |
ADHFE1 | 6444.5 |
GeneID | Gene Rank |
---|---|
ACO2 | 8817.5 |
PDP1 | 8638.5 |
PDHX | 8564.5 |
PDHB | 8238.5 |
BSG | 8186.5 |
DLST | 8106.5 |
ME3 | 8005.5 |
FAHD1 | 7997.5 |
LDHB | 7435.0 |
IDH2 | 7427.5 |
LDHC | 7413.5 |
PDK2 | 7219.5 |
IDH3A | 7182.5 |
SDHB | 6907.5 |
DLAT | 6848.5 |
HAGH | 6790.5 |
IDH3B | 6732.5 |
PDHA1 | 6639.5 |
FH | 6469.5 |
ADHFE1 | 6444.5 |
PDPR | 6116.5 |
CS | 5894.5 |
MPC1 | 5835.5 |
MPC2 | 4845.5 |
SDHC | 4606.5 |
OGDH | 4470.5 |
L2HGDH | 4434.5 |
VDAC1 | 4260.5 |
SDHA | 4232.0 |
PDK1 | 4175.5 |
SUCLG1 | 3325.5 |
SUCLA2 | 3268.5 |
DLD | 2984.5 |
IDH3G | 2586.5 |
PPARD | 2501.5 |
PDP2 | 2306.5 |
SDHD | 2278.0 |
LDHA | 1562.5 |
GLO1 | 1280.5 |
MDH2 | 1129.5 |
NNT | 785.5 |
D2HGDH | 530.5 |
RXRA | 395.5 |
ME2 | 9.5 |
ME1 | -80.5 |
SUCLG2 | -231.5 |
SLC16A1 | -369.5 |
SLC16A3 | -371.5 |
PDK4 | -495.5 |
SLC16A8 | -5262.5 |
PDK3 | -6753.5 |
GSTZ1 | -7866.5 |
Metabolism of polyamines
686 | |
---|---|
set | Metabolism of polyamines |
setSize | 57 |
pANOVA | 1.49e-07 |
s.dist | 0.402 |
p.adjustANOVA | 7.71e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PAOX | 7705.0 |
PSMC1 | 7622.5 |
PSMA6 | 7345.5 |
SRM | 7229.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
ODC1 | 6863.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
AMD1 | 5673.5 |
PSMA4 | 5533.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PAOX | 7705.0 |
PSMC1 | 7622.5 |
PSMA6 | 7345.5 |
SRM | 7229.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
ODC1 | 6863.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
AMD1 | 5673.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
OAZ2 | 5164.5 |
PSMD10 | 5093.5 |
NQO1 | 5061.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
AZIN2 | 4480.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
AZIN1 | 2497.5 |
OAZ1 | 2182.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
OAZ3 | 346.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
SMS | -1156.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
SMOX | -1471.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
AGMAT | -4568.5 |
SAT1 | -5390.5 |
Cross-presentation of soluble exogenous antigens (endosomes)
231 | |
---|---|
set | Cross-presentation of soluble exogenous antigens (endosomes) |
setSize | 48 |
pANOVA | 1.56e-07 |
s.dist | 0.438 |
p.adjustANOVA | 7.8e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
FCGR1A | 7708.0 |
FCGR1B | 7708.0 |
PSMC1 | 7622.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
FCGR1A | 7708.0 |
FCGR1B | 7708.0 |
PSMC1 | 7622.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
CD207 | 4077.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
PSMA5 | 5.5 |
MRC1 | -413.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
MRC2 | -2840.5 |
Mitochondrial Fatty Acid Beta-Oxidation
703 | |
---|---|
set | Mitochondrial Fatty Acid Beta-Oxidation |
setSize | 36 |
pANOVA | 1.69e-07 |
s.dist | 0.504 |
p.adjustANOVA | 8.09e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ACAA2 | 8392.5 |
PCCA | 8219.5 |
ACADS | 7996.5 |
DBI | 7888.5 |
ECI1 | 7640.5 |
ACBD6 | 7437.5 |
MECR | 7404.5 |
ECHS1 | 7149.5 |
ACADVL | 6798.5 |
ACADM | 6715.5 |
HADHB | 6348.5 |
MCAT | 6165.5 |
HADH | 5956.5 |
ACOT11 | 5798.5 |
ACOT7 | 5658.5 |
ACOT1 | 5390.0 |
ACOT2 | 5390.0 |
HADHA | 5276.5 |
MCEE | 5227.5 |
ACBD7 | 4955.5 |
GeneID | Gene Rank |
---|---|
ACAA2 | 8392.5 |
PCCA | 8219.5 |
ACADS | 7996.5 |
DBI | 7888.5 |
ECI1 | 7640.5 |
ACBD6 | 7437.5 |
MECR | 7404.5 |
ECHS1 | 7149.5 |
ACADVL | 6798.5 |
ACADM | 6715.5 |
HADHB | 6348.5 |
MCAT | 6165.5 |
HADH | 5956.5 |
ACOT11 | 5798.5 |
ACOT7 | 5658.5 |
ACOT1 | 5390.0 |
ACOT2 | 5390.0 |
HADHA | 5276.5 |
MCEE | 5227.5 |
ACBD7 | 4955.5 |
ACAD10 | 4554.5 |
ACADL | 4411.5 |
NDUFAB1 | 4350.5 |
ACAD11 | 4281.5 |
ACOT13 | 4095.5 |
ACSF2 | 3919.5 |
MMUT | 3678.5 |
THEM5 | 3298.5 |
MMAA | 3070.5 |
PCCB | 3066.5 |
ACSM3 | 2050.5 |
THEM4 | 1879.5 |
ACOT9 | 1689.5 |
DECR1 | -1704.5 |
ACOT12 | -3398.5 |
PCTP | -5012.5 |
Vif-mediated degradation of APOBEC3G
1391 | |
---|---|
set | Vif-mediated degradation of APOBEC3G |
setSize | 50 |
pANOVA | 1.8e-07 |
s.dist | 0.427 |
p.adjustANOVA | 8.09e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
ELOC | 5925.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
ELOC | 5925.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
CUL5 | 4698.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
RBX1 | 4159.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
ELOB | -5059.5 |
Degradation of GLI1 by the proteasome
285 | |
---|---|
set | Degradation of GLI1 by the proteasome |
setSize | 56 |
pANOVA | 1.8e-07 |
s.dist | 0.403 |
p.adjustANOVA | 8.09e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PRKACA | 7262.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PRKACA | 7262.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
SUFU | 5369.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
RBX1 | 4159.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PRKACB | 1490.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
GLI1 | 620.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
ITCH | -558.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
BTRC | -1843.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
NUMB | -8051.5 |
Vpu mediated degradation of CD4
1399 | |
---|---|
set | Vpu mediated degradation of CD4 |
setSize | 49 |
pANOVA | 1.85e-07 |
s.dist | 0.431 |
p.adjustANOVA | 8.09e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
CD4 | 1967.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
BTRC | -1843.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
Mitochondrial protein import
707 | |
---|---|
set | Mitochondrial protein import |
setSize | 62 |
pANOVA | 1.99e-07 |
s.dist | 0.382 |
p.adjustANOVA | 8.45e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
TIMM50 | 8913.5 |
ACO2 | 8817.5 |
LDHD | 8757.5 |
CMC2 | 8574.5 |
PITRM1 | 8463.5 |
TOMM40 | 8333.5 |
FXN | 8330.5 |
PMPCA | 8171.5 |
SLC25A13 | 7672.5 |
SLC25A12 | 7665.5 |
GRPEL1 | 7654.5 |
CHCHD5 | 7532.5 |
TIMM44 | 7140.5 |
MTX1 | 6581.5 |
TOMM6 | 6247.5 |
TIMM23 | 6237.5 |
PMPCB | 6193.5 |
TIMM8A | 6184.5 |
SAMM50 | 6128.5 |
TIMM21 | 6056.5 |
GeneID | Gene Rank |
---|---|
TIMM50 | 8913.5 |
ACO2 | 8817.5 |
LDHD | 8757.5 |
CMC2 | 8574.5 |
PITRM1 | 8463.5 |
TOMM40 | 8333.5 |
FXN | 8330.5 |
PMPCA | 8171.5 |
SLC25A13 | 7672.5 |
SLC25A12 | 7665.5 |
GRPEL1 | 7654.5 |
CHCHD5 | 7532.5 |
TIMM44 | 7140.5 |
MTX1 | 6581.5 |
TOMM6 | 6247.5 |
TIMM23 | 6237.5 |
PMPCB | 6193.5 |
TIMM8A | 6184.5 |
SAMM50 | 6128.5 |
TIMM21 | 6056.5 |
CHCHD4 | 6017.5 |
CS | 5894.5 |
TIMM8B | 5797.5 |
HSPD1 | 5605.5 |
TAZ | 5561.5 |
CYC1 | 5440.5 |
COQ2 | 5364.5 |
TIMM10 | 5314.5 |
SLC25A4 | 5264.5 |
HSPA9 | 5108.5 |
TIMM10B | 5095.0 |
ATP5F1B | 5063.5 |
CHCHD3 | 5047.5 |
NDUFB8 | 4615.0 |
VDAC1 | 4260.5 |
TIMM17A | 3995.5 |
TIMM22 | 3837.5 |
OTC | 3799.5 |
BCS1L | 3714.5 |
TOMM20 | 3158.5 |
COA4 | 3056.5 |
TOMM22 | 2933.5 |
TOMM70 | 2806.5 |
IDH3G | 2586.5 |
PAM16 | 1923.5 |
CHCHD7 | 1405.5 |
TIMM9 | 1333.5 |
COA6 | 1213.5 |
CMC4 | 1002.5 |
MTX2 | 965.5 |
COX17 | 646.5 |
TIMM13 | 27.5 |
DNAJC19 | -270.5 |
COX19 | -1192.5 |
GRPEL2 | -4259.5 |
GFER | -4610.5 |
HSCB | -4732.5 |
TOMM7 | -4954.5 |
ATP5F1A | -6042.5 |
TIMM17B | -6725.5 |
CHCHD10 | -7851.5 |
CHCHD2 | -7918.5 |
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis
381 | |
---|---|
set | FBXL7 down-regulates AURKA during mitotic entry and in early mitosis |
setSize | 52 |
pANOVA | 2.46e-07 |
s.dist | 0.414 |
p.adjustANOVA | 1.02e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
RBX1 | 4159.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
AURKA | -982.5 |
PSMB10 | -1181.5 |
FBXL18 | -1363.5 |
PSMF1 | -1438.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
FBXL7 | -3388.5 |
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
819 | |
---|---|
set | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha |
setSize | 63 |
pANOVA | 2.79e-07 |
s.dist | 0.374 |
p.adjustANOVA | 1.12e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
EGLN1 | 8386.0 |
PSMC1 | 7622.5 |
EGLN2 | 7426.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
CUL2 | 7195.5 |
UBE2D3 | 7189.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
ELOC | 5925.5 |
PSMD11 | 5787.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
EGLN1 | 8386.0 |
PSMC1 | 7622.5 |
EGLN2 | 7426.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
CUL2 | 7195.5 |
UBE2D3 | 7189.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
ELOC | 5925.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
EGLN3 | 4702.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
RBX1 | 4159.5 |
PSMA7 | 3962.5 |
HIF3A | 3792.5 |
EPAS1 | 3670.5 |
PSMD12 | 3211.5 |
UBE2D1 | 3169.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
UBE2D2 | 126.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
LIMD1 | -224.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
WTIP | -2033.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
VHL | -4639.5 |
ELOB | -5059.5 |
AJUBA | -5412.5 |
HIF1A | -6851.5 |
Regulation of activated PAK-2p34 by proteasome mediated degradation
1038 | |
---|---|
set | Regulation of activated PAK-2p34 by proteasome mediated degradation |
setSize | 47 |
pANOVA | 2.88e-07 |
s.dist | 0.433 |
p.adjustANOVA | 1.13e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PAK2 | 449.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
Deubiquitination
297 | |
---|---|
set | Deubiquitination |
setSize | 231 |
pANOVA | 2.98e-07 |
s.dist | 0.196 |
p.adjustANOVA | 1.13e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
USP2 | 8778.5 |
USP20 | 8761.5 |
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
FOXO4 | 8664.5 |
RAD23A | 8618.5 |
TNIP1 | 8492.5 |
USP25 | 8470.5 |
RHOT1 | 8433.5 |
USP4 | 8388.5 |
RUVBL1 | 8255.5 |
MAVS | 8242.5 |
USP15 | 8228.5 |
NFRKB | 8144.5 |
NOD1 | 8105.5 |
MAT2B | 8081.5 |
ACTR8 | 8001.5 |
HGS | 7865.5 |
FKBP8 | 7818.5 |
NEDD8 | 7736.5 |
GeneID | Gene Rank |
---|---|
USP2 | 8778.5 |
USP20 | 8761.5 |
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
FOXO4 | 8664.5 |
RAD23A | 8618.5 |
TNIP1 | 8492.5 |
USP25 | 8470.5 |
RHOT1 | 8433.5 |
USP4 | 8388.5 |
RUVBL1 | 8255.5 |
MAVS | 8242.5 |
USP15 | 8228.5 |
NFRKB | 8144.5 |
NOD1 | 8105.5 |
MAT2B | 8081.5 |
ACTR8 | 8001.5 |
HGS | 7865.5 |
FKBP8 | 7818.5 |
NEDD8 | 7736.5 |
USP48 | 7686.5 |
PSMC1 | 7622.5 |
USP19 | 7579.5 |
USP5 | 7503.5 |
UBA52 | 7357.5 |
UIMC1 | 7349.5 |
PSMA6 | 7345.5 |
INO80E | 7337.5 |
USP30 | 7330.5 |
TNIP2 | 7247.5 |
PTEN | 7076.5 |
PSMD4 | 7024.5 |
USP13 | 7000.5 |
TAF10 | 6985.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
ESR1 | 6813.5 |
INO80B | 6726.0 |
MDM2 | 6693.5 |
OTUD3 | 6668.5 |
TRAF2 | 6628.5 |
TNFAIP3 | 6624.5 |
VCP | 6599.5 |
BAP1 | 6571.5 |
PSMA8 | 6529.5 |
KEAP1 | 6518.5 |
USP21 | 6463.5 |
PSME1 | 6431.5 |
VDAC2 | 6210.5 |
PSMD14 | 6156.5 |
INO80C | 6134.5 |
MBD5 | 6111.5 |
PSMB6 | 6079.5 |
KAT2B | 6027.5 |
USP47 | 6014.5 |
PSMB7 | 5988.5 |
OTUB1 | 5970.5 |
ATXN3 | 5958.0 |
ATXN3L | 5958.0 |
PSMD7 | 5955.5 |
TGFBR2 | 5914.5 |
MUL1 | 5864.5 |
MYC | 5828.5 |
PSMD11 | 5787.5 |
IKBKG | 5786.5 |
PSMD8 | 5682.5 |
RAD23B | 5659.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
TADA3 | 5438.5 |
USP12 | 5428.5 |
PSMC2 | 5421.5 |
KAT2A | 5284.5 |
SMAD7 | 5247.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
TRAF3 | 5171.5 |
RNF123 | 5138.5 |
USP14 | 5122.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
ADRM1 | 4905.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
OTUD5 | 4643.5 |
USP24 | 4607.5 |
H2AC1 | 4603.5 |
GATA3 | 4430.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
APC | 4290.5 |
H2AC21 | 4285.5 |
VDAC1 | 4260.5 |
USP11 | 4212.5 |
AXIN2 | 4074.5 |
WDR48 | 4040.5 |
DDX58 | 4015.5 |
PSMA7 | 3962.5 |
JOSD1 | 3957.5 |
STAMBP | 3927.5 |
USP10 | 3877.5 |
SUDS3 | 3848.5 |
OTUB2 | 3739.5 |
TNIP3 | 3734.5 |
TADA2B | 3675.5 |
USP49 | 3646.5 |
BABAM1 | 3557.5 |
JOSD2 | 3490.5 |
USP16 | 3451.5 |
OTUD7B | 3367.5 |
TAB1 | 3233.5 |
PSMD12 | 3211.5 |
UBE2D1 | 3169.5 |
TOMM20 | 3158.5 |
IL33 | 3098.5 |
RNF146 | 3078.5 |
EP300 | 2949.5 |
PSMB2 | 2944.5 |
VDAC3 | 2927.5 |
TOMM70 | 2806.5 |
RCE1 | 2747.5 |
SMURF2 | 2597.5 |
POLB | 2550.5 |
PSME2 | 2547.5 |
H2BC1 | 2483.5 |
FOXK1 | 2423.5 |
YY1 | 2391.5 |
ZRANB1 | 2308.5 |
RPS27A | 2261.5 |
YOD1 | 2244.5 |
RHOA | 2014.5 |
TFPT | 1969.5 |
PSMA1 | 1867.5 |
UCHL5 | 1761.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
H2BC11 | 1257.5 |
USP8 | 1256.5 |
MCRS1 | 1074.5 |
ARRB1 | 770.5 |
WDR20 | 500.5 |
SENP8 | 470.5 |
PSMB3 | 391.5 |
BARD1 | 384.5 |
CFTR | 341.5 |
BIRC2 | 238.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
ATXN7 | -150.5 |
CCP110 | -194.5 |
IDE | -266.5 |
TRAF6 | -331.5 |
PSMA3 | -754.5 |
ASXL2 | -989.5 |
TRIM25 | -1015.5 |
PSMB10 | -1181.5 |
ACTL6A | -1190.5 |
USP28 | -1197.5 |
ARRB2 | -1362.5 |
PSMF1 | -1438.5 |
MBD6 | -1439.5 |
TGFB1 | -1494.5 |
STAM | -1589.5 |
CDC25A | -1611.5 |
RIPK2 | -1709.5 |
USP44 | -1803.5 |
STAM2 | -1842.5 |
USP33 | -1939.5 |
ACTR5 | -1944.5 |
AR | -1955.5 |
USP22 | -2034.5 |
USP18 | -2198.0 |
BRCC3 | -2379.5 |
USP3 | -2439.5 |
MDM4 | -2459.5 |
TNKS2 | -2539.5 |
USP34 | -2548.5 |
PSMD9 | -2755.0 |
USP9X | -2762.5 |
PSMD13 | -2775.5 |
STAMBPL1 | -2799.5 |
INO80D | -2837.5 |
IFIH1 | -2885.5 |
UCHL1 | -3161.5 |
ADRB2 | -3195.5 |
HCFC1 | -3268.5 |
NOD2 | -3286.5 |
TAF9B | -3457.5 |
SMAD3 | -3534.5 |
OTUD7A | -3546.5 |
MAP3K7 | -3694.5 |
VCPIP1 | -3803.5 |
SIAH2 | -3808.5 |
MYSM1 | -3819.5 |
RNF128 | -3922.5 |
UCHL3 | -4145.5 |
ASXL1 | -4189.5 |
FOXK2 | -4210.5 |
SKP2 | -4252.5 |
SMAD1 | -4336.5 |
PTRH2 | -5069.5 |
USP7 | -5134.5 |
SMAD4 | -5135.5 |
USP42 | -5582.5 |
H2BC3 | -5930.5 |
RIPK1 | -5961.5 |
TNKS | -6095.5 |
USP37 | -6101.5 |
H2BU1 | -6178.5 |
BRCA1 | -6186.5 |
KDM1B | -6307.5 |
TGFBR1 | -6311.5 |
HIF1A | -6851.5 |
DDB2 | -6883.5 |
H2BC12 | -7021.5 |
CCNA1 | -7120.5 |
INO80 | -7269.5 |
CCNA2 | -7508.5 |
BECN1 | -7524.5 |
BIRC3 | -7702.5 |
OGT | -7946.5 |
NLRP3 | -8069.5 |
ACTB | -8079.5 |
CYLD | -8088.5 |
CDC20 | -8352.5 |
CLSPN | -8372.5 |
SMAD2 | -8431.5 |
CDK1 | -8596.5 |
Interleukin-1 family signaling
586 | |
---|---|
set | Interleukin-1 family signaling |
setSize | 127 |
pANOVA | 3.64e-07 |
s.dist | 0.261 |
p.adjustANOVA | 1.35e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
AGER | 8956.5 |
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
SQSTM1 | 8697.5 |
NFKBIB | 8429.5 |
IL4 | 8331.5 |
PTPN6 | 8246.5 |
NOD1 | 8105.5 |
NKIRAS2 | 7943.5 |
PTPN11 | 7913.5 |
APP | 7804.5 |
IL18BP | 7738.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
NKIRAS1 | 7353.5 |
PSMA6 | 7345.5 |
TNIP2 | 7247.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
GeneID | Gene Rank |
---|---|
AGER | 8956.5 |
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
SQSTM1 | 8697.5 |
NFKBIB | 8429.5 |
IL4 | 8331.5 |
PTPN6 | 8246.5 |
NOD1 | 8105.5 |
NKIRAS2 | 7943.5 |
PTPN11 | 7913.5 |
APP | 7804.5 |
IL18BP | 7738.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
NKIRAS1 | 7353.5 |
PSMA6 | 7345.5 |
TNIP2 | 7247.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
TAB2 | 6793.5 |
PELI3 | 6700.5 |
IL1B | 6648.5 |
IL36RN | 6617.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
MAP3K8 | 6329.5 |
TBK1 | 6213.5 |
PTPN14 | 6203.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
STAT3 | 6074.5 |
PSMB7 | 5988.5 |
PTPN18 | 5965.5 |
PSMD7 | 5955.5 |
NFKB2 | 5930.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
IKBKG | 5786.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
IL1RAP | 5449.5 |
TAB3 | 5441.5 |
PSMC2 | 5421.5 |
MAP2K1 | 5275.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PTPN5 | 5043.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
IL13 | 4648.5 |
CASP1 | 4564.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
RBX1 | 4159.5 |
PSMA7 | 3962.5 |
IL18R1 | 3945.5 |
UBE2N | 3887.0 |
MAP2K6 | 3880.5 |
TAB1 | 3233.5 |
PSMD12 | 3211.5 |
IL33 | 3098.5 |
PSMB2 | 2944.5 |
IRAK2 | 2926.5 |
PSME2 | 2547.5 |
MAP3K3 | 2535.5 |
NFKB1 | 2395.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
IL1F10 | 1737.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
MYD88 | 1336.5 |
TOLLIP | 1309.5 |
IKBKB | 1146.5 |
PTPN13 | 1079.5 |
IL1R2 | 1075.5 |
IL1RN | 670.5 |
IL18RAP | 586.5 |
IRAK1 | 408.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
TRAF6 | -331.5 |
MAPK8 | -572.5 |
PSMA3 | -754.5 |
PTPN2 | -1057.5 |
PSMB10 | -1181.5 |
FBXW11 | -1203.5 |
MAP2K4 | -1376.5 |
PSMF1 | -1438.5 |
IL36A | -1550.5 |
RIPK2 | -1709.5 |
PTPN23 | -1727.5 |
PTPN9 | -1763.5 |
BTRC | -1843.5 |
IL1RL2 | -2384.5 |
CHUK | -2390.5 |
SIGIRR | -2397.5 |
HMGB1 | -2574.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
NOD2 | -3286.5 |
SMAD3 | -3534.5 |
MAP3K7 | -3694.5 |
IL36B | -3940.5 |
PELI2 | -4274.5 |
IL1RAPL1 | -4448.5 |
ALOX5 | -4740.5 |
PTPN7 | -5621.5 |
IRAK3 | -5654.5 |
IL18 | -5965.5 |
PELI1 | -6202.5 |
RELA | -6220.5 |
IRAK4 | -6357.5 |
PTPN4 | -6358.5 |
IL1R1 | -7048.5 |
IL1A | -7386.5 |
PTPN12 | -7680.5 |
IL1RL1 | -7942.5 |
GLI3 is processed to GLI3R by the proteasome
459 | |
---|---|
set | GLI3 is processed to GLI3R by the proteasome |
setSize | 56 |
pANOVA | 3.98e-07 |
s.dist | 0.392 |
p.adjustANOVA | 1.44e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PRKACA | 7262.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PRKACA | 7262.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
SUFU | 5369.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
RBX1 | 4159.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PRKACB | 1490.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
GSK3B | -787.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
BTRC | -1843.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
CSNK1A1 | -5751.5 |
GLI3 | -7127.5 |
SCF-beta-TrCP mediated degradation of Emi1
1095 | |
---|---|
set | SCF-beta-TrCP mediated degradation of Emi1 |
setSize | 52 |
pANOVA | 4.35e-07 |
s.dist | 0.405 |
p.adjustANOVA | 1.53e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
FBXO5 | 2702.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
FZR1 | 1968.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
BTRC | -1843.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
CDC20 | -8352.5 |
Cell surface interactions at the vascular wall
170 | |
---|---|
set | Cell surface interactions at the vascular wall |
setSize | 155 |
pANOVA | 4.47e-07 |
s.dist | -0.235 |
p.adjustANOVA | 1.54e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CD244 | -8468.5 |
APOB | -8370.5 |
PPIA | -8361.0 |
L1CAM | -8213.5 |
CEACAM1 | -8171.0 |
CEACAM3 | -8171.0 |
CEACAM5 | -8171.0 |
CEACAM6 | -8171.0 |
CEACAM8 | -8171.0 |
PSG1 | -8171.0 |
PSG11 | -8171.0 |
PSG2 | -8171.0 |
PSG3 | -8171.0 |
PSG4 | -8171.0 |
PSG5 | -8171.0 |
PSG6 | -8171.0 |
PSG7 | -8171.0 |
PSG8 | -8171.0 |
PSG9 | -8171.0 |
VPREB3 | -8135.5 |
GeneID | Gene Rank |
---|---|
CD244 | -8468.5 |
APOB | -8370.5 |
PPIA | -8361.0 |
L1CAM | -8213.5 |
CEACAM1 | -8171.0 |
CEACAM3 | -8171.0 |
CEACAM5 | -8171.0 |
CEACAM6 | -8171.0 |
CEACAM8 | -8171.0 |
PSG1 | -8171.0 |
PSG11 | -8171.0 |
PSG2 | -8171.0 |
PSG3 | -8171.0 |
PSG4 | -8171.0 |
PSG5 | -8171.0 |
PSG6 | -8171.0 |
PSG7 | -8171.0 |
PSG8 | -8171.0 |
PSG9 | -8171.0 |
VPREB3 | -8135.5 |
CD99L2 | -8057.5 |
CD44 | -7979.5 |
YES1 | -7705.5 |
CD47 | -7660.5 |
NRAS | -7625.5 |
ITGAM | -7426.5 |
MAG | -7389.5 |
SDC1 | -7234.5 |
IGKV1-12 | -7039.0 |
IGKV1-16 | -7039.0 |
IGKV1-17 | -7039.0 |
IGKV1-39 | -7039.0 |
IGKV1-5 | -7039.0 |
IGKV1D-12 | -7039.0 |
IGKV1D-16 | -7039.0 |
IGKV1D-39 | -7039.0 |
SLC7A7 | -6965.5 |
SDC2 | -6795.5 |
KRAS | -6786.5 |
ATP1B2 | -6306.5 |
FN1 | -6177.5 |
CXADR | -6141.5 |
CAV1 | -5750.5 |
IGLV3-16 | -5675.5 |
IGLV3-22 | -5675.5 |
IGLV3-25 | -5675.5 |
IGLV3-27 | -5675.5 |
GRB7 | -5611.5 |
PROS1 | -5462.5 |
CD2 | -5386.5 |
SLC16A8 | -5262.5 |
SPN | -5108.5 |
IGLC1 | -4828.0 |
IGLC2 | -4828.0 |
IGLC3 | -4828.0 |
IGLC7 | -4828.0 |
IGLL1 | -4828.0 |
TREM1 | -4405.5 |
IGHV4-34 | -4385.0 |
IGHV4-39 | -4385.0 |
IGHV4-59 | -4385.0 |
CD48 | -4366.5 |
JCHAIN | -4348.5 |
PIK3CB | -4270.5 |
ITGAX | -4225.5 |
PROCR | -4108.5 |
ITGB3 | -3942.0 |
FCAMR | -3865.5 |
PIK3CA | -3786.5 |
VPREB1 | -3776.5 |
MERTK | -3750.5 |
SDC4 | -3567.5 |
LYN | -3527.5 |
DOK2 | -3469.5 |
ANGPT2 | -3298.5 |
SLC7A5 | -3157.5 |
SLC7A11 | -3154.5 |
PLCG1 | -3094.5 |
ATP1B3 | -3029.5 |
ITGA6 | -2918.5 |
IGHV2-5 | -2844.5 |
IGHV2-70 | -2844.5 |
GYPC | -2758.5 |
LCK | -2739.5 |
GLG1 | -2576.5 |
TEK | -2432.5 |
SRC | -2361.5 |
MIF | -2210.5 |
SLC7A8 | -1980.5 |
ITGA4 | -1928.5 |
SELP | -1681.5 |
TGFB1 | -1494.5 |
SLC3A2 | -1390.5 |
PROC | -1175.5 |
PICK1 | -1117.5 |
SHC1 | -1008.5 |
EPCAM | -887.5 |
IGHV7-81 | -695.0 |
CD177 | -611.5 |
INPP5D | -584.5 |
IGKV2-28 | -517.5 |
IGKV2D-28 | -517.5 |
IGKV2D-40 | -517.5 |
F11R | -514.5 |
SLC16A3 | -371.5 |
SLC16A1 | -369.5 |
FYN | -339.5 |
ITGB2 | 145.5 |
SELE | 342.5 |
IGKV4-1 | 362.5 |
SLC7A6 | 369.5 |
F2 | 644.5 |
GP6 | 928.5 |
SOS1 | 1229.5 |
JAM3 | 1395.5 |
SDC3 | 1408.5 |
PIK3R2 | 1532.0 |
FCER1G | 1820.5 |
SELPLG | 1885.5 |
ANGPT4 | 2123.5 |
CD84 | 2345.5 |
SLC7A9 | 2794.5 |
ANGPT1 | 3009.5 |
OLR1 | 3343.5 |
CD99 | 4293.5 |
JAM2 | 4714.5 |
SELL | 4757.5 |
ITGA5 | 4984.5 |
PIK3R1 | 5011.5 |
TSPAN7 | 5291.0 |
ITGAL | 5399.5 |
GRB2 | 5591.5 |
ESAM | 5603.5 |
ITGB1 | 5760.5 |
PPIL2 | 5869.5 |
SLC7A10 | 5949.5 |
THBD | 6089.5 |
ITGAV | 6100.5 |
IGKV2-30 | 6283.0 |
IGKV2D-30 | 6283.0 |
GPC1 | 6312.5 |
GRB14 | 6551.5 |
SIRPA | 6690.0 |
SIRPG | 6690.0 |
IGLV6-57 | 6930.5 |
IGHM | 7883.5 |
PTPN11 | 7913.5 |
ITGA3 | 8156.5 |
BSG | 8186.5 |
PTPN6 | 8246.5 |
HRAS | 8620.5 |
CD74 | 8687.5 |
ATP1B1 | 8849.5 |
IGKC | 8857.5 |
GAS6 | 9006.5 |
Hedgehog ligand biogenesis
528 | |
---|---|
set | Hedgehog ligand biogenesis |
setSize | 61 |
pANOVA | 5.34e-07 |
s.dist | 0.371 |
p.adjustANOVA | 1.8e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
SYVN1 | 7703.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
VCP | 6599.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
P4HB | 6271.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
SYVN1 | 7703.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
VCP | 6599.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
P4HB | 6271.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
OS9 | 4799.5 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
HHAT | 4670.5 |
PSMD5 | 4655.5 |
SEL1L | 4548.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
PSMA7 | 3962.5 |
DERL2 | 3262.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
ERLEC1 | 2361.5 |
IHH | 2289.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
ADAM17 | -478.5 |
SHH | -695.0 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
DHH | -1812.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
DISP2 | -5005.5 |
NOTUM | -5332.5 |
SCUBE2 | -6218.5 |
Degradation of DVL
284 | |
---|---|
set | Degradation of DVL |
setSize | 54 |
pANOVA | 5.86e-07 |
s.dist | 0.393 |
p.adjustANOVA | 1.9e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
RBX1 | 4159.5 |
PSMA7 | 3962.5 |
HECW1 | 3566.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
DVL3 | 2855.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
DVL2 | 2062.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
DVL1 | 1473.5 |
PSME3 | 1442.5 |
CUL3 | 572.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
KLHL12 | -1721.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
DACT1 | -3592.5 |
Regulation of RUNX2 expression and activity
1026 | |
---|---|
set | Regulation of RUNX2 expression and activity |
setSize | 69 |
pANOVA | 6.03e-07 |
s.dist | 0.347 |
p.adjustANOVA | 1.9e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
STAT1 | 8891.5 |
PSMB8 | 8750.5 |
ESRRA | 8712.5 |
PSMD1 | 8707.5 |
PPARGC1B | 7660.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
ESR1 | 6813.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
CUL1 | 5811.5 |
GeneID | Gene Rank |
---|---|
STAT1 | 8891.5 |
PSMB8 | 8750.5 |
ESRRA | 8712.5 |
PSMD1 | 8707.5 |
PPARGC1B | 7660.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
ESR1 | 6813.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
NR3C1 | 5325.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
STUB1 | 5004.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
RBX1 | 4159.5 |
TWIST1 | 4084.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
DLX6 | 2658.5 |
PSME2 | 2547.5 |
BMP2 | 2527.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PPARGC1A | 1116.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
DLX5 | -96.5 |
PSMA3 | -754.5 |
GSK3B | -787.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
MSX2 | -1752.5 |
WWP1 | -2403.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
FBXW7 | -3647.5 |
SMURF1 | -3855.5 |
SKP2 | -4252.5 |
CBFB | -4500.5 |
RUNX2 | -5866.5 |
HIVEP3 | -7071.5 |
Dectin-1 mediated noncanonical NF-kB signaling
265 | |
---|---|
set | Dectin-1 mediated noncanonical NF-kB signaling |
setSize | 59 |
pANOVA | 6.05e-07 |
s.dist | 0.376 |
p.adjustANOVA | 1.9e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBE2M | 7376.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
CCL17 | 6273.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
NFKB2 | 5930.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
SKP1 | 7381.5 |
UBE2M | 7376.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
CCL17 | 6273.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
NFKB2 | 5930.5 |
CUL1 | 5811.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
MAP3K14 | 2011.5 |
PSMA1 | 1867.5 |
UBA3 | 1735.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
RELB | 1279.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
FBXW11 | -1203.5 |
PSMF1 | -1438.5 |
BTRC | -1843.5 |
CHUK | -2390.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
RELA | -6220.5 |
CCL22 | -7744.5 |
Cellular response to hypoxia
177 | |
---|---|
set | Cellular response to hypoxia |
setSize | 72 |
pANOVA | 6.2e-07 |
s.dist | 0.34 |
p.adjustANOVA | 1.91e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
VEGFA | 8964.5 |
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
EGLN1 | 8386.0 |
PSMC1 | 7622.5 |
EGLN2 | 7426.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
CUL2 | 7195.5 |
UBE2D3 | 7189.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
ELOC | 5925.5 |
GeneID | Gene Rank |
---|---|
VEGFA | 8964.5 |
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
EGLN1 | 8386.0 |
PSMC1 | 7622.5 |
EGLN2 | 7426.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
CUL2 | 7195.5 |
UBE2D3 | 7189.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
ELOC | 5925.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
HIGD1A | 5350.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
EGLN3 | 4702.5 |
CITED2 | 4699.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
RBX1 | 4159.5 |
PSMA7 | 3962.5 |
HIF3A | 3792.5 |
HIF1AN | 3788.5 |
EPAS1 | 3670.5 |
PSMD12 | 3211.5 |
UBE2D1 | 3169.5 |
EP300 | 2949.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
UBE2D2 | 126.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
LIMD1 | -224.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
WTIP | -2033.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
CREBBP | -2899.5 |
CA9 | -3419.5 |
VHL | -4639.5 |
ARNT | -4995.5 |
ELOB | -5059.5 |
EPO | -5264.5 |
AJUBA | -5412.5 |
HIF1A | -6851.5 |
Autodegradation of the E3 ubiquitin ligase COP1
102 | |
---|---|
set | Autodegradation of the E3 ubiquitin ligase COP1 |
setSize | 47 |
pANOVA | 6.4e-07 |
s.dist | 0.42 |
p.adjustANOVA | 1.93e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
GeneID | Gene Rank |
---|---|
PSMB8 | 8750.5 |
PSMD1 | 8707.5 |
PSMC1 | 7622.5 |
UBA52 | 7357.5 |
PSMA6 | 7345.5 |
PSMD4 | 7024.5 |
PSMB5 | 6910.5 |
PSMB9 | 6825.5 |
PSMA8 | 6529.5 |
PSME1 | 6431.5 |
PSMD14 | 6156.5 |
PSMB6 | 6079.5 |
PSMB7 | 5988.5 |
PSMD7 | 5955.5 |
PSMD11 | 5787.5 |
PSMD8 | 5682.5 |
PSMA4 | 5533.5 |
PSMD3 | 5512.5 |
PSMC2 | 5421.5 |
PSME4 | 5222.5 |
PSMB1 | 5207.5 |
PSMD10 | 5093.5 |
PSMC3 | 4982.5 |
PSMA2 | 4823.0 |
PSMC4 | 4751.5 |
PSMD2 | 4685.5 |
PSMD5 | 4655.5 |
PSMD6 | 4428.5 |
PSMC5 | 4349.5 |
PSMA7 | 3962.5 |
PSMD12 | 3211.5 |
PSMB2 | 2944.5 |
PSME2 | 2547.5 |
RPS27A | 2261.5 |
PSMA1 | 1867.5 |
PSMB4 | 1567.5 |
PSMC6 | 1488.5 |
PSME3 | 1442.5 |
PSMB3 | 391.5 |
UBC | 100.5 |
PSMA5 | 5.5 |
PSMA3 | -754.5 |
PSMB10 | -1181.5 |
PSMF1 | -1438.5 |
PSMD9 | -2755.0 |
PSMD13 | -2775.5 |
ATM | -4881.5 |
FCGR3A-mediated phagocytosis
387 | |
---|---|
set | FCGR3A-mediated phagocytosis |
setSize | 87 |
pANOVA | 7.68e-07 |
s.dist | -0.307 |
p.adjustANOVA | 2.18e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ARPC2 | -8638.5 |
ARPC5 | -8617.5 |
CYFIP2 | -8558.5 |
MYO5A | -8482.5 |
MYO9B | -8423.5 |
WASF2 | -8403.5 |
ACTB | -8079.5 |
CD247 | -8071.5 |
ACTR3 | -7923.5 |
RAC1 | -7765.5 |
YES1 | -7705.5 |
SYK | -7580.5 |
BTK | -7424.5 |
VAV1 | -7406.5 |
ELMO2 | -7347.5 |
VAV3 | -7293.5 |
ELMO1 | -7076.5 |
IGKV1-12 | -7039.0 |
IGKV1-16 | -7039.0 |
IGKV1-17 | -7039.0 |
GeneID | Gene Rank |
---|---|
ARPC2 | -8638.5 |
ARPC5 | -8617.5 |
CYFIP2 | -8558.5 |
MYO5A | -8482.5 |
MYO9B | -8423.5 |
WASF2 | -8403.5 |
ACTB | -8079.5 |
CD247 | -8071.5 |
ACTR3 | -7923.5 |
RAC1 | -7765.5 |
YES1 | -7705.5 |
SYK | -7580.5 |
BTK | -7424.5 |
VAV1 | -7406.5 |
ELMO2 | -7347.5 |
VAV3 | -7293.5 |
ELMO1 | -7076.5 |
IGKV1-12 | -7039.0 |
IGKV1-16 | -7039.0 |
IGKV1-17 | -7039.0 |
IGKV1-39 | -7039.0 |
IGKV1-5 | -7039.0 |
IGKV1D-12 | -7039.0 |
IGKV1D-16 | -7039.0 |
IGKV1D-39 | -7039.0 |
ACTR2 | -6872.5 |
MYO10 | -6643.5 |
WAS | -6573.5 |
CYFIP1 | -6275.5 |
NCKAP1L | -5905.5 |
DOCK1 | -5681.5 |
IGLV3-16 | -5675.5 |
IGLV3-22 | -5675.5 |
IGLV3-25 | -5675.5 |
IGLV3-27 | -5675.5 |
PTK2 | -5506.5 |
ARPC1B | -5078.5 |
WIPF1 | -5015.5 |
IGLC1 | -4828.0 |
IGLC2 | -4828.0 |
IGLC3 | -4828.0 |
IGLC7 | -4828.0 |
ABI1 | -4717.5 |
ABI2 | -4575.5 |
NCKIPSD | -4420.5 |
IGHV4-34 | -4385.0 |
IGHV4-39 | -4385.0 |
IGHV4-59 | -4385.0 |
WIPF2 | -4347.5 |
LYN | -3527.5 |
IGHV2-5 | -2844.5 |
IGHV2-70 | -2844.5 |
CDC42 | -2813.5 |
WASL | -2730.5 |
SRC | -2361.5 |
NCKAP1 | -1488.5 |
MYH9 | -1301.5 |
CD3G | -891.5 |
IGHV7-81 | -695.0 |
MAPK1 | -523.5 |
IGKV2-28 | -517.5 |
IGKV2D-28 | -517.5 |
IGKV2D-40 | -517.5 |
FYN | -339.5 |
ARPC3 | 305.5 |
IGKV4-1 | 362.5 |
HCK | 1919.5 |
WASF1 | 2249.5 |
MAPK3 | 2999.5 |
ARPC4 | 3107.5 |
ACTG1 | 3383.5 |
BRK1 | 4083.5 |
FCGR3A | 4854.0 |
ABL1 | 5165.5 |
NCK1 | 5332.5 |
CRK | 5404.5 |
GRB2 | 5591.5 |
WIPF3 | 5919.5 |
IGKV2-30 | 6283.0 |
IGKV2D-30 | 6283.0 |
IGLV6-57 | 6930.5 |
BAIAP2 | 8026.5 |
FGR | 8128.5 |
VAV2 | 8325.5 |
MYO1C | 8565.5 |
WASF3 | 8828.5 |
IGKC | 8857.5 |
Leishmania phagocytosis
636 | |
---|---|
set | Leishmania phagocytosis |
setSize | 87 |
pANOVA | 7.68e-07 |
s.dist | -0.307 |
p.adjustANOVA | 2.18e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ARPC2 | -8638.5 |
ARPC5 | -8617.5 |
CYFIP2 | -8558.5 |
MYO5A | -8482.5 |
MYO9B | -8423.5 |
WASF2 | -8403.5 |
ACTB | -8079.5 |
CD247 | -8071.5 |
ACTR3 | -7923.5 |
RAC1 | -7765.5 |
YES1 | -7705.5 |
SYK | -7580.5 |
BTK | -7424.5 |
VAV1 | -7406.5 |
ELMO2 | -7347.5 |
VAV3 | -7293.5 |
ELMO1 | -7076.5 |
IGKV1-12 | -7039.0 |
IGKV1-16 | -7039.0 |
IGKV1-17 | -7039.0 |
GeneID | Gene Rank |
---|---|
ARPC2 | -8638.5 |
ARPC5 | -8617.5 |
CYFIP2 | -8558.5 |
MYO5A | -8482.5 |
MYO9B | -8423.5 |
WASF2 | -8403.5 |
ACTB | -8079.5 |
CD247 | -8071.5 |
ACTR3 | -7923.5 |
RAC1 | -7765.5 |
YES1 | -7705.5 |
SYK | -7580.5 |
BTK | -7424.5 |
VAV1 | -7406.5 |
ELMO2 | -7347.5 |
VAV3 | -7293.5 |
ELMO1 | -7076.5 |
IGKV1-12 | -7039.0 |
IGKV1-16 | -7039.0 |
IGKV1-17 | -7039.0 |
IGKV1-39 | -7039.0 |
IGKV1-5 | -7039.0 |
IGKV1D-12 | -7039.0 |
IGKV1D-16 | -7039.0 |
IGKV1D-39 | -7039.0 |
ACTR2 | -6872.5 |
MYO10 | -6643.5 |
WAS | -6573.5 |
CYFIP1 | -6275.5 |
NCKAP1L | -5905.5 |
DOCK1 | -5681.5 |
IGLV3-16 | -5675.5 |
IGLV3-22 | -5675.5 |
IGLV3-25 | -5675.5 |
IGLV3-27 | -5675.5 |
PTK2 | -5506.5 |
ARPC1B | -5078.5 |
WIPF1 | -5015.5 |
IGLC1 | -4828.0 |
IGLC2 | -4828.0 |
IGLC3 | -4828.0 |
IGLC7 | -4828.0 |
ABI1 | -4717.5 |
ABI2 | -4575.5 |
NCKIPSD | -4420.5 |
IGHV4-34 | -4385.0 |
IGHV4-39 | -4385.0 |
IGHV4-59 | -4385.0 |
WIPF2 | -4347.5 |
LYN | -3527.5 |
IGHV2-5 | -2844.5 |
IGHV2-70 | -2844.5 |
CDC42 | -2813.5 |
WASL | -2730.5 |
SRC | -2361.5 |
NCKAP1 | -1488.5 |
MYH9 | -1301.5 |
CD3G | -891.5 |
IGHV7-81 | -695.0 |
MAPK1 | -523.5 |
IGKV2-28 | -517.5 |
IGKV2D-28 | -517.5 |
IGKV2D-40 | -517.5 |
FYN | -339.5 |
ARPC3 | 305.5 |
IGKV4-1 | 362.5 |
HCK | 1919.5 |
WASF1 | 2249.5 |
MAPK3 | 2999.5 |
ARPC4 | 3107.5 |
ACTG1 | 3383.5 |
BRK1 | 4083.5 |
FCGR3A | 4854.0 |
ABL1 | 5165.5 |
NCK1 | 5332.5 |
CRK | 5404.5 |
GRB2 | 5591.5 |
WIPF3 | 5919.5 |
IGKV2-30 | 6283.0 |
IGKV2D-30 | 6283.0 |
IGLV6-57 | 6930.5 |
BAIAP2 | 8026.5 |
FGR | 8128.5 |
VAV2 | 8325.5 |
MYO1C | 8565.5 |
WASF3 | 8828.5 |
IGKC | 8857.5 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.0.3 (2020-10-10)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 18.04.5 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.7.1
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.7.1
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.1.0 GGally_2.0.0
## [3] ggplot2_3.3.2 beeswarm_0.2.3
## [5] gtools_3.8.2 tibble_3.0.4
## [7] dplyr_1.0.2 echarts4r_0.3.3
## [9] gplots_3.1.0 mitch_1.2.2
## [11] DESeq2_1.30.0 SummarizedExperiment_1.20.0
## [13] Biobase_2.50.0 MatrixGenerics_1.2.0
## [15] matrixStats_0.57.0 GenomicRanges_1.42.0
## [17] GenomeInfoDb_1.26.0 IRanges_2.24.0
## [19] S4Vectors_0.28.0 BiocGenerics_0.36.0
## [21] reshape2_1.4.4
##
## loaded via a namespace (and not attached):
## [1] httr_1.4.2 jsonlite_1.7.1 bit64_4.0.5
## [4] splines_4.0.3 assertthat_0.2.1 shiny_1.5.0
## [7] highr_0.8 blob_1.2.1 GenomeInfoDbData_1.2.4
## [10] yaml_2.2.1 backports_1.2.0 pillar_1.4.6
## [13] RSQLite_2.2.1 lattice_0.20-41 glue_1.4.2
## [16] digest_0.6.27 RColorBrewer_1.1-2 promises_1.1.1
## [19] XVector_0.30.0 colorspace_2.0-0 htmltools_0.5.0
## [22] httpuv_1.5.4 Matrix_1.2-18 plyr_1.8.6
## [25] XML_3.99-0.5 pkgconfig_2.0.3 genefilter_1.72.0
## [28] zlibbioc_1.36.0 purrr_0.3.4 xtable_1.8-4
## [31] scales_1.1.1 later_1.1.0.1 BiocParallel_1.24.1
## [34] annotate_1.68.0 generics_0.1.0 ellipsis_0.3.1
## [37] withr_2.3.0 survival_3.2-7 magrittr_1.5
## [40] crayon_1.3.4 mime_0.9 evaluate_0.14
## [43] memoise_1.1.0 MASS_7.3-53 tools_4.0.3
## [46] lifecycle_0.2.0 stringr_1.4.0 munsell_0.5.0
## [49] locfit_1.5-9.4 DelayedArray_0.16.0 AnnotationDbi_1.52.0
## [52] compiler_4.0.3 caTools_1.18.0 rlang_0.4.8
## [55] grid_4.0.3 RCurl_1.98-1.2 htmlwidgets_1.5.2
## [58] rmarkdown_2.5 bitops_1.0-6 testthat_3.0.0
## [61] gtable_0.3.0 DBI_1.1.0 reshape_0.8.8
## [64] R6_2.5.0 gridExtra_2.3 knitr_1.30
## [67] fastmap_1.0.1 bit_4.0.4 rprojroot_1.3-2
## [70] desc_1.2.0 KernSmooth_2.23-18 stringi_1.5.3
## [73] Rcpp_1.0.5 vctrs_0.3.4 geneplotter_1.68.0
## [76] tidyselect_1.1.0 xfun_0.19
END of report